data_1c89_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c89 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.247 0.546 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' O ' HD22 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 5.8 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 39.7 m-20 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.457 ' SD ' HD13 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' CG2' HG23 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 32' ' ' ILE . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 36' ' ' GLU . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.456 ' SD ' HG22 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG12 ' CE ' ' A' ' 43' ' ' MET . 22.8 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.195 0.522 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.442 HG12 HD12 ' A' ' 107' ' ' ILE . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.523 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 121' ' ' LEU . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.537 ' CG2' ' CG2' ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 18.7 t-20 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.537 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 112' ' ' GLY . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.475 ' HE1' ' CD1' ' A' ' 81' ' ' ILE . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.43 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.471 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.491 ' N ' HG21 ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.53 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 125' ' ' LEU . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.465 ' N ' ' CD1' ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' HG13 ' A' ' 102' ' ' ILE . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.551 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.502 ' CB ' HG21 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 70.9 m-80 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 20' ' ' ILE . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 ' CB ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 6' ' ' VAL . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.641 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.556 ' O ' ' CG ' ' A' ' 43' ' ' MET . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.556 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 27.6 m-80 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.328 0.585 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.517 HG21 ' CG2' ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG1' ' HB1' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.517 ' CG2' HG21 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.5 HG21 ' CA ' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.538 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.481 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.52 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.52 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.458 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 107' ' ' ILE . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 108' ' ' SER . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.5 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.481 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.423 ' C ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.504 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 42' ' ' GLY . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HG2' HG22 ' A' ' 54' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.458 HG22 HD23 ' A' ' 40' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' MET . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.512 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.536 HG13 ' CB ' ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.536 ' CB ' HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.446 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.427 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG12 ' CE ' ' A' ' 43' ' ' MET . 52.4 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.389 0.614 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 92' ' ' MET . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' N ' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.531 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' CA ' ' A' ' 112' ' ' GLY . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.492 ' HG3' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 98' ' ' SER . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 97' ' ' VAL . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.473 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 108' ' ' SER . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.484 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 126' ' ' MET . 45.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.197 0.522 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.447 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD2' ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG2' HG23 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.518 ' CB ' HD21 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' OE2' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD21 ' CB ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.444 ' HB2' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' A' ' 56' ' ' MET . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 122' ' ' ASP . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.458 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.459 ' HA ' HG22 ' A' ' 111' ' ' VAL . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 108' ' ' SER . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 121' ' ' LEU . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' HD13 ' A' ' 102' ' ' ILE . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.254 0.549 . . . . 0.0 110.31 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 26' ' ' VAL . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.493 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.441 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.0 t-20 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.429 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.5 p30 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' C ' ' HB3' ' A' ' 3' ' ' ALA . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.526 HG21 ' CB ' ' A' ' 3' ' ' ALA . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' HG23 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.509 ' CD1' HD13 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.487 ' O ' HD13 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.557 ' N ' HD11 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.552 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.571 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.428 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.324 0.583 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.531 ' O ' ' CD2' ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.473 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 11.6 p30 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.534 HG21 ' CA ' ' A' ' 112' ' ' GLY . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.456 ' SD ' HD13 ' A' ' 81' ' ' ILE . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.519 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' THR . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.519 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.504 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HB2' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.535 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 126' ' ' MET . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.328 0.585 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG23 HD12 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CG2' HG23 ' A' ' 15' ' ' THR . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.429 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.445 ' CD1' HD11 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.432 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HD11 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.52 ' CB ' HG11 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.45 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.302 0.573 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 102' ' ' ILE . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.423 ' O ' ' HE2' ' A' ' 92' ' ' MET . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' ' CD1' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.454 HG21 ' N ' ' A' ' 98' ' ' SER . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 102' ' ' ILE . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.435 ' N ' HD11 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 113' ' ' MET . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 117' ' ' ARG . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD11 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.472 ' N ' HD12 ' A' ' 102' ' ' ILE . 47.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.256 0.551 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' CG1' ' CG ' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.405 ' CG ' ' CG1' ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.439 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.528 ' CG2' ' OE2' ' A' ' 36' ' ' GLU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.561 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 36' ' ' GLU . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.52 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HD2' ' CG1' ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.578 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.519 ' HB2' ' CA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 110.423 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.528 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 85' ' ' THR . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.53 ' CB ' ' HB ' ' A' ' 81' ' ' ILE . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 92' ' ' MET . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' N ' ' HE1' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' OG1' ' A' ' 88' ' ' THR . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 108' ' ' SER . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 21.1 t-20 -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.589 ' CB ' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.445 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' HG21 ' A' ' 11' ' ' ILE . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' GLY . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.529 ' CE ' HG21 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 32' ' ' ILE . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.511 ' CB ' HD21 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 40' ' ' LEU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG21 ' CE ' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.514 ' HE3' ' CG1' ' A' ' 60' ' ' VAL . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' N ' HG21 ' A' ' 13' ' ' ILE . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG11 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.428 ' SD ' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.514 ' CG1' ' HE3' ' A' ' 43' ' ' MET . 44.6 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 97' ' ' VAL . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' HD12 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 118' ' ' ALA . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.526 HG21 ' CA ' ' A' ' 112' ' ' GLY . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 88' ' ' THR . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.522 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 76' ' ' VAL . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.424 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 111' ' ' VAL . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.457 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.53 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.246 0.546 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' CB ' ' HG3' ' A' ' 23' ' ' LYS . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . 9.1 p30 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.445 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.493 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG2' HG11 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' HG23 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.452 HG21 ' HD2' ' A' ' 33' ' ' PRO . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' HG21 ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.559 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.533 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG2' HD13 ' A' ' 121' ' ' LEU . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.434 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.416 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.301 0.572 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.428 HG13 ' SD ' ' A' ' 92' ' ' MET . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.496 ' N ' HG21 ' A' ' 83' ' ' ILE . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.529 HG21 ' CA ' ' A' ' 112' ' ' GLY . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.524 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 75' ' ' VAL . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.443 ' OE2' HG12 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.512 ' CG2' HG23 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.529 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.405 ' O ' ' HG3' ' A' ' 113' ' ' MET . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.532 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 124' ' ' THR . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' N ' HD13 ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.299 0.571 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.417 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.451 ' CG2' ' HE2' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 3' ' ' ALA . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 HG21 ' HE1' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.463 ' HE1' HG21 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 55' ' ' LEU . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.556 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.454 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG12 ' HE1' ' A' ' 43' ' ' MET . 6.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 124' ' ' THR . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.475 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.506 HG21 ' CA ' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 91' ' ' MET . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.519 ' N ' HG21 ' A' ' 90' ' ' VAL . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.46 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.484 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 111' ' ' VAL . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.45 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.484 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.253 0.549 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.438 HG22 HG21 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.456 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.48 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' HG11 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.416 0.627 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 123' ' ' GLN . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.521 HG21 ' CG2' ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' CA ' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.521 ' CG2' HG21 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.512 ' SD ' ' CD1' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.54 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' HG21 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 49.8 tp60 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.167 0.508 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 11' ' ' ILE . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' CD2' HD12 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.432 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD13 ' CE ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.528 ' CG2' HG11 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' CG1' ' HE2' ' A' ' 43' ' ' MET . 87.2 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' HD11 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.519 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 11.3 p30 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 89' ' ' LEU . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.606 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.449 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 106' ' ' GLU . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.498 HD11 ' N ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.498 ' N ' HD11 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' A' ' 106' ' ' GLU . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 88' ' ' THR . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.515 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' NH2' ' O ' ' A' ' 118' ' ' ALA . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.46 ' HB3' HG12 ' A' ' 102' ' ' ILE . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.228 0.537 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG2' ' CA ' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.49 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HG21 ' A' ' 11' ' ' ILE . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.0 p30 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 41' ' ' VAL . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.441 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 3' ' ' ALA . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG23 ' A' ' 6' ' ' VAL . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.518 ' CD1' HD13 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG12 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.427 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.288 0.566 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 122' ' ' ASP . 27.4 t-20 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD12 ' A' ' 121' ' ' LEU . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 83' ' ' ILE . 8.0 p30 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.529 HG23 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.539 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.413 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.523 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.529 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.475 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HD3' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.558 ' N ' ' CD1' ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.523 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 48.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.269 0.556 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' HD23 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.4 p30 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.461 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.522 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 43' ' ' MET . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.527 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.54 ' CB ' HG11 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 56' ' ' MET . 40.5 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.317 0.58 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 8.4 p30 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' LEU . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.481 ' HB2' HD21 ' A' ' 121' ' ' LEU . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.48 ' N ' HG21 ' A' ' 83' ' ' ILE . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.505 ' HA ' ' CG ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.505 ' CG ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.497 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.511 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' MET . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.212 0.529 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG11 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HA ' HD22 ' A' ' 51' ' ' LEU . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.417 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.524 ' CG2' ' HE3' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.524 ' HE3' ' CG2' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' HG11 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.561 ' CD1' ' CE ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.561 ' CE ' ' CD1' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.515 HG11 ' CB ' ' A' ' 53' ' ' THR . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.515 ' CB ' HG11 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.46 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 56' ' ' MET . 75.9 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 4.3 pttt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.317 0.579 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.6 m-80 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 83' ' ' ILE . 8.0 p30 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 112' ' ' GLY . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.522 ' CE ' HD13 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.508 ' CD1' ' HE3' ' A' ' 92' ' ' MET . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.518 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 99' ' ' PRO . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.423 ' C ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.255 0.55 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.462 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' CD1' ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.489 HG23 ' CA ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD23 HG23 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.457 ' CE ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 3' ' ' ALA . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.443 HG23 ' HG ' ' A' ' 40' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.525 ' CB ' HD21 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' ' 40' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' CA ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.516 ' CB ' HG11 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD13 ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.441 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.179 0.514 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 49.6 t30 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.546 HD12 ' CB ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.534 HG23 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.497 ' CE ' HD13 ' A' ' 87' ' ' LEU . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG13 ' CG2' ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.503 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.451 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 113' ' ' MET . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.468 HG21 HG21 ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.546 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.527 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' HD11 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.462 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.223 0.535 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.8 p30 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.496 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 HD11 ' A' ' 32' ' ' ILE . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.0 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.7 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 93' ' ' LYS . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.533 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 78.1 m-20 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG2' ' OG1' ' A' ' 88' ' ' THR . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.485 ' CE ' HD13 ' A' ' 81' ' ' ILE . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.519 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.523 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.522 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 111' ' ' VAL . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 121' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.523 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HA ' HD13 ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.212 0.529 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.51 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 11' ' ' ILE . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.0 p30 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.518 ' CG ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.432 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 30.6 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 102' ' ' ILE . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' HB ' ' OE1' ' A' ' 95' ' ' GLU . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.47 ' O ' HD12 ' A' ' 121' ' ' LEU . 2.0 t-20 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' LEU . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 85' ' ' THR . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.509 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.534 HG23 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.438 ' HG3' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.469 ' SD ' ' CD1' ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' CG ' ' CG2' ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' CG2' ' CG ' ' A' ' 95' ' ' GLU . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 108' ' ' SER . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.509 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.491 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.2 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.422 ' CB ' ' HE3' ' A' ' 23' ' ' LYS . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.515 ' ND2' HG23 ' A' ' 13' ' ' ILE . 69.9 m-80 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 42' ' ' GLY . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.489 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HE3' ' CB ' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG11 ' C ' ' A' ' 26' ' ' VAL . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.524 ' CD1' HD11 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' ASN . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.566 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 5.6 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' CG2' HG11 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.452 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG13 ' HE3' ' A' ' 43' ' ' MET . 11.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.311 0.577 . . . . 0.0 110.713 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.512 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.497 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.485 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.479 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.479 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.512 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.485 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.432 ' C ' HD13 ' A' ' 102' ' ' ILE . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.478 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.182 0.515 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.458 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 55' ' ' LEU . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 14.5 p30 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 42' ' ' GLY . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.446 ' HE1' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.467 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 3' ' ' ALA . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.524 ' CD1' HD13 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' ' 14' ' ' ASN . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD2' HG12 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG12 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.404 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.404 ' HG3' ' CB ' ' A' ' 56' ' ' MET . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.198 0.523 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG22 HG13 ' A' ' 97' ' ' VAL . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' A' ' 118' ' ' ALA . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.51 ' N ' HG21 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 112' ' ' GLY . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.531 ' CG ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' SER . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.522 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 76' ' ' VAL . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.461 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 108' ' ' SER . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 127' ' ' PRO . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.373 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.448 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.3 p30 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' HG23 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG2' HG23 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.482 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.465 HG21 ' HD2' ' A' ' 33' ' ' PRO . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 32' ' ' ILE . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.48 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.51 ' N ' HD21 ' A' ' 40' ' ' LEU . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.522 ' HE3' ' CD2' ' A' ' 55' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.532 ' CB ' HG11 ' A' ' 49' ' ' VAL . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD2' ' HE3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.468 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.525 0.679 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.506 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 HG22 ' CG2' ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' OG1' ' A' ' 85' ' ' THR . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.529 ' CG1' ' HB1' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 77.1 m-20 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' LEU . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.497 ' N ' HG12 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.454 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.462 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.517 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.196 0.522 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 6' ' ' VAL . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 5' ' ' VAL . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' VAL . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.7 p30 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 43' ' ' MET . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 40' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.618 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 32' ' ' ILE . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.513 ' CG ' HD11 ' A' ' 17' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 47' ' ' ARG . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.53 ' CB ' HG11 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.313 0.578 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 79' ' ' GLN . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 4.7 m-80 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 114' ' ' GLN . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.506 HG23 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.519 ' CG ' HD13 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.526 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.427 ' C ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 123' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.414 ' C ' HD13 ' A' ' 102' ' ' ILE . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' HD21 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CG ' HD12 ' A' ' 11' ' ' ILE . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 49' ' ' VAL . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.487 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.513 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' C ' HG11 ' A' ' 27' ' ' VAL . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 26' ' ' VAL . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.525 HD13 ' CD1' ' A' ' 55' ' ' LEU . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' MET . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' ARG . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' CB ' HG11 ' A' ' 49' ' ' VAL . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.315 0.579 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' CA ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' HG12 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.431 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' A' ' 77' ' ' ALA . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.474 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.523 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.469 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HB2' HD13 ' A' ' 51' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 17' ' ' LEU . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.3 p30 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 11' ' ' ILE . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 27' ' ' VAL . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' CD2' ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 60' ' ' VAL . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG11 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.523 ' CB ' HG11 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG12 ' CE ' ' A' ' 43' ' ' MET . 77.2 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.324 0.583 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 123' ' ' GLN . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' HD12 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.55 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.462 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.517 HG21 ' CA ' ' A' ' 112' ' ' GLY . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.528 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.444 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.611 ' CG1' ' CD1' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.514 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.514 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 113' ' ' MET . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.512 ' CG2' HG23 ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.517 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.448 ' OG1' ' CG1' ' A' ' 97' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.611 ' CD1' ' CG1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.469 ' HA ' HD12 ' A' ' 102' ' ' ILE . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.507 ' HB2' ' CD ' ' A' ' 23' ' ' LYS . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HA ' HD22 ' A' ' 51' ' ' LEU . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' HB2' HD13 ' A' ' 51' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.493 HD13 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 48' ' ' ALA . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 17.1 p30 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD22 ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.493 ' CE ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.449 ' CE ' HD22 ' A' ' 19' ' ' LEU . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' CG2' HG23 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.513 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.516 ' CB ' HG11 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.441 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HD3' HG13 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.263 0.554 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 107' ' ' ILE . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD12 ' A' ' 121' ' ' LEU . 4.1 t-20 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.525 HG23 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HA ' ' HG2' ' A' ' 92' ' ' MET . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 76' ' ' VAL . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.472 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.445 ' OG ' ' HE3' ' A' ' 92' ' ' MET . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.512 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.525 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.478 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 121' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.519 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.445 ' HA ' HD13 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.172 0.51 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.454 ' HA ' HD22 ' A' ' 51' ' ' LEU . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.525 HG13 ' CD2' ' A' ' 17' ' ' LEU . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.43 ' HE3' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' N ' ' HE3' ' A' ' 22' ' ' MET . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.477 ' CG2' HD22 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' OE1' ' CB ' ' A' ' 39' ' ' ASN . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' MET . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.541 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 ' CB ' HG11 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.408 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.408 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.293 0.568 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 24.5 m120 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.526 HG21 ' CA ' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.526 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 113' ' ' MET . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 81' ' ' ILE . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.531 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.477 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.468 ' N ' HD13 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.284 0.564 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 8' ' ' ASN . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLY . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.495 HG22 ' CE ' ' A' ' 21' ' ' MET . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.495 ' CE ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.457 ' HG2' HG11 ' A' ' 5' ' ' VAL . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 HG12 ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.585 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 36' ' ' GLU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 47' ' ' ARG . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' O ' HG22 ' A' ' 45' ' ' VAL . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' HG11 ' A' ' 49' ' ' VAL . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.405 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 55' ' ' LEU . 55.9 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 15.7 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.413 0.625 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' CB ' ' HG3' ' A' ' 93' ' ' LYS . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HA ' HD12 ' A' ' 121' ' ' LEU . 4.2 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.52 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 87' ' ' LEU . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' MET . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 88' ' ' THR . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.507 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 95' ' ' GLU . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.491 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.451 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' HG21 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.451 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.52 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 121' ' ' LEU . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.504 ' N ' HD13 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.491 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 46.9 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.469 ' HG3' HD12 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 17' ' ' LEU . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 ' CD1' ' C ' ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 71.0 m-20 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 11' ' ' ILE . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.461 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.502 ' CE ' ' HB3' ' A' ' 40' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 47' ' ' ARG . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' C ' HG23 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.484 ' HB ' HG11 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 60' ' ' VAL . 55.1 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.242 0.544 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 92' ' ' MET . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.524 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.534 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG21 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.485 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' OE2' HG13 ' A' ' 76' ' ' VAL . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.413 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.518 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.408 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.452 ' O ' HG22 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 89' ' ' LEU . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.509 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.518 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.249 0.547 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 1.8 p-10 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 6.6 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CD1' HD23 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' ' CB ' ' A' ' 15' ' ' THR . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.2 p30 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.479 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.468 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.406 ' OE1' HG12 ' A' ' 27' ' ' VAL . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' ALA . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 55' ' ' LEU . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' HG22 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.517 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 19' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.476 ' HE2' HD13 ' A' ' 40' ' ' LEU . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 13' ' ' ILE . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' ' CG1' ' A' ' 49' ' ' VAL . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 56' ' ' MET . 23.5 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.571 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.329 0.585 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' N ' ' A' ' 118' ' ' ALA . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.515 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 75' ' ' VAL . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.414 ' N ' HD11 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' N ' HD13 ' A' ' 102' ' ' ILE . 46.5 Cg_endo . . . . . 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.242 0.544 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.8 t-20 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.525 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 1.6 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.463 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.468 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.525 ' HG2' ' NE2' ' A' ' 9' ' ' GLN . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.512 ' CE ' HG21 ' A' ' 41' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.632 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' ND2' ' HG2' ' A' ' 38' ' ' PRO . 32.5 m-80 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.497 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.521 ' CB ' HG11 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 HG12 ' SD ' ' A' ' 43' ' ' MET . 98.3 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.0 pttt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 HG11 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 123' ' ' GLN . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG13 ' CB ' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.528 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 113' ' ' MET . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 88' ' ' THR . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' VAL . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HG3' ' CG2' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.47 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.4 ' HE3' ' HG2' ' A' ' 99' ' ' PRO . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.222 0.534 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 26' ' ' VAL . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.485 HG12 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.498 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 4.5 pt20 -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.476 HD12 ' HG3' ' A' ' 9' ' ' GLN . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.512 HG23 ' ND2' ' A' ' 14' ' ' ASN . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 13' ' ' ILE . 71.6 m-80 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLY . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' N ' HD21 ' A' ' 19' ' ' LEU . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.498 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.429 ' O ' ' CG ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' N ' HD11 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.485 ' CA ' HG12 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 2.3 pttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.305 0.574 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG13 ' CG ' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.522 HG23 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.466 ' CG ' HG13 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' N ' ' A' ' 98' ' ' SER . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.486 ' N ' HG21 ' A' ' 97' ' ' VAL . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.534 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.468 ' CB ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.548 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 106' ' ' GLU . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.486 HG21 ' N ' ' A' ' 125' ' ' LEU . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.534 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.255 0.55 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 55' ' ' LEU . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.502 HD12 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.515 ' ND2' HG21 ' A' ' 13' ' ' ILE . 35.7 m-80 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' HG23 ' A' ' 11' ' ' ILE . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' CD2' HD12 ' A' ' 11' ' ' ILE . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.459 ' HE2' ' HB3' ' A' ' 17' ' ' LEU . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 3' ' ' ALA . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 32' ' ' ILE . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' CG ' ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.491 ' SD ' ' CG ' ' A' ' 40' ' ' LEU . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.518 HG11 ' CG2' ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG11 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.41 ' CD2' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG1' ' CE ' ' A' ' 43' ' ' MET . 31.4 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.512 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.481 ' O ' HD11 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 87' ' ' LEU . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.527 HG22 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.518 ' CE ' HD12 ' A' ' 87' ' ' LEU . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' CD1' ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.624 ' N ' ' CG ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 102' ' ' ILE . 44.8 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.265 0.555 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.467 ' HA ' HD22 ' A' ' 51' ' ' LEU . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.491 ' CD1' ' CA ' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.4 p30 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.402 ' HE1' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' C ' ' HE1' ' A' ' 22' ' ' MET . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.472 ' CG2' HG23 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' CD1' ' SD ' ' A' ' 43' ' ' MET . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.545 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' C ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' CA ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.514 ' CB ' HG11 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.454 HD22 ' HE3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 56' ' ' MET . 79.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.421 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' HB ' HD21 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.9 p-10 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 119' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 71.6 m-80 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.522 HG21 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 107' ' ' ILE . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.496 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.495 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.493 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.495 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 81' ' ' ILE . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.431 ' C ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.266 0.555 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 49' ' ' VAL . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 0.9 OUTLIER 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' GLY . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 19' ' ' LEU . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.48 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 3' ' ' ALA . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.508 ' CG2' HG23 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' C ' HD11 ' A' ' 13' ' ' ILE . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.587 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 56' ' ' MET . 24.1 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.31 0.576 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 102' ' ' ILE . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 123' ' ' GLN . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 HG23 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.464 ' HE3' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 98' ' ' SER . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.483 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.483 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 108' ' ' SER . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.498 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD13 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.249 0.547 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.454 ' O ' ' CG ' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CD1' HD11 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' CB ' HD21 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.421 ' HB ' HG12 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.494 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 95' ' ' GLU . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.618 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.437 HG21 ' OG1' ' A' ' 88' ' ' THR . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.42 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' CG ' HG22 ' A' ' 76' ' ' VAL . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.484 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.496 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 108' ' ' SER . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.538 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.491 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.0 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.484 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.421 ' C ' HD13 ' A' ' 102' ' ' ILE . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.211 0.529 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 ' CE ' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG12 ' CA ' ' A' ' 54' ' ' THR . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' HD13 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 42' ' ' GLY . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 26' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.505 HD11 ' CD1' ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.518 ' CB ' HD22 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.635 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.499 ' SD ' ' CG ' ' A' ' 55' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 76.2 m-20 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.5 ' CA ' HG12 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.464 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 59' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.8 mtpm? . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.463 ' CG ' ' O ' ' A' ' 83' ' ' ILE . 9.7 p30 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.53 HG23 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.517 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.53 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.43 ' N ' ' CD1' ' A' ' 125' ' ' LEU . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' CA ' HG21 ' A' ' 26' ' ' VAL . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.465 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.53 ' CD1' HD22 ' A' ' 17' ' ' LEU . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 12.9 p30 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' CD1' ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' CA ' ' A' ' 3' ' ' ALA . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' CG2' HG22 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 32' ' ' ILE . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' MET . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 14' ' ' ASN . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' ILE . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 50' ' ' PRO . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.485 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.485 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG13 ' HE3' ' A' ' 43' ' ' MET . 21.6 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.421 0.629 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.52 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.513 HG21 ' CA ' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.459 ' SD ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 96' ' ' GLU . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.481 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.521 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.509 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 108' ' ' SER . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.509 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.514 HG12 ' NE2' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.481 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' C ' ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 21' ' ' MET . 3.2 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 HG12 ' HE1' ' A' ' 21' ' ' MET . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD2' HG21 ' A' ' 11' ' ' ILE . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 14' ' ' ASN . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' HG21 ' A' ' 13' ' ' ILE . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 20' ' ' ILE . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' THR . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.514 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.408 ' SD ' ' CD1' ' A' ' 37' ' ' ILE . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' CG ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.577 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 36' ' ' GLU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 40' ' ' LEU . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' NE ' ' SD ' ' A' ' 59' ' ' MET . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CB ' HG11 ' A' ' 49' ' ' VAL . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.463 ' HG3' ' HE1' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.34 0.591 . . . . 0.0 110.338 . . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' HD12 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.498 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.498 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.53 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' MET . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.494 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.494 ' HG3' ' CG2' ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.487 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.403 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.504 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 6' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.414 ' HE1' ' O ' ' A' ' 30' ' ' MET . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 ' CG2' ' HD2' ' A' ' 33' ' ' PRO . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 11.9 m120 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.477 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.424 ' CA ' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.526 ' CG2' HG22 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.538 HG23 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.515 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.525 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.468 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.425 ' C ' ' HG2' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.538 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.425 ' HG2' ' C ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 117' ' ' ARG . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' N ' ' CD1' ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.428 ' C ' HD13 ' A' ' 102' ' ' ILE . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' CB ' HD13 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.523 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 11' ' ' ILE . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.441 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 40' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.593 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.593 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.455 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.455 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 HD23 ' A' ' 55' ' ' LEU . 69.3 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 HG12 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.6 p30 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' THR . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.456 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.497 ' CG2' HG22 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.546 ' CE ' ' CD1' ' A' ' 87' ' ' LEU . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.502 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.53 ' N ' ' CG ' ' A' ' 117' ' ' ARG . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' CA ' HD12 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.198 0.523 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 154.92 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' O ' HD22 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 5.8 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 39.7 m-20 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.469 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.457 ' SD ' HD13 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' CG2' HG23 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' CG2' ' OE2' ' A' ' 64' ' ' GLU . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' NZ ' ' A' ' 61' ' ' LYS . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.456 ' SD ' HG22 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 22.8 t -120.14 129.88 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' NZ ' ' OD1' ' A' ' 46' ' ' ASN . 7.7 mtmt -62.81 -103.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.86 75.21 6.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.97 -1.081 . . . . 0.0 109.813 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.534 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.4 OUTLIER -53.28 -30.98 41.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 2.9 pt-20 169.31 163.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.18 -0.95 . . . . 0.0 110.229 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -85.97 52.64 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.16 2.84 86.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -84.89 154.02 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.1 m -106.25 -73.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.34 117.95 65.88 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.2 Cg_endo -72.26 -90.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.826 1.435 . . . . 0.0 110.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.2 -70.65 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.3 mt -87.8 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -1.153 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 116.75 9.77 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.442 HG12 HD12 ' A' ' 107' ' ' ILE . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.523 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 121' ' ' LEU . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.537 ' CG2' ' CG2' ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 18.7 t-20 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.537 ' CG2' ' CG2' ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 112' ' ' GLY . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.475 ' HE1' ' CD1' ' A' ' 81' ' ' ILE . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.43 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.522 HD12 ' CE2' ' A' ' 133' ' ' TYR . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.491 ' N ' HG21 ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.537 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.49 HG22 ' CE ' ' A' ' 129' ' ' MET . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.53 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 125' ' ' LEU . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.465 ' N ' ' CD1' ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' HG13 ' A' ' 102' ' ' ILE . 48.2 Cg_endo -75.19 -7.33 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 129' ' ' MET . 3.4 p30 -85.94 -22.02 27.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.391 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.49 ' CE ' HG22 ' A' ' 115' ' ' VAL . 4.2 ptm -93.84 -14.96 25.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 131' ' ' LYS . 91.8 t -92.65 172.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' N ' HG13 ' A' ' 130' ' ' VAL . 6.5 mttt -81.98 -131.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.149 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -99.46 116.0 30.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.988 -1.07 . . . . 0.0 110.388 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CE2' HD12 ' A' ' 102' ' ' ILE . 7.3 m-85 -68.37 -167.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.213 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.956 0.408 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -80.9 -176.03 5.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.862 -1.149 . . . . 0.0 110.21 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' CB ' HG21 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 70.9 m-80 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 20' ' ' ILE . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG21 ' CB ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 6' ' ' VAL . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.641 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 ' O ' ' CG ' ' A' ' 43' ' ' MET . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.556 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 27.6 m-80 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 63' ' ' TYR . 53.5 t -120.04 133.89 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -65.64 -130.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -70.14 76.76 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.92 -1.113 . . . . 0.0 110.173 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.466 ' HB2' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -53.62 -94.55 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.912 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.0 pt-20 -121.81 -159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.806 -1.184 . . . . 0.0 110.197 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -86.1 57.06 4.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.85 23.47 14.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -92.89 161.88 14.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -1.195 . . . . 0.0 110.211 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -85.23 -140.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 140.74 98.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.965 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' LEU . 47.2 Cg_endo -72.19 -94.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.034 1.544 . . . . 0.0 110.423 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.03 -78.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.4 mt -87.28 53.02 2.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm -88.71 119.92 29.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.509 -0.745 . . . . 0.0 110.455 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.517 HG21 ' CG2' ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG1' ' HB1' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.517 ' CG2' HG21 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.5 HG21 ' CA ' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.538 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 72' ' ' LEU . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.481 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.52 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' HG3' HD13 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.52 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.458 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 107' ' ' ILE . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 108' ' ' SER . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.5 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.47 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.426 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.481 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.423 ' C ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 46.1 Cg_endo -73.28 -24.48 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.61 -24.97 62.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.4 mtt -86.93 -46.72 9.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.116 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.422 HG12 ' HE3' ' A' ' 113' ' ' MET . 69.4 t -83.6 93.07 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 116' ' ' ASN . 12.7 ptpt -90.49 5.85 45.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -94.08 45.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.23 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.12 176.72 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.437 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.148 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.266 0.555 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -77.82 -172.49 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.504 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 42' ' ' GLY . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HG2' HG22 ' A' ' 54' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.458 HG22 HD23 ' A' ' 40' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' MET . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.512 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' HD3' ' A' ' 61' ' ' LYS . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.536 HG13 ' CB ' ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.536 ' CB ' HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.446 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.427 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG12 ' CE ' ' A' ' 43' ' ' MET . 52.4 t -120.36 131.63 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HD3' ' CG ' ' A' ' 46' ' ' ASN . 11.1 tptt -70.53 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' OD1' HG12 ' A' ' 97' ' ' VAL . 12.9 m-80 -84.72 77.29 10.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.404 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 40.2 mm-40 -130.1 -148.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.874 -1.141 . . . . 0.0 110.274 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -86.4 36.61 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.384 -0.822 . . . . 0.0 110.363 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.12 17.09 53.65 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.45 HG21 ' OH ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -82.37 -155.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -1.094 . . . . 0.0 110.222 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 p -97.52 -127.6 0.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 13.9 m -82.75 144.9 49.3 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.917 -1.114 . . . . 0.0 110.675 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.89 -150.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.119 1.589 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.21 -65.94 1.56 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.48 52.0 2.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -1.12 . . . . 0.0 109.525 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -74.19 112.83 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.675 . . . . 0.0 110.563 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 92' ' ' MET . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.511 HG12 ' N ' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.531 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' CA ' ' A' ' 112' ' ' GLY . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.492 ' HG3' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 98' ' ' SER . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 97' ' ' VAL . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.473 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 108' ' ' SER . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.449 ' OD1' HG11 ' A' ' 130' ' ' VAL . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.484 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 126' ' ' MET . 45.9 Cg_endo -72.5 -22.3 21.44 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -87.06 4.52 41.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.169 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 tpt -100.48 -52.61 3.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.449 HG11 ' OD1' ' A' ' 116' ' ' ASN . 95.7 t -90.1 124.01 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -77.98 -5.15 50.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 110.143 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -101.99 29.66 4.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.454 ' CE1' HD12 ' A' ' 102' ' ' ILE . 15.9 t80 -66.55 166.59 12.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.212 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.88 165.25 17.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD2' ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.459 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG2' HG23 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.518 ' CB ' HD21 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' OE2' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CB ' ' HG3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.511 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.444 ' HB2' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' A' ' 56' ' ' MET . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -115.1 125.62 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 2.0 pttt -63.91 -135.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' ND2' ' OG1' ' A' ' 124' ' ' THR . 9.9 m-80 -71.07 85.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -54.16 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 2.4 mt-10 -138.26 -136.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 109.983 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.99 49.83 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.079 -1.013 . . . . 0.0 110.255 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.16 33.18 5.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 p -92.98 -147.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -1.209 . . . . 0.0 110.208 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 69' ' ' SER . 5.1 t -101.79 -140.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -75.7 161.41 76.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 110.358 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.452 ' CA ' ' HG3' ' A' ' 96' ' ' GLU . 47.7 Cg_endo -72.65 -152.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.273 1.67 . . . . 0.0 110.288 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.63 -68.17 1.56 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.449 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.6 mt -86.77 51.04 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 109.722 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt -69.53 119.25 13.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.683 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 122' ' ' ASP . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.458 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.459 ' HA ' HG22 ' A' ' 111' ' ' VAL . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 108' ' ' SER . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.543 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 121' ' ' LEU . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.504 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' HD13 ' A' ' 102' ' ' ILE . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.39 -33.92 8.3 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.91 -8.04 54.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.46 ' HE3' ' CD1' ' A' ' 125' ' ' LEU . 28.1 ttp -81.24 -54.74 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.9 t -76.33 123.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.259 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -79.65 -34.87 40.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.68 43.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -78.97 139.3 38.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.216 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.25 0.548 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.23 167.21 11.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 26' ' ' VAL . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.0 t-20 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.429 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 14.5 p30 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' C ' ' HB3' ' A' ' 3' ' ' ALA . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.526 HG21 ' CB ' ' A' ' 3' ' ' ALA . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' HG23 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.509 ' CD1' HD13 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' O ' HD13 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.557 ' N ' HD11 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.552 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.571 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.428 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 23.5 t -113.65 127.66 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -124.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' ND2' HG12 ' A' ' 97' ' ' VAL . 1.9 m120 -77.3 75.96 3.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.145 . . . . 0.0 110.592 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.87 -102.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.333 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 18.2 mm-40 -125.32 -162.9 1.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.938 -1.101 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 38.6 p-10 -86.27 56.29 3.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.282 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.6 -18.43 73.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -74.72 171.9 13.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.49 -79.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -74.45 115.88 47.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.323 -0.861 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 44.0 Cg_endo -71.83 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.926 1.488 . . . . 0.0 110.421 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.81 -82.44 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.11 47.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.15 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -92.09 132.96 36.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 110.517 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.531 ' O ' ' CD2' ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 11.6 p30 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.534 HG21 ' CA ' ' A' ' 112' ' ' GLY . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.456 ' SD ' HD13 ' A' ' 81' ' ' ILE . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.519 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.526 HG12 ' ND2' ' A' ' 62' ' ' ASN . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.464 ' O ' HG22 ' A' ' 124' ' ' THR . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.519 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.504 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.448 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 8.5 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HB2' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.535 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CB ' ' CG2' ' A' ' 130' ' ' VAL . 43.5 Cg_endo -73.49 75.64 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -91.69 -37.3 13.11 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.164 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.3 27.81 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.316 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.581 ' CG2' ' CB ' ' A' ' 127' ' ' PRO . 96.3 t -71.76 128.76 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 110.128 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -15.12 62.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 114' ' ' GLN . 0.1 OUTLIER -91.49 -6.17 53.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.039 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.439 ' OH ' HG22 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -71.55 147.62 47.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.407 ' HG3' HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.179 0.514 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.62 175.02 8.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.136 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG23 HD12 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CG2' HG23 ' A' ' 15' ' ' THR . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.429 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG23 HG23 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.445 ' CD1' HD11 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.432 ' HD2' HG21 ' A' ' 32' ' ' ILE . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HD11 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.433 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.52 ' CB ' HG11 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.45 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 5.3 t -120.16 117.86 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -69.07 -95.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 122' ' ' ASP . 7.7 p30 -91.36 78.35 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.983 . . . . 0.0 110.269 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.66 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.112 -0.993 . . . . 0.0 110.435 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 40' ' ' LEU . 1.5 pm0 -139.53 -149.51 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.91 -1.119 . . . . 0.0 110.358 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.47 54.76 0.77 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 110.261 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.53 -12.83 56.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -94.27 149.23 21.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -1.136 . . . . 0.0 110.464 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.7 -81.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.179 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.97 135.45 45.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 46.7 Cg_endo -73.15 -91.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.93 -81.24 0.55 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 mt -86.93 52.87 2.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.78 113.27 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 110.447 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 102' ' ' ILE . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.423 ' O ' ' HE2' ' A' ' 92' ' ' MET . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' ' CD1' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.454 HG21 ' N ' ' A' ' 98' ' ' SER . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 102' ' ' ILE . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.435 ' N ' HD11 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 133' ' ' TYR . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 117' ' ' ARG . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD11 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HA ' ' OH ' ' A' ' 133' ' ' TYR . 47.3 Cg_endo -73.77 -13.3 24.4 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.52 -12.31 40.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.456 ' CG ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -100.63 -43.74 6.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 133' ' ' TYR . 4.8 t -90.27 107.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.356 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -90.59 42.64 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -111.0 -75.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.333 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CE2' ' HB ' ' A' ' 130' ' ' VAL . 45.0 p90 -68.19 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.299 0.571 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -179.98 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' CG1' ' CG ' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.493 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.405 ' CG ' ' CG1' ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.439 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' CG2' ' OE2' ' A' ' 36' ' ' GLU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.561 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 36' ' ' GLU . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 62' ' ' ASN . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.429 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HD2' ' CG1' ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.533 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.578 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.43 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 3.3 mppt? -70.61 -93.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 110.485 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' ' CE ' ' A' ' 43' ' ' MET . 6.7 t30 -90.39 80.67 6.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 110.415 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.536 ' O ' ' CE ' ' A' ' 43' ' ' MET . 0.5 OUTLIER -64.94 -50.18 67.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.255 -0.903 . . . . 0.0 110.628 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER 173.86 -177.83 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.869 -1.144 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.33 54.51 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.59 -4.69 87.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.09 165.21 12.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -1.157 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -79.27 -133.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 147.31 97.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.12 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 47.2 Cg_endo -72.97 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.532 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.65 -78.82 0.72 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 mt -87.76 51.83 2.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -1.127 . . . . 0.0 110.249 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.519 ' HB2' ' CA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -78.66 114.25 17.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.528 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 85' ' ' THR . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.53 ' CB ' ' HB ' ' A' ' 81' ' ' ILE . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 92' ' ' MET . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' N ' ' HE1' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' OG1' ' A' ' 88' ' ' THR . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 88' ' ' THR . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.408 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 108' ' ' SER . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 21.1 t-20 -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.502 ' HD3' ' CB ' ' A' ' 129' ' ' MET . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.589 ' CB ' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 129' ' ' MET . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.55 -5.61 17.38 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.76 -26.05 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.512 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 5.6 ptp -87.89 -24.52 23.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.188 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' N ' ' HG3' ' A' ' 129' ' ' MET . 39.2 t -92.21 124.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -90.56 -20.12 22.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.508 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 36.3 p30 -95.2 11.21 33.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' CE1' ' CG2' ' A' ' 102' ' ' ILE . 26.6 t80 -61.24 138.87 58.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.282 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.476 ' ND2' ' HG2' ' A' ' 30' ' ' MET . 51.5 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.207 0.527 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -78.03 179.12 6.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.123 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.445 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.516 HD11 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' HG21 ' A' ' 11' ' ' ILE . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' GLY . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.529 ' CE ' HG21 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.476 ' HG2' ' ND2' ' A' ' 1' ' ' ASN . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 32' ' ' ILE . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.511 ' CB ' HD21 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' N ' HD21 ' A' ' 40' ' ' LEU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG21 ' CE ' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.514 ' HE3' ' CG1' ' A' ' 60' ' ' VAL . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' N ' HG21 ' A' ' 13' ' ' ILE . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG11 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.428 ' SD ' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 ' CG1' ' HE3' ' A' ' 43' ' ' MET . 44.6 t -120.17 129.23 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 1.1 tttp -68.77 -111.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' VAL . 6.0 m120 -90.96 86.07 6.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.164 . . . . 0.0 110.265 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -69.92 54.67 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.231 -0.918 . . . . 0.0 110.783 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 18.1 mm-40 42.69 -148.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.22 57.31 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.159 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.07 -9.03 59.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 170.76 9.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 0.0 110.263 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 69' ' ' SER . 48.9 m -92.17 -90.36 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.12 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -73.56 135.33 78.56 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 45.7 Cg_endo -72.82 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.984 1.518 . . . . 0.0 110.551 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.94 -81.16 0.44 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.93 51.79 2.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -1.103 . . . . 0.0 110.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.58 113.66 10.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.454 -0.778 . . . . 0.0 110.277 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 97' ' ' VAL . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' HD12 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 118' ' ' ALA . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.526 HG21 ' CA ' ' A' ' 112' ' ' GLY . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 88' ' ' THR . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.522 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.47 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG23 ' HA ' ' A' ' 62' ' ' ASN . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.424 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 111' ' ' VAL . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.457 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.457 ' OD1' ' HE3' ' A' ' 131' ' ' LYS . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.53 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo -78.05 -0.01 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -41.83 68.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.539 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.415 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 2.2 tpp -98.22 -18.44 18.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.306 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.9 t -75.2 89.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.01 . . . . 0.0 110.229 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.457 ' HE3' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -90.54 14.34 13.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.3 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.59 27.8 6.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.181 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 154.43 28.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.337 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' HG3' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.563 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 170.3 16.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' CB ' ' HG3' ' A' ' 23' ' ' LYS . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . 9.1 p30 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.445 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.493 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG2' HG11 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' HG23 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.452 HG21 ' HD2' ' A' ' 33' ' ' PRO . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' HG21 ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 64' ' ' GLU . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.533 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG2' HD13 ' A' ' 121' ' ' LEU . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.515 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.416 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 19.4 t -119.79 122.44 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -70.72 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 0.0 110.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -90.94 73.49 6.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -53.54 -98.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.051 -1.03 . . . . 0.0 110.262 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 2.6 pt-20 -75.96 1.52 15.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.914 -1.116 . . . . 0.0 110.767 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -74.98 54.93 0.68 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 110.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.32 75.49 0.42 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.8 p -73.33 164.54 26.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.281 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -90.32 -45.65 8.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 20.0 m -64.31 135.2 96.24 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' LEU . 49.4 Cg_endo -72.88 -97.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 -82.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' PRO . 10.0 mt -88.64 51.32 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -1.079 . . . . 0.0 110.324 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.78 115.19 21.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 0.0 110.093 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.428 HG13 ' SD ' ' A' ' 92' ' ' MET . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.496 ' N ' HG21 ' A' ' 83' ' ' ILE . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.529 HG21 ' CA ' ' A' ' 112' ' ' GLY . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.524 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 75' ' ' VAL . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' OE2' HG12 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.552 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.512 ' CG2' HG23 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.529 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.405 ' O ' ' HG3' ' A' ' 113' ' ' MET . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.532 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 124' ' ' THR . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' N ' HD13 ' A' ' 102' ' ' ILE . 45.8 Cg_endo -73.21 -27.24 13.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.82 -16.83 62.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -46.93 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.42 121.77 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 110.371 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -89.68 -14.63 34.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.903 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -93.11 10.39 31.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.429 ' OH ' ' CG2' ' A' ' 102' ' ' ILE . 25.9 t80 -70.44 167.32 18.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.207 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.277 0.561 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -74.18 -177.62 3.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.451 ' CG2' ' HE2' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 3' ' ' ALA . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 HG21 ' HE1' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.463 ' HE1' HG21 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 ' CE2' ' A' ' 63' ' ' TYR . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.556 ' CG ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.454 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 61' ' ' LYS . 6.4 t -100.47 121.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 2.0 pttt -61.66 -136.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.889 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' ND2' ' CG1' ' A' ' 76' ' ' VAL . 2.0 p-10 -70.28 101.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.094 -1.004 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.559 ' CE2' HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.53 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.157 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 34.2 mm-40 -113.62 -156.16 0.59 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.967 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.88 54.52 3.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.115 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.17 11.44 57.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 43.4 p -82.98 150.05 26.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.119 . . . . 0.0 110.324 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 m -100.13 -87.29 0.37 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.164 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -76.91 141.3 67.86 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.123 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' LEU . 47.4 Cg_endo -72.76 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.949 1.499 . . . . 0.0 110.585 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 59.04 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 15.5 mt -88.1 52.51 2.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.084 . . . . 0.0 109.607 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.47 139.89 57.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -0.771 . . . . 0.0 110.366 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' CG1' ' ND2' ' A' ' 62' ' ' ASN . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.475 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.443 ' OD1' HG23 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.506 HG21 ' CA ' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 91' ' ' MET . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.519 ' N ' HG21 ' A' ' 90' ' ' VAL . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.46 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.484 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 111' ' ' VAL . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.416 ' CG ' ' HD3' ' A' ' 131' ' ' LYS . 3.3 t-20 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.484 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' HD13 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -72.86 -16.48 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -83.25 -3.31 57.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -47.88 6.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 t -91.49 124.3 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HD3' ' CG ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -82.01 -13.65 57.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.37 17.01 9.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 110.274 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.29 137.92 47.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' OXT' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.328 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.93 169.12 18.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG11 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.441 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.438 HG22 HG21 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.48 ' HE3' ' CD1' ' A' ' 37' ' ' ILE . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' CB ' HG11 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 9.5 t -111.14 125.22 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 2.8 mmmp? -70.8 -105.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.003 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.43 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 37.2 p-10 -91.02 79.59 5.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.835 -1.166 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.405 -0.809 . . . . 0.0 110.502 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 2.4 mp0 -107.52 -170.84 1.76 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.832 -1.167 . . . . 0.0 110.368 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.09 46.8 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.788 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.43 19.73 51.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -89.16 160.41 17.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -1.15 . . . . 0.0 110.243 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.2 t -76.85 -140.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.104 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.481 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -67.04 168.88 9.55 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.2 Cg_endo -72.43 -92.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.973 1.512 . . . . 0.0 110.417 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -79.09 0.38 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 10.4 mt -83.9 53.86 2.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -1.096 . . . . 0.0 109.861 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp -66.82 129.26 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.491 -0.755 . . . . 0.0 110.641 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 123' ' ' GLN . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.521 HG21 ' CG2' ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' CA ' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.521 ' CG2' HG21 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.512 ' SD ' ' CD1' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.54 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' HG21 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 49.8 tp60 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.447 ' OG1' ' NZ ' ' A' ' 61' ' ' LYS . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.5 Cg_endo -74.09 -0.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.43 -30.17 19.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.421 ' HG3' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -91.65 -24.03 19.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 126' ' ' MET . 46.3 t -84.19 96.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -73.19 -8.91 57.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -96.38 20.43 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.42 -174.78 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.168 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.28 0.562 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.66 -176.81 6.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 11' ' ' ILE . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' CD2' HD12 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.432 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' OE1' ' CA ' ' A' ' 66' ' ' GLY . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.528 ' CG2' HG11 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 87.2 t -119.64 115.35 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -62.49 -140.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.976 . . . . 0.0 110.0 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 21.1 m120 -70.26 76.58 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.016 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.56 -102.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.172 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 28.0 mm-40 -129.2 176.8 7.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.795 -1.191 . . . . 0.0 110.653 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' HB2' ' CB ' ' A' ' 97' ' ' VAL . 4.3 t0 -88.22 -65.05 1.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.373 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' OE1' ' A' ' 36' ' ' GLU . . . 104.42 15.22 21.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.46 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -91.52 172.15 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -1.088 . . . . 0.0 110.335 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.3 m -100.45 -68.53 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.876 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.456 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 18.3 m -84.74 123.87 73.62 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 110.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 47.0 Cg_endo -73.28 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.9 1.474 . . . . 0.0 110.461 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.66 -77.7 1.85 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.61 47.42 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.139 . . . . 0.0 108.815 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.53 129.43 39.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' HD11 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.519 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 11.3 p30 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 89' ' ' LEU . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.606 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.449 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 106' ' ' GLU . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.498 HD11 ' N ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.498 ' N ' HD11 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' A' ' 106' ' ' GLU . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 88' ' ' THR . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.515 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' NH2' ' O ' ' A' ' 118' ' ' ALA . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.46 ' HB3' HG12 ' A' ' 102' ' ' ILE . 47.8 Cg_endo -74.29 -30.68 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.96 -37.07 72.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.576 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -80.48 -49.42 11.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 125' ' ' LEU . 58.9 t -75.39 109.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 32.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -108.32 -27.79 9.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -171.17 0.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' A' ' 106' ' ' GLU . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -77.79 175.26 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG2' ' CA ' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HD2' HG21 ' A' ' 11' ' ' ILE . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.0 p30 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 41' ' ' VAL . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.441 ' HG2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 3' ' ' ALA . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG23 ' A' ' 6' ' ' VAL . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.518 ' CD1' HD13 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 43' ' ' MET . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG12 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.427 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 61.4 t -119.98 130.47 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -68.31 -108.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.516 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . 1.2 t-20 -84.06 68.0 9.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.84 -1.162 . . . . 0.0 110.922 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.94 -98.44 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.908 . . . . 0.0 110.406 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.31 -167.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.07 . . . . 0.0 110.333 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -78.27 51.54 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.41 -17.44 78.94 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.21 122.02 32.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -1.143 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.449 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 32.2 m -96.29 -53.7 3.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.867 . . . . 0.0 110.175 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -82.7 111.42 29.11 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 110.183 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.3 Cg_endo -72.47 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.915 1.481 . . . . 0.0 110.624 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.52 -81.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.4 mt -88.07 54.94 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -1.05 . . . . 0.0 109.956 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -77.37 119.5 21.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' ND2' ' OD1' ' A' ' 122' ' ' ASP . 27.4 t-20 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD12 ' A' ' 121' ' ' LEU . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 83' ' ' ILE . 8.0 p30 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.529 HG23 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.539 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.413 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.523 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.529 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.475 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HD3' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.558 ' N ' ' CD1' ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.523 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 48.4 Cg_endo -75.6 -25.67 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -20.52 63.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.234 -0.916 . . . . 0.0 110.256 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.452 ' HE1' ' CZ ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -92.65 -49.14 6.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.146 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 115' ' ' VAL . 21.9 m -82.69 111.54 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -88.53 28.59 1.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.96 40.4 1.93 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -169.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.204 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.286 0.565 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -76.65 179.82 5.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CD1' HD23 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.4 p30 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.504 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.461 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.54 ' CB ' HG11 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' HB3' ' CG1' ' A' ' 32' ' ' ILE . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.469 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG13 ' CD2' ' A' ' 63' ' ' TYR . 40.5 t -111.2 125.16 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -60.69 -144.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.114 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 63' ' ' TYR . 8.0 m120 -78.74 71.87 5.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.91 -105.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 40' ' ' LEU . 46.5 mt-10 -152.05 5.41 0.42 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.016 -1.052 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -86.82 -8.67 57.12 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.8 -23.79 19.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 67' ' ' THR . 15.5 m -74.76 60.33 0.93 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.208 -1.172 . . . . 0.0 110.193 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -107.87 -96.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 110.223 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -84.88 139.65 37.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.983 -1.073 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.77 -154.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.125 1.592 . . . . 0.0 110.04 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.82 -70.82 1.8 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 12.3 mt -87.41 52.62 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -1.143 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -79.32 113.25 17.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.663 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 8.4 p30 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' LEU . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.481 ' HB2' HD21 ' A' ' 121' ' ' LEU . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.506 HG12 ' N ' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.48 ' N ' HG21 ' A' ' 83' ' ' ILE . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.505 ' HA ' ' CG ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.505 ' CG ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB3' ' HE2' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.497 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.511 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' CD1' ' OE2' ' A' ' 134' ' ' GLU . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.496 ' CE ' HG12 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 129' ' ' MET . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.476 ' CD ' ' HG3' ' A' ' 129' ' ' MET . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.18 -42.61 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 129' ' ' MET . 42.4 p-10 -72.03 -14.44 61.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.476 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 31.4 ttm -85.87 -46.02 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG12 ' CE ' ' A' ' 113' ' ' MET . 34.4 t -91.19 108.34 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.171 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 131' ' ' LYS . 20.8 mmtt -72.8 -8.25 54.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 132' ' ' ASN . 61.8 t-20 -91.55 5.78 48.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -66.44 -169.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.388 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.221 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.222 0.534 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 177.06 7.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG11 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HA ' HD22 ' A' ' 51' ' ' LEU . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.417 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.524 ' CG2' ' HE3' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.524 ' HE3' ' CG2' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.495 ' CG ' HG11 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 3' ' ' ALA . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.561 ' CD1' ' CE ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.561 ' CE ' ' CD1' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG11 ' CB ' ' A' ' 53' ' ' THR . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.515 ' CB ' HG11 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.46 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.5 ' CB ' ' CE1' ' A' ' 63' ' ' TYR . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 56' ' ' MET . 75.9 t -120.15 138.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.27 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -70.07 91.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.972 -1.08 . . . . 0.0 110.04 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.5 ' CE1' ' CB ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -53.73 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.237 -0.914 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -165.19 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 55.89 2.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.107 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.8 8.23 76.63 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.0 p -90.79 125.23 35.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.4 m -83.75 -80.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.44 123.09 85.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.1 Cg_endo -73.63 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.863 1.454 . . . . 0.0 110.444 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.53 -79.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.8 mt -87.62 52.74 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 4.3 pttt -85.22 115.21 22.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.587 -0.696 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.6 m-80 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 83' ' ' ILE . 8.0 p30 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 112' ' ' GLY . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.522 ' CE ' HD13 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.563 HG22 ' CE1' ' A' ' 133' ' ' TYR . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.508 ' CD1' ' HE3' ' A' ' 92' ' ' MET . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.518 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 99' ' ' PRO . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.423 ' C ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.83 -28.55 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -2.23 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -29.22 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 110.283 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 131' ' ' LYS . 48.2 t -92.92 171.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -84.21 -65.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.232 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.42 75.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.563 ' CE1' HG22 ' A' ' 102' ' ' ILE . 56.3 t80 -68.16 161.87 26.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.223 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.354 0.597 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.61 167.99 11.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.389 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.462 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' CD1' ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.489 HG23 ' CA ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD23 HG23 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.457 ' CE ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 3' ' ' ALA . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.443 HG23 ' HG ' ' A' ' 40' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' CB ' HD21 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.504 ' CE ' HD11 ' A' ' 40' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' OD1' ' HG2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' CA ' HG23 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.516 ' CB ' HG11 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD13 ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.441 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 24.9 t -120.01 142.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 15.9 mmtt -70.04 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.99 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . 38.1 t-20 -90.83 71.67 6.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.986 -1.071 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.7 p90 -53.75 -38.69 64.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.138 -0.976 . . . . 0.0 110.297 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 1.9 pt-20 179.82 -173.99 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.159 -0.963 . . . . 0.0 110.359 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -86.49 48.49 1.64 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 110.054 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.83 23.77 28.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 HG23 ' OE1' ' A' ' 95' ' ' GLU . 4.8 p -79.21 142.27 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -1.163 . . . . 0.0 110.068 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.432 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 13.6 p -82.49 -99.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.184 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -85.0 141.77 38.06 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.022 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.613 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 41.2 Cg_endo -71.47 -78.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.992 1.522 . . . . 0.0 110.204 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.31 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.9 mt -87.66 45.84 1.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.393 -1.063 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt -68.16 122.14 17.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.657 -0.652 . . . . 0.0 110.082 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG2' HG13 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 49.6 t30 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' A' ' 118' ' ' ALA . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.546 HD12 ' CB ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.534 HG23 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.497 ' CE ' HD13 ' A' ' 87' ' ' LEU . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.613 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG13 ' CG2' ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' NZ ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.503 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.451 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 113' ' ' MET . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG21 HG21 ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.423 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.546 ' CB ' HD12 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.527 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.509 ' N ' HD11 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.462 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo -78.64 -22.66 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.49 -23.86 62.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.131 -0.981 . . . . 0.0 110.367 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mtt -84.59 -40.37 17.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.87 99.07 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 110.387 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.46 4.47 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -94.43 36.05 1.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.25 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.37 124.9 27.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.281 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.436 ' CG ' HD23 ' A' ' 110' ' ' LEU . 2.6 pp20? . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.18 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.293 0.568 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -80.76 173.68 12.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.8 p30 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.496 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' CG2' HG23 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG23 HD11 ' A' ' 32' ' ' ILE . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.0 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 4.7 t -120.05 133.35 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -71.15 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -91.9 62.31 4.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.179 -0.951 . . . . 0.0 111.018 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -53.84 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.922 -1.112 . . . . 0.0 109.984 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' OE1' HG23 ' A' ' 32' ' ' ILE . 5.3 pt-20 -132.88 -164.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.876 -1.14 . . . . 0.0 110.492 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.92 54.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.398 -0.814 . . . . 0.0 110.243 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.59 -21.97 77.82 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.6 p -84.3 162.79 19.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -1.124 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.4 m -106.19 -90.2 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 t -79.91 130.04 68.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.928 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.1 Cg_endo -73.54 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.485 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.29 -73.09 0.58 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 mt -86.78 53.1 2.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -1.109 . . . . 0.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 3.7 mttt -68.91 116.46 9.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.532 -0.73 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 93' ' ' LYS . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 85' ' ' THR . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.533 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 78.1 m-20 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 92' ' ' MET . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG2' ' OG1' ' A' ' 88' ' ' THR . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.485 ' CE ' HD13 ' A' ' 81' ' ' ILE . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.519 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.568 HG22 ' CZ ' ' A' ' 133' ' ' TYR . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.522 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 111' ' ' VAL . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.449 ' O ' ' O ' ' A' ' 121' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.523 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HA ' HD13 ' A' ' 102' ' ' ILE . 47.1 Cg_endo -73.71 -18.03 22.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 22.2 p30 -70.43 -15.41 62.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 3.4 mtt -99.01 -47.34 5.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 t -73.77 103.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -80.37 -2.32 44.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -107.22 2.6 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.568 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 13.3 t80 -64.36 140.08 58.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.209 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.4 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.183 0.516 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.43 -178.93 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.51 ' CA ' HG23 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG11 ' CG ' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.472 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 11' ' ' ILE . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.0 p30 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.518 ' CG ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.438 ' O ' ' CG ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB3' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.432 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' LYS . 84.0 t -120.16 135.98 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 0.5 OUTLIER -55.97 -165.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 110.145 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -71.92 77.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.084 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 16.0 mm-40 -107.91 -141.36 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.991 -1.068 . . . . 0.0 110.29 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.23 54.39 2.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.26 -7.64 69.57 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -92.97 166.61 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.115 -1.226 . . . . 0.0 110.24 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.9 p -77.45 -138.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 144.55 98.59 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.1 -1.0 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.0 Cg_endo -73.19 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.045 1.55 . . . . 0.0 110.518 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.17 1.34 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 72' ' ' LEU . 11.6 mt -87.89 57.33 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 109.641 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 30.6 mtpt -72.07 120.13 17.24 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.523 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 102' ' ' ILE . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' HB ' ' OE1' ' A' ' 95' ' ' GLU . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.47 ' O ' HD12 ' A' ' 121' ' ' LEU . 2.0 t-20 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' LEU . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 85' ' ' THR . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.509 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.534 HG23 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.438 ' HG3' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.469 ' SD ' ' CD1' ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' CG ' ' CG2' ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' CG2' ' CG ' ' A' ' 95' ' ' GLU . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.469 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.462 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 108' ' ' SER . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' A' ' 131' ' ' LYS . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' CB ' ' HE1' ' A' ' 129' ' ' MET . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.509 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.541 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.2 Cg_endo -73.42 -24.57 16.25 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.03 7.12 9.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.229 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.5 ' HE1' ' CB ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -99.0 -22.26 15.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG21 ' CE ' ' A' ' 113' ' ' MET . 45.7 t -88.14 161.22 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -73.24 -79.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.79 . . . . 0.0 110.365 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -102.63 77.52 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 102' ' ' ILE . 40.2 t80 -64.53 151.0 45.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.222 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.161 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.254 0.549 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 65.0 mmtt -75.94 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' CB ' ' HE3' ' A' ' 23' ' ' LYS . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.515 ' ND2' HG23 ' A' ' 13' ' ' ILE . 69.9 m-80 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 42' ' ' GLY . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.489 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HE3' ' CB ' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG11 ' C ' ' A' ' 26' ' ' VAL . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.524 ' CD1' HD11 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' ASN . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.566 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.513 ' CE ' ' HB3' ' A' ' 63' ' ' TYR . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' THR . 5.6 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' CG2' HG11 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.519 ' CB ' ' OH ' ' A' ' 63' ' ' TYR . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.452 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG13 ' HE3' ' A' ' 43' ' ' MET . 11.4 t -112.05 159.07 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.41 -154.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.133 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 63' ' ' TYR . 3.9 m120 -71.23 82.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.22 -0.925 . . . . 0.0 110.354 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -53.69 -100.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.237 -0.914 . . . . 0.0 109.825 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 24.5 mm-40 -116.78 -152.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.855 -1.153 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -71.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.921 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.37 -46.43 3.21 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.49 167.52 11.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.337 -1.096 . . . . 0.0 110.356 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -67.23 -114.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.02 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.1 m -64.41 140.85 98.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.738 -1.226 . . . . 0.0 110.124 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 45.3 Cg_endo -73.59 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.037 1.546 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.29 -80.77 1.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.98 52.41 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 109.678 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -82.15 130.88 35.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.75 . . . . 0.0 110.713 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.512 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.517 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.497 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.485 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.479 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.479 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.512 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.485 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.432 ' C ' HD13 ' A' ' 102' ' ' ILE . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.478 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 45.9 Cg_endo -73.36 -19.52 22.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -0.02 29.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.456 ' HA ' ' HE1' ' A' ' 129' ' ' MET . 1.0 OUTLIER -94.43 -21.32 19.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.208 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.77 168.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -75.59 -82.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 110.134 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.89 82.58 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.34 159.15 31.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.325 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.265 0.555 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.71 -178.18 4.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.276 -0.89 . . . . 0.0 110.266 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.458 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 55' ' ' LEU . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 14.5 p30 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 42' ' ' GLY . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.446 ' HE1' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.467 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 3' ' ' ALA . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.524 ' CD1' HD13 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' ' 14' ' ' ASN . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD2' HG12 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' HG12 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.404 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.404 ' HG3' ' CB ' ' A' ' 56' ' ' MET . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t -108.48 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -60.84 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 43' ' ' MET . 0.4 OUTLIER -90.42 89.76 7.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' CA ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -54.1 -56.39 18.57 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.467 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER 174.99 165.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.163 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -85.44 44.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.75 15.44 60.52 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.45 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 18.0 p -74.04 156.02 37.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.183 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.8 m -107.46 -78.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -76.4 120.19 80.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 46.1 Cg_endo -72.97 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.919 1.484 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.43 -77.29 0.26 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -87.59 52.59 2.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 110.022 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt -69.24 114.59 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -0.762 . . . . 0.0 110.219 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 HG11 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG22 HG13 ' A' ' 97' ' ' VAL . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG13 ' CB ' ' A' ' 118' ' ' ALA . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.51 ' N ' HG21 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.525 HG21 ' CA ' ' A' ' 112' ' ' GLY . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.531 ' CG ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' SER . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.522 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 76' ' ' VAL . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.461 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 108' ' ' SER . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 127' ' ' PRO . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.446 ' HA ' HD13 ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.97 -24.45 17.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.72 -25.15 62.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 2.5 ttm -80.41 -36.91 33.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 133' ' ' TYR . 33.0 t -86.54 116.51 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -83.64 -18.78 36.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -107.13 28.45 8.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.486 ' N ' HG11 ' A' ' 130' ' ' VAL . 28.7 t80 -66.66 162.29 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.167 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.189 0.518 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.9 176.6 6.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 110.373 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 27' ' ' VAL . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.448 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.448 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 14' ' ' ASN . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.3 p30 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' HG23 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG2' HG23 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.482 ' O ' ' CG ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.465 HG21 ' HD2' ' A' ' 33' ' ' PRO . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 32' ' ' ILE . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.48 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 63' ' ' TYR . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.522 ' HE3' ' CD2' ' A' ' 55' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' OD1' ' CG ' ' A' ' 61' ' ' LYS . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.532 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.532 ' CB ' HG11 ' A' ' 49' ' ' VAL . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD2' ' HE3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.468 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.468 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 50.5 t -106.78 119.31 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 29.8 mmtt -69.95 -91.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 31.1 p-10 -90.76 72.65 6.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.401 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.52 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -53.58 -33.03 53.38 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.19 -0.944 . . . . 0.0 110.22 -179.724 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' HD23 ' A' ' 40' ' ' LEU . 3.1 pt-20 -174.68 -167.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.01 -1.056 . . . . 0.0 110.316 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -80.79 56.43 2.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.246 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.14 -14.72 81.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -86.41 95.05 9.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -1.191 . . . . 0.0 110.347 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -82.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.925 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.74 158.21 73.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 109.954 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.0 Cg_endo -73.26 -91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.854 1.449 . . . . 0.0 110.505 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.92 -75.12 0.12 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 5.9 mt -87.67 56.12 3.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.59 131.43 45.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.506 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 HG22 ' CG2' ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' OG1' ' A' ' 85' ' ' THR . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.529 ' CG1' ' HB1' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 77.1 m-20 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' LEU . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.497 ' N ' HG12 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.454 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.548 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.517 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.477 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.529 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.462 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.517 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.6 -21.58 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.65 -0.63 51.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.44 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -84.31 -44.49 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 110.262 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 131' ' ' LYS . 51.0 t -78.88 162.88 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.7 mtmt -76.53 -73.71 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.255 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 132' ' ' ASN . 11.4 p30 -105.28 68.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.886 . . . . 0.0 110.338 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.465 ' OH ' HG22 ' A' ' 102' ' ' ILE . 60.7 t80 -62.81 101.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.281 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.284 0.564 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 178.54 8.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.893 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 6' ' ' VAL . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 5' ' ' VAL . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.519 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' VAL . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.7 p30 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 43' ' ' MET . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD12 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 40' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.618 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 32' ' ' ILE . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.513 ' CG ' HD11 ' A' ' 17' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 47' ' ' ARG . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.53 ' CB ' HG11 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 51.7 t -117.74 111.25 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -50.02 -99.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 110.119 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' ND2' ' OE2' ' A' ' 95' ' ' GLU . 9.3 t30 -83.45 103.11 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CE1' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -75.74 -76.09 0.16 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.174 -0.954 . . . . 0.0 109.402 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -133.63 174.42 10.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -0.786 . . . . 0.0 109.968 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.45 48.6 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.896 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.99 45.08 1.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -84.41 164.85 18.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.253 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -67.8 -138.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.1 m -64.19 151.94 89.31 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.131 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.8 Cg_endo -73.7 -92.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.945 1.498 . . . . 0.0 110.575 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.11 -82.43 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mt -88.21 52.36 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -1.098 . . . . 0.0 109.988 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -81.66 115.7 21.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -0.789 . . . . 0.0 110.48 -179.732 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 79' ' ' GLN . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 4.7 m-80 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 114' ' ' GLN . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.506 HG23 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.519 ' CG ' HD13 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 62' ' ' ASN . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.526 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.503 ' CB ' ' HG2' ' A' ' 131' ' ' LYS . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.427 ' C ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 123' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.414 ' C ' HD13 ' A' ' 102' ' ' ILE . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.1 Cg_endo -73.36 -7.37 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -90.68 -20.28 22.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 31.7 ttm -85.79 -52.17 5.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.235 -0.915 . . . . 0.0 110.345 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.34 110.64 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.503 ' HG2' ' CB ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -76.13 -5.2 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.283 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -98.06 -6.93 30.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.302 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 28.4 t80 -59.6 156.1 14.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.174 -179.93 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' N ' ' HE2' ' A' ' 30' ' ' MET . 7.8 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.213 0.53 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -91.28 179.91 5.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' HG2' ' A' ' 22' ' ' MET . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' HD21 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CG ' HD12 ' A' ' 11' ' ' ILE . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 49' ' ' VAL . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.487 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.513 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' C ' HG11 ' A' ' 27' ' ' VAL . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 26' ' ' VAL . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.471 ' HE2' ' N ' ' A' ' 1' ' ' ASN . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 63' ' ' TYR . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 64' ' ' GLU . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' ARG . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' CB ' HG11 ' A' ' 49' ' ' VAL . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.86 127.57 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 122' ' ' ASP . 10.5 mtmm -59.22 -91.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.47 92.38 8.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 109.709 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.584 ' HB2' ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.72 -5.78 49.48 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -179.33 163.27 1.24 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.913 -1.117 . . . . 0.0 110.398 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.89 45.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 110.074 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.93 -8.27 87.81 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 HG23 ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -84.48 116.65 23.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -1.206 . . . . 0.0 110.248 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.97 -76.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.239 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.25 134.12 56.01 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 45.1 Cg_endo -72.86 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 0.0 110.354 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.6 -78.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.6 mt -87.38 51.15 2.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.06 161.93 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -0.813 . . . . 0.0 110.301 179.648 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG11 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' CA ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' HG12 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.431 ' HG3' HG12 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' A' ' 77' ' ' ALA . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.474 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.523 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 45.8 Cg_endo -72.44 -24.51 19.14 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.03 -28.3 63.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.173 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 9.2 mtt -82.29 -45.33 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.415 HG12 ' HE3' ' A' ' 113' ' ' MET . 38.8 t -88.86 109.99 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 8.53 34.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.229 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -92.43 -25.37 18.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.15 174.08 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.315 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 -179.983 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 179.98 7.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.518 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HB2' HD13 ' A' ' 51' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 17' ' ' LEU . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.3 p30 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 11' ' ' ILE . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' OE1' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 27' ' ' VAL . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' CD1' ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' ASN . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' CD2' ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 60' ' ' VAL . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG11 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.523 ' CB ' HG11 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG12 ' CE ' ' A' ' 43' ' ' MET . 77.2 t -100.11 137.01 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 7.4 mmmt -70.64 -101.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -90.91 68.55 6.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.162 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.628 ' CE2' ' CB ' ' A' ' 57' ' ' PRO . 1.2 p90 -53.7 -38.59 64.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.257 -0.902 . . . . 0.0 110.573 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 2.6 pt-20 -178.17 -159.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.049 . . . . 0.0 110.365 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -75.49 54.67 0.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.533 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.53 30.4 7.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -86.91 119.14 26.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -1.172 . . . . 0.0 110.029 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.5 p -71.01 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.17 117.09 33.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.209 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.7 Cg_endo -72.08 -92.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.974 1.513 . . . . 0.0 110.484 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.24 -73.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.9 mt -87.18 51.99 2.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 109.929 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -71.4 113.56 8.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 110.641 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 123' ' ' GLN . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' HD12 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 119' ' ' VAL . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.55 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.462 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.517 HG21 ' CA ' ' A' ' 112' ' ' GLY . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.528 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.611 ' CG1' ' CD1' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.514 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.514 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 133' ' ' TYR . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.512 ' CG2' HG23 ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.517 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 ' CG2' HG11 ' A' ' 130' ' ' VAL . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.448 ' OG1' ' CG1' ' A' ' 97' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.611 ' CD1' ' CG1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.469 ' HA ' HD12 ' A' ' 102' ' ' ILE . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo -77.32 -13.99 16.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 1.9 p30 -72.9 -33.14 65.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.444 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -81.09 -49.51 10.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.199 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.437 HG11 ' CG2' ' A' ' 115' ' ' VAL . 31.0 m -75.63 -171.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -97.95 112.57 24.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.483 ' CE1' HD11 ' A' ' 110' ' ' LEU . 2.4 m-85 -70.56 -169.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.18 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.331 0.586 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.32 179.1 5.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.32 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.507 ' HB2' ' CD ' ' A' ' 23' ' ' LYS . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HA ' HD22 ' A' ' 51' ' ' LEU . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' HB2' HD13 ' A' ' 51' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 HD13 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 48' ' ' ALA . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 17.1 p30 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD22 ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.493 ' CE ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.449 ' CE ' HD22 ' A' ' 19' ' ' LEU . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' CG2' HG23 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 32' ' ' ILE . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' CB ' HD12 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.516 HG11 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.516 ' CB ' HG11 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.441 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HD3' HG13 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 17.9 t -118.8 130.09 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.3 -146.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -0.883 . . . . 0.0 110.073 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' CB ' ' A' ' 65' ' ' ASP . 4.4 m120 -70.25 75.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.936 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 64' ' ' GLU . 3.8 p90 -67.72 -10.82 55.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.413 -0.804 . . . . 0.0 111.303 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.593 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 17.7 pt-20 -140.22 5.37 2.08 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.794 -1.191 . . . . 0.0 111.024 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 62' ' ' ASN . 2.4 t0 -77.6 58.12 1.72 Allowed 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.407 -0.808 . . . . 0.0 109.917 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.53 71.63 0.33 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.7 p -73.14 162.01 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.097 . . . . 0.0 110.508 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 4.0 m -68.93 -64.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 110.339 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -64.4 110.97 4.61 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.1 Cg_endo -73.82 -89.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.008 1.53 . . . . 0.0 110.603 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.9 -81.87 1.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.94 52.49 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -1.103 . . . . 0.0 109.92 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -75.04 130.32 39.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.809 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 107' ' ' ILE . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD12 ' A' ' 121' ' ' LEU . 4.1 t-20 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.525 HG23 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HA ' ' HG2' ' A' ' 92' ' ' MET . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 92' ' ' MET . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG2' ' OD1' ' A' ' 62' ' ' ASN . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 133' ' ' TYR . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.445 ' OG ' ' HE3' ' A' ' 92' ' ' MET . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.512 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.525 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.478 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.471 ' O ' ' O ' ' A' ' 121' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.519 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.445 ' HA ' HD13 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -73.12 -18.31 23.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.75 7.9 11.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -100.29 -36.36 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 133' ' ' TYR . 25.4 t -79.61 152.74 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 42.1 mtpt -70.43 -75.12 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.66 66.79 0.8 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.565 ' CZ ' HD12 ' A' ' 102' ' ' ILE . 88.6 t80 -73.21 120.51 18.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.336 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.253 179.88 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.275 0.56 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -75.94 160.8 29.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.454 ' HA ' HD22 ' A' ' 51' ' ' LEU . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 HG13 ' CD2' ' A' ' 17' ' ' LEU . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.43 ' HE3' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' N ' ' HE3' ' A' ' 22' ' ' MET . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 ' CG2' HD22 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CG ' ' OE1' ' A' ' 64' ' ' GLU . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' CB ' ' OE1' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 64' ' ' GLU . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.541 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 ' CB ' HG11 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.408 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.408 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 47.5 t -120.17 130.32 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' NZ ' HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.63 -95.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.278 -0.889 . . . . 0.0 110.071 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -90.96 70.93 6.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 110.307 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -53.42 -36.98 62.1 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.219 -0.925 . . . . 0.0 110.238 -179.709 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 7.0 pt-20 179.88 -172.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.26 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.44 41.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.379 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.76 8.13 67.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.71 162.84 22.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -1.152 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 69' ' ' SER . 4.0 t -106.31 -129.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.986 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 68' ' ' THR . 0.9 OUTLIER -64.05 120.67 66.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.007 -1.058 . . . . 0.0 110.165 -179.931 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 45.4 Cg_endo -72.46 -91.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.906 1.477 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.79 -82.4 0.84 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.03 53.42 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.09 . . . . 0.0 109.982 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.04 161.56 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.802 . . . . 0.0 110.124 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 24.5 m120 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.526 HG21 ' CA ' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.482 HG12 ' NZ ' ' A' ' 61' ' ' LYS . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.526 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 113' ' ' MET . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 81' ' ' ILE . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 129' ' ' MET . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.531 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.477 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 61' ' ' LYS . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.468 ' N ' HD13 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 47.7 Cg_endo -73.41 -32.72 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -70.41 -14.64 62.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.195 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.407 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 2.9 mtp -86.41 -52.19 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.285 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 96.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 110.288 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 8.03 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -103.47 41.86 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.49 177.25 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.152 179.997 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -74.64 -178.97 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 8' ' ' ASN . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 42' ' ' GLY . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.495 HG22 ' CE ' ' A' ' 21' ' ' MET . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.495 ' CE ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.457 ' HG2' HG11 ' A' ' 5' ' ' VAL . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 HG12 ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.585 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 36' ' ' GLU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.523 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 47' ' ' ARG . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' O ' HG22 ' A' ' 45' ' ' VAL . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' CB ' HG11 ' A' ' 49' ' ' VAL . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.405 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 55' ' ' LEU . 55.9 t -115.35 118.58 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 62' ' ' ASN . 5.3 ttpt -60.07 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 122' ' ' ASP . 1.3 m120 -90.74 84.86 5.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.157 -0.964 . . . . 0.0 110.237 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.523 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -54.1 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.675 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 63' ' ' TYR . 8.4 pm0 -136.77 168.86 18.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.29 45.49 1.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 110.273 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.73 30.02 11.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -74.06 108.98 7.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -1.112 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 3.7 m -91.73 -64.74 1.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.239 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 111.92 30.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 44.8 Cg_endo -73.19 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.931 1.49 . . . . 0.0 110.383 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.32 -74.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.7 mt -87.94 53.79 2.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -1.1 . . . . 0.0 109.871 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 15.7 mtpt -68.25 139.8 56.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.719 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' CB ' ' HG3' ' A' ' 93' ' ' LYS . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HA ' HD12 ' A' ' 121' ' ' LEU . 4.2 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.52 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 87' ' ' LEU . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' MET . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 88' ' ' THR . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.507 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 95' ' ' GLU . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.491 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.451 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' HG21 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.451 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.52 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 121' ' ' LEU . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.504 ' N ' HD13 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.491 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 46.9 Cg_endo -73.73 -24.81 15.31 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -9.0 59.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 110.026 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.446 ' HE2' HG23 ' A' ' 119' ' ' VAL . 6.1 ttp -87.52 -33.81 18.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.04 177.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 132' ' ' ASN . 2.7 pttt -71.27 -139.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 110.378 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.504 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -91.0 60.42 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 -179.942 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -58.81 128.65 38.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.862 0.839 . . . . 0.0 110.832 -179.808 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' CD ' ' CD2' ' A' ' 110' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.697 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.186 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.225 0.536 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -84.99 176.61 8.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.186 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.469 ' HG3' HD12 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 17' ' ' LEU . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 ' CD1' ' C ' ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 71.0 m-20 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 11' ' ' ILE . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.461 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.502 ' CE ' ' HB3' ' A' ' 40' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 47' ' ' ARG . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' C ' HG23 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.484 ' HB ' HG11 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' CB ' ' CE2' ' A' ' 63' ' ' TYR . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 55.1 t -120.38 82.1 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -72.31 -2.08 17.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 0.0 111.303 -179.757 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.447 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.4 m120 -91.25 -36.93 13.62 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.823 -1.173 . . . . 0.0 112.146 -178.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -53.66 111.11 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.888 -1.132 . . . . 0.0 109.465 -179.3 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 21.8 mm-40 -48.14 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.668 0.746 . . . . 0.0 111.119 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -64.98 1.06 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.298 179.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.78 9.06 19.68 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.78 -179.58 7.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -1.089 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 69' ' ' SER . 29.1 m -107.71 -85.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.468 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' N ' HG21 ' A' ' 68' ' ' THR . 0.4 OUTLIER -74.66 133.88 76.32 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.364 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.44 -89.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.999 1.526 . . . . 0.0 110.564 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.15 -81.55 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.86 52.27 2.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.922 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 1.0 OUTLIER -89.06 129.71 35.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 110.348 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 92' ' ' MET . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.524 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.534 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG21 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.485 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' OE2' HG13 ' A' ' 76' ' ' VAL . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.413 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.518 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.408 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.452 ' O ' HG22 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 134' ' ' GLU . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG12 HD21 ' A' ' 89' ' ' LEU . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.509 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.518 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.42 -13.73 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -20.43 60.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.287 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.424 ' HE2' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -81.36 -47.42 13.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 133' ' ' TYR . 17.8 t -87.93 134.29 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.922 . . . . 0.0 110.106 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -70.53 -79.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.94 63.07 3.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.459 ' HB3' ' HB ' ' A' ' 130' ' ' VAL . 5.3 p90 -77.01 155.15 32.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 110' ' ' LEU . 21.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.23 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.6 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.75 176.15 6.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.19 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 26' ' ' VAL . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 1.8 p-10 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 6.6 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CD1' HD23 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HG2' ' CB ' ' A' ' 15' ' ' THR . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.2 p30 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.479 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' GLY . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.468 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.406 ' OE1' HG12 ' A' ' 27' ' ' VAL . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 3' ' ' ALA . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.561 HD13 ' CE2' ' A' ' 63' ' ' TYR . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' HG22 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.517 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' CD1' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 19' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.476 ' HE2' HD13 ' A' ' 40' ' ' LEU . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' ' CD ' ' A' ' 61' ' ' LYS . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 13' ' ' ILE . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' ' CG1' ' A' ' 49' ' ' VAL . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 56' ' ' MET . 23.5 t -120.09 97.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' CD ' ' OD1' ' A' ' 46' ' ' ASN . 21.8 tttt -62.59 -59.17 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.559 179.576 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' O ' ' HE3' ' A' ' 43' ' ' MET . 11.3 t-20 -79.77 62.69 4.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.418 -0.801 . . . . 0.0 109.693 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.561 ' CE2' HD13 ' A' ' 32' ' ' ILE . 26.6 t80 -71.09 104.43 3.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE1' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -34.16 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.776 0.798 . . . . 0.0 111.875 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.59 53.82 1.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 110.285 179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.16 19.32 15.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.538 ' CG2' ' CE1' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -73.95 168.15 20.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -1.089 . . . . 0.0 110.375 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -133.65 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.828 . . . . 0.0 109.915 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 139.36 97.7 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 110.116 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.47 -88.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.103 1.58 . . . . 0.0 110.502 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.94 -82.4 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 17.8 mt -87.91 51.46 2.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -1.118 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.571 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.0 132.25 47.52 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.566 -0.709 . . . . 0.0 110.567 -179.79 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' N ' ' A' ' 118' ' ' ALA . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.461 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 63' ' ' TYR . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.515 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 75' ' ' VAL . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.462 ' CE ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.463 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.414 ' N ' HD11 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' N ' HD13 ' A' ' 102' ' ' ILE . 46.5 Cg_endo -74.05 -14.91 23.5 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.12 -3.35 58.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.4 tpp -97.2 -13.59 21.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG23 ' CE ' ' A' ' 113' ' ' MET . 21.9 t -92.66 152.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.8 mtpt -70.47 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.21 83.47 5.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -65.25 168.37 7.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.24 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.306 0.574 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -90.22 175.7 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.138 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' CG1' ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' O ' HD21 ' A' ' 51' ' ' LEU . 17.8 t-20 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.525 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 1.6 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.463 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.468 ' N ' HD21 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.525 ' HG2' ' NE2' ' A' ' 9' ' ' GLN . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.512 ' CE ' HG21 ' A' ' 41' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HG2' HG22 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.632 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 32.5 m-80 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.497 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.521 ' CB ' HG11 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 61' ' ' LYS . 98.3 t -119.37 125.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.65 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 109.789 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.515 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 1.7 t-20 -69.59 93.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.817 179.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.464 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -53.52 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 -179.286 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.471 ' OE2' ' HB2' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.62 178.42 4.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.1 . . . . 0.0 110.503 -179.588 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -86.8 59.67 5.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.535 -0.728 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.2 27.02 7.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 p -94.01 102.22 14.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -1.165 . . . . 0.0 110.223 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -81.32 -82.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.968 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 m -83.75 111.02 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 47.8 Cg_endo -73.48 -90.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.982 1.517 . . . . 0.0 110.561 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.74 -82.42 0.61 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.12 39.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.375 -1.073 . . . . 0.0 110.183 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 3.0 pttt -74.33 155.32 38.3 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.631 -0.668 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 HG11 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 123' ' ' GLN . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG13 ' CB ' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.528 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.488 HD23 ' CG ' ' A' ' 134' ' ' GLU . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 88' ' ' THR . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' VAL . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HG3' ' CG2' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.47 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.4 ' HE3' ' HG2' ' A' ' 99' ' ' PRO . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.645 ' CB ' ' CD2' ' A' ' 133' ' ' TYR . 47.1 Cg_endo -83.08 60.31 6.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.9 -72.32 0.6 Allowed 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.463 -0.773 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.513 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 21.6 ptm -101.68 2.63 38.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.454 -0.779 . . . . 0.0 111.1 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 133' ' ' TYR . 3.9 m -72.14 123.56 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.939 -1.101 . . . . 0.0 110.19 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 131' ' ' LYS . 1.9 mtmt -91.21 -10.05 43.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.294 -0.879 . . . . 0.0 110.739 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -90.67 1.9 56.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.146 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.645 ' CD2' ' CB ' ' A' ' 127' ' ' PRO . 10.8 t80 -79.5 137.84 37.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.84 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.488 ' CG ' HD23 ' A' ' 110' ' ' LEU . 24.8 mt-10 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.173 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.482 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.41 0.624 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 1' ' ' ASN . 0.3 OUTLIER -73.53 -172.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.797 . . . . 0.0 110.207 179.994 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 26' ' ' VAL . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.485 HG12 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.498 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 4.5 pt20 -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.476 HD12 ' HG3' ' A' ' 9' ' ' GLN . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.512 HG23 ' ND2' ' A' ' 14' ' ' ASN . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 13' ' ' ILE . 71.6 m-80 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLY . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' N ' HD21 ' A' ' 19' ' ' LEU . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.498 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.429 ' O ' ' CE ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.429 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.429 ' O ' ' CG ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.56 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD11 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' N ' HD11 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.485 ' CA ' HG12 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 HD11 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.1 128.03 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -152.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 63' ' ' TYR . 47.0 t30 -72.28 79.83 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.267 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.93 -102.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.323 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.6 mm-40 -106.47 -150.26 0.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 110.316 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -86.22 56.63 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.94 -25.34 75.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.15 139.06 31.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -1.119 . . . . 0.0 110.3 179.898 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.492 ' CG2' ' N ' ' A' ' 69' ' ' SER . 14.0 t -105.2 -40.67 5.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 68' ' ' THR . 3.4 m -83.69 111.07 29.33 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 45.5 Cg_endo -73.35 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.053 1.554 . . . . 0.0 110.704 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.48 -82.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 72' ' ' LEU . 6.5 mt -88.45 52.67 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -1.054 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 73' ' ' LYS . 2.3 pttp -86.1 122.29 29.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -0.757 . . . . 0.0 110.646 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG13 ' CG ' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.522 HG23 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.466 ' CG ' HG13 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG21 ' N ' ' A' ' 98' ' ' SER . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.486 ' N ' HG21 ' A' ' 97' ' ' VAL . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 HD12 ' CZ ' ' A' ' 133' ' ' TYR . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.468 ' CB ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.548 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 106' ' ' GLU . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.518 ' CB ' ' HG3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.486 HG21 ' N ' ' A' ' 125' ' ' LEU . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.534 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.479 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 49.2 Cg_endo -75.65 -14.42 19.78 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 126' ' ' MET . 3.0 p30 -80.14 -17.57 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 0.0 110.589 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 126' ' ' MET . 5.8 ptp -94.72 -17.35 22.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 133' ' ' TYR . 85.1 t -92.69 141.86 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.518 ' HG3' ' CB ' ' A' ' 116' ' ' ASN . 1.6 mmmp? -80.7 -72.55 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.348 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.5 62.15 4.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.866 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.536 ' CZ ' HD12 ' A' ' 102' ' ' ILE . 7.3 t80 -79.55 147.89 31.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 23.1 mt-10 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.276 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.251 0.548 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -179.41 4.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.425 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 55' ' ' LEU . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.502 HD12 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.515 ' ND2' HG21 ' A' ' 13' ' ' ILE . 35.7 m-80 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' HG23 ' A' ' 11' ' ' ILE . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' CD2' HD12 ' A' ' 11' ' ' ILE . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.459 ' HE2' ' HB3' ' A' ' 17' ' ' LEU . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 3' ' ' ALA . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 32' ' ' ILE . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' CG ' ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.532 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.518 HG11 ' CG2' ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CG2' HG11 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 ' CD2' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.589 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 31.4 t -98.04 134.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -84.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 179.648 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' ND2' ' CB ' ' A' ' 122' ' ' ASP . 26.1 p-10 -91.27 104.11 16.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 3.7 m-85 -74.63 -63.82 1.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.745 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -176.59 174.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.021 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.01 58.45 5.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.86 33.04 4.92 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 p -92.83 156.65 16.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -1.165 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 p -97.93 -97.98 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.7 m -82.99 128.66 64.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 110.178 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 45.6 Cg_endo -73.23 -89.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.825 1.434 . . . . 0.0 110.652 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.63 -81.1 1.0 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.62 53.24 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 109.931 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -78.86 116.54 19.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.483 -0.761 . . . . 0.0 110.598 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.512 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.481 ' O ' HD11 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 87' ' ' LEU . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.527 HG22 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.518 ' CE ' HD12 ' A' ' 87' ' ' LEU . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.588 ' N ' ' CD1' ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.624 ' N ' ' CG ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' CB ' ' ND2' ' A' ' 62' ' ' ASN . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 102' ' ' ILE . 44.8 Cg_endo -72.67 -15.13 27.23 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 4.0 m-20 -89.51 -8.26 53.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.91 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -55.26 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.7 178.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 110.065 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -80.56 -142.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.47 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 28.2 t-20 -91.72 68.03 5.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.564 ' CD2' ' OXT' ' A' ' 134' ' ' GLU . 11.2 p90 -59.41 -171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' OXT' ' CD2' ' A' ' 133' ' ' TYR . 31.2 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.29 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.232 0.539 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 175.08 9.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.467 ' HA ' HD22 ' A' ' 51' ' ' LEU . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.491 ' CD1' ' CA ' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.4 p30 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.402 ' HE1' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' C ' ' HE1' ' A' ' 22' ' ' MET . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.472 ' CG2' HG23 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' CD1' ' SD ' ' A' ' 43' ' ' MET . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.545 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' C ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' CA ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.514 ' CB ' HG11 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD22 ' HE3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 56' ' ' MET . 79.2 t -105.01 133.0 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -61.46 -146.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 179.921 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -69.98 79.04 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.087 . . . . 0.0 110.139 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 p90 -53.36 -39.27 64.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.103 -179.791 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 4.6 pt-20 176.15 170.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 179.268 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.61 -85.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.879 . . . . 0.0 110.553 -179.698 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -21.77 36.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.22 153.96 20.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -1.091 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 13.6 t -107.19 -21.34 13.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.456 ' N ' HG21 ' A' ' 68' ' ' THR . 73.3 m -84.24 111.32 32.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.297 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.1 Cg_endo -75.34 -89.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.941 1.495 . . . . 0.0 110.613 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -82.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' PRO . 1.6 pt? -88.73 39.73 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -1.036 . . . . 0.0 109.828 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.45 123.42 20.36 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.645 -0.659 . . . . 0.0 110.421 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' HB ' HD21 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.9 p-10 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 119' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 71.6 m-80 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.522 HG21 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 107' ' ' ILE . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.496 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.495 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.493 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.495 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.408 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 81' ' ' ILE . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.496 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.431 ' C ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -73.12 -24.59 16.91 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 30.4 p-10 -82.55 1.57 37.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.344 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 51.6 ttp -100.87 -21.77 15.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.6 t -92.82 164.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -70.02 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 110.133 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -90.64 71.21 6.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.9 140.84 58.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -0.799 . . . . 0.0 110.171 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.171 -179.992 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.228 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.62 170.03 14.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 49' ' ' VAL . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 0.9 OUTLIER 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' GLY . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 19' ' ' LEU . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.48 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 3' ' ' ALA . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.508 ' CG2' HG23 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' OD1' ' HE2' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' C ' HD11 ' A' ' 13' ' ' ILE . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.587 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 63' ' ' TYR . 24.1 t -101.37 127.39 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CD ' ' O ' ' A' ' 122' ' ' ASP . 1.2 ttmm -67.08 -139.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 97' ' ' VAL . 63.2 t30 -70.19 78.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.0 110.336 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 55.1 mm-40 -136.39 -141.59 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.52 44.18 1.02 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.142 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.25 -16.11 75.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.1 141.87 31.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -1.163 . . . . 0.0 110.102 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.0 p -68.6 -96.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.75 145.4 44.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.9 Cg_endo -73.3 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.995 1.524 . . . . 0.0 110.337 179.816 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.4 -74.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' PRO . 4.9 mt -84.76 52.24 2.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -1.12 . . . . 0.0 109.979 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -77.22 116.06 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.821 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 102' ' ' ILE . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 123' ' ' GLN . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 87' ' ' LEU . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 HG23 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.464 ' HE3' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 62' ' ' ASN . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.483 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.483 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 108' ' ' SER . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.498 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.462 ' CE ' HG13 ' A' ' 130' ' ' VAL . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD13 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 -26.78 15.37 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.31 -20.27 59.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.5 -46.98 7.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.167 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG13 ' CE ' ' A' ' 113' ' ' MET . 6.7 t -85.29 111.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.79 9.98 8.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -105.32 -11.64 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.97 136.37 58.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.205 179.89 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -88.8 178.07 6.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' HG21 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.454 ' O ' ' CG ' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CD1' HD11 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' CB ' HD21 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.517 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HD2' HG22 ' A' ' 53' ' ' THR . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 9' ' ' GLN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.421 ' HB ' HG12 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 61' ' ' LYS . 33.6 t -120.29 127.67 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -58.93 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.905 179.807 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' ND2' ' OG1' ' A' ' 124' ' ' THR . 14.6 m-80 -72.26 82.44 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 110.15 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.652 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.412 -0.805 . . . . 0.0 110.331 179.989 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 4.7 mm-40 -125.61 -151.6 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.945 -1.097 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.26 58.79 5.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.0 110.335 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.99 -6.7 88.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.413 ' CG2' ' OE1' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -81.17 -160.6 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.373 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.0 t -104.7 -129.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.001 179.988 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.5 t -64.18 151.41 90.5 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.933 -1.104 . . . . 0.0 109.916 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 45.0 Cg_endo -72.15 -93.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.033 1.544 . . . . 0.0 110.573 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' O ' ' HD3' ' A' ' 73' ' ' LYS . . . 66.59 -82.41 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.36 39.84 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.312 -1.111 . . . . 0.0 110.293 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -69.94 154.17 42.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.673 179.992 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.494 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 95' ' ' GLU . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.618 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 ' CA ' ' A' ' 112' ' ' GLY . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.437 HG21 ' OG1' ' A' ' 88' ' ' THR . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.42 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' CG ' HG22 ' A' ' 76' ' ' VAL . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 HG12 ' OD1' ' A' ' 62' ' ' ASN . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.577 HG22 ' CZ ' ' A' ' 133' ' ' TYR . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 108' ' ' SER . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.538 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.538 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.491 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.0 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.503 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.484 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.421 ' C ' HD13 ' A' ' 102' ' ' ILE . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.82 -20.15 22.9 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.77 -6.96 59.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.337 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -40.94 18.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 131' ' ' LYS . 85.1 t -81.83 172.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 130' ' ' VAL . 34.5 mtpt -74.73 -87.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 132' ' ' ASN . 38.1 p-10 -101.96 79.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.577 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 20.7 t80 -62.22 153.89 29.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.117 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.279 -179.959 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.264 0.554 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 179.25 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 ' CE ' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG12 ' CA ' ' A' ' 54' ' ' THR . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' HD13 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 42' ' ' GLY . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 26' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.505 HD11 ' CD1' ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.518 ' CB ' HD22 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.635 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.499 ' SD ' ' CG ' ' A' ' 55' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 76.2 m-20 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.5 ' CA ' HG12 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.464 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 59' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 17.5 t -114.85 138.99 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -69.21 -95.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 2.8 t-20 -90.96 67.21 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.03 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.521 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . 1.7 p90 -53.56 -39.59 64.87 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.176 -0.952 . . . . 0.0 110.292 -179.703 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 2.5 pt-20 -178.37 -149.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 179.468 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.31 43.91 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.257 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 27.3 19.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -78.95 169.09 18.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.212 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.9 p -82.67 -150.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.271 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -67.8 153.96 94.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 110.336 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' CB ' ' HD2' ' A' ' 73' ' ' LYS . 44.9 Cg_endo -71.68 -153.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.123 1.591 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.61 -74.39 1.55 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.9 mt -88.04 50.46 1.99 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -1.091 . . . . 0.0 109.852 179.619 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.8 mtpm? -79.65 121.21 25.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.434 -0.791 . . . . 0.0 110.408 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.463 ' CG ' ' O ' ' A' ' 83' ' ' ILE . 9.7 p30 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.53 HG23 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.517 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 62' ' ' ASN . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.53 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.455 ' HE2' ' OD2' ' A' ' 128' ' ' ASP . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.63 -30.23 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 34.1 p-10 -71.98 -26.34 62.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.468 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -80.3 -54.65 5.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 0.0 110.01 179.838 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 133' ' ' TYR . 76.3 t -86.06 98.12 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -90.21 18.67 5.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.148 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 38.5 t30 -111.55 -18.54 12.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 163.03 16.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.296 179.995 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.137 179.969 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.456 ' O ' HG12 ' A' ' 26' ' ' VAL . 4.9 t-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.294 0.569 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 176.12 9.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' CA ' HG21 ' A' ' 26' ' ' VAL . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.465 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.53 ' CD1' HD22 ' A' ' 17' ' ' LEU . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 12.9 p30 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' CD1' ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.439 ' HG2' HG12 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 1' ' ' ASN . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' CG2' HG22 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' OG1' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 32' ' ' ILE . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 64' ' ' GLU . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.485 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 14' ' ' ASN . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 11' ' ' ILE . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HD2' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 50' ' ' PRO . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.485 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HB2' ' OH ' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.485 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG13 ' HE3' ' A' ' 43' ' ' MET . 21.6 t -119.47 123.6 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 179.556 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -91.41 108.75 20.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.974 179.399 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.453 ' OH ' ' HB2' ' A' ' 57' ' ' PRO . 2.8 m-85 -62.92 -59.02 5.42 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.123 -0.986 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -141.89 -177.32 5.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.989 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.1 58.88 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.79 48.07 1.0 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 p -94.14 168.35 10.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.288 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.34 -140.0 0.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -64.37 138.15 97.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.996 179.856 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' O ' ' CD1' ' A' ' 72' ' ' LEU . 46.1 Cg_endo -72.04 -93.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.947 1.498 . . . . 0.0 110.454 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.93 -81.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -85.77 29.85 0.68 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -1.118 . . . . 0.0 111.821 -179.549 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pttt -67.13 151.84 46.86 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.33 -0.856 . . . . 0.0 110.262 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.52 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.513 HG21 ' CA ' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 92' ' ' MET . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.459 ' SD ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 62' ' ' ASN . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.481 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.521 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.509 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 108' ' ' SER . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.509 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.514 HG12 ' NE2' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.481 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' C ' ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.14 -8.56 22.26 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.38 -21.58 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 0.2 OUTLIER -84.71 -50.88 7.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.278 -179.926 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.0 t -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 110.285 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -89.76 -1.46 58.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 132' ' ' ASN . 29.3 t-20 -92.42 0.8 57.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.156 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -71.82 167.19 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.244 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.221 -179.971 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 170.31 16.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.934 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 26' ' ' VAL . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 21' ' ' MET . 3.2 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 HG12 ' HE1' ' A' ' 21' ' ' MET . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HD2' HG21 ' A' ' 11' ' ' ILE . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 14' ' ' ASN . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' HG21 ' A' ' 13' ' ' ILE . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 20' ' ' ILE . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 18' ' ' THR . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.408 ' SD ' ' CD1' ' A' ' 37' ' ' ILE . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.404 ' O ' ' CG ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.577 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 36' ' ' GLU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.514 ' CE ' HD11 ' A' ' 40' ' ' LEU . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' NE ' ' SD ' ' A' ' 59' ' ' MET . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CB ' HG11 ' A' ' 49' ' ' VAL . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.463 ' HG3' ' HE1' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 40.9 t -114.98 128.63 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -63.11 -96.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 3.9 m120 -90.65 107.43 19.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.03 . . . . 0.0 109.969 179.641 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.593 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 0.8 OUTLIER -74.86 -50.54 16.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 0.0 109.409 179.94 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -158.15 178.75 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.945 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.66 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 110.125 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.62 58.77 0.59 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 p -79.03 145.58 33.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -1.149 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.6 t -74.66 -134.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -64.14 113.14 9.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HB2' ' CD ' ' A' ' 73' ' ' LYS . 46.9 Cg_endo -72.26 -95.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.959 1.505 . . . . 0.0 110.371 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 65.17 -76.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.72 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 pt? -86.06 41.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -1.166 . . . . 0.0 110.772 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -66.44 112.89 4.3 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 110.338 179.795 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' O ' HD12 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.498 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.498 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.53 ' CG2' ' N ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 113' ' ' MET . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.494 ' CG2' ' HG3' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.494 ' HG3' ' CG2' ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.487 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HA ' ' CD1' ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.32 -19.31 19.76 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 2.5 p30 -85.73 -17.94 34.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.451 ' HG3' ' HD3' ' A' ' 117' ' ' ARG . 2.0 tpt -90.28 -32.65 16.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 131' ' ' LYS . 71.5 t -86.22 172.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.466 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 22.3 pttt -70.35 -139.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 7.9 m120 -91.26 70.2 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.92 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -59.27 159.0 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.453 -179.805 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.173 -179.975 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 2' ' ' LYS . 8.5 p30 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' O ' ' OD1' ' A' ' 1' ' ' ASN . 11.4 mttt -83.47 177.52 8.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.09 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 34' ' ' ALA . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 27' ' ' VAL . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.403 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' HE1' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.504 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 6' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.414 ' HE1' ' O ' ' A' ' 30' ' ' MET . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 ' CG2' ' HD2' ' A' ' 33' ' ' PRO . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 11.9 m120 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 37' ' ' ILE . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.477 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.424 ' CA ' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HD2' HG11 ' A' ' 49' ' ' VAL . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 64.9 t -120.04 127.28 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.35 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 0.0 109.755 179.669 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 63' ' ' TYR . 52.7 t30 -70.82 69.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 109.825 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.92 -103.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.747 . . . . 0.0 110.627 -179.941 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 pt-20 -82.8 171.43 13.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.066 . . . . 0.0 110.264 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -85.91 -87.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.377 -0.827 . . . . 0.0 110.041 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.19 3.25 69.16 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 p -94.09 120.3 34.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -1.165 . . . . 0.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.2 p -86.65 -65.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.056 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.95 142.23 72.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 48.2 Cg_endo -73.51 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.079 1.568 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.91 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' PRO . 10.4 mt -82.61 51.99 1.99 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.16 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -67.15 126.59 29.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 110.449 -179.905 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 ' CG1' ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.526 HG22 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.526 ' CG2' HG22 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.538 HG23 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.515 ' SD ' ' CG1' ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.403 ' CG2' ' OD1' ' A' ' 62' ' ' ASN . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.525 ' CG1' ' HA ' ' A' ' 104' ' ' SER . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.468 ' HA ' HG22 ' A' ' 111' ' ' VAL . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 ' C ' ' HG2' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.538 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.425 ' HG2' ' C ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 117' ' ' ARG . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' N ' ' CD1' ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.504 ' CG ' ' HE3' ' A' ' 129' ' ' MET . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.5 -29.72 8.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.21 3.55 10.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.558 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.504 ' HE3' ' CG ' ' A' ' 126' ' ' MET . 6.8 ttp -94.47 -45.03 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.327 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 t -81.43 123.69 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mmpp? -78.24 -20.04 52.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.074 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -93.01 14.51 17.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.12 108.74 4.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.197 179.862 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 t30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.241 0.543 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -74.42 173.9 9.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' CB ' HD13 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 HG12 ' CD2' ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 11' ' ' ILE . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.441 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.536 ' CD1' ' HG2' ' A' ' 64' ' ' GLU . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 40' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.593 ' CG1' ' CG2' ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.593 ' CG2' ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.455 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.411 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.455 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 HD23 ' A' ' 55' ' ' LEU . 69.3 t -120.03 140.12 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HE2' ' OG1' ' A' ' 124' ' ' THR . 0.0 OUTLIER -63.02 -145.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.834 179.797 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 t-20 -70.12 76.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -53.38 -33.92 55.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.705 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 1.8 pt-20 -172.75 -161.94 0.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.988 -1.07 . . . . 0.0 110.705 179.432 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -86.35 58.99 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 -179.688 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.42 -15.08 74.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.761 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -94.1 120.78 34.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -84.64 -68.53 0.71 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.6 m -76.57 126.8 85.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.176 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.5 Cg_endo -73.46 -92.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.369 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 63.23 -73.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.777 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' PRO . 6.8 mt -87.87 53.93 2.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.131 . . . . 0.0 110.109 -179.879 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -75.64 125.06 28.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.506 -0.746 . . . . 0.0 110.28 -179.943 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 HG12 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.6 p30 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' THR . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' O ' ' OG1' ' A' ' 85' ' ' THR . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.497 ' CG2' HG22 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.546 ' CE ' ' CD1' ' A' ' 87' ' ' LEU . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.502 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' CE ' HD11 ' A' ' 72' ' ' LEU . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 88' ' ' THR . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 118' ' ' ALA . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.53 ' N ' ' CG ' ' A' ' 117' ' ' ARG . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' CA ' HD12 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.1 -14.2 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.74 -20.58 29.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.468 ' HG2' ' CD ' ' A' ' 117' ' ' ARG . 6.9 mtt -90.55 -49.47 6.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.189 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -86.23 116.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.32 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 3.87 30.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.147 179.95 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -95.01 -7.34 40.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.178 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -65.29 136.49 56.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.152 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.201 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.247 0.546 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.561 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 22' ' ' MET . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 13' ' ' ILE . 14.9 m120 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.698 ' CE ' HD12 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.561 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 55' ' ' LEU . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 5' ' ' VAL . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 ' CE ' ' A' ' 22' ' ' MET . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 49' ' ' VAL . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.588 HG21 HG11 ' A' ' 45' ' ' VAL . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.73 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.73 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.799 HG23 ' SD ' ' A' ' 56' ' ' MET . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.857 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.799 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.857 HG21 ' CD2' ' A' ' 55' ' ' LEU . 22.8 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.195 0.522 . . . . 0.0 110.146 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG11 ' SD ' ' A' ' 92' ' ' MET . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.54 HD12 HD23 ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.724 HG23 HG21 ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.632 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 83' ' ' ILE . 2.8 t30 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.714 ' OG1' HG22 ' A' ' 90' ' ' VAL . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.731 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.714 HG22 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.594 ' N ' HG23 ' A' ' 90' ' ' VAL . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 87' ' ' LEU . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.673 ' HG3' HG23 ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.673 HG23 ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 127' ' ' PRO . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.945 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 113' ' ' MET . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.826 HG22 ' H ' ' A' ' 117' ' ' ARG . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.826 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.002 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 1.002 ' N ' HD12 ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.551 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 10' ' ' LEU . 3.1 pt20 -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 15' ' ' THR . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 34.5 m120 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 11' ' ' ILE . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.56 ' HE2' ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.756 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.852 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.582 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 15.0 m120 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.494 ' HB ' HG13 ' A' ' 49' ' ' VAL . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.756 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.328 0.585 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.589 ' O ' HD13 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.951 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.647 HG23 HG21 ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.671 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.647 HG21 HG23 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.627 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 127' ' ' PRO . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.534 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE1' HD11 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' ILE . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD11 ' OE1' ' A' ' 106' ' ' GLU . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.627 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.879 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.555 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.951 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 126' ' ' MET . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.659 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.885 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.684 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 22' ' ' MET . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.59 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.914 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.44 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.914 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 11' ' ' ILE . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.519 ' HE3' HD23 ' A' ' 17' ' ' LEU . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG22 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.76 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.628 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.628 HD13 ' CB ' ' A' ' 36' ' ' GLU . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 55' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.847 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.847 HG21 HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.59 ' CA ' HG13 ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' MET . 52.4 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.389 0.614 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 102' ' ' ILE . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 87' ' ' LEU . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' HG21 ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 92' ' ' MET . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.994 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.197 0.522 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 37' ' ' ILE . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.449 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m120 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD21 HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.531 ' CG ' HG13 ' A' ' 5' ' ' VAL . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.764 HD12 HD12 ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.624 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.855 ' HD2' HG21 ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.855 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 29' ' ' PRO . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.764 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 104' ' ' SER . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 123' ' ' GLN . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 81' ' ' ILE . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 80' ' ' LEU . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.652 HD11 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.899 HD13 ' N ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 90' ' ' VAL . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.597 ' N ' HG13 ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.557 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.968 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.674 ' HB3' HG22 ' A' ' 75' ' ' VAL . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.479 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ILE . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 115' ' ' VAL . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.586 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.637 ' HB ' HD12 ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.76 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 76' ' ' VAL . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.65 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.968 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.254 0.549 . . . . 0.0 110.31 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.659 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 54' ' ' THR . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.879 HD13 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.879 ' CD2' HD13 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.982 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.029 HG21 HG13 ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.002 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.452 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.324 0.583 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.77 ' O ' HD23 ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.002 HG22 ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.968 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.968 ' N ' HD13 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.678 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.617 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.2 p-10 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.726 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 90' ' ' VAL . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG23 ' A' ' 90' ' ' VAL . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.726 ' SD ' HD12 ' A' ' 87' ' ' LEU . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 98' ' ' SER . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.937 HD12 ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' CD ' ' A' ' 105' ' ' GLU . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' CD ' ' HG2' ' A' ' 103' ' ' PRO . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.996 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.941 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.546 ' CB ' ' HE1' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.656 ' C ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 1.002 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.014 HD12 ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 1.014 ' CD ' HD12 ' A' ' 125' ' ' LEU . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.328 0.585 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.786 ' CD1' HD23 ' A' ' 17' ' ' LEU . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.597 HG21 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.786 HD23 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG2' HG13 ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.751 HG22 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.751 ' SD ' HG22 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.706 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.889 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 5' ' ' VAL . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' HD12 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.528 ' CA ' HG13 ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.463 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.463 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.302 0.573 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HB ' HD23 ' A' ' 125' ' ' LEU . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.053 HD11 ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.609 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.427 ' CE ' HG12 ' A' ' 81' ' ' ILE . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.053 ' CE ' HD11 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 102' ' ' ILE . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 125' ' ' LEU . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.081 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.081 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.785 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.609 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.625 ' OD1' HD12 ' A' ' 121' ' ' LEU . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD23 ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.759 ' N ' HD12 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.256 0.551 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.823 ' HG2' HG13 ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 3' ' ' ALA . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 40' ' ' LEU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.644 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.742 HD11 HG21 ' A' ' 32' ' ' ILE . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.62 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 45' ' ' VAL . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 13' ' ' ILE . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.898 HG21 HG13 ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.714 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 110.423 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' OE1' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 80' ' ' LEU . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 85' ' ' THR . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.051 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.964 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.606 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' HE2' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 91' ' ' MET . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.523 ' N ' HG23 ' A' ' 90' ' ' VAL . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.964 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' A' ' 127' ' ' PRO . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.556 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.051 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.742 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.723 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.679 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 51' ' ' LEU . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.673 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HE2' HG22 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 26' ' ' VAL . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.866 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.862 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD23 ' CB ' ' A' ' 36' ' ' GLU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.673 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.723 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 56' ' ' MET . 44.6 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 74' ' ' SER . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 85' ' ' THR . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.579 HG22 ' OD1' ' A' ' 84' ' ' ASN . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.579 ' OD1' HG22 ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 81' ' ' ILE . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 111' ' ' VAL . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 90' ' ' VAL . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.941 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 125' ' ' LEU . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.014 ' O ' HG23 ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 107' ' ' ILE . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.014 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 126' ' ' MET . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.721 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.246 0.546 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.608 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.851 HG13 ' HG2' ' A' ' 22' ' ' MET . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.687 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 p-10 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.851 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 55' ' ' LEU . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.57 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 53' ' ' THR . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.99 ' HB ' HG13 ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 HD11 ' A' ' 55' ' ' LEU . 19.4 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.301 0.572 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 104' ' ' SER . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HD23 ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.559 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.54 ' OG1' HG12 ' A' ' 90' ' ' VAL . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.559 ' CE ' HD12 ' A' ' 87' ' ' LEU . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.623 ' OE2' HG11 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 75' ' ' VAL . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.735 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.735 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.784 HD11 HD12 ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.724 ' N ' HD12 ' A' ' 125' ' ' LEU . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.446 ' N ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.299 0.571 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.772 HG13 HD21 ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HB ' HG22 ' A' ' 11' ' ' ILE . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.772 HD21 HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.727 ' CE ' HD12 ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' C ' HG13 ' A' ' 27' ' ' VAL . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HE2' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.052 HD12 HD12 ' A' ' 55' ' ' LEU . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.727 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.59 HD12 ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.572 ' CE ' HG11 ' A' ' 60' ' ' VAL . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.632 HG23 ' CG ' ' A' ' 56' ' ' MET . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.052 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.632 ' CG ' HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG11 ' CE ' ' A' ' 43' ' ' MET . 6.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 123' ' ' GLN . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 121' ' ' LEU . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.625 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 115' ' ' VAL . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.497 HG22 ' OG1' ' A' ' 88' ' ' THR . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 98' ' ' SER . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.557 HD11 ' CA ' ' A' ' 127' ' ' PRO . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.058 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.803 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.803 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 126' ' ' MET . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.653 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.253 0.549 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG13 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.43 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.646 ' HG2' HG13 ' A' ' 5' ' ' VAL . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.589 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.818 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.611 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 45' ' ' VAL . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 49' ' ' VAL . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.642 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.818 HD11 ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.416 0.627 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HB ' HD23 ' A' ' 125' ' ' LEU . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.764 HG23 HG21 ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.764 HG21 HG23 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.07 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.805 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.07 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' SER . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 125' ' ' LEU . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.0 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 85' ' ' THR . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.7 tp-100 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.586 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.574 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.167 0.508 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.525 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.594 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 17' ' ' LEU . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.2 p-10 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.804 ' HE2' HD12 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG22 ' CA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.009 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.804 HD12 ' HE2' ' A' ' 22' ' ' MET . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 43' ' ' MET . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.756 HG21 HG13 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.521 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.438 ' CG ' HG23 ' A' ' 54' ' ' THR . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.635 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.61 HG12 ' SD ' ' A' ' 92' ' ' MET . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.995 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.995 ' N ' HD13 ' A' ' 80' ' ' LEU . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.757 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.607 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.5 p-10 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.538 HG22 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 75' ' ' VAL . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.635 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' ILE . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.789 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.789 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.757 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 102' ' ' ILE . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' LEU . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.702 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.228 0.537 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 4' ' ' SER . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 4.1 p-10 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 HG23 ' HE3' ' A' ' 21' ' ' MET . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.895 ' HB2' HG22 ' A' ' 5' ' ' VAL . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.827 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.595 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.944 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.944 HG21 HG13 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.421 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.288 0.566 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.541 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' CB ' HG11 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.829 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.5 t30 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.802 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 82' ' ' PRO . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.614 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.1 p-10 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.625 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.89 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.89 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 76' ' ' VAL . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.953 HD12 HD11 ' A' ' 125' ' ' LEU . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.033 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.033 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.911 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 34.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.07 HD12 ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 1.07 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.665 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.269 0.556 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 55' ' ' LEU . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.685 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.893 ' CG2' HD21 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.8 p-10 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD21 ' CG2' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' MET . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.503 ' HE1' HG13 ' A' ' 60' ' ' VAL . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG13 HG21 ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 HG13 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.732 ' CA ' HG13 ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 56' ' ' MET . 40.5 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.317 0.58 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.764 HG13 ' SD ' ' A' ' 92' ' ' MET . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 124' ' ' THR . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.1 p-10 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 85' ' ' THR . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.845 HG21 HG23 ' A' ' 81' ' ' ILE . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.764 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 127' ' ' PRO . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.038 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 113' ' ' MET . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.038 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.452 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.809 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.509 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.585 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.836 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.212 0.529 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.625 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.467 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.556 ' H ' ' HE2' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.556 ' HE2' ' H ' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.625 ' CG ' HG13 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.681 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 6' ' ' VAL . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.938 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.692 ' HE1' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 45' ' ' VAL . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.509 ' CB ' HG13 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.938 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 4.3 pttt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.317 0.579 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 107' ' ' ILE . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 124' ' ' THR . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 2.8 m120 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.989 ' N ' HD13 ' A' ' 80' ' ' LEU . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.642 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.613 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.1 p-10 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.981 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.981 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 HG21 ' A' ' 76' ' ' VAL . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 127' ' ' PRO . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.022 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.022 HG23 ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.606 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 126' ' ' MET . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.834 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.835 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.255 0.55 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.961 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.961 ' CD2' HD13 ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.698 ' SD ' HD23 ' A' ' 17' ' ' LEU . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 26' ' ' VAL . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.765 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' HG21 ' A' ' 54' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD12 ' A' ' 55' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.672 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.672 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.578 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.788 ' CG ' HD12 ' A' ' 17' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 13' ' ' ILE . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.61 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.61 HG21 HG13 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.623 HG21 ' HD2' ' A' ' 29' ' ' PRO . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.747 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.458 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.179 0.514 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG11 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.593 ' ND2' ' OD2' ' A' ' 122' ' ' ASP . 12.0 t-20 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 85' ' ' THR . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.709 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.501 ' SD ' HG11 ' A' ' 75' ' ' VAL . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 102' ' ' ILE . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 109' ' ' LYS . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.967 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.709 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 115' ' ' VAL . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.909 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 120' ' ' TYR . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.588 ' N ' HG12 ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 78' ' ' ASN . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.979 ' N ' HD12 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.223 0.535 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.76 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.857 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.5 p-10 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.76 ' HG2' HG13 ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 3' ' ' ALA . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' THR . 3.9 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.005 HG21 HG13 ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.7 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG13 ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.606 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 27.9 m120 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.74 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.67 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.71 HG23 ' H ' ' A' ' 91' ' ' MET . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.71 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.566 ' SD ' HG13 ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.073 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 107' ' ' ILE . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.74 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.865 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 126' ' ' MET . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.731 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.212 0.529 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.716 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.1 p-10 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.551 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.584 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.438 ' CG ' ' O ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 45' ' ' VAL . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.73 ' HB ' HD23 ' A' ' 125' ' ' LEU . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 97' ' ' VAL . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 28.7 t30 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.582 ' HB ' HG21 ' A' ' 85' ' ' THR . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.632 ' O ' HD23 ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.692 HG22 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.447 ' HG3' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 76' ' ' VAL . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.962 HD11 ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.586 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.692 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.933 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.933 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.73 HD23 ' HB ' ' A' ' 75' ' ' VAL . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.671 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.962 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.2 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.663 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.021 HD13 HD21 ' A' ' 17' ' ' LEU . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.7 m120 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.021 HD21 HD13 ' A' ' 11' ' ' ILE . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.87 ' HE3' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 ' CA ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' C ' HG23 ' A' ' 5' ' ' VAL . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.604 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.67 ' HE2' HG11 ' A' ' 60' ' ' VAL . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' THR . 17.3 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' VAL . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 HG21 ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.517 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.67 HG11 ' HE2' ' A' ' 43' ' ' MET . 11.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.311 0.577 . . . . 0.0 110.713 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.83 ' HB ' HD23 ' A' ' 125' ' ' LEU . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 74' ' ' SER . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.033 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 83' ' ' ILE . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 81' ' ' ILE . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.582 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.578 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.77 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.675 HD11 ' CA ' ' A' ' 127' ' ' PRO . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.923 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.923 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.6 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.033 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.829 ' N ' HD12 ' A' ' 125' ' ' LEU . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.675 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.182 0.515 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 22' ' ' MET . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.77 HD13 ' CD2' ' A' ' 17' ' ' LEU . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.477 ' H ' HG22 ' A' ' 45' ' ' VAL . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.77 ' CD2' HD13 ' A' ' 11' ' ' ILE . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.448 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.548 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.527 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 15' ' ' THR . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.708 HG13 HG21 ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 HG13 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.812 ' CA ' HG13 ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.705 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.593 HG21 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.198 0.523 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.954 HG13 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 124' ' ' THR . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.673 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.976 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.976 ' N ' HD13 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' OD1' ' A' ' 84' ' ' ASN . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.718 ' OD1' HG22 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 90' ' ' VAL . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.954 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE2' HG11 ' A' ' 76' ' ' VAL . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 98' ' ' SER . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 97' ' ' VAL . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.505 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.688 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.973 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.492 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.914 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.914 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.939 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.373 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.834 HG13 ' HG3' ' A' ' 22' ' ' MET . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' CA ' ' A' ' 54' ' ' THR . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.472 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.514 HG13 HD21 ' A' ' 17' ' ' LEU . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.7 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.7 p-10 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.826 HD12 ' HG3' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG3' ' OE1' ' A' ' 9' ' ' GLN . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.834 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD13 ' A' ' 55' ' ' LEU . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.705 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.893 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.893 ' HD3' HG22 ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 36' ' ' GLU . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.789 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.826 ' HG3' HD12 ' A' ' 17' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 50' ' ' PRO . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.567 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG21 ' CD2' ' A' ' 55' ' ' LEU . 50.5 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.525 0.679 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG12 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 123' ' ' GLN . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.744 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 22.7 m120 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.684 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 75' ' ' VAL . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 98' ' ' SER . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.668 HD11 ' HA ' ' A' ' 127' ' ' PRO . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.075 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.846 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.846 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 126' ' ' MET . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.792 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.668 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.196 0.522 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.754 HG12 HD23 ' A' ' 55' ' ' LEU . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' HD23 ' A' ' 51' ' ' LEU . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 15' ' ' THR . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 46' ' ' ASN . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.4 p-10 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 11' ' ' ILE . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.663 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.998 HD12 HD12 ' A' ' 55' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD22 ' CE ' ' A' ' 43' ' ' MET . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.556 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.721 ' CE ' HD22 ' A' ' 40' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.728 HG21 HG13 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.998 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG11 ' HE2' ' A' ' 43' ' ' MET . 51.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.313 0.578 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.879 ' C ' HD12 ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.879 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 5.2 m120 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.766 ' O ' HD23 ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.712 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.8 HD11 ' CA ' ' A' ' 127' ' ' PRO . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.003 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.792 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.792 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.693 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 79' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 99' ' ' PRO . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 126' ' ' MET . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.754 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.8 ' CA ' HD11 ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 37' ' ' ILE . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.757 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 17' ' ' LEU . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 4.1 p-10 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 11' ' ' ILE . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.729 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.825 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 40' ' ' LEU . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.815 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.815 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.479 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.825 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.315 0.579 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.766 HG12 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.627 HG21 HG11 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.668 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' LEU . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.673 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.425 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.547 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' HG12 ' A' ' 75' ' ' VAL . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 127' ' ' PRO . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 75' ' ' VAL . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.895 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.479 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 115' ' ' VAL . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.673 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.5 tt0 -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 126' ' ' MET . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.767 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.891 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.416 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.676 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.9 p-10 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 12' ' ' PRO . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD12 ' CG ' ' A' ' 43' ' ' MET . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 3' ' ' ALA . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 54' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.739 HD12 HD12 ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 37' ' ' ILE . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 40' ' ' LEU . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.476 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.658 ' CB ' HG13 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 29' ' ' PRO . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.739 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 43' ' ' MET . 77.2 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.324 0.583 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.894 ' HB ' HD23 ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 124' ' ' THR . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.845 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.845 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 83' ' ' ILE . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.856 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 114' ' ' GLN . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.556 ' HA ' HG13 ' A' ' 111' ' ' VAL . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.789 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.037 HG13 HD11 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.53 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' A' ' 113' ' ' MET . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 117' ' ' ARG . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.91 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD1' HD12 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.729 ' O ' HG13 ' A' ' 76' ' ' VAL . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.776 ' HA ' HG22 ' A' ' 76' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.511 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 22' ' ' MET . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' CG2' ' A' ' 27' ' ' VAL . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.739 ' O ' HD23 ' A' ' 51' ' ' LEU . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.735 HD12 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.624 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.735 ' CE ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HG2' HG13 ' A' ' 5' ' ' VAL . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.725 ' CG2' HG21 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.991 HD12 HD12 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CB ' HD13 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.628 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.628 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.736 ' CB ' HG13 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.453 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CA ' HD11 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.263 0.554 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.878 HG13 ' SD ' ' A' ' 92' ' ' MET . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.619 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 t30 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.662 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.878 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.744 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 76' ' ' VAL . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.063 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.571 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.629 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.503 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.662 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.773 HD12 ' N ' ' A' ' 126' ' ' MET . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.773 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.172 0.51 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.587 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' A' ' 22' ' ' MET . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.766 ' O ' HD23 ' A' ' 51' ' ' LEU . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.458 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG21 ' A' ' 15' ' ' THR . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.547 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.587 HG22 ' CA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.938 ' CG2' HD21 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.938 HD21 ' CG2' ' A' ' 32' ' ' ILE . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' MET . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 49' ' ' VAL . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CB ' HG13 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.293 0.568 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.001 HG13 ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 74' ' ' SER . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.998 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.833 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 83.2 m-20 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.001 ' HG3' HG13 ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 124' ' ' THR . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.87 HD11 ' HA ' ' A' ' 127' ' ' PRO . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 75' ' ' VAL . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.047 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 106' ' ' GLU . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.9 ' H ' HG22 ' A' ' 115' ' ' VAL . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.79 HG23 HD11 ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.547 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.998 HD23 HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 99' ' ' PRO . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.806 HD11 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.701 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.87 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.284 0.564 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' HD23 ' A' ' 51' ' ' LEU . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 6.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG13 HD21 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.648 HD21 HG13 ' A' ' 11' ' ' ILE . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.643 HD23 ' CE ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.631 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' HD23 ' A' ' 19' ' ' LEU . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.615 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.591 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD2' HG21 ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.796 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 15.7 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.413 0.625 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 102' ' ' ILE . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 121' ' ' LEU . 6.3 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' HD22 ' A' ' 121' ' ' LEU . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.637 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 81' ' ' ILE . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.807 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 76' ' ' VAL . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.753 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' CD ' HD11 ' A' ' 110' ' ' LEU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD11 ' CD ' ' A' ' 106' ' ' GLU . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.807 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.469 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.995 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.9 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 22' ' ' MET . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' HD11 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.672 HD12 ' HE3' ' A' ' 21' ' ' MET . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.781 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.62 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.9 m120 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.775 HD12 ' HG3' ' A' ' 43' ' ' MET . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 22' ' ' MET . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.672 ' HE3' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 5' ' ' VAL . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.714 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.053 ' CB ' HD13 ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.677 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.053 HD13 ' CB ' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD12 ' A' ' 17' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 49' ' ' VAL . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' C ' HG22 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 45' ' ' VAL . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 55' ' ' LEU . 55.1 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.242 0.544 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 104' ' ' SER . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.58 HG13 ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.638 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.757 HD23 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.638 HG22 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.601 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.637 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 75' ' ' VAL . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.948 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.834 ' H ' HG22 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' HG22 ' A' ' 76' ' ' VAL . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.249 0.547 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.585 HG23 ' C ' ' A' ' 33' ' ' PRO . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.857 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.648 ' O ' HD23 ' A' ' 51' ' ' LEU . 9.9 p30 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.3 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.96 HG23 HD21 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.494 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.96 HD21 HG23 ' A' ' 11' ' ' ILE . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.532 ' CG ' HG13 ' A' ' 5' ' ' VAL . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.649 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.756 ' CG2' HG21 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.822 HD12 HD12 ' A' ' 55' ' ' LEU . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.793 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.507 ' HE3' ' HG ' ' A' ' 40' ' ' LEU . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' PRO . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.552 ' O ' HG23 ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 56' ' ' MET . 23.5 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.329 0.585 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG11 ' SD ' ' A' ' 92' ' ' MET . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.62 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.846 HG22 ' OD1' ' A' ' 84' ' ' ASN . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.846 ' OD1' HG22 ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 98' ' ' SER . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.604 HD11 ' CA ' ' A' ' 127' ' ' PRO . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.024 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 88' ' ' THR . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.721 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 126' ' ' MET . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.781 ' N ' HD12 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.604 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.5 Cg_endo . . . . . 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.242 0.544 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.668 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.726 HG13 ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.726 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 7.0 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.8 p-10 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.726 ' HG3' HG13 ' A' ' 5' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.571 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.921 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG22 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.542 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.738 HG21 HG11 ' A' ' 45' ' ' VAL . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.624 ' CB ' HG13 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.571 HG21 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' CE ' ' A' ' 43' ' ' MET . 98.3 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.0 pttt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.757 HG12 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 97' ' ' VAL . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.533 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.737 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ILE . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.789 ' O ' HD23 ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 104' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.461 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 124' ' ' THR . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.699 HD12 HD11 ' A' ' 125' ' ' LEU . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 110' ' ' LEU . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.851 ' O ' HG23 ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 106' ' ' GLU . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.89 HG22 ' H ' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.89 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.912 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.912 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.222 0.534 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 33' ' ' PRO . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' HE3' ' A' ' 21' ' ' MET . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m120 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HE1' ' A' ' 21' ' ' MET . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.729 ' HE3' HD12 ' A' ' 11' ' ' ILE . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.712 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 6' ' ' VAL . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.637 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.566 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' NE2' HD23 ' A' ' 121' ' ' LEU . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 2.3 pttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.305 0.574 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.98 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.98 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.7 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.65 HG22 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.543 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.549 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.041 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.896 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.896 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.663 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.255 0.55 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 22' ' ' MET . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' ' 13' ' ' ILE . 23.2 m120 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.681 HD12 ' CG ' ' A' ' 43' ' ' MET . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.496 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.595 ' HG3' HG13 ' A' ' 5' ' ' VAL . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.555 ' OE1' HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 ' OE1' ' A' ' 25' ' ' GLU . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.602 HG22 ' SD ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.83 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.83 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.969 ' CE ' HG11 ' A' ' 60' ' ' VAL . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 45' ' ' VAL . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.473 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 29' ' ' PRO . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.969 HG11 ' CE ' ' A' ' 43' ' ' MET . 31.4 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.745 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.558 HG21 ' CD ' ' A' ' 95' ' ' GLU . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.846 HG23 HG21 ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.015 HD13 ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.8 t-20 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.846 HG21 HG23 ' A' ' 81' ' ' ILE . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.649 HG23 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.745 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' CD ' HG21 ' A' ' 76' ' ' VAL . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.017 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.649 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.552 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.82 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.82 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.015 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.009 HD23 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.751 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.265 0.555 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG23 ' HB2' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.456 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 17' ' ' LEU . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.3 p-10 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.55 HG21 HG23 ' A' ' 11' ' ' ILE . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD21 HG21 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.495 ' HE1' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.639 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.916 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.932 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 40' ' ' LEU . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 60' ' ' VAL . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.782 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG13 ' CB ' ' A' ' 53' ' ' THR . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.731 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 45' ' ' VAL . 79.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.421 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.814 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.4 p30 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.728 ' CD1' HG11 ' A' ' 115' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.871 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 33.9 m120 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.505 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.56 ' HE2' HD22 ' A' ' 125' ' ' LEU . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.505 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.513 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.893 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.593 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.882 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.847 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.266 0.555 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.879 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.63 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 7' ' ' ALA . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 8.1 m-20 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 17' ' ' LEU . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.432 ' CG ' HG13 ' A' ' 5' ' ' VAL . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.676 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.806 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.806 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.576 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 45' ' ' VAL . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.657 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.856 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.856 HG21 HG13 ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.879 ' CA ' HG13 ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.759 HG21 ' CD1' ' A' ' 55' ' ' LEU . 24.1 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.31 0.576 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 125' ' ' LEU . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.569 ' N ' HD23 ' A' ' 80' ' ' LEU . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.551 HG21 HG23 ' A' ' 81' ' ' ILE . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.625 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.466 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.625 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.771 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.771 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.488 ' N ' HD12 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.249 0.547 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.563 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 22' ' ' MET . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 27' ' ' VAL . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.631 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.461 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.5 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.563 HG22 ' CA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.068 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.573 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 13' ' ' ILE . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.87 HG11 ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.609 ' O ' HD13 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.653 HG23 ' CG2' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.653 ' CG2' HG23 ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.662 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 91' ' ' MET . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.599 ' N ' HG23 ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.87 ' SD ' HG11 ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 127' ' ' PRO . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.064 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.563 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.589 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.904 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.904 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 78' ' ' ASN . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.5 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 126' ' ' MET . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HD12 ' A' ' 125' ' ' LEU . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.4 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.211 0.529 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 27' ' ' VAL . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.567 ' HG2' HD11 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.585 HG13 HD21 ' A' ' 17' ' ' LEU . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.632 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 11' ' ' ILE . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.744 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.504 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HE1' ' A' ' 43' ' ' MET . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.717 ' HE1' HD12 ' A' ' 40' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 32.6 m120 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' HG2' ' A' ' 59' ' ' MET . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.504 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.529 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.8 mtpm? . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 124' ' ' THR . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 85' ' ' THR . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.666 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.2 p-10 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.542 HG21 HG23 ' A' ' 81' ' ' ILE . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.571 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.589 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.76 HD12 HD11 ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.998 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.998 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.913 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.666 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.923 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.923 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' CA ' HD11 ' A' ' 102' ' ' ILE . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.967 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.835 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 15' ' ' THR . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.5 p-10 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.738 HG21 ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.503 ' HG2' HG13 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.753 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.967 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 28' ' ' THR . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.955 ' HB2' HD13 ' A' ' 40' ' ' LEU . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.642 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 36' ' ' GLU . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' MET . . . . . 1.116 ' HE2' HG11 ' A' ' 60' ' ' VAL . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.709 HG12 HG22 ' A' ' 60' ' ' VAL . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' C ' HG23 ' A' ' 13' ' ' ILE . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG13 HG21 ' A' ' 53' ' ' THR . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 49' ' ' VAL . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.116 HG11 ' HE2' ' A' ' 43' ' ' MET . 21.6 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 1.1 pttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.421 0.629 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 92' ' ' MET . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.565 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.689 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' HA2' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 90' ' ' VAL . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.54 ' HB3' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 96' ' ' GLU . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 127' ' ' PRO . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.907 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.948 HG13 ' CD ' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.948 ' CD ' HG13 ' A' ' 119' ' ' VAL . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.886 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 22' ' ' MET . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.433 ' NE2' ' HE3' ' A' ' 21' ' ' MET . 11.8 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 47' ' ' ARG . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.692 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 ' H ' ' A' ' 20' ' ' ILE . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.541 ' HE1' HG23 ' A' ' 11' ' ' ILE . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HG3' HG13 ' A' ' 5' ' ' VAL . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.476 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.086 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.573 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 40' ' ' LEU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.647 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.486 ' CG ' HD12 ' A' ' 17' ' ' LEU . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 13' ' ' ILE . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 13' ' ' ILE . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.584 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HD2' ' A' ' 50' ' ' PRO . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.463 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.34 0.591 . . . . 0.0 110.338 . . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.079 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.945 HG23 HG21 ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.945 HG21 HG23 ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.536 HG23 ' HA2' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.909 ' SD ' HG12 ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 76' ' ' VAL . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.982 HD11 ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.997 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 113' ' ' MET . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.837 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' CZ ' ' A' ' 117' ' ' ARG . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.661 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' HG22 ' A' ' 76' ' ' VAL . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.989 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.989 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.982 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.711 HG13 ' HG3' ' A' ' 22' ' ' MET . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.79 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' ND2' ' CD1' ' A' ' 120' ' ' TYR . 3.9 m-20 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 18' ' ' THR . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.711 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.489 ' C ' HG13 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 26' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.638 HD12 HD12 ' A' ' 55' ' ' LEU . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HB2' HD13 ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 64.4 m-20 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.636 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 45' ' ' VAL . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.89 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.89 HG21 HG13 ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 32' ' ' ILE . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG11 ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.784 HG23 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.581 ' SD ' HG11 ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' SER . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.878 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.537 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.072 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.072 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.658 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.474 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 85' ' ' THR . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.688 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.976 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.636 HD12 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.835 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.878 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG3' ' A' ' 22' ' ' MET . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.447 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.742 HG12 HD21 ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CG ' ' A' ' 43' ' ' MET . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.447 ' HG2' ' CD ' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' C ' HG13 ' A' ' 27' ' ' VAL . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG13 ' C ' ' A' ' 26' ' ' VAL . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 54' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.984 HD12 HD12 ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.921 ' HB2' HD13 ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.921 HD13 ' HB2' ' A' ' 36' ' ' GLU . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.571 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 55' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 45' ' ' VAL . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.919 ' CG1' HG21 ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.919 HG21 ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.501 HG21 ' HD2' ' A' ' 29' ' ' PRO . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.3 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 2.9 p-10 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' HD22 ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.635 HD11 ' SD ' ' A' ' 91' ' ' MET . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.574 HG21 HG23 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 90' ' ' VAL . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HD11 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.862 HD11 ' CA ' ' A' ' 127' ' ' PRO . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.043 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.445 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 113' ' ' MET . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.043 HG23 ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.811 ' H ' HG22 ' A' ' 115' ' ' VAL . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 126' ' ' MET . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.542 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.862 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.198 0.523 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 154.92 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.561 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 22' ' ' MET . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 13' ' ' ILE . 14.9 m120 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.698 ' CE ' HD12 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.561 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' CG2' ' OE2' ' A' ' 64' ' ' GLU . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 5' ' ' VAL . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 ' CE ' ' A' ' 22' ' ' MET . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.58 ' HE3' ' HA ' ' A' ' 63' ' ' TYR . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 49' ' ' VAL . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 61' ' ' LYS . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.588 HG21 HG11 ' A' ' 45' ' ' VAL . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.73 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.73 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.799 HG23 ' SD ' ' A' ' 56' ' ' MET . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.857 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.799 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.857 HG21 ' CD2' ' A' ' 55' ' ' LEU . 22.8 t -120.14 129.88 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 123' ' ' GLN . 7.7 mtmt -62.81 -103.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -90.86 75.21 6.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.97 -1.081 . . . . 0.0 109.813 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -53.28 -30.98 41.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 2.9 pt-20 169.31 163.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.18 -0.95 . . . . 0.0 110.229 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -85.97 52.64 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.16 2.84 86.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -84.89 154.02 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.1 m -106.25 -73.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.34 117.95 65.88 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.2 Cg_endo -72.26 -90.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.826 1.435 . . . . 0.0 110.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.2 -70.65 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.3 mt -87.8 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -1.153 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 116.75 9.77 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG11 ' SD ' ' A' ' 92' ' ' MET . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.54 HD12 HD23 ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.724 HG23 HG21 ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.632 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 83' ' ' ILE . 2.8 t30 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.714 ' OG1' HG22 ' A' ' 90' ' ' VAL . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.731 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.714 HG22 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.594 ' N ' HG23 ' A' ' 90' ' ' VAL . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 87' ' ' LEU . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.673 ' HG3' HG23 ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.673 HG23 ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 127' ' ' PRO . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.945 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' A' ' 133' ' ' TYR . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.475 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.826 HG22 ' H ' ' A' ' 117' ' ' ARG . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.826 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.002 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 1.002 ' N ' HD12 ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.2 Cg_endo -75.19 -7.33 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 129' ' ' MET . 3.4 p30 -85.94 -22.02 27.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.391 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.507 ' HG3' HG23 ' A' ' 130' ' ' VAL . 4.2 ptm -93.84 -14.96 25.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 131' ' ' LYS . 91.8 t -92.65 172.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 130' ' ' VAL . 6.5 mttt -81.98 -131.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.149 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -99.46 116.0 30.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.988 -1.07 . . . . 0.0 110.388 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 102' ' ' ILE . 7.3 m-85 -68.37 -167.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.213 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.956 0.408 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -80.9 -176.03 5.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.862 -1.149 . . . . 0.0 110.21 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 10' ' ' LEU . 3.1 pt20 -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 15' ' ' THR . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 34.5 m120 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 11' ' ' ILE . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.56 ' HE2' ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.756 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.852 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.668 HD11 ' OE2' ' A' ' 64' ' ' GLU . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.582 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 15.0 m120 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.494 ' HB ' HG13 ' A' ' 49' ' ' VAL . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.756 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.5 t -120.04 133.89 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -65.64 -130.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -70.14 76.76 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.92 -1.113 . . . . 0.0 110.173 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' O ' ' HE2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -53.62 -94.55 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.912 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 40' ' ' LEU . 8.0 pt-20 -121.81 -159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.806 -1.184 . . . . 0.0 110.197 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -86.1 57.06 4.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.85 23.47 14.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.89 161.88 14.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -1.195 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -85.23 -140.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 140.74 98.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.965 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 47.2 Cg_endo -72.19 -94.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.034 1.544 . . . . 0.0 110.423 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.03 -78.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.4 mt -87.28 53.02 2.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm -88.71 119.92 29.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.509 -0.745 . . . . 0.0 110.455 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.589 ' O ' HD13 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.951 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.647 HG23 HG21 ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.671 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.647 HG21 HG23 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.627 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 72' ' ' LEU . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 127' ' ' PRO . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.534 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE1' HD11 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' ILE . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD11 ' OE1' ' A' ' 106' ' ' GLU . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.627 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.454 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.879 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.555 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.951 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 126' ' ' MET . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.659 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.885 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.1 Cg_endo -73.28 -24.48 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.61 -24.97 62.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.4 mtt -86.93 -46.72 9.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.116 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.4 t -83.6 93.07 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 116' ' ' ASN . 12.7 ptpt -90.49 5.85 45.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -94.08 45.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.23 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.12 176.72 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.437 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.148 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.266 0.555 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -77.82 -172.49 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.684 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 22' ' ' MET . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.59 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.914 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.914 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 11' ' ' ILE . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.519 ' HE3' HD23 ' A' ' 17' ' ' LEU . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG22 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.76 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.628 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.439 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.628 HD13 ' CB ' ' A' ' 36' ' ' GLU . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 55' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 61' ' ' LYS . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.847 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.847 HG21 HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.59 ' CA ' HG13 ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.423 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' MET . 52.4 t -120.36 131.63 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HD3' ' CG ' ' A' ' 46' ' ' ASN . 11.1 tptt -70.53 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.691 ' OD1' HG11 ' A' ' 97' ' ' VAL . 12.9 m-80 -84.72 77.29 10.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.404 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 40.2 mm-40 -130.1 -148.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.874 -1.141 . . . . 0.0 110.274 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -86.4 36.61 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.384 -0.822 . . . . 0.0 110.363 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.12 17.09 53.65 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' OH ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -82.37 -155.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -1.094 . . . . 0.0 110.222 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 p -97.52 -127.6 0.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 13.9 m -82.75 144.9 49.3 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.917 -1.114 . . . . 0.0 110.675 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.89 -150.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.119 1.589 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.21 -65.94 1.56 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.48 52.0 2.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -1.12 . . . . 0.0 109.525 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -74.19 112.83 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.675 . . . . 0.0 110.563 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 102' ' ' ILE . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 87' ' ' LEU . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' HG21 ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 92' ' ' MET . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG11 ' OD1' ' A' ' 62' ' ' ASN . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.994 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.5 -22.3 21.44 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -87.06 4.52 41.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.169 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 tpt -100.48 -52.61 3.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 132' ' ' ASN . 95.7 t -90.1 124.01 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -77.98 -5.15 50.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 110.143 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' H ' HG12 ' A' ' 130' ' ' VAL . 1.4 m-20 -101.99 29.66 4.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.123 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -66.55 166.59 12.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.212 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.88 165.25 17.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 37' ' ' ILE . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.449 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m120 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD21 HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.531 ' CG ' HG13 ' A' ' 5' ' ' VAL . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.764 HD12 HD12 ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.624 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' C ' ' OE1' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.855 ' HD2' HG21 ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.855 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 29' ' ' PRO . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.764 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -115.1 125.62 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 2.0 pttt -63.91 -135.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' ND2' ' OG1' ' A' ' 124' ' ' THR . 9.9 m-80 -71.07 85.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -54.16 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 2.4 mt-10 -138.26 -136.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 109.983 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.99 49.83 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.079 -1.013 . . . . 0.0 110.255 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.16 33.18 5.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.426 HG21 ' HB ' ' A' ' 97' ' ' VAL . 26.5 p -92.98 -147.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -1.209 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 69' ' ' SER . 5.1 t -101.79 -140.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -75.7 161.41 76.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 110.358 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' C ' ' HG3' ' A' ' 96' ' ' GLU . 47.7 Cg_endo -72.65 -152.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.273 1.67 . . . . 0.0 110.288 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.63 -68.17 1.56 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.6 mt -86.77 51.04 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 109.722 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt -69.53 119.25 13.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.683 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 104' ' ' SER . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 123' ' ' GLN . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 81' ' ' ILE . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 80' ' ' LEU . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.652 HD11 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.899 HD13 ' N ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 90' ' ' VAL . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.597 ' N ' HG13 ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.557 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' A' ' 67' ' ' THR . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.968 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.674 ' HB3' HG22 ' A' ' 75' ' ' VAL . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.479 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ILE . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 115' ' ' VAL . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.586 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.637 ' HB ' HD12 ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.76 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.504 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.65 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.968 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.39 -33.92 8.3 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.91 -8.04 54.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.447 ' HG3' ' HD2' ' A' ' 117' ' ' ARG . 28.1 ttp -81.24 -54.74 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 ' HE2' ' A' ' 129' ' ' MET . 54.9 t -76.33 123.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.259 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' HG3' ' CB ' ' A' ' 116' ' ' ASN . 1.8 mmpt? -79.65 -34.87 40.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.68 43.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -78.97 139.3 38.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.216 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.25 0.548 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.23 167.21 11.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.659 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 54' ' ' THR . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.879 HD13 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.879 ' CD2' HD13 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.982 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.029 HG21 HG13 ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.002 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.452 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG11 ' HB3' ' A' ' 63' ' ' TYR . 23.5 t -113.65 127.66 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -124.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.9 m120 -77.3 75.96 3.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.145 . . . . 0.0 110.592 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.69 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.87 -102.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.333 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 18.2 mm-40 -125.32 -162.9 1.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.938 -1.101 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 38.6 p-10 -86.27 56.29 3.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.282 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.6 -18.43 73.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -74.72 171.9 13.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.49 -79.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -74.45 115.88 47.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.323 -0.861 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 44.0 Cg_endo -71.83 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.926 1.488 . . . . 0.0 110.421 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.81 -82.44 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.11 47.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.15 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -92.09 132.96 36.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 110.517 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.77 ' O ' HD23 ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.002 HG22 ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.968 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.968 ' N ' HD13 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.678 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.617 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.2 p-10 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.726 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 90' ' ' VAL . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG23 ' A' ' 90' ' ' VAL . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.726 ' SD ' HD12 ' A' ' 87' ' ' LEU . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 98' ' ' SER . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.937 HD12 ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' CD ' ' A' ' 105' ' ' GLU . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' CD ' ' HG2' ' A' ' 103' ' ' PRO . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.996 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 11.9 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.941 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.542 ' HB2' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.656 ' C ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 1.002 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.014 HD12 ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 1.014 ' CD ' HD12 ' A' ' 125' ' ' LEU . 43.5 Cg_endo -73.49 75.64 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -91.69 -37.3 13.11 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.164 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.3 27.81 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.316 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.837 HG21 ' HB2' ' A' ' 127' ' ' PRO . 96.3 t -71.76 128.76 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 110.128 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -15.12 62.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.672 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -91.49 -6.17 53.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.039 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -71.55 147.62 47.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.179 0.514 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.62 175.02 8.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.136 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.786 ' CD1' HD23 ' A' ' 17' ' ' LEU . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.597 HG21 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.786 HD23 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG2' HG13 ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.751 HG22 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.751 ' SD ' HG22 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.706 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.889 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 5' ' ' VAL . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' HD12 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.528 ' CA ' HG13 ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.463 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.463 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.83 HG11 ' HB3' ' A' ' 63' ' ' TYR . 5.3 t -120.16 117.86 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -69.07 -95.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 2.9 p-10 -91.36 78.35 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.983 . . . . 0.0 110.269 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.83 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.66 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.112 -0.993 . . . . 0.0 110.435 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' OE1' HD13 ' A' ' 40' ' ' LEU . 1.5 pm0 -139.53 -149.51 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.91 -1.119 . . . . 0.0 110.358 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.47 54.76 0.77 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 110.261 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.53 -12.83 56.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -94.27 149.23 21.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -1.136 . . . . 0.0 110.464 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.7 -81.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.179 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.97 135.45 45.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 46.7 Cg_endo -73.15 -91.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.93 -81.24 0.55 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.5 mt -86.93 52.87 2.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 109.861 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.78 113.27 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 110.447 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HB ' HD23 ' A' ' 125' ' ' LEU . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.053 HD11 ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.609 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.427 ' CE ' HG12 ' A' ' 81' ' ' ILE . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.053 ' CE ' HD11 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 102' ' ' ILE . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 125' ' ' LEU . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.081 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 133' ' ' TYR . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.081 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.785 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.609 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.625 ' OD1' HD12 ' A' ' 121' ' ' LEU . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD23 ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.759 ' N ' HD12 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.3 Cg_endo -73.77 -13.3 24.4 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.52 -12.31 40.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.456 ' CG ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -100.63 -43.74 6.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 133' ' ' TYR . 4.8 t -90.27 107.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.356 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -90.59 42.64 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -111.0 -75.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.333 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.766 ' HB2' HD22 ' A' ' 110' ' ' LEU . 45.0 p90 -68.19 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.299 0.571 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -179.98 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.823 ' HG2' HG13 ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 3' ' ' ALA . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 40' ' ' LEU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.644 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 63' ' ' TYR . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.62 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 45' ' ' VAL . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 13' ' ' ILE . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.898 HG21 HG13 ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.714 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 63' ' ' TYR . 74.3 t -119.43 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 3.3 mppt? -70.61 -93.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 110.485 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' ' CE ' ' A' ' 43' ' ' MET . 6.7 t30 -90.39 80.67 6.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 110.415 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.934 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.94 -50.18 67.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.255 -0.903 . . . . 0.0 110.628 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER 173.86 -177.83 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.869 -1.144 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.33 54.51 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.59 -4.69 87.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.09 165.21 12.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -1.157 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -79.27 -133.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 147.31 97.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.12 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 47.2 Cg_endo -72.97 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.532 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.65 -78.82 0.72 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 mt -87.76 51.83 2.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -1.127 . . . . 0.0 110.249 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -78.66 114.25 17.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' OE1' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 80' ' ' LEU . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 85' ' ' THR . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.051 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.964 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.606 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' HE2' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 91' ' ' MET . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.523 ' N ' HG23 ' A' ' 90' ' ' VAL . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.964 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' A' ' 127' ' ' PRO . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.556 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.051 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.742 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.3 Cg_endo -73.55 -5.61 17.38 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.76 -26.05 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.746 ' HG3' HG23 ' A' ' 130' ' ' VAL . 5.6 ptp -87.89 -24.52 23.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.188 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' HG3' ' A' ' 129' ' ' MET . 39.2 t -92.21 124.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' HG3' ' N ' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -90.56 -20.12 22.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 36.3 p30 -95.2 11.21 33.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' CE1' ' CG2' ' A' ' 102' ' ' ILE . 26.6 t80 -61.24 138.87 58.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.282 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 30' ' ' MET . 51.5 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.207 0.527 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -78.03 179.12 6.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.123 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.723 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.679 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 51' ' ' LEU . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.673 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HE2' HG22 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 26' ' ' VAL . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 1' ' ' ASN . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.866 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.862 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD23 ' CB ' ' A' ' 36' ' ' GLU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.673 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.49 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.723 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 63' ' ' TYR . 44.6 t -120.17 129.23 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 1.1 tttp -68.77 -111.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.538 ' HA ' HG21 ' A' ' 97' ' ' VAL . 6.0 m120 -90.96 86.07 6.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.164 . . . . 0.0 110.265 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.735 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -69.92 54.67 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.231 -0.918 . . . . 0.0 110.783 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 18.1 mm-40 42.69 -148.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.22 57.31 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.159 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.07 -9.03 59.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 170.76 9.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 0.0 110.263 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 69' ' ' SER . 48.9 m -92.17 -90.36 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.12 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' N ' HG22 ' A' ' 68' ' ' THR . 0.1 OUTLIER -73.56 135.33 78.56 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 45.7 Cg_endo -72.82 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.984 1.518 . . . . 0.0 110.551 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.94 -81.16 0.44 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.93 51.79 2.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -1.103 . . . . 0.0 110.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.58 113.66 10.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.454 -0.778 . . . . 0.0 110.277 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 74' ' ' SER . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 85' ' ' THR . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.579 HG22 ' OD1' ' A' ' 84' ' ' ASN . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' OD1' HG22 ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 81' ' ' ILE . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 111' ' ' VAL . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 90' ' ' VAL . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.941 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG23 ' CE1' ' A' ' 63' ' ' TYR . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 125' ' ' LEU . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.014 ' O ' HG23 ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 107' ' ' ILE . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.014 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.484 ' OD1' ' HE3' ' A' ' 131' ' ' LYS . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 126' ' ' MET . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.721 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo -78.05 -0.01 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -41.83 68.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.539 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.422 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 2.2 tpp -98.22 -18.44 18.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.306 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 130' ' ' VAL . 37.9 t -75.2 89.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.01 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HE3' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -90.54 14.34 13.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.3 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.59 27.8 6.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.181 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 154.43 28.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.337 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.563 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 170.3 16.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.608 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.851 HG13 ' HG2' ' A' ' 22' ' ' MET . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.687 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 p-10 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.851 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 55' ' ' LEU . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.57 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 53' ' ' THR . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.99 ' HB ' HG13 ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 63' ' ' TYR . 19.4 t -119.79 122.44 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -70.72 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 0.0 110.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -90.94 73.49 6.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.822 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -53.54 -98.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.051 -1.03 . . . . 0.0 110.262 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 2.6 pt-20 -75.96 1.52 15.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.914 -1.116 . . . . 0.0 110.767 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -74.98 54.93 0.68 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 110.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.32 75.49 0.42 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.8 p -73.33 164.54 26.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.281 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -90.32 -45.65 8.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 20.0 m -64.31 135.2 96.24 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 49.4 Cg_endo -72.88 -97.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 -82.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' PRO . 10.0 mt -88.64 51.32 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -1.079 . . . . 0.0 110.324 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.78 115.19 21.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 0.0 110.093 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 104' ' ' SER . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HD23 ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.559 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.54 ' OG1' HG12 ' A' ' 90' ' ' VAL . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.559 ' CE ' HD12 ' A' ' 87' ' ' LEU . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.623 ' OE2' HG11 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 75' ' ' VAL . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.735 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.735 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.784 HD11 HD12 ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.724 ' N ' HD12 ' A' ' 125' ' ' LEU . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.446 ' N ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo -73.21 -27.24 13.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.82 -16.83 62.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -46.93 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.42 121.77 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 110.371 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -89.68 -14.63 34.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.903 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -93.11 10.39 31.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 25.9 t80 -70.44 167.32 18.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.207 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.277 0.561 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -74.18 -177.62 3.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.772 HG13 HD21 ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HB ' HG22 ' A' ' 11' ' ' ILE . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.772 HD21 HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.727 ' CE ' HD12 ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' C ' HG13 ' A' ' 27' ' ' VAL . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HE2' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.052 HD12 HD12 ' A' ' 55' ' ' LEU . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.727 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.59 HD12 ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.572 ' CE ' HG11 ' A' ' 60' ' ' VAL . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.632 HG23 ' CG ' ' A' ' 56' ' ' MET . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.052 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.632 ' CG ' HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG11 ' CE ' ' A' ' 43' ' ' MET . 6.4 t -100.47 121.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 2.0 pttt -61.66 -136.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.889 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.623 ' HB3' HG11 ' A' ' 97' ' ' VAL . 2.0 p-10 -70.28 101.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.094 -1.004 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -75.53 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.157 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 34.2 mm-40 -113.62 -156.16 0.59 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.967 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.88 54.52 3.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.115 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.17 11.44 57.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.48 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 43.4 p -82.98 150.05 26.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.119 . . . . 0.0 110.324 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 69' ' ' SER . 44.5 m -100.13 -87.29 0.37 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.446 ' N ' HG22 ' A' ' 68' ' ' THR . 0.7 OUTLIER -76.91 141.3 67.86 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.123 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' LEU . 47.4 Cg_endo -72.76 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.949 1.499 . . . . 0.0 110.585 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 59.04 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 15.5 mt -88.1 52.51 2.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.084 . . . . 0.0 109.607 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.47 139.89 57.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -0.771 . . . . 0.0 110.366 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 123' ' ' GLN . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 121' ' ' LEU . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.625 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 115' ' ' VAL . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.497 HG22 ' OG1' ' A' ' 88' ' ' THR . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 62' ' ' ASN . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.557 HD11 ' CA ' ' A' ' 127' ' ' PRO . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.058 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.803 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 131' ' ' LYS . 3.3 t-20 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.803 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 126' ' ' MET . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.653 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -72.86 -16.48 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -83.25 -3.31 57.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -47.88 6.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 t -91.49 124.3 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HD3' ' CG ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -82.01 -13.65 57.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.37 17.01 9.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 110.274 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.29 137.92 47.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' OE2' ' OXT' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.328 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.93 169.12 18.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG13 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.43 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.646 ' HG2' HG13 ' A' ' 5' ' ' VAL . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.589 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.818 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.611 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 45' ' ' VAL . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 49' ' ' VAL . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.642 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.818 HD11 ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 63' ' ' TYR . 9.5 t -111.14 125.22 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 2.8 mmmp? -70.8 -105.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.003 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.43 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 37.2 p-10 -91.02 79.59 5.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.835 -1.166 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.747 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.69 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.405 -0.809 . . . . 0.0 110.502 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 2.4 mp0 -107.52 -170.84 1.76 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.832 -1.167 . . . . 0.0 110.368 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.09 46.8 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.788 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.43 19.73 51.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -89.16 160.41 17.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -1.15 . . . . 0.0 110.243 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.2 t -76.85 -140.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.104 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -67.04 168.88 9.55 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.2 Cg_endo -72.43 -92.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.973 1.512 . . . . 0.0 110.417 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -79.09 0.38 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 10.4 mt -83.9 53.86 2.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -1.096 . . . . 0.0 109.861 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp -66.82 129.26 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.491 -0.755 . . . . 0.0 110.641 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HB ' HD23 ' A' ' 125' ' ' LEU . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.764 HG23 HG21 ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.764 HG21 HG23 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.07 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.805 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.07 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.599 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' SER . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 125' ' ' LEU . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.0 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 85' ' ' THR . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.7 tp-100 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.447 ' OG1' ' NZ ' ' A' ' 61' ' ' LYS . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.586 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.574 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.5 Cg_endo -74.09 -0.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.43 -30.17 19.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.43 ' HG3' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -91.65 -24.03 19.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 129' ' ' MET . 46.3 t -84.19 96.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -73.19 -8.91 57.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.38 20.43 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.42 -174.78 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.168 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.28 0.562 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.66 -176.81 6.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.525 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.594 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 17' ' ' LEU . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.2 p-10 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.804 ' HE2' HD12 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG22 ' CA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.009 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' OE1' ' CA ' ' A' ' 66' ' ' GLY . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.804 HD12 ' HE2' ' A' ' 22' ' ' MET . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.756 HG21 HG13 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.521 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.438 ' CG ' HG23 ' A' ' 54' ' ' THR . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 87.2 t -119.64 115.35 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -62.49 -140.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.976 . . . . 0.0 110.0 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 21.1 m120 -70.26 76.58 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.016 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -53.56 -102.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.172 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 28.0 mm-40 -129.2 176.8 7.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.795 -1.191 . . . . 0.0 110.653 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.74 ' OD1' HG23 ' A' ' 67' ' ' THR . 4.3 t0 -88.22 -65.05 1.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.373 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' OE1' ' A' ' 36' ' ' GLU . . . 104.42 15.22 21.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' OD1' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -91.52 172.15 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -1.088 . . . . 0.0 110.335 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.3 m -100.45 -68.53 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.876 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.456 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 18.3 m -84.74 123.87 73.62 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 110.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.535 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 47.0 Cg_endo -73.28 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.9 1.474 . . . . 0.0 110.461 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.66 -77.7 1.85 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.61 47.42 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.139 . . . . 0.0 108.815 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.635 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.53 129.43 39.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.61 HG12 ' SD ' ' A' ' 92' ' ' MET . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.995 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.995 ' N ' HD13 ' A' ' 80' ' ' LEU . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.757 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.5 p-10 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.538 HG22 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 75' ' ' VAL . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.635 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' ILE . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.789 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.789 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.757 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.679 ' CD1' HG21 ' A' ' 130' ' ' VAL . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' LEU . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.702 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.8 Cg_endo -74.29 -30.68 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.96 -37.07 72.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.576 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -80.48 -49.42 11.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.679 HG21 ' CD1' ' A' ' 125' ' ' LEU . 58.9 t -75.39 109.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 32.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -108.32 -27.79 9.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -171.17 0.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' OE2' ' HB3' ' A' ' 106' ' ' GLU . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -77.79 175.26 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 4' ' ' SER . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 4.1 p-10 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 HG23 ' HE3' ' A' ' 21' ' ' MET . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.895 ' HB2' HG22 ' A' ' 5' ' ' VAL . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.827 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.595 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.944 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.944 HG21 HG13 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.421 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 63' ' ' TYR . 61.4 t -119.98 130.47 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -68.31 -108.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.516 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . 1.1 t30 -84.06 68.0 9.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.84 -1.162 . . . . 0.0 110.922 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.794 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.94 -98.44 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.908 . . . . 0.0 110.406 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.31 -167.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.07 . . . . 0.0 110.333 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -78.27 51.54 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.41 -17.44 78.94 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 96' ' ' GLU . 0.8 OUTLIER -89.21 122.02 32.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -1.143 . . . . 0.0 110.203 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 32.2 m -96.29 -53.7 3.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.867 . . . . 0.0 110.175 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -82.7 111.42 29.11 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 110.183 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.3 Cg_endo -72.47 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.915 1.481 . . . . 0.0 110.624 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.52 -81.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.4 mt -88.07 54.94 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -1.05 . . . . 0.0 109.956 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -77.37 119.5 21.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.541 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' CB ' HG11 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.829 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.5 t30 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.802 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 82' ' ' PRO . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.614 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.1 p-10 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.625 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.89 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.89 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.675 ' O ' HG21 ' A' ' 67' ' ' THR . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 76' ' ' VAL . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.953 HD12 HD11 ' A' ' 125' ' ' LEU . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.033 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.472 HD11 ' OE2' ' A' ' 134' ' ' GLU . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.033 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.978 HG23 HG12 ' A' ' 130' ' ' VAL . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.911 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 34.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.07 HD12 ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 1.07 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.665 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.4 Cg_endo -75.6 -25.67 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -20.52 63.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.234 -0.916 . . . . 0.0 110.256 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.65 -49.14 6.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.978 HG12 HG23 ' A' ' 115' ' ' VAL . 21.9 m -82.69 111.54 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -88.53 28.59 1.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.96 40.4 1.93 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -169.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' OE2' HD11 ' A' ' 110' ' ' LEU . 18.1 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.204 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.286 0.565 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -76.65 179.82 5.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 55' ' ' LEU . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.685 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.893 ' CG2' HD21 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.8 p-10 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD21 ' CG2' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 64' ' ' GLU . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.503 ' HE1' HG13 ' A' ' 60' ' ' VAL . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG13 HG21 ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 HG13 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.732 ' CA ' HG13 ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG11 ' HD2' ' A' ' 63' ' ' TYR . 40.5 t -111.2 125.16 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -60.69 -144.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.114 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' ND2' HG11 ' A' ' 97' ' ' VAL . 8.0 m120 -78.74 71.87 5.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.91 -105.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HG3' HD21 ' A' ' 40' ' ' LEU . 46.5 mt-10 -152.05 5.41 0.42 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.016 -1.052 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -86.82 -8.67 57.12 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.8 -23.79 19.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.809 HG22 ' O ' ' A' ' 67' ' ' THR . 15.5 m -74.76 60.33 0.93 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.208 -1.172 . . . . 0.0 110.193 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -107.87 -96.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 110.223 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -84.88 139.65 37.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.983 -1.073 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.77 -154.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.125 1.592 . . . . 0.0 110.04 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.82 -70.82 1.8 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 12.3 mt -87.41 52.62 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -1.143 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -79.32 113.25 17.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.663 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.764 HG13 ' SD ' ' A' ' 92' ' ' MET . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 124' ' ' THR . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.1 p-10 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 85' ' ' THR . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.845 HG21 HG23 ' A' ' 81' ' ' ILE . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.764 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' ND2' ' A' ' 62' ' ' ASN . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 127' ' ' PRO . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.038 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD11 ' CG ' ' A' ' 134' ' ' GLU . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.038 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.525 ' CE ' HG11 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 129' ' ' MET . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.809 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.509 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.585 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.836 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.0 Cg_endo -73.18 -42.61 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 129' ' ' MET . 42.4 p-10 -72.03 -14.44 61.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 31.4 ttm -85.87 -46.02 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 115' ' ' VAL . 34.4 t -91.19 108.34 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.171 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -72.8 -8.25 54.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 61.8 t-20 -91.55 5.78 48.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -66.44 -169.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.388 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.541 ' CG ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.221 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.222 0.534 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 177.06 7.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.625 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.467 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.556 ' H ' ' HE2' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.556 ' HE2' ' H ' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.625 ' CG ' HG13 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 6' ' ' VAL . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.938 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.692 ' HE1' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 45' ' ' VAL . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.509 ' CB ' HG13 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.938 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.15 138.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.27 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -70.07 91.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.972 -1.08 . . . . 0.0 110.04 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -53.73 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.237 -0.914 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -165.19 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 55.89 2.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.107 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.8 8.23 76.63 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.0 p -90.79 125.23 35.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.4 m -83.75 -80.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.44 123.09 85.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.1 Cg_endo -73.63 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.863 1.454 . . . . 0.0 110.444 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 61.53 -79.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 72' ' ' LEU . 5.8 mt -87.62 52.74 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 4.3 pttt -85.22 115.21 22.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.587 -0.696 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 107' ' ' ILE . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 124' ' ' THR . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 2.8 m120 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.989 ' N ' HD13 ' A' ' 80' ' ' LEU . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.642 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.613 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.1 p-10 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.981 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.981 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 HG21 ' A' ' 76' ' ' VAL . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 127' ' ' PRO . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.022 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.022 HG23 ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.606 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 126' ' ' MET . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.834 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.835 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.6 Cg_endo -73.83 -28.55 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -2.23 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -29.22 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 110.283 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 131' ' ' LYS . 48.2 t -92.92 171.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -84.21 -65.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.232 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.42 75.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.74 ' CE1' HD13 ' A' ' 102' ' ' ILE . 56.3 t80 -68.16 161.87 26.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.223 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.354 0.597 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.61 167.99 11.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.389 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.961 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.961 ' CD2' HD13 ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.698 ' SD ' HD23 ' A' ' 17' ' ' LEU . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 26' ' ' VAL . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.765 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' HG21 ' A' ' 54' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD12 ' A' ' 55' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.672 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.672 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.578 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.788 ' CG ' HD12 ' A' ' 17' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 13' ' ' ILE . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HG2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.61 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.61 HG21 HG13 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.623 HG21 ' HD2' ' A' ' 29' ' ' PRO . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.747 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.458 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 63' ' ' TYR . 24.9 t -120.01 142.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 15.9 mmtt -70.04 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.99 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . 38.1 t-20 -90.83 71.67 6.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.986 -1.071 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.7 p90 -53.75 -38.69 64.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.138 -0.976 . . . . 0.0 110.297 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' CD ' HD21 ' A' ' 40' ' ' LEU . 1.9 pt-20 179.82 -173.99 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.159 -0.963 . . . . 0.0 110.359 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -86.49 48.49 1.64 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 110.054 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.83 23.77 28.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.529 HG21 ' OE1' ' A' ' 95' ' ' GLU . 4.8 p -79.21 142.27 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -1.163 . . . . 0.0 110.068 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.432 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 13.6 p -82.49 -99.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.184 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -85.0 141.77 38.06 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.022 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 41.2 Cg_endo -71.47 -78.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.992 1.522 . . . . 0.0 110.204 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.31 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD13 ' HZ2' ' A' ' 100' ' ' LYS . 8.9 mt -87.66 45.84 1.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.393 -1.063 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt -68.16 122.14 17.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.657 -0.652 . . . . 0.0 110.082 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG11 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.593 ' ND2' ' OD2' ' A' ' 122' ' ' ASP . 12.0 t-20 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 85' ' ' THR . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.709 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.501 ' SD ' HG11 ' A' ' 75' ' ' VAL . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.604 ' HZ2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 102' ' ' ILE . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 109' ' ' LYS . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.967 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.65 HD21 ' CG ' ' A' ' 134' ' ' GLU . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.709 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.668 HG23 HG12 ' A' ' 130' ' ' VAL . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.909 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 120' ' ' TYR . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.588 ' N ' HG12 ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 78' ' ' ASN . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.979 ' N ' HD12 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo -78.64 -22.66 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.49 -23.86 62.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.131 -0.981 . . . . 0.0 110.367 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mtt -84.59 -40.37 17.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.668 HG12 HG23 ' A' ' 115' ' ' VAL . 27.1 m -90.87 99.07 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 110.387 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.46 4.47 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -94.43 36.05 1.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.25 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.37 124.9 27.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.281 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.65 ' CG ' HD21 ' A' ' 110' ' ' LEU . 2.6 pp20? . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.18 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.293 0.568 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -80.76 173.68 12.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.76 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.857 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.5 p-10 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.76 ' HG2' HG13 ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 3' ' ' ALA . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' THR . 3.9 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.005 HG21 HG13 ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.745 HG11 ' HB3' ' A' ' 63' ' ' TYR . 4.7 t -120.05 133.35 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -71.15 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -91.9 62.31 4.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.179 -0.951 . . . . 0.0 111.018 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -53.84 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.922 -1.112 . . . . 0.0 109.984 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' OE1' HG21 ' A' ' 32' ' ' ILE . 5.3 pt-20 -132.88 -164.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.876 -1.14 . . . . 0.0 110.492 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.92 54.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.398 -0.814 . . . . 0.0 110.243 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.59 -21.97 77.82 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.6 p -84.3 162.79 19.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -1.124 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 69' ' ' SER . 48.4 m -106.19 -90.2 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 68' ' ' THR . 2.2 t -79.91 130.04 68.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.928 . . . . 0.0 110.29 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.1 Cg_endo -73.54 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.485 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.29 -73.09 0.58 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.2 mt -86.78 53.1 2.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -1.109 . . . . 0.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 3.7 mttt -68.91 116.46 9.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.532 -0.73 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG13 ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.606 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 27.9 m120 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.74 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.67 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.71 HG23 ' H ' ' A' ' 91' ' ' MET . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.71 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.566 ' SD ' HG13 ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.073 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 107' ' ' ILE . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.74 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.865 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.445 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 126' ' ' MET . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.731 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.71 -18.03 22.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 22.2 p30 -70.43 -15.41 62.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 3.4 mtt -99.01 -47.34 5.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 t -73.77 103.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -80.37 -2.32 44.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -107.22 2.6 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.423 ' OH ' HG23 ' A' ' 102' ' ' ILE . 13.3 t80 -64.36 140.08 58.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.209 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.4 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.183 0.516 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.43 -178.93 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.716 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.1 p-10 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.551 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.584 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.438 ' CG ' ' O ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 45' ' ' VAL . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' LYS . 84.0 t -120.16 135.98 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 0.5 OUTLIER -55.97 -165.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 110.145 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -71.92 77.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.084 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 40' ' ' LEU . 16.0 mm-40 -107.91 -141.36 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.991 -1.068 . . . . 0.0 110.29 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.23 54.39 2.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.26 -7.64 69.57 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -92.97 166.61 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.115 -1.226 . . . . 0.0 110.24 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.9 p -77.45 -138.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 144.55 98.59 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.1 -1.0 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.547 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.0 Cg_endo -73.19 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.045 1.55 . . . . 0.0 110.518 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.17 1.34 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.6 mt -87.89 57.33 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 109.641 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 30.6 mtpt -72.07 120.13 17.24 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.523 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.73 ' HB ' HD23 ' A' ' 125' ' ' LEU . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 97' ' ' VAL . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 28.7 t30 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.582 ' HB ' HG21 ' A' ' 85' ' ' THR . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.632 ' O ' HD23 ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.692 HG22 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.447 ' HG3' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 76' ' ' VAL . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.962 HD11 ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.586 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.692 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 130' ' ' VAL . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.933 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' OD1' ' HE2' ' A' ' 131' ' ' LYS . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.933 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.73 HD23 ' HB ' ' A' ' 75' ' ' VAL . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.671 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.962 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.2 Cg_endo -73.42 -24.57 16.25 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.03 7.12 9.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.229 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -99.0 -22.26 15.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 113' ' ' MET . 45.7 t -88.14 161.22 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -73.24 -79.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.79 . . . . 0.0 110.365 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -102.63 77.52 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 102' ' ' ILE . 40.2 t80 -64.53 151.0 45.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.222 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.161 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.254 0.549 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 65.0 mmtt -75.94 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.663 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.021 HD13 HD21 ' A' ' 17' ' ' LEU . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.7 m120 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.021 HD21 HD13 ' A' ' 11' ' ' ILE . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.87 ' HE3' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 ' CA ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' C ' HG23 ' A' ' 5' ' ' VAL . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.604 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.67 ' HE2' HG11 ' A' ' 60' ' ' VAL . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' THR . 17.3 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' VAL . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 HG21 ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.517 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.519 ' CB ' ' OH ' ' A' ' 63' ' ' TYR . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.67 HG11 ' HE2' ' A' ' 43' ' ' MET . 11.4 t -112.05 159.07 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.41 -154.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.133 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.737 ' HB3' HG11 ' A' ' 97' ' ' VAL . 3.9 m120 -71.23 82.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.22 -0.925 . . . . 0.0 110.354 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.532 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -53.69 -100.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.237 -0.914 . . . . 0.0 109.825 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 24.5 mm-40 -116.78 -152.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.855 -1.153 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -71.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.921 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.37 -46.43 3.21 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.49 167.52 11.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.337 -1.096 . . . . 0.0 110.356 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' SER . 1.8 t -67.23 -114.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 48.1 m -64.41 140.85 98.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.738 -1.226 . . . . 0.0 110.124 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 45.3 Cg_endo -73.59 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.037 1.546 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.29 -80.77 1.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.98 52.41 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 109.678 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.15 130.88 35.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.75 . . . . 0.0 110.713 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.83 ' HB ' HD23 ' A' ' 125' ' ' LEU . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 74' ' ' SER . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.033 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 83' ' ' ILE . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 81' ' ' ILE . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.582 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.578 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.77 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.737 HG11 ' HB3' ' A' ' 62' ' ' ASN . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 133' ' ' TYR . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.923 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.923 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.6 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.033 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.829 ' N ' HD12 ' A' ' 125' ' ' LEU . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.675 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -73.36 -19.52 22.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -0.02 29.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -94.43 -21.32 19.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.208 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 131' ' ' LYS . 48.5 t -92.77 168.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' HG12 ' A' ' 130' ' ' VAL . 17.6 mtpt -75.59 -82.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 110.134 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.89 82.58 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -68.34 159.15 31.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.325 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.265 0.555 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.71 -178.18 4.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.276 -0.89 . . . . 0.0 110.266 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 22' ' ' MET . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.77 HD13 ' CD2' ' A' ' 17' ' ' LEU . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.9 OUTLIER 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.477 ' H ' HG22 ' A' ' 45' ' ' VAL . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.77 ' CD2' HD13 ' A' ' 11' ' ' ILE . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.448 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.548 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.527 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 15' ' ' THR . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.708 HG13 HG21 ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 HG13 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.812 ' CA ' HG13 ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.705 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.593 HG21 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t -108.48 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -60.84 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' O ' ' HE3' ' A' ' 43' ' ' MET . 0.4 OUTLIER -90.42 89.76 7.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.1 -56.39 18.57 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.467 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER 174.99 165.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.163 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -85.44 44.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.75 15.44 60.52 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 18.0 p -74.04 156.02 37.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.183 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.8 m -107.46 -78.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -76.4 120.19 80.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 46.1 Cg_endo -72.97 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.919 1.484 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.43 -77.29 0.26 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -87.59 52.59 2.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 110.022 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt -69.24 114.59 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -0.762 . . . . 0.0 110.219 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.954 HG13 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 124' ' ' THR . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.673 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.976 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.976 ' N ' HD13 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' OD1' ' A' ' 84' ' ' ASN . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.718 ' OD1' HG22 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 90' ' ' VAL . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.954 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE2' HG11 ' A' ' 76' ' ' VAL . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 98' ' ' SER . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 97' ' ' VAL . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.505 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.688 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.973 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.492 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.914 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.914 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.939 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.97 -24.45 17.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.72 -25.15 62.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 119' ' ' VAL . 2.5 ttm -80.41 -36.91 33.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 133' ' ' TYR . 33.0 t -86.54 116.51 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -83.64 -18.78 36.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -107.13 28.45 8.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 130' ' ' VAL . 28.7 t80 -66.66 162.29 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.167 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.189 0.518 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.9 176.6 6.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 110.373 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.834 HG13 ' HG3' ' A' ' 22' ' ' MET . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' CA ' ' A' ' 54' ' ' THR . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.472 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.514 HG13 HD21 ' A' ' 17' ' ' LEU . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.7 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.7 p-10 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.826 HD12 ' HG3' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG3' ' OE1' ' A' ' 9' ' ' GLN . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.834 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD13 ' A' ' 55' ' ' LEU . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.705 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.893 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.893 ' HD3' HG22 ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.001 HD13 ' O ' ' A' ' 63' ' ' TYR . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.789 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.834 ' HE2' HD21 ' A' ' 55' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' OD1' ' CG ' ' A' ' 61' ' ' LYS . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 50' ' ' PRO . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.567 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.834 HD21 ' HE2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.728 HG11 ' HB3' ' A' ' 63' ' ' TYR . 50.5 t -106.78 119.31 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 29.8 mmtt -69.95 -91.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 31.1 p-10 -90.76 72.65 6.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.401 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.001 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -53.58 -33.03 53.38 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.19 -0.944 . . . . 0.0 110.22 -179.724 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' HB3' HD22 ' A' ' 40' ' ' LEU . 3.1 pt-20 -174.68 -167.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.01 -1.056 . . . . 0.0 110.316 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -80.79 56.43 2.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.246 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.14 -14.72 81.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.499 ' CG2' HG23 ' A' ' 97' ' ' VAL . 27.1 p -86.41 95.05 9.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -1.191 . . . . 0.0 110.347 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -82.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.925 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.74 158.21 73.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 109.954 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.61 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.0 Cg_endo -73.26 -91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.854 1.449 . . . . 0.0 110.505 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.92 -75.12 0.12 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 5.9 mt -87.67 56.12 3.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.59 131.43 45.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG12 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 123' ' ' GLN . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.744 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 22.7 m120 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.684 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 75' ' ' VAL . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 98' ' ' SER . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.668 HD11 ' HA ' ' A' ' 127' ' ' PRO . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.075 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.846 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.551 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.846 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 126' ' ' MET . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.792 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.668 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.3 Cg_endo -72.6 -21.58 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.65 -0.63 51.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -84.31 -44.49 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 110.262 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 131' ' ' LYS . 51.0 t -78.88 162.88 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.7 mtmt -76.53 -73.71 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.255 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 132' ' ' ASN . 1.2 p-10 -105.28 68.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.886 . . . . 0.0 110.338 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE1' HD13 ' A' ' 102' ' ' ILE . 60.7 t80 -62.81 101.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.281 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.284 0.564 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 178.54 8.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.893 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.754 HG12 HD23 ' A' ' 55' ' ' LEU . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' HD23 ' A' ' 51' ' ' LEU . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 15' ' ' THR . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 46' ' ' ASN . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 2.4 p-10 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 11' ' ' ILE . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.663 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.998 HD12 HD12 ' A' ' 55' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD22 ' CE ' ' A' ' 43' ' ' MET . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.556 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.721 ' CE ' HD22 ' A' ' 40' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 13' ' ' ILE . 1.3 t30 -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.728 HG21 HG13 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.998 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 51.7 t -117.74 111.25 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -50.02 -99.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 110.119 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' ND2' ' OE2' ' A' ' 95' ' ' GLU . 9.3 t30 -83.45 103.11 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.74 -76.09 0.16 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.174 -0.954 . . . . 0.0 109.402 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.703 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -133.63 174.42 10.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -0.786 . . . . 0.0 109.968 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.45 48.6 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.896 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.99 45.08 1.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -84.41 164.85 18.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.253 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 68' ' ' THR . 22.4 p -67.8 -138.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.1 m -64.19 151.94 89.31 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.131 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.8 Cg_endo -73.7 -92.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.945 1.498 . . . . 0.0 110.575 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.11 -82.43 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mt -88.21 52.36 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -1.098 . . . . 0.0 109.988 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -81.66 115.7 21.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -0.789 . . . . 0.0 110.48 -179.732 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.879 ' C ' HD12 ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.879 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 5.2 m120 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.766 ' O ' HD23 ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.712 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 62' ' ' ASN . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.8 HD11 ' CA ' ' A' ' 127' ' ' PRO . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.003 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.792 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 131' ' ' LYS . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.792 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.693 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 79' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 99' ' ' PRO . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 126' ' ' MET . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.754 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.8 ' CA ' HD11 ' A' ' 102' ' ' ILE . 47.1 Cg_endo -73.36 -7.37 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -90.68 -20.28 22.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 31.7 ttm -85.79 -52.17 5.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.235 -0.915 . . . . 0.0 110.345 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 115' ' ' VAL . 42.1 t -73.34 110.64 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -76.13 -5.2 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.283 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -98.06 -6.93 30.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.302 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 28.4 t80 -59.6 156.1 14.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.174 -179.93 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.213 0.53 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -91.28 179.91 5.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 37' ' ' ILE . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.757 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 17' ' ' LEU . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 4.1 p-10 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 11' ' ' ILE . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.729 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.825 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 64' ' ' GLU . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' CG ' ' HZ3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.815 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.815 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.479 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.825 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.86 127.57 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HZ3' ' CG ' ' A' ' 46' ' ' ASN . 10.5 mtmm -59.22 -91.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.771 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -90.47 92.38 8.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 109.709 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.67 ' HB2' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.72 -5.78 49.48 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 1.047 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -179.33 163.27 1.24 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.913 -1.117 . . . . 0.0 110.398 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.89 45.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 110.074 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.93 -8.27 87.81 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.48 116.65 23.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -1.206 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.97 -76.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.239 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.25 134.12 56.01 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 45.1 Cg_endo -72.86 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 0.0 110.354 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.6 -78.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.6 mt -87.38 51.15 2.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.06 161.93 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -0.813 . . . . 0.0 110.301 179.648 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.766 HG12 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.627 HG21 HG11 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.668 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' LEU . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.673 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.425 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.547 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' HG12 ' A' ' 75' ' ' VAL . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 127' ' ' PRO . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 75' ' ' VAL . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.895 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.479 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 115' ' ' VAL . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.673 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.5 tt0 -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 126' ' ' MET . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.767 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.891 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo -72.44 -24.51 19.14 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.03 -28.3 63.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.173 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 9.2 mtt -82.29 -45.33 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -88.86 109.99 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 8.53 34.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.229 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -92.43 -25.37 18.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.15 174.08 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.315 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 -179.983 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 179.98 7.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.676 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.9 p-10 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 12' ' ' PRO . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD12 ' CG ' ' A' ' 43' ' ' MET . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 3' ' ' ALA . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 54' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.739 HD12 HD12 ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 37' ' ' ILE . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 40' ' ' LEU . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.476 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.658 ' CB ' HG13 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 29' ' ' PRO . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.739 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 63' ' ' TYR . 77.2 t -100.11 137.01 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 7.4 mmmt -70.64 -101.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -90.91 68.55 6.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.162 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.2 p90 -53.7 -38.59 64.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.257 -0.902 . . . . 0.0 110.573 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 2.6 pt-20 -178.17 -159.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.049 . . . . 0.0 110.365 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -75.49 54.67 0.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.533 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.53 30.4 7.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -86.91 119.14 26.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -1.172 . . . . 0.0 110.029 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.5 p -71.01 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.17 117.09 33.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.209 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.7 Cg_endo -72.08 -92.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.974 1.513 . . . . 0.0 110.484 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.24 -73.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.9 mt -87.18 51.99 2.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 109.929 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -71.4 113.56 8.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 110.641 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.894 ' HB ' HD23 ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 124' ' ' THR . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.845 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.845 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 83' ' ' ILE . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.856 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 114' ' ' GLN . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.556 ' HA ' HG13 ' A' ' 111' ' ' VAL . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.789 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.037 HG13 HD11 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.53 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' A' ' 113' ' ' MET . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 117' ' ' ARG . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.91 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD1' HD12 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.729 ' O ' HG13 ' A' ' 76' ' ' VAL . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.776 ' HA ' HG22 ' A' ' 76' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.511 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo -77.32 -13.99 16.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 1.9 p30 -72.9 -33.14 65.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.444 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -81.09 -49.51 10.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.199 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.813 HG12 HG23 ' A' ' 115' ' ' VAL . 31.0 m -75.63 -171.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -97.95 112.57 24.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 130' ' ' VAL . 2.4 m-85 -70.56 -169.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.18 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.331 0.586 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.32 179.1 5.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.32 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 22' ' ' MET . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' CG2' ' A' ' 27' ' ' VAL . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.739 ' O ' HD23 ' A' ' 51' ' ' LEU . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.735 HD12 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.624 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.735 ' CE ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HG2' HG13 ' A' ' 5' ' ' VAL . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.725 ' CG2' HG21 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.991 HD12 HD12 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CB ' HD13 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.628 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.736 ' CB ' HG13 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.453 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CA ' HD11 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 17.9 t -118.8 130.09 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.3 -146.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -0.883 . . . . 0.0 110.073 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.556 ' OD1' HG22 ' A' ' 97' ' ' VAL . 4.4 m120 -70.25 75.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.936 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 3.8 p90 -67.72 -10.82 55.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.413 -0.804 . . . . 0.0 111.303 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 17.7 pt-20 -140.22 5.37 2.08 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.794 -1.191 . . . . 0.0 111.024 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' CB ' ' HB3' ' A' ' 62' ' ' ASN . 2.4 t0 -77.6 58.12 1.72 Allowed 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.407 -0.808 . . . . 0.0 109.917 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.53 71.63 0.33 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.7 p -73.14 162.01 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.097 . . . . 0.0 110.508 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 4.0 m -68.93 -64.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 110.339 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -64.4 110.97 4.61 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.1 Cg_endo -73.82 -89.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.008 1.53 . . . . 0.0 110.603 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.9 -81.87 1.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 72' ' ' LEU . 10.2 mt -87.94 52.49 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -1.103 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -75.04 130.32 39.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.809 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.878 HG13 ' SD ' ' A' ' 92' ' ' MET . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.619 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 t30 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.662 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.878 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.744 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 76' ' ' VAL . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 ' CZ ' ' A' ' 133' ' ' TYR . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.063 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.571 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.629 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.503 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.662 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.773 HD12 ' N ' ' A' ' 126' ' ' MET . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.773 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 -18.31 23.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.75 7.9 11.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -100.29 -36.36 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 133' ' ' TYR . 25.4 t -79.61 152.74 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 42.1 mtpt -70.43 -75.12 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.66 66.79 0.8 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.548 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 88.6 t80 -73.21 120.51 18.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.336 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.253 179.88 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.275 0.56 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -75.94 160.8 29.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.587 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' A' ' 22' ' ' MET . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.766 ' O ' HD23 ' A' ' 51' ' ' LEU . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG21 ' A' ' 15' ' ' THR . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.547 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.587 HG22 ' CA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.938 ' CG2' HD21 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CG ' ' OE1' ' A' ' 64' ' ' GLU . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.938 HD21 ' CG2' ' A' ' 32' ' ' ILE . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' MET . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 49' ' ' VAL . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CB ' HG13 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 63' ' ' TYR . 47.5 t -120.17 130.32 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 0.3 OUTLIER -70.63 -95.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.278 -0.889 . . . . 0.0 110.071 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -90.96 70.93 6.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 110.307 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.74 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -53.42 -36.98 62.1 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.219 -0.925 . . . . 0.0 110.238 -179.709 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 7.0 pt-20 179.88 -172.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.26 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.44 41.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.379 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.76 8.13 67.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.71 162.84 22.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -1.152 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 68' ' ' THR . 4.0 t -106.31 -129.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.986 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 68' ' ' THR . 0.9 OUTLIER -64.05 120.67 66.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.007 -1.058 . . . . 0.0 110.165 -179.931 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 45.4 Cg_endo -72.46 -91.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.906 1.477 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.79 -82.4 0.84 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.03 53.42 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.09 . . . . 0.0 109.982 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.04 161.56 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.802 . . . . 0.0 110.124 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.001 HG13 ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 74' ' ' SER . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.998 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.833 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 83.2 m-20 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.001 ' HG3' HG13 ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.569 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 124' ' ' THR . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.87 HD11 ' HA ' ' A' ' 127' ' ' PRO . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 75' ' ' VAL . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.047 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.63 HD21 ' HG3' ' A' ' 134' ' ' GLU . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 129' ' ' MET . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.9 ' H ' HG22 ' A' ' 115' ' ' VAL . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.79 HG23 HD11 ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.547 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.998 HD23 HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 99' ' ' PRO . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.806 HD11 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.701 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.87 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.7 Cg_endo -73.41 -32.72 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -70.41 -14.64 62.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.195 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.455 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 2.9 mtp -86.41 -52.19 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.285 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 96.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 110.288 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 8.03 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -103.47 41.86 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.49 177.25 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.63 ' HG3' HD21 ' A' ' 110' ' ' LEU . 40.8 mt-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -74.64 -178.97 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' HD23 ' A' ' 51' ' ' LEU . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 6.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG13 HD21 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.648 HD21 HG13 ' A' ' 11' ' ' ILE . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.643 HD23 ' CE ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.631 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' HD23 ' A' ' 19' ' ' LEU . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.615 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.591 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD2' HG21 ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.796 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.35 118.58 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 62' ' ' ASN . 5.3 ttpt -60.07 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 122' ' ' ASP . 1.3 m120 -90.74 84.86 5.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.157 -0.964 . . . . 0.0 110.237 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.539 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -54.1 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.675 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' OE1' ' HB2' ' A' ' 63' ' ' TYR . 8.4 pm0 -136.77 168.86 18.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.29 45.49 1.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 110.273 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.73 30.02 11.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -74.06 108.98 7.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -1.112 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 3.7 m -91.73 -64.74 1.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.239 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 111.92 30.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 44.8 Cg_endo -73.19 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.931 1.49 . . . . 0.0 110.383 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.32 -74.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.7 mt -87.94 53.79 2.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -1.1 . . . . 0.0 109.871 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 15.7 mtpt -68.25 139.8 56.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.719 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 102' ' ' ILE . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 121' ' ' LEU . 6.3 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' HD22 ' A' ' 121' ' ' LEU . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.637 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 81' ' ' ILE . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.807 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 76' ' ' VAL . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.753 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' CD ' HD11 ' A' ' 110' ' ' LEU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.942 HD21 ' CD ' ' A' ' 134' ' ' GLU . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.807 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.469 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.995 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.9 Cg_endo -73.73 -24.81 15.31 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -9.0 59.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 110.026 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.1 ttp -87.52 -33.81 18.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 131' ' ' LYS . 16.8 t -89.04 177.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.581 ' H ' HG12 ' A' ' 130' ' ' VAL . 2.7 pttt -71.27 -139.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 110.378 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -91.0 60.42 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 -179.942 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -58.81 128.65 38.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.862 0.839 . . . . 0.0 110.832 -179.808 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.942 ' CD ' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.697 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.186 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.225 0.536 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -84.99 176.61 8.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.186 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 22' ' ' MET . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' HD11 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.672 HD12 ' HE3' ' A' ' 21' ' ' MET . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.781 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.62 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.9 m120 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.775 HD12 ' HG3' ' A' ' 43' ' ' MET . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 22' ' ' MET . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.672 ' HE3' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 5' ' ' VAL . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.714 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.053 ' CB ' HD13 ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.677 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.053 HD13 ' CB ' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD12 ' A' ' 17' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 49' ' ' VAL . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' C ' HG22 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 45' ' ' VAL . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 55' ' ' LEU . 55.1 t -120.38 82.1 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -72.31 -2.08 17.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 0.0 111.303 -179.757 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.447 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.4 m120 -91.25 -36.93 13.62 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.823 -1.173 . . . . 0.0 112.146 -178.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -53.66 111.11 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.888 -1.132 . . . . 0.0 109.465 -179.3 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 21.8 mm-40 -48.14 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.668 0.746 . . . . 0.0 111.119 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -64.98 1.06 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.298 179.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.78 9.06 19.68 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.78 -179.58 7.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -1.089 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 69' ' ' SER . 29.1 m -107.71 -85.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.468 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -74.66 133.88 76.32 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.364 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.44 -89.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.999 1.526 . . . . 0.0 110.564 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.15 -81.55 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.86 52.27 2.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.922 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -89.06 129.71 35.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 110.348 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 104' ' ' SER . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.58 HG13 ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.638 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.757 HD23 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.638 HG22 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.601 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.637 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 75' ' ' VAL . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.948 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 134' ' ' GLU . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.834 ' H ' HG22 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' HG22 ' A' ' 76' ' ' VAL . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.42 -13.73 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -20.43 60.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.287 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.447 ' HG3' ' HD2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -81.36 -47.42 13.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 133' ' ' TYR . 17.8 t -87.93 134.29 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.922 . . . . 0.0 110.106 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -70.53 -79.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.94 63.07 3.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 130' ' ' VAL . 5.3 p90 -77.01 155.15 32.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.726 ' HB2' HD21 ' A' ' 110' ' ' LEU . 21.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.23 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.6 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -91.75 176.15 6.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.585 HG23 ' C ' ' A' ' 33' ' ' PRO . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.857 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.648 ' O ' HD23 ' A' ' 51' ' ' LEU . 9.9 p30 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.3 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.96 HG23 HD21 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.494 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.96 HD21 HG23 ' A' ' 11' ' ' ILE . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.532 ' CG ' HG13 ' A' ' 5' ' ' VAL . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.756 ' CG2' HG21 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD11 ' CE2' ' A' ' 63' ' ' TYR . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.959 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.793 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.605 ' HE2' ' O ' ' A' ' 62' ' ' ASN . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' PRO . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' ' CD ' ' A' ' 61' ' ' LYS . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.552 ' O ' HG23 ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 56' ' ' MET . 23.5 t -120.09 97.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' CD ' ' OD1' ' A' ' 46' ' ' ASN . 21.8 tttt -62.59 -59.17 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.559 179.576 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' O ' ' HE2' ' A' ' 43' ' ' MET . 11.3 t-20 -79.77 62.69 4.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.418 -0.801 . . . . 0.0 109.693 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.982 ' CE1' HG23 ' A' ' 67' ' ' THR . 26.6 t80 -71.09 104.43 3.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.959 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -34.16 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.776 0.798 . . . . 0.0 111.875 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.59 53.82 1.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 110.285 179.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.16 19.32 15.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.982 HG23 ' CE1' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -73.95 168.15 20.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -1.089 . . . . 0.0 110.375 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -133.65 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.828 . . . . 0.0 109.915 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 139.36 97.7 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 110.116 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.47 -88.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.103 1.58 . . . . 0.0 110.502 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.94 -82.4 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 17.8 mt -87.91 51.46 2.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -1.118 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.0 132.25 47.52 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.566 -0.709 . . . . 0.0 110.567 -179.79 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG11 ' SD ' ' A' ' 92' ' ' MET . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.62 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.846 HG22 ' OD1' ' A' ' 84' ' ' ASN . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.846 ' OD1' HG22 ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 98' ' ' SER . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.604 HD11 ' CA ' ' A' ' 127' ' ' PRO . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.024 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 88' ' ' THR . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.721 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 126' ' ' MET . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.781 ' N ' HD12 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.604 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.5 Cg_endo -74.05 -14.91 23.5 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.12 -3.35 58.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.4 tpp -97.2 -13.59 21.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.66 152.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.8 mtpt -70.47 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.21 83.47 5.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -65.25 168.37 7.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.24 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.306 0.574 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -90.22 175.7 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.138 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.668 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.726 HG13 ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.726 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t30 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 7.0 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.8 p-10 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.726 ' HG3' HG13 ' A' ' 5' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.571 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.921 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 16.5 m120 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG22 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.542 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.738 HG21 HG11 ' A' ' 45' ' ' VAL . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.624 ' CB ' HG13 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.571 HG21 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' CE ' ' A' ' 43' ' ' MET . 98.3 t -119.37 125.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.65 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 109.789 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 20.3 t30 -69.59 93.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.817 179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -53.52 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 -179.286 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -106.62 178.42 4.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.1 . . . . 0.0 110.503 -179.588 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -86.8 59.67 5.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.535 -0.728 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.2 27.02 7.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 p -94.01 102.22 14.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -1.165 . . . . 0.0 110.223 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -81.32 -82.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.968 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 m -83.75 111.02 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 47.8 Cg_endo -73.48 -90.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.982 1.517 . . . . 0.0 110.561 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.74 -82.42 0.61 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.12 39.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.375 -1.073 . . . . 0.0 110.183 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 3.0 pttt -74.33 155.32 38.3 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.631 -0.668 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.757 HG12 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 97' ' ' VAL . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.533 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.737 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ILE . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.789 ' O ' HD23 ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 104' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.461 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.704 ' OE2' HD21 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 124' ' ' THR . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.699 HD12 HD11 ' A' ' 125' ' ' LEU . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 110' ' ' LEU . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.851 ' O ' HG23 ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.633 HD11 ' OE1' ' A' ' 134' ' ' GLU . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.89 HG22 ' H ' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.89 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.912 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.912 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.645 ' CB ' ' CD2' ' A' ' 133' ' ' TYR . 47.1 Cg_endo -83.08 60.31 6.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.9 -72.32 0.6 Allowed 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.463 -0.773 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.535 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 21.6 ptm -101.68 2.63 38.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.454 -0.779 . . . . 0.0 111.1 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 130' ' ' VAL . 3.9 m -72.14 123.56 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.939 -1.101 . . . . 0.0 110.19 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 131' ' ' LYS . 1.9 mtmt -91.21 -10.05 43.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.294 -0.879 . . . . 0.0 110.739 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB3' ' CE ' ' A' ' 113' ' ' MET . 3.6 t-20 -90.67 1.9 56.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.146 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.645 ' CD2' ' CB ' ' A' ' 127' ' ' PRO . 10.8 t80 -79.5 137.84 37.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.84 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.633 ' OE1' HD11 ' A' ' 110' ' ' LEU . 24.8 mt-10 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.173 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.482 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.41 0.624 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 1' ' ' ASN . 0.3 OUTLIER -73.53 -172.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.797 . . . . 0.0 110.207 179.994 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 33' ' ' PRO . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' HE3' ' A' ' 21' ' ' MET . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m120 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HE1' ' A' ' 21' ' ' MET . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.729 ' HE3' HD12 ' A' ' 11' ' ' ILE . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.712 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 6' ' ' VAL . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.637 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.566 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' NE2' HD23 ' A' ' 121' ' ' LEU . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.1 128.03 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -152.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 63' ' ' TYR . 12.0 t-20 -72.28 79.83 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.267 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.93 -102.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.323 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.6 mm-40 -106.47 -150.26 0.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 110.316 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -86.22 56.63 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.94 -25.34 75.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.15 139.06 31.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -1.119 . . . . 0.0 110.3 179.898 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 69' ' ' SER . 14.0 t -105.2 -40.67 5.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 68' ' ' THR . 3.4 m -83.69 111.07 29.33 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 45.5 Cg_endo -73.35 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.053 1.554 . . . . 0.0 110.704 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.48 -82.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 72' ' ' LEU . 6.5 mt -88.45 52.67 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -1.054 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 2.3 pttp -86.1 122.29 29.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -0.757 . . . . 0.0 110.646 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.98 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.98 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.7 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.65 HG22 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 133' ' ' TYR . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.549 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.041 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.896 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.544 ' CB ' ' HG3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.896 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.663 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 49.2 Cg_endo -75.65 -14.42 19.78 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 126' ' ' MET . 3.0 p30 -80.14 -17.57 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 0.0 110.589 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 126' ' ' MET . 5.8 ptp -94.72 -17.35 22.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 133' ' ' TYR . 85.1 t -92.69 141.86 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.544 ' HG3' ' CB ' ' A' ' 116' ' ' ASN . 1.6 mmmp? -80.7 -72.55 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.348 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.5 62.15 4.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.866 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 7.3 t80 -79.55 147.89 31.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 23.1 mt-10 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.276 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.251 0.548 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -179.41 4.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 22' ' ' MET . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' ' 13' ' ' ILE . 23.2 m120 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.681 HD12 ' CG ' ' A' ' 43' ' ' MET . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.496 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.595 ' HG3' HG13 ' A' ' 5' ' ' VAL . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' OE1' HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 ' OE1' ' A' ' 25' ' ' GLU . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.602 HG22 ' SD ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.83 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.83 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.969 ' CE ' HG11 ' A' ' 60' ' ' VAL . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 45' ' ' VAL . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.473 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 29' ' ' PRO . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.969 HG11 ' CE ' ' A' ' 43' ' ' MET . 31.4 t -98.04 134.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -70.96 -84.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 179.648 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' ND2' ' CB ' ' A' ' 122' ' ' ASP . 26.1 p-10 -91.27 104.11 16.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 3.7 m-85 -74.63 -63.82 1.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.745 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -176.59 174.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.021 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.01 58.45 5.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.86 33.04 4.92 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 p -92.83 156.65 16.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -1.165 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 p -97.93 -97.98 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.7 m -82.99 128.66 64.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 110.178 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 45.6 Cg_endo -73.23 -89.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.825 1.434 . . . . 0.0 110.652 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.63 -81.1 1.0 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.4 mt -87.62 53.24 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 109.931 179.592 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -78.86 116.54 19.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.483 -0.761 . . . . 0.0 110.598 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.745 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.558 HG21 ' CD ' ' A' ' 95' ' ' GLU . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.846 HG23 HG21 ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.015 HD13 ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.8 t-20 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.846 HG21 HG23 ' A' ' 81' ' ' ILE . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.649 HG23 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.745 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' CD ' HG21 ' A' ' 76' ' ' VAL . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.017 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.649 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.552 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.82 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.82 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.015 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.009 HD23 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.751 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.67 -15.13 27.23 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.0 m-20 -89.51 -8.26 53.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.91 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -55.26 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 131' ' ' LYS . 13.6 t -79.7 178.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.581 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -80.56 -142.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.463 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 28.2 t-20 -91.72 68.03 5.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.564 ' CD2' ' OXT' ' A' ' 134' ' ' GLU . 11.2 p90 -59.41 -171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' OXT' ' CD2' ' A' ' 133' ' ' TYR . 31.2 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.29 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.232 0.539 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 175.08 9.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG23 ' HB2' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.456 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 17' ' ' LEU . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 3.3 p-10 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.55 HG21 HG23 ' A' ' 11' ' ' ILE . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD21 HG21 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.495 ' HE1' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.639 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.916 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.932 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 40' ' ' LEU . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 60' ' ' VAL . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.782 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG13 ' CB ' ' A' ' 53' ' ' THR . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.731 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.768 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 45' ' ' VAL . 79.2 t -105.01 133.0 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -61.46 -146.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 179.921 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 7.5 m120 -69.98 79.04 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.087 . . . . 0.0 110.139 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 p90 -53.36 -39.27 64.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.103 -179.791 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 4.6 pt-20 176.15 170.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 179.268 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.61 -85.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.879 . . . . 0.0 110.553 -179.698 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -21.77 36.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.22 153.96 20.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -1.091 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 13.6 t -107.19 -21.34 13.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.3 m -84.24 111.32 32.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.297 -179.86 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.1 Cg_endo -75.34 -89.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.941 1.495 . . . . 0.0 110.613 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -82.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.84 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.6 pt? -88.73 39.73 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -1.036 . . . . 0.0 109.828 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.45 123.42 20.36 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.645 -0.659 . . . . 0.0 110.421 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.814 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.4 p30 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.728 ' CD1' HG11 ' A' ' 115' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.871 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 33.9 m120 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.505 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.56 ' HE2' HD22 ' A' ' 125' ' ' LEU . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' HB2' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.505 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.893 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.593 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.882 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.847 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -73.12 -24.59 16.91 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 30.4 p-10 -82.55 1.57 37.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.344 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.414 ' SD ' HG22 ' A' ' 119' ' ' VAL . 51.6 ttp -100.87 -21.77 15.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 131' ' ' LYS . 94.6 t -92.82 164.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 130' ' ' VAL . 1.9 pttm -70.02 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 110.133 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -90.64 71.21 6.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.9 140.84 58.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -0.799 . . . . 0.0 110.171 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.171 -179.992 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.228 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.62 170.03 14.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.879 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.63 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 7' ' ' ALA . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 8.1 m-20 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 17' ' ' LEU . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.432 ' CG ' HG13 ' A' ' 5' ' ' VAL . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.676 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.806 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.806 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.576 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 45' ' ' VAL . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.657 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.856 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.856 HG21 HG13 ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.879 ' CA ' HG13 ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.759 HG21 ' CD1' ' A' ' 55' ' ' LEU . 24.1 t -101.37 127.39 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CD ' ' O ' ' A' ' 122' ' ' ASP . 1.2 ttmm -67.08 -139.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' ND2' HG11 ' A' ' 76' ' ' VAL . 63.2 t30 -70.19 78.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.0 110.336 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 55.1 mm-40 -136.39 -141.59 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.52 44.18 1.02 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.142 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.25 -16.11 75.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.1 141.87 31.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -1.163 . . . . 0.0 110.102 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.0 p -68.6 -96.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.75 145.4 44.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.9 Cg_endo -73.3 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.995 1.524 . . . . 0.0 110.337 179.816 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.4 -74.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' PRO . 4.9 mt -84.76 52.24 2.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -1.12 . . . . 0.0 109.979 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -77.22 116.06 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.821 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 125' ' ' LEU . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.569 ' N ' HD23 ' A' ' 80' ' ' LEU . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.551 HG21 HG23 ' A' ' 81' ' ' ILE . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.625 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.466 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 62' ' ' ASN . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.625 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 130' ' ' VAL . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.771 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.771 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.488 ' N ' HD12 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.5 Cg_endo -72.83 -26.78 15.37 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.31 -20.27 59.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.5 -46.98 7.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.167 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 125' ' ' LEU . 6.7 t -85.29 111.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.79 9.98 8.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -105.32 -11.64 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.97 136.37 58.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.205 179.89 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -88.8 178.07 6.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.563 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 22' ' ' MET . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 27' ' ' VAL . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.631 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.5 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.563 HG22 ' CA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.068 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.573 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 13' ' ' ILE . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 61' ' ' LYS . 33.6 t -120.29 127.67 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -58.93 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.905 179.807 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' HB2' HG11 ' A' ' 76' ' ' VAL . 14.6 m-80 -72.26 82.44 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 110.15 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.412 -0.805 . . . . 0.0 110.331 179.989 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.534 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 4.7 mm-40 -125.61 -151.6 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.945 -1.097 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.26 58.79 5.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.0 110.335 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.99 -6.7 88.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.413 ' CG2' ' OE1' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -81.17 -160.6 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.373 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 68' ' ' THR . 3.0 t -104.7 -129.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.001 179.988 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.5 t -64.18 151.41 90.5 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.933 -1.104 . . . . 0.0 109.916 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 45.0 Cg_endo -72.15 -93.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.033 1.544 . . . . 0.0 110.573 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' LYS . . . 66.59 -82.41 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.36 39.84 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.312 -1.111 . . . . 0.0 110.293 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -69.94 154.17 42.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.673 179.992 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.87 HG11 ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 62' ' ' ASN . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.609 ' O ' HD13 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.653 HG23 ' CG2' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.653 ' CG2' HG23 ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.662 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 91' ' ' MET . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.599 ' N ' HG23 ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.87 ' SD ' HG11 ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 62' ' ' ASN . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 127' ' ' PRO . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.064 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.563 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.904 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.904 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 78' ' ' ASN . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.0 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.503 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 126' ' ' MET . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HD12 ' A' ' 125' ' ' LEU . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.4 Cg_endo -72.82 -20.15 22.9 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.77 -6.96 59.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.337 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.42 ' HG3' ' NE ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -83.64 -40.94 18.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 179.992 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 131' ' ' LYS . 85.1 t -81.83 172.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.6 ' N ' HG12 ' A' ' 130' ' ' VAL . 34.5 mtpt -74.73 -87.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -101.96 79.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.453 ' OH ' HG23 ' A' ' 102' ' ' ILE . 20.7 t80 -62.22 153.89 29.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.117 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.279 -179.959 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.264 0.554 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 179.25 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 27' ' ' VAL . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.567 ' HG2' HD11 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.585 HG13 HD21 ' A' ' 17' ' ' LEU . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.632 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 11' ' ' ILE . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.744 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.504 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HE1' ' A' ' 43' ' ' MET . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.717 ' HE1' HD12 ' A' ' 40' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 32.6 m120 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' HG2' ' A' ' 59' ' ' MET . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.504 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.529 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 63' ' ' TYR . 17.5 t -114.85 138.99 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE2' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -69.21 -95.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 11.4 t30 -90.96 67.21 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.03 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.644 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.7 p90 -53.56 -39.59 64.87 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.176 -0.952 . . . . 0.0 110.292 -179.703 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 2.5 pt-20 -178.37 -149.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 179.468 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.31 43.91 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.257 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 27.3 19.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 95' ' ' GLU . 2.4 p -78.95 169.09 18.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.212 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.9 p -82.67 -150.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.271 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -67.8 153.96 94.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 110.336 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' LYS . 44.9 Cg_endo -71.68 -153.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.123 1.591 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.61 -74.39 1.55 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.9 mt -88.04 50.46 1.99 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -1.091 . . . . 0.0 109.852 179.619 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' A' ' 70' ' ' PRO . 2.8 mtpm? -79.65 121.21 25.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.434 -0.791 . . . . 0.0 110.408 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 124' ' ' THR . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 85' ' ' THR . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.666 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.2 p-10 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.542 HG21 HG23 ' A' ' 81' ' ' ILE . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.571 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.589 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.469 ' HB2' HG21 ' A' ' 67' ' ' THR . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.76 HD12 HD11 ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.998 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.998 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.913 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.666 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 ' HE2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.923 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.923 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' CA ' HD11 ' A' ' 102' ' ' ILE . 44.9 Cg_endo -72.63 -30.23 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 34.1 p-10 -71.98 -26.34 62.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.468 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -80.3 -54.65 5.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 0.0 110.01 179.838 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 115' ' ' VAL . 76.3 t -86.06 98.12 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 131' ' ' LYS . 1.4 ptmt -90.21 18.67 5.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.148 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB3' ' HE1' ' A' ' 113' ' ' MET . 38.5 t30 -111.55 -18.54 12.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 163.03 16.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.296 179.995 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.137 179.969 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.1 t30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.294 0.569 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 176.12 9.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.967 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.835 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 15' ' ' THR . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.5 p-10 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.738 HG21 ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.503 ' HG2' HG13 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.753 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.967 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 28' ' ' THR . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.955 ' HB2' HD13 ' A' ' 40' ' ' LEU . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.642 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 36' ' ' GLU . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' MET . . . . . 1.116 ' HE2' HG11 ' A' ' 60' ' ' VAL . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.709 HG12 HG22 ' A' ' 60' ' ' VAL . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' C ' HG23 ' A' ' 13' ' ' ILE . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG13 HG21 ' A' ' 53' ' ' THR . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 49' ' ' VAL . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.116 HG11 ' HE2' ' A' ' 43' ' ' MET . 21.6 t -119.47 123.6 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 179.556 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.595 ' ND2' ' OE2' ' A' ' 95' ' ' GLU . 5.1 t-20 -91.41 108.75 20.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.974 179.399 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 57' ' ' PRO . 2.8 m-85 -62.92 -59.02 5.42 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.123 -0.986 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -141.89 -177.32 5.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.989 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.1 58.88 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.79 48.07 1.0 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.483 HG21 ' OE2' ' A' ' 95' ' ' GLU . 18.4 p -94.14 168.35 10.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.288 -179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.34 -140.0 0.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -64.37 138.15 97.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.996 179.856 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' O ' HD12 ' A' ' 72' ' ' LEU . 46.1 Cg_endo -72.04 -93.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.947 1.498 . . . . 0.0 110.454 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.93 -81.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.024 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -85.77 29.85 0.68 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -1.118 . . . . 0.0 111.821 -179.549 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 1.1 pttt -67.13 151.84 46.86 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.33 -0.856 . . . . 0.0 110.262 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 92' ' ' MET . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.565 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.689 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' HA2' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 90' ' ' VAL . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.54 ' HB3' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.595 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 127' ' ' PRO . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.907 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.948 HG13 ' CD ' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.948 ' CD ' HG13 ' A' ' 119' ' ' VAL . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.886 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.14 -8.56 22.26 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.38 -21.58 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 0.2 OUTLIER -84.71 -50.88 7.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.278 -179.926 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' VAL . 8.0 t -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 110.285 -179.831 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -89.76 -1.46 58.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 29.3 t-20 -92.42 0.8 57.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.156 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -71.82 167.19 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.244 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.221 -179.971 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 170.31 16.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 22' ' ' MET . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.433 ' NE2' ' HE3' ' A' ' 21' ' ' MET . 11.8 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 47' ' ' ARG . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.692 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 ' H ' ' A' ' 20' ' ' ILE . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.541 ' HE1' HG23 ' A' ' 11' ' ' ILE . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HG3' HG13 ' A' ' 5' ' ' VAL . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.476 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.086 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.573 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' A' ' 64' ' ' GLU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.647 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.56 ' HE2' ' HA ' ' A' ' 63' ' ' TYR . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 13' ' ' ILE . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 13' ' ' ILE . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.584 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HD2' ' A' ' 50' ' ' PRO . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.463 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.65 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 40.9 t -114.98 128.63 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -63.11 -96.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 3.9 m120 -90.65 107.43 19.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.03 . . . . 0.0 109.969 179.641 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.65 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 0.8 OUTLIER -74.86 -50.54 16.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 0.0 109.409 179.94 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.702 ' HG2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.15 178.75 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.945 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.66 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 110.125 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.62 58.77 0.59 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 p -79.03 145.58 33.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -1.149 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.6 t -74.66 -134.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -64.14 113.14 9.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.739 ' O ' HD23 ' A' ' 72' ' ' LEU . 46.9 Cg_endo -72.26 -95.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.959 1.505 . . . . 0.0 110.371 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 65.17 -76.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.72 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.803 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.8 pt? -86.06 41.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -1.166 . . . . 0.0 110.772 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -66.44 112.89 4.3 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 110.338 179.795 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.079 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.945 HG23 HG21 ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.945 HG21 HG23 ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.536 HG23 ' HA2' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.909 ' SD ' HG12 ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 72' ' ' LEU . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 76' ' ' VAL . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.647 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.982 HD11 ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.997 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' O ' ' A' ' 134' ' ' GLU . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.837 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' CZ ' ' A' ' 117' ' ' ARG . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.661 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' HG22 ' A' ' 76' ' ' VAL . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.989 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.989 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.982 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.32 -19.31 19.76 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 2.5 p30 -85.73 -17.94 34.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.445 ' HG3' ' HD3' ' A' ' 117' ' ' ARG . 2.0 tpt -90.28 -32.65 16.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 131' ' ' LYS . 71.5 t -86.22 172.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 130' ' ' VAL . 22.3 pttt -70.35 -139.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 7.9 m120 -91.26 70.2 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.92 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.27 159.0 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.453 -179.805 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.884 ' O ' HD11 ' A' ' 110' ' ' LEU . 46.8 mt-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.173 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 2' ' ' LYS . 8.5 p30 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' O ' ' OD1' ' A' ' 1' ' ' ASN . 11.4 mttt -83.47 177.52 8.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.09 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.711 HG13 ' HG3' ' A' ' 22' ' ' MET . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.79 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' ND2' ' CD1' ' A' ' 120' ' ' TYR . 3.9 m-20 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 18' ' ' THR . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.711 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.489 ' C ' HG13 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 26' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.638 HD12 HD12 ' A' ' 55' ' ' LEU . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HB2' HD13 ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 64.4 m-20 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.636 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 45' ' ' VAL . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.89 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.89 HG21 HG13 ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 32' ' ' ILE . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 HG11 ' HD2' ' A' ' 63' ' ' TYR . 64.9 t -120.04 127.28 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.35 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 0.0 109.755 179.669 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.89 ' OD1' HG21 ' A' ' 97' ' ' VAL . 52.7 t30 -70.82 69.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 109.825 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.92 -103.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.747 . . . . 0.0 110.627 -179.941 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 pt-20 -82.8 171.43 13.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.066 . . . . 0.0 110.264 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -85.91 -87.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.377 -0.827 . . . . 0.0 110.041 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.19 3.25 69.16 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 p -94.09 120.3 34.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -1.165 . . . . 0.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.2 p -86.65 -65.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.056 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.95 142.23 72.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.596 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 48.2 Cg_endo -73.51 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.079 1.568 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.91 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 10.4 mt -82.61 51.99 1.99 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.16 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -67.15 126.59 29.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 110.449 -179.905 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG11 ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.784 HG23 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.581 ' SD ' HG11 ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.596 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.89 HG21 ' OD1' ' A' ' 62' ' ' ASN . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.878 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.537 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.072 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.072 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.658 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.474 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 85' ' ' THR . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.688 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.976 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.636 HD12 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.835 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.878 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.5 -29.72 8.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.21 3.55 10.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.558 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.455 ' CB ' ' HG3' ' A' ' 126' ' ' MET . 6.8 ttp -94.47 -45.03 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.327 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 t -81.43 123.69 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mmpp? -78.24 -20.04 52.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.074 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -93.01 14.51 17.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.12 108.74 4.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.197 179.862 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 t30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.241 0.543 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -74.42 173.9 9.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG3' ' A' ' 22' ' ' MET . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.447 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.742 HG12 HD21 ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CG ' ' A' ' 43' ' ' MET . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.447 ' HG2' ' CD ' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' C ' HG13 ' A' ' 27' ' ' VAL . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG13 ' C ' ' A' ' 26' ' ' VAL . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 54' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.984 HD12 HD12 ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.921 ' HB2' HD13 ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.921 HD13 ' HB2' ' A' ' 36' ' ' GLU . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.571 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 55' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 45' ' ' VAL . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.919 ' CG1' HG21 ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.919 HG21 ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.501 HG21 ' HD2' ' A' ' 29' ' ' PRO . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.3 t -120.03 140.12 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HE2' ' OG1' ' A' ' 124' ' ' THR . 0.0 OUTLIER -63.02 -145.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.834 179.797 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 t-20 -70.12 76.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -53.38 -33.92 55.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.705 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 40' ' ' LEU . 1.8 pt-20 -172.75 -161.94 0.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.988 -1.07 . . . . 0.0 110.705 179.432 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -86.35 58.99 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 -179.688 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.42 -15.08 74.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.761 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 96' ' ' GLU . 23.3 p -94.1 120.78 34.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -84.64 -68.53 0.71 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.6 m -76.57 126.8 85.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.176 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.5 Cg_endo -73.46 -92.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.369 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 63.23 -73.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.777 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.771 HD13 ' HE2' ' A' ' 100' ' ' LYS . 6.8 mt -87.87 53.93 2.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.131 . . . . 0.0 110.109 -179.879 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -75.64 125.06 28.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.506 -0.746 . . . . 0.0 110.28 -179.943 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.519 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 2.9 p-10 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' HD22 ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.635 HD11 ' SD ' ' A' ' 91' ' ' MET . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.574 HG21 HG23 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 90' ' ' VAL . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HD11 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 67' ' ' THR . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.771 ' HE2' HD13 ' A' ' 72' ' ' LEU . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.862 HD11 ' CA ' ' A' ' 127' ' ' PRO . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.043 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.445 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' CD ' ' A' ' 134' ' ' GLU . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.043 HG23 ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.811 ' H ' HG22 ' A' ' 115' ' ' VAL . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.468 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 126' ' ' MET . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.542 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.862 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.1 -14.2 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.74 -20.58 29.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.477 ' HG2' ' CD ' ' A' ' 117' ' ' ARG . 6.9 mtt -90.55 -49.47 6.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.189 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 HG23 ' A' ' 115' ' ' VAL . 41.6 t -86.23 116.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.32 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 3.87 30.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.147 179.95 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -95.01 -7.34 40.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.178 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -65.29 136.49 56.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.152 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' CD ' HD21 ' A' ' 110' ' ' LEU . 28.5 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.247 0.546 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.561 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 22' ' ' MET . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 5.8 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' ND2' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.653 ' ND2' HG22 ' A' ' 13' ' ' ILE . 39.7 m-20 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.698 ' CE ' HD12 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.561 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 55' ' ' LEU . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 5' ' ' VAL . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 ' CE ' ' A' ' 22' ' ' MET . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 49' ' ' VAL . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.588 HG21 HG11 ' A' ' 45' ' ' VAL . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.73 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.73 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.799 HG23 ' SD ' ' A' ' 56' ' ' MET . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.857 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.799 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.857 HG21 ' CD2' ' A' ' 55' ' ' LEU . 22.8 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.195 0.522 . . . . 0.0 110.146 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG11 ' SD ' ' A' ' 92' ' ' MET . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.54 HD12 HD23 ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.724 HG23 HG21 ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.632 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 83' ' ' ILE . 18.7 t-20 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.714 ' OG1' HG22 ' A' ' 90' ' ' VAL . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.731 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.714 HG22 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.594 ' N ' HG23 ' A' ' 90' ' ' VAL . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 87' ' ' LEU . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.673 ' HG3' HG23 ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.673 HG23 ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 127' ' ' PRO . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.945 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 113' ' ' MET . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.826 HG22 ' H ' ' A' ' 117' ' ' ARG . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.826 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.002 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 1.002 ' N ' HD12 ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.256 0.551 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.473 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 15' ' ' THR . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 70.9 m-80 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 11' ' ' ILE . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.521 ' HE2' ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.756 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.852 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.582 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 27.6 m-80 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.494 ' HB ' HG13 ' A' ' 49' ' ' VAL . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.756 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.328 0.585 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.589 ' O ' HD13 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.951 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.647 HG23 HG21 ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.671 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.647 HG21 HG23 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.627 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 127' ' ' PRO . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.534 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE1' HD11 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' ILE . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD11 ' OE1' ' A' ' 106' ' ' GLU . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.627 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.879 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.555 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.951 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 126' ' ' MET . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.659 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.885 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.684 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 22' ' ' MET . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.59 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.914 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.44 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.914 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 11' ' ' ILE . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.519 ' HE3' HD23 ' A' ' 17' ' ' LEU . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG22 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.76 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.628 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.628 HD13 ' CB ' ' A' ' 36' ' ' GLU . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 55' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.847 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.847 HG21 HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.59 ' CA ' HG13 ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' MET . 52.4 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.389 0.614 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 102' ' ' ILE . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 87' ' ' LEU . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' HG21 ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 92' ' ' MET . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.994 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.197 0.522 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 37' ' ' ILE . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.449 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD21 HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.531 ' CG ' HG13 ' A' ' 5' ' ' VAL . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.764 HD12 HD12 ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.624 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' OE2' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.855 ' HD2' HG21 ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.855 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 29' ' ' PRO . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.764 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 104' ' ' SER . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 123' ' ' GLN . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 81' ' ' ILE . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 80' ' ' LEU . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.652 HD11 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.899 HD13 ' N ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 90' ' ' VAL . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.597 ' N ' HG13 ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.557 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.968 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.674 ' HB3' HG22 ' A' ' 75' ' ' VAL . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.479 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ILE . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 115' ' ' VAL . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.586 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.637 ' HB ' HD12 ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.76 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 76' ' ' VAL . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.65 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.968 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.254 0.549 . . . . 0.0 110.31 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.659 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 54' ' ' THR . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.0 t-20 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.879 HD13 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 14.5 p30 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.879 ' CD2' HD13 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.982 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.029 HG21 HG13 ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.002 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.452 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.324 0.583 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.77 ' O ' HD23 ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.002 HG22 ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.968 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.968 ' N ' HD13 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.678 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 11.6 p30 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.726 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 90' ' ' VAL . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG23 ' A' ' 90' ' ' VAL . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.726 ' SD ' HD12 ' A' ' 87' ' ' LEU . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 98' ' ' SER . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.937 HD12 ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' CD ' ' A' ' 105' ' ' GLU . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' CD ' ' HG2' ' A' ' 103' ' ' PRO . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.996 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.941 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.546 ' CB ' ' HE1' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.656 ' C ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 1.002 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.014 HD12 ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 1.014 ' CD ' HD12 ' A' ' 125' ' ' LEU . 43.5 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.328 0.585 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.786 ' CD1' HD23 ' A' ' 17' ' ' LEU . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.597 HG21 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.786 HD23 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG2' HG13 ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.751 HG22 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.751 ' SD ' HG22 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.706 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.889 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 5' ' ' VAL . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' HD12 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.528 ' CA ' HG13 ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.463 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.463 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.302 0.573 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HB ' HD23 ' A' ' 125' ' ' LEU . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.053 HD11 ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.609 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.427 ' CE ' HG12 ' A' ' 81' ' ' ILE . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.053 ' CE ' HD11 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 102' ' ' ILE . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 125' ' ' LEU . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.081 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.081 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.785 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.609 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.625 ' OD1' HD12 ' A' ' 121' ' ' LEU . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD23 ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.759 ' N ' HD12 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.3 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.256 0.551 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.823 ' HG2' HG13 ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 3' ' ' ALA . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 40' ' ' LEU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.644 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.742 HD11 HG21 ' A' ' 32' ' ' ILE . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.62 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 45' ' ' VAL . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 13' ' ' ILE . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.898 HG21 HG13 ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.714 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 110.423 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG22 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 80' ' ' LEU . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.601 HG22 ' NE2' ' A' ' 79' ' ' GLN . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.051 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.964 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.606 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' HE2' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 91' ' ' MET . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.523 ' N ' HG23 ' A' ' 90' ' ' VAL . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.964 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' A' ' 127' ' ' PRO . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 21.1 t-20 -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.051 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.742 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.3 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.723 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.679 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 51' ' ' LEU . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.673 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HE2' HG22 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 26' ' ' VAL . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.866 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.862 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD23 ' CB ' ' A' ' 36' ' ' GLU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.673 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.723 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 56' ' ' MET . 44.6 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.23 0.538 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 74' ' ' SER . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 85' ' ' THR . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.579 HG22 ' OD1' ' A' ' 84' ' ' ASN . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.579 ' OD1' HG22 ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 81' ' ' ILE . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 111' ' ' VAL . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 90' ' ' VAL . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.941 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 125' ' ' LEU . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.014 ' O ' HG23 ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 107' ' ' ILE . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.014 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 126' ' ' MET . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.721 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.246 0.546 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.608 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.851 HG13 ' HG2' ' A' ' 22' ' ' MET . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.687 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.549 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . 9.1 p30 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.851 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 55' ' ' LEU . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.57 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 53' ' ' THR . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.99 ' HB ' HG13 ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 HD11 ' A' ' 55' ' ' LEU . 19.4 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.301 0.572 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 104' ' ' SER . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HD23 ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.559 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.54 ' OG1' HG12 ' A' ' 90' ' ' VAL . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.559 ' CE ' HD12 ' A' ' 87' ' ' LEU . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.623 ' OE2' HG11 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 75' ' ' VAL . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.735 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.735 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.784 HD11 HD12 ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.724 ' N ' HD12 ' A' ' 125' ' ' LEU . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.446 ' N ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.299 0.571 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.772 HG13 HD21 ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.551 ' HB ' HG22 ' A' ' 11' ' ' ILE . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.772 HD21 HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.727 ' CE ' HD12 ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' C ' HG13 ' A' ' 27' ' ' VAL . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HE2' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.052 HD12 HD12 ' A' ' 55' ' ' LEU . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.727 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.59 HD12 ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.572 ' CE ' HG11 ' A' ' 60' ' ' VAL . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.632 HG23 ' CG ' ' A' ' 56' ' ' MET . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.052 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.632 ' CG ' HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG11 ' CE ' ' A' ' 43' ' ' MET . 6.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 123' ' ' GLN . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 121' ' ' LEU . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.625 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 115' ' ' VAL . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.497 HG22 ' OG1' ' A' ' 88' ' ' THR . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 98' ' ' SER . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.557 HD11 ' CA ' ' A' ' 127' ' ' PRO . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.058 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.803 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.803 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 126' ' ' MET . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.653 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.557 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.253 0.549 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG13 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.43 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.646 ' HG2' HG13 ' A' ' 5' ' ' VAL . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.589 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.818 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.611 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 45' ' ' VAL . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 49' ' ' VAL . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.642 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.818 HD11 ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.416 0.627 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HB ' HD23 ' A' ' 125' ' ' LEU . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.764 HG23 HG21 ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.764 HG21 HG23 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.07 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.805 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.07 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' SER . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 125' ' ' LEU . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.0 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 85' ' ' THR . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 49.8 tp60 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.586 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.574 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.167 0.508 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.525 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.594 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 17' ' ' LEU . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.804 ' HE2' HD12 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG22 ' CA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.009 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.804 HD12 ' HE2' ' A' ' 22' ' ' MET . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 43' ' ' MET . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.756 HG21 HG13 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.521 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.438 ' CG ' HG23 ' A' ' 54' ' ' THR . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.635 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.61 HG12 ' SD ' ' A' ' 92' ' ' MET . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.995 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.995 ' N ' HD13 ' A' ' 80' ' ' LEU . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.757 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG22 ' A' ' 83' ' ' ILE . 11.3 p30 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.538 HG22 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 75' ' ' VAL . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.635 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' ILE . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.789 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.789 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.757 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 102' ' ' ILE . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' LEU . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.702 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.8 Cg_endo . . . . . 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.228 0.537 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 4' ' ' SER . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 8.0 p30 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 HG23 ' HE3' ' A' ' 21' ' ' MET . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.895 ' HB2' HG22 ' A' ' 5' ' ' VAL . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.827 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.595 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.944 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.944 HG21 HG13 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.421 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.288 0.566 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.541 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' CB ' HG11 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.829 ' O ' HD13 ' A' ' 121' ' ' LEU . 27.4 t-20 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.802 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 82' ' ' PRO . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 83' ' ' ILE . 8.0 p30 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.625 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.89 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.89 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 76' ' ' VAL . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.953 HD12 HD11 ' A' ' 125' ' ' LEU . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.033 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.033 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.911 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 12.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.07 HD12 ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 1.07 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.665 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.269 0.556 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 55' ' ' LEU . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.685 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.893 ' CG2' HD21 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 9.4 p30 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD21 ' CG2' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' MET . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.503 ' HE1' HG13 ' A' ' 60' ' ' VAL . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG13 HG21 ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 HG13 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.732 ' CA ' HG13 ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 56' ' ' MET . 40.5 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.317 0.58 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.764 HG13 ' SD ' ' A' ' 92' ' ' MET . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 124' ' ' THR . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.4 p30 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 85' ' ' THR . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.845 HG21 HG23 ' A' ' 81' ' ' ILE . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.764 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 127' ' ' PRO . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.038 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 113' ' ' MET . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.038 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.452 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.809 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.509 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.585 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.836 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.212 0.529 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.625 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.467 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.556 ' H ' ' HE2' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.556 ' HE2' ' H ' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.625 ' CG ' HG13 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.681 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 6' ' ' VAL . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.938 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.692 ' HE1' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 45' ' ' VAL . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.509 ' CB ' HG13 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.938 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 4.3 pttt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.317 0.579 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 107' ' ' ILE . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 124' ' ' THR . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.6 m-80 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.989 ' N ' HD13 ' A' ' 80' ' ' LEU . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.642 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 83' ' ' ILE . 8.0 p30 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.981 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.981 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 HG21 ' A' ' 76' ' ' VAL . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 127' ' ' PRO . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.022 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.022 HG23 ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.606 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 126' ' ' MET . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.834 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.835 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.255 0.55 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.961 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.961 ' CD2' HD13 ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.698 ' SD ' HD23 ' A' ' 17' ' ' LEU . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 26' ' ' VAL . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.765 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' HG21 ' A' ' 54' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD12 ' A' ' 55' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.672 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.672 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.578 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.788 ' CG ' HD12 ' A' ' 17' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 13' ' ' ILE . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.61 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.61 HG21 HG13 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.623 HG21 ' HD2' ' A' ' 29' ' ' PRO . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.747 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.458 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.179 0.514 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG11 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.577 ' O ' HD13 ' A' ' 121' ' ' LEU . 49.6 t30 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 85' ' ' THR . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.709 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.501 ' SD ' HG11 ' A' ' 75' ' ' VAL . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 102' ' ' ILE . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 109' ' ' LYS . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.967 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.709 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 115' ' ' VAL . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.909 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 120' ' ' TYR . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.588 ' N ' HG12 ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.979 ' N ' HD12 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.223 0.535 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.76 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.857 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.8 p30 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.76 ' HG2' HG13 ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 3' ' ' ALA . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.0 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.005 HG21 HG13 ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.7 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG13 ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.606 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 83' ' ' ILE . 78.1 m-20 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.74 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.67 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.71 HG23 ' H ' ' A' ' 91' ' ' MET . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.71 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.566 ' SD ' HG13 ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.073 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 107' ' ' ILE . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.74 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.865 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 126' ' ' MET . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.731 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.212 0.529 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.716 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.0 p30 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.551 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.584 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.438 ' CG ' ' O ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 45' ' ' VAL . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.73 ' HB ' HD23 ' A' ' 125' ' ' LEU . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 97' ' ' VAL . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.0 t-20 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.582 ' HB ' HG21 ' A' ' 85' ' ' THR . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.632 ' O ' HD23 ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.692 HG22 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.447 ' HG3' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 76' ' ' VAL . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.962 HD11 ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.586 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.459 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.692 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.933 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.933 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.73 HD23 ' HB ' ' A' ' 75' ' ' VAL . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.671 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.962 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.2 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.663 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.021 HD13 HD21 ' A' ' 17' ' ' LEU . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.021 HD21 HD13 ' A' ' 11' ' ' ILE . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.87 ' HE3' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 ' CA ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' C ' HG23 ' A' ' 5' ' ' VAL . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.604 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.67 ' HE2' HG11 ' A' ' 60' ' ' VAL . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' THR . 5.6 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' VAL . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 HG21 ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.517 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.67 HG11 ' HE2' ' A' ' 43' ' ' MET . 11.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.311 0.577 . . . . 0.0 110.713 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.83 ' HB ' HD23 ' A' ' 125' ' ' LEU . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 74' ' ' SER . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.033 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 83' ' ' ILE . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 81' ' ' ILE . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.582 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.578 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.77 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.675 HD11 ' CA ' ' A' ' 127' ' ' PRO . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.923 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.923 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.6 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.033 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.829 ' N ' HD12 ' A' ' 125' ' ' LEU . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.675 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo . . . . . 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.182 0.515 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 22' ' ' MET . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.77 HD13 ' CD2' ' A' ' 17' ' ' LEU . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 14.5 p30 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.477 ' H ' HG22 ' A' ' 45' ' ' VAL . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.77 ' CD2' HD13 ' A' ' 11' ' ' ILE . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.448 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.548 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.527 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 15' ' ' THR . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.708 HG13 HG21 ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 HG13 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.812 ' CA ' HG13 ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.705 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.593 HG21 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.198 0.523 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.954 HG13 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 124' ' ' THR . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.673 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.976 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.976 ' N ' HD13 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' OD1' ' A' ' 84' ' ' ASN . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.718 ' OD1' HG22 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 90' ' ' VAL . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.954 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE2' HG11 ' A' ' 76' ' ' VAL . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 98' ' ' SER . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 97' ' ' VAL . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.505 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.688 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.973 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.492 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.914 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.914 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.939 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo . . . . . 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.373 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.834 HG13 ' HG3' ' A' ' 22' ' ' MET . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' CA ' ' A' ' 54' ' ' THR . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.472 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.514 HG13 HD21 ' A' ' 17' ' ' LEU . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.7 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.3 p30 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.826 HD12 ' HG3' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG3' ' OE1' ' A' ' 9' ' ' GLN . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.834 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD13 ' A' ' 55' ' ' LEU . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.705 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.893 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.893 ' HD3' HG22 ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 36' ' ' GLU . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.789 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.826 ' HG3' HD12 ' A' ' 17' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 50' ' ' PRO . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.567 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG21 ' CD2' ' A' ' 55' ' ' LEU . 50.5 t . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.525 0.679 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG12 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 123' ' ' GLN . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.744 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.52 ' ND2' HG22 ' A' ' 83' ' ' ILE . 77.1 m-20 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.684 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 75' ' ' VAL . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 73' ' ' LYS . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 98' ' ' SER . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.668 HD11 ' HA ' ' A' ' 127' ' ' PRO . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.075 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.846 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.846 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 126' ' ' MET . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.792 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.668 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.196 0.522 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.754 HG12 HD23 ' A' ' 55' ' ' LEU . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' HD23 ' A' ' 51' ' ' LEU . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 15' ' ' THR . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 46' ' ' ASN . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.7 p30 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 11' ' ' ILE . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.663 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.998 HD12 HD12 ' A' ' 55' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD22 ' CE ' ' A' ' 43' ' ' MET . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.556 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.721 ' CE ' HD22 ' A' ' 40' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.728 HG21 HG13 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.998 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG11 ' HE2' ' A' ' 43' ' ' MET . 51.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.313 0.578 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.879 ' C ' HD12 ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.879 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.734 HD22 HG22 ' A' ' 83' ' ' ILE . 4.7 m-80 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.766 ' O ' HD23 ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.712 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.8 HD11 ' CA ' ' A' ' 127' ' ' PRO . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.003 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.792 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.792 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.693 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 79' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 99' ' ' PRO . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 126' ' ' MET . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.754 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.8 ' CA ' HD11 ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 37' ' ' ILE . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.757 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.529 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 17' ' ' LEU . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.487 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 11' ' ' ILE . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.729 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.825 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 40' ' ' LEU . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.815 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.815 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.479 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.825 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.315 0.579 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.766 HG12 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.627 HG21 HG11 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.668 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' LEU . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.673 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.425 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.547 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' HG12 ' A' ' 75' ' ' VAL . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 127' ' ' PRO . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 75' ' ' VAL . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.895 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.479 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 115' ' ' VAL . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.673 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 126' ' ' MET . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.767 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.891 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.416 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.676 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.3 p30 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 12' ' ' PRO . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD12 ' CG ' ' A' ' 43' ' ' MET . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 3' ' ' ALA . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 54' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.739 HD12 HD12 ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 37' ' ' ILE . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 40' ' ' LEU . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.476 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.658 ' CB ' HG13 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 29' ' ' PRO . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.739 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG21 ' HE2' ' A' ' 43' ' ' MET . 77.2 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.324 0.583 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.894 ' HB ' HD23 ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 124' ' ' THR . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.845 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.845 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 83' ' ' ILE . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.856 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 114' ' ' GLN . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.556 ' HA ' HG13 ' A' ' 111' ' ' VAL . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.789 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.037 HG13 HD11 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.53 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' A' ' 113' ' ' MET . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 117' ' ' ARG . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.91 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD1' HD12 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.729 ' O ' HG13 ' A' ' 76' ' ' VAL . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.776 ' HA ' HG22 ' A' ' 76' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.511 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 22' ' ' MET . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' CG2' ' A' ' 27' ' ' VAL . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.739 ' O ' HD23 ' A' ' 51' ' ' LEU . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.735 HD12 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 17.1 p30 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.735 ' CE ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HG2' HG13 ' A' ' 5' ' ' VAL . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.725 ' CG2' HG21 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.991 HD12 HD12 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CB ' HD13 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.628 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.628 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.736 ' CB ' HG13 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.453 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CA ' HD11 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.263 0.554 . . . . 0.0 110.42 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.878 HG13 ' SD ' ' A' ' 92' ' ' MET . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.619 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.1 t-20 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.662 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.878 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.744 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 76' ' ' VAL . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.063 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.571 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.629 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.503 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.662 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.773 HD12 ' N ' ' A' ' 126' ' ' MET . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.773 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.172 0.51 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.587 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' A' ' 22' ' ' MET . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.766 ' O ' HD23 ' A' ' 51' ' ' LEU . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.458 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG21 ' A' ' 15' ' ' THR . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.547 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.587 HG22 ' CA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.938 ' CG2' HD21 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.938 HD21 ' CG2' ' A' ' 32' ' ' ILE . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' MET . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 49' ' ' VAL . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.583 ' CB ' HG13 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.293 0.568 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.001 HG13 ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 74' ' ' SER . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.998 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.833 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 24.5 m120 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.001 ' HG3' HG13 ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 124' ' ' THR . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.87 HD11 ' HA ' ' A' ' 127' ' ' PRO . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 75' ' ' VAL . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.047 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 106' ' ' GLU . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.9 ' H ' HG22 ' A' ' 115' ' ' VAL . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.79 HG23 HD11 ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.547 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.998 HD23 HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 99' ' ' PRO . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.806 HD11 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.701 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.87 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.7 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.284 0.564 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' HD23 ' A' ' 51' ' ' LEU . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.648 HG13 HD21 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.648 HD21 HG13 ' A' ' 11' ' ' ILE . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.643 HD23 ' CE ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.631 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' HD23 ' A' ' 19' ' ' LEU . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.615 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.591 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD2' HG21 ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.796 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 15.7 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.413 0.625 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 102' ' ' ILE . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 121' ' ' LEU . 4.2 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' HD22 ' A' ' 121' ' ' LEU . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.637 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 81' ' ' ILE . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.807 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 76' ' ' VAL . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.753 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.511 ' CD ' HD11 ' A' ' 110' ' ' LEU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD11 ' CD ' ' A' ' 106' ' ' GLU . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.807 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.469 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.995 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.9 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 22' ' ' MET . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' HD11 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.672 HD12 ' HE3' ' A' ' 21' ' ' MET . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.781 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.62 ' HB2' HD12 ' A' ' 13' ' ' ILE . 71.0 m-20 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.775 HD12 ' HG3' ' A' ' 43' ' ' MET . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 22' ' ' MET . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.672 ' HE3' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 5' ' ' VAL . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.714 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.053 ' CB ' HD13 ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.677 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.053 HD13 ' CB ' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD12 ' A' ' 17' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 49' ' ' VAL . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' C ' HG22 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 45' ' ' VAL . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 55' ' ' LEU . 55.1 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.242 0.544 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 104' ' ' SER . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.58 HG13 ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.638 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.757 HD23 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.638 HG22 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.601 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.637 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 75' ' ' VAL . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.948 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.834 ' H ' HG22 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' HG22 ' A' ' 76' ' ' VAL . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.249 0.547 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.585 HG23 ' C ' ' A' ' 33' ' ' PRO . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.857 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.648 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.8 p-10 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 6.6 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.96 HG23 HD21 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.2 p30 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.494 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.96 HD21 HG23 ' A' ' 11' ' ' ILE . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.532 ' CG ' HG13 ' A' ' 5' ' ' VAL . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.649 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.756 ' CG2' HG21 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.822 HD12 HD12 ' A' ' 55' ' ' LEU . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.793 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.507 ' HE3' ' HG ' ' A' ' 40' ' ' LEU . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' PRO . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.552 ' O ' HG23 ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 56' ' ' MET . 23.5 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.329 0.585 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG11 ' SD ' ' A' ' 92' ' ' MET . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.62 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.846 HG22 ' OD1' ' A' ' 84' ' ' ASN . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.846 ' OD1' HG22 ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.595 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 98' ' ' SER . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.604 HD11 ' CA ' ' A' ' 127' ' ' PRO . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.024 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 88' ' ' THR . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.721 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 126' ' ' MET . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.781 ' N ' HD12 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.604 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.5 Cg_endo . . . . . 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.242 0.544 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.668 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.726 HG13 ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.726 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.8 t-20 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.546 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 1.6 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.546 ' HG2' ' NE2' ' A' ' 9' ' ' GLN . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.726 ' HG3' HG13 ' A' ' 5' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.571 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.921 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' HG2' ' A' ' 38' ' ' PRO . 32.5 m-80 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG22 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.542 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.738 HG21 HG11 ' A' ' 45' ' ' VAL . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.624 ' CB ' HG13 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.571 HG21 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' CE ' ' A' ' 43' ' ' MET . 98.3 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 3.0 pttt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.757 HG12 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 97' ' ' VAL . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.533 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.737 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ILE . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.789 ' O ' HD23 ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 104' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.461 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 124' ' ' THR . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.699 HD12 HD11 ' A' ' 125' ' ' LEU . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 110' ' ' LEU . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.851 ' O ' HG23 ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 106' ' ' GLU . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.89 HG22 ' H ' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.89 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.912 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.912 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.222 0.534 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 33' ' ' PRO . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' HD11 ' A' ' 11' ' ' ILE . 4.5 pt20 -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' HE3' ' A' ' 21' ' ' MET . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.415 ' ND2' HG22 ' A' ' 13' ' ' ILE . 71.6 m-80 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HE1' ' A' ' 21' ' ' MET . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.729 ' HE3' HD12 ' A' ' 11' ' ' ILE . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.712 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 6' ' ' VAL . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.637 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.566 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' NE2' HD23 ' A' ' 121' ' ' LEU . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 2.3 pttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.305 0.574 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.98 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.98 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.7 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.65 HG22 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.543 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.549 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.041 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.896 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.896 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.663 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.255 0.55 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 22' ' ' MET . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.582 HG22 ' ND2' ' A' ' 14' ' ' ASN . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.582 ' ND2' HG22 ' A' ' 13' ' ' ILE . 35.7 m-80 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.681 HD12 ' CG ' ' A' ' 43' ' ' MET . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.496 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.595 ' HG3' HG13 ' A' ' 5' ' ' VAL . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.555 ' OE1' HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 ' OE1' ' A' ' 25' ' ' GLU . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.602 HG22 ' SD ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.83 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.83 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.969 ' CE ' HG11 ' A' ' 60' ' ' VAL . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 45' ' ' VAL . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.473 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 29' ' ' PRO . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.969 HG11 ' CE ' ' A' ' 43' ' ' MET . 31.4 t . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.244 0.545 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.745 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.558 HG21 ' CD ' ' A' ' 95' ' ' GLU . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.846 HG23 HG21 ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.015 HD13 ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.846 HG21 HG23 ' A' ' 81' ' ' ILE . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.649 HG23 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.745 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' CD ' HG21 ' A' ' 76' ' ' VAL . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.017 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.649 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.552 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.82 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.82 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.015 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.009 HD23 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.751 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.265 0.555 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG23 ' HB2' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.456 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 17' ' ' LEU . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.4 p30 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.55 HG21 HG23 ' A' ' 11' ' ' ILE . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD21 HG21 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.495 ' HE1' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.639 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.916 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.932 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 40' ' ' LEU . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 60' ' ' VAL . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.782 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG13 ' CB ' ' A' ' 53' ' ' THR . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.731 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.768 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 45' ' ' VAL . 79.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.421 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.814 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.9 p-10 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.728 ' CD1' HG11 ' A' ' 115' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.871 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 71.6 m-80 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.505 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.56 ' HE2' HD22 ' A' ' 125' ' ' LEU . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.505 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.513 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.893 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.593 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.882 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.847 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.266 0.555 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.879 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.63 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 7' ' ' ALA . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 0.9 OUTLIER 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 17' ' ' LEU . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.432 ' CG ' HG13 ' A' ' 5' ' ' VAL . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.676 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.806 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.806 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.576 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 45' ' ' VAL . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.657 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.856 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.856 HG21 HG13 ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.879 ' CA ' HG13 ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.759 HG21 ' CD1' ' A' ' 55' ' ' LEU . 24.1 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.31 0.576 . . . . 0.0 110.46 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 125' ' ' LEU . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.569 ' N ' HD23 ' A' ' 80' ' ' LEU . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.551 HG21 HG23 ' A' ' 81' ' ' ILE . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.625 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.466 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.625 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.771 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.771 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.488 ' N ' HD12 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.5 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.249 0.547 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.563 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 22' ' ' MET . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 27' ' ' VAL . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.631 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.461 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.5 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.563 HG22 ' CA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.068 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.573 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 13' ' ' ILE . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.87 HG11 ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.609 ' O ' HD13 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.653 HG23 ' CG2' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.653 ' CG2' HG23 ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.662 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 91' ' ' MET . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.599 ' N ' HG23 ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.87 ' SD ' HG11 ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 127' ' ' PRO . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.064 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.563 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.589 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.904 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.904 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 78' ' ' ASN . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.0 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 126' ' ' MET . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HD12 ' A' ' 125' ' ' LEU . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.4 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.211 0.529 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 27' ' ' VAL . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.567 ' HG2' HD11 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.585 HG13 HD21 ' A' ' 17' ' ' LEU . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.632 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 11' ' ' ILE . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.744 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.504 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HE1' ' A' ' 43' ' ' MET . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.717 ' HE1' HD12 ' A' ' 40' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 76.2 m-20 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' HG2' ' A' ' 59' ' ' MET . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.504 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.529 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.8 mtpm? . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.368 0.604 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 124' ' ' THR . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 85' ' ' THR . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.666 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.463 ' CG ' ' O ' ' A' ' 83' ' ' ILE . 9.7 p30 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.542 HG21 HG23 ' A' ' 81' ' ' ILE . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.571 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.589 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.76 HD12 HD11 ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.998 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.998 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.913 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.666 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.923 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.923 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' CA ' HD11 ' A' ' 102' ' ' ILE . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.967 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.835 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 15' ' ' THR . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 12.9 p30 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.738 HG21 ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.503 ' HG2' HG13 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.753 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.967 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 28' ' ' THR . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.955 ' HB2' HD13 ' A' ' 40' ' ' LEU . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.642 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 36' ' ' GLU . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 1.116 ' HE2' HG11 ' A' ' 60' ' ' VAL . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.709 HG12 HG22 ' A' ' 60' ' ' VAL . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' C ' HG23 ' A' ' 13' ' ' ILE . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG13 HG21 ' A' ' 53' ' ' THR . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 49' ' ' VAL . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.116 HG11 ' HE2' ' A' ' 43' ' ' MET . 21.6 t . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 1.1 pttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.421 0.629 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 92' ' ' MET . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.565 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.689 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' HA2' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 90' ' ' VAL . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.54 ' HB3' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 96' ' ' GLU . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 127' ' ' PRO . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.907 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.948 HG13 ' CD ' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.948 ' CD ' HG13 ' A' ' 119' ' ' VAL . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.886 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.176 0.512 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 22' ' ' MET . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 21' ' ' MET . 3.2 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 47' ' ' ARG . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.692 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 ' H ' ' A' ' 20' ' ' ILE . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.541 ' HE1' HG23 ' A' ' 11' ' ' ILE . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.476 ' HG3' HG13 ' A' ' 5' ' ' VAL . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.476 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.086 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.578 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.573 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 40' ' ' LEU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.647 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.486 ' CG ' HD12 ' A' ' 17' ' ' LEU . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 13' ' ' ILE . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 13' ' ' ILE . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.584 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HD2' ' A' ' 50' ' ' PRO . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.463 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.34 0.591 . . . . 0.0 110.338 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.079 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.945 HG23 HG21 ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.945 HG21 HG23 ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.536 HG23 ' HA2' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.909 ' SD ' HG12 ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 76' ' ' VAL . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.982 HD11 ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.997 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 113' ' ' MET . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.837 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' CZ ' ' A' ' 117' ' ' ARG . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.661 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' HG22 ' A' ' 76' ' ' VAL . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.989 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.989 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.982 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mttt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.711 HG13 ' HG3' ' A' ' 22' ' ' MET . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.79 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 18' ' ' THR . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.711 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.489 ' C ' HG13 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 26' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.638 HD12 HD12 ' A' ' 55' ' ' LEU . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HB2' HD13 ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 11.9 m120 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.636 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 45' ' ' VAL . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.89 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.89 HG21 HG13 ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 32' ' ' ILE . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.581 HG11 ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.784 HG23 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.581 ' SD ' HG11 ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' SER . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.878 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.537 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.072 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.072 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.658 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.474 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 85' ' ' THR . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.688 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.976 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.636 HD12 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.835 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.878 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG3' ' A' ' 22' ' ' MET . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.447 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.742 HG12 HD21 ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CG ' ' A' ' 43' ' ' MET . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.447 ' HG2' ' CD ' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' C ' HG13 ' A' ' 27' ' ' VAL . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG13 ' C ' ' A' ' 26' ' ' VAL . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 54' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.984 HD12 HD12 ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.921 ' HB2' HD13 ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.921 HD13 ' HB2' ' A' ' 36' ' ' GLU . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.571 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 55' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 45' ' ' VAL . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.919 ' CG1' HG21 ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.919 HG21 ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.501 HG21 ' HD2' ' A' ' 29' ' ' PRO . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.3 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 93' ' ' LYS . 6.6 p30 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' HD22 ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.635 HD11 ' SD ' ' A' ' 91' ' ' MET . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.574 HG21 HG23 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 90' ' ' VAL . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HD11 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.521 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.862 HD11 ' CA ' ' A' ' 127' ' ' PRO . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.043 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.445 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 113' ' ' MET . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.043 HG23 ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.811 ' H ' HG22 ' A' ' 115' ' ' VAL . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 126' ' ' MET . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.542 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.862 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 50.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.198 0.523 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 154.92 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.561 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -75.89 152.54 37.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 5.3 t -101.45 175.05 5.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 22' ' ' MET . 96.4 t -84.59 93.22 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 27' ' ' VAL . 4.1 t -109.86 115.24 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.97 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.27 129.18 40.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' O ' HD23 ' A' ' 51' ' ' LEU . 3.8 p-10 -82.8 -41.94 18.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 5.8 pt20 -92.11 175.46 6.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.164 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -90.1 131.24 36.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.83 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 20.0 mm -112.57 140.03 23.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 110.531 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -75.32 -162.05 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.041 1.548 . . . . 0.0 110.148 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' ND2' ' A' ' 14' ' ' ASN . 2.7 mp -89.61 143.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.653 ' ND2' HG22 ' A' ' 13' ' ' ILE . 39.7 m-20 58.95 66.15 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 51.1 m -137.08 119.63 15.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.461 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.76 114.69 8.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.933 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.4 mt -72.5 148.92 44.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 110.57 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.0 p -120.68 -172.97 2.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.429 -0.795 . . . . 0.0 109.858 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.493 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -68.71 -44.0 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.301 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.487 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 14.6 mtm -82.23 -5.17 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.107 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.698 ' CE ' HD12 ' A' ' 37' ' ' ILE . 13.9 tmm? -102.6 114.8 29.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.174 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.39 122.85 48.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.561 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.66 76.46 9.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.05 148.11 26.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.5 t -88.21 75.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 6' ' ' VAL . 18.4 m -118.3 167.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.38 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.0 t -109.05 152.46 42.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -77.35 153.51 95.06 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.611 -2.245 . . . . 0.0 110.501 -0.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mtt -72.65 79.1 1.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 0.0 110.007 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -136.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' CG2' ' OE2' ' A' ' 64' ' ' GLU . 3.7 mt -72.69 139.17 80.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 110.24 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 5' ' ' VAL . 45.8 Cg_endo -72.89 -171.12 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -112.35 12.35 20.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' OE1' ' CG ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -60.43 -36.77 78.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.983 . . . . 0.0 110.609 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' CG ' ' OE1' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -94.88 14.96 19.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.269 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 ' CE ' ' A' ' 22' ' ' MET . 4.8 mm -42.37 -55.46 6.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.3 Cg_endo -69.22 -2.9 10.6 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.582 1.306 . . . . 0.0 110.758 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.2 m120 -103.26 -57.66 2.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -92.33 3.66 54.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 111.082 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.57 151.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 0.0 109.014 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.575 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.88 13.01 81.0 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.58 ' HE3' ' HA ' ' A' ' 63' ' ' TYR . 15.0 ptm -68.75 129.79 40.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.136 -1.214 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -82.36 157.41 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG11 HG21 ' A' ' 49' ' ' VAL . 25.8 m -103.81 167.54 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 61' ' ' LYS . 1.2 t-20 -92.14 -19.18 22.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -142.94 177.45 8.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.183 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.53 58.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.588 HG21 HG11 ' A' ' 45' ' ' VAL . 3.3 t -110.09 127.61 26.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.73 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -72.51 -172.07 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.888 1.467 . . . . 0.0 110.335 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.8 140.63 31.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 62.53 34.87 90.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.73 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.4 m -86.33 119.76 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.163 . . . . 0.0 110.21 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.799 HG23 ' SD ' ' A' ' 56' ' ' MET . 2.3 t -69.94 156.92 38.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.857 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -71.75 110.76 6.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.799 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.45 149.28 36.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.84 -36.55 3.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.02 1.537 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' HG3' ' A' ' 59' ' ' MET . 18.8 p-10 -79.06 -17.87 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 56' ' ' MET . 14.9 mtt -95.81 -14.48 23.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 110.236 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.857 HG21 ' CD2' ' A' ' 55' ' ' LEU . 22.8 t -120.14 129.88 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 123' ' ' GLN . 7.7 mtmt -62.81 -103.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.86 75.21 6.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.97 -1.081 . . . . 0.0 109.813 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -53.28 -30.98 41.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE2' ' CG2' ' A' ' 32' ' ' ILE . 2.9 pt-20 169.31 163.76 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.18 -0.95 . . . . 0.0 110.229 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -85.97 52.64 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.16 2.84 86.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -84.89 154.02 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.147 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 55.1 m -106.25 -73.4 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.34 117.95 65.88 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 110.189 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.2 Cg_endo -72.26 -90.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.826 1.435 . . . . 0.0 110.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.2 -70.65 0.14 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.3 mt -87.8 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -1.153 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 116.75 9.77 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 110.146 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -99.4 155.04 17.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG11 ' SD ' ' A' ' 92' ' ' MET . 17.9 t -79.96 125.87 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 110.167 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 34.9 t -129.23 128.88 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.06 84.3 4.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.4 m120 -57.32 -21.76 37.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.849 . . . . 0.0 110.617 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -110.39 -172.72 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.54 HD12 HD23 ' A' ' 121' ' ' LEU . 1.8 tt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.383 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.724 HG23 HG21 ' A' ' 85' ' ' THR . 18.4 mm -120.7 128.42 25.79 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 109.936 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.3 Cg_endo -73.41 151.47 48.03 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.881 1.464 . . . . 0.0 110.833 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.632 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.5 mt -42.01 158.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.265 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 83' ' ' ILE . 18.7 t-20 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.724 HG21 HG23 ' A' ' 81' ' ' ILE . 6.0 m -142.88 107.87 4.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.59 85.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.125 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -85.54 141.84 29.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.714 ' OG1' HG22 ' A' ' 90' ' ' VAL . 14.0 p -121.58 -170.69 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.185 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.731 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -56.29 -29.55 61.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.722 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.714 HG22 ' OG1' ' A' ' 88' ' ' THR . 33.7 m -59.45 -46.68 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.379 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.594 ' N ' HG23 ' A' ' 90' ' ' VAL . 1.5 mtp -85.2 -20.12 30.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 87' ' ' LEU . 7.6 mtm -102.22 131.87 48.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 2.1 mmmt -117.24 98.64 6.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.77 93.39 0.95 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.673 ' HG3' HG23 ' A' ' 97' ' ' VAL . 1.3 pt-20 -123.68 162.2 23.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.871 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.07 98.31 2.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 110.177 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.673 HG23 ' HG3' ' A' ' 95' ' ' GLU . 23.3 t -134.9 156.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.397 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.48 151.34 42.11 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 110.043 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.11 178.29 35.68 Favored 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.649 -2.23 . . . . 0.0 110.328 -0.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.56 85.79 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.302 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.2 -104.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 127' ' ' PRO . 6.4 mt -109.66 118.76 49.61 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.48 150.23 57.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.857 1.451 . . . . 0.0 110.548 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 53.6 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.392 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -67.38 -68.21 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.91 31.35 6.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.957 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.945 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -51.8 -38.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.469 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 3.3 m -53.02 -24.77 10.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.26 -35.39 13.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' A' ' 133' ' ' TYR . 23.0 mt -92.41 -3.57 55.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.8 t -59.18 144.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.309 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.25 6.17 87.65 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.475 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 22.9 ptm -73.91 149.69 41.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -1.187 . . . . 0.0 109.892 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -84.97 132.39 34.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.277 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.826 HG22 ' H ' ' A' ' 117' ' ' ARG . 15.0 p -87.39 154.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.43 -4.45 28.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.826 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -124.82 162.8 23.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.231 -0.918 . . . . 0.0 109.708 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -79.19 143.69 35.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.259 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 46.8 t -118.87 136.57 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.138 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 6.1 m-85 -94.19 -163.66 1.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -59.06 -148.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.423 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 37.4 p30 -43.99 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.886 . . . . 0.0 111.032 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.8 tt0 -118.21 146.07 44.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -0.75 . . . . 0.0 109.88 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 79.1 m -78.84 121.9 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.002 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -73.97 127.75 33.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.18 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 1.002 ' N ' HD12 ' A' ' 125' ' ' LEU . 25.3 mtm -123.62 159.56 54.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.249 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.54 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.2 Cg_endo -75.19 -7.33 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.008 1.531 . . . . 0.0 110.444 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 129' ' ' MET . 3.4 p30 -85.94 -22.02 27.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.391 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.507 ' HG3' HG23 ' A' ' 130' ' ' VAL . 4.2 ptm -93.84 -14.96 25.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 131' ' ' LYS . 91.8 t -92.65 172.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 130' ' ' VAL . 6.5 mttt -81.98 -131.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 110.149 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -99.46 116.0 30.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.988 -1.07 . . . . 0.0 110.388 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 102' ' ' ILE . 7.3 m-85 -68.37 -167.75 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.213 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.956 0.408 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -80.9 -176.03 5.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.862 -1.149 . . . . 0.0 110.21 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.62 149.37 38.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 t -105.76 174.99 5.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 55' ' ' LEU . 69.2 t -82.47 102.95 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 110.157 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.6 t -115.3 111.85 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.59 135.82 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 38.0 t-20 -83.02 -47.35 11.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.473 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 0.1 OUTLIER -92.47 -177.5 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 110.034 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HB2' HD12 ' A' ' 51' ' ' LEU . 1.5 tt -89.4 122.62 32.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 15' ' ' THR . 32.2 mm -106.67 123.74 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.484 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.53 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.879 1.463 . . . . 0.0 110.592 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 13.6 mm -82.35 158.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' ILE . 70.9 m-80 44.37 71.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.12 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 11' ' ' ILE . 42.1 m -139.22 109.37 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.404 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.66 89.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.189 -0.944 . . . . 0.0 109.737 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.7 mt -43.85 147.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.616 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 36.7 p -121.02 161.42 21.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -26.49 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 110.099 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.16 -54.16 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.302 -0.873 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.521 ' HE2' ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -82.46 -1.97 51.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.493 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -93.61 112.01 23.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.176 -0.952 . . . . 0.0 110.555 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.27 136.82 49.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.248 179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.56 72.78 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -0.891 . . . . 0.0 110.272 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.08 150.89 23.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.3 t -88.17 101.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.192 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 m -138.48 161.93 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.9 t -101.25 151.65 37.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.16 159.92 96.17 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.685 -2.215 . . . . 0.0 110.434 -0.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -70.84 81.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.82 -140.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.756 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -80.53 138.99 51.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -1.127 . . . . 0.0 110.261 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.83 163.32 38.75 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.984 1.518 . . . . 0.0 110.413 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . . . -88.68 12.1 15.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -52.96 -53.12 54.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.078 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 22.0 mm-40 -92.83 56.79 2.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.852 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -70.55 -30.24 1.77 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.976 . . . . 0.0 111.915 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.9 Cg_endo -76.66 -9.43 18.46 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -104.46 -37.67 7.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 109.642 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.668 HD11 ' OE2' ' A' ' 64' ' ' GLU . 46.4 mt -89.99 -3.5 57.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.19 151.11 10.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.954 -1.092 . . . . 0.0 110.49 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.35 7.49 26.29 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.582 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 70.3 mmm -70.56 134.7 47.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.771 -1.429 . . . . 0.0 110.158 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -90.01 134.27 34.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.01 160.04 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.381 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.427 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 27.6 m-80 -100.97 2.25 40.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.905 . . . . 0.0 110.183 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 5.9 mtp180 -134.12 170.52 15.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.858 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -74.61 137.5 42.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 t -120.03 112.05 35.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.013 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 53' ' ' THR . 45.1 Cg_endo -72.23 -168.59 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.993 1.523 . . . . 0.0 110.757 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -78.66 151.98 31.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 54.8 31.71 54.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.494 ' HB ' HG13 ' A' ' 49' ' ' VAL . 76.0 m -84.08 128.65 34.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.124 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.5 t -74.21 169.08 18.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.875 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.756 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.94 103.13 12.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.7 mtt -94.63 122.57 60.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -13.4 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.792 1.417 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.53 -20.1 40.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mtm -101.12 -0.46 36.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.295 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.5 t -120.04 133.89 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -65.64 -130.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -70.14 76.76 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.92 -1.113 . . . . 0.0 110.173 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' O ' ' HE2' ' A' ' 43' ' ' MET . 0.1 OUTLIER -53.62 -94.55 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.912 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' A' ' 40' ' ' LEU . 8.0 pt-20 -121.81 -159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.806 -1.184 . . . . 0.0 110.197 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -86.1 57.06 4.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.232 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.85 23.47 14.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.89 161.88 14.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -1.195 . . . . 0.0 110.211 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -85.23 -140.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 140.74 98.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.965 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 47.2 Cg_endo -72.19 -94.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.034 1.544 . . . . 0.0 110.423 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.03 -78.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 5.4 mt -87.28 53.02 2.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.3 pttm -88.71 119.92 29.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.509 -0.745 . . . . 0.0 110.455 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -93.58 153.9 18.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.078 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 92' ' ' MET . 50.3 t -66.61 129.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 93' ' ' LYS . 54.8 t -126.35 129.23 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.49 91.06 4.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.922 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.589 ' O ' HD13 ' A' ' 121' ' ' LEU . 11.4 p-10 -57.38 -26.88 61.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.344 -0.848 . . . . 0.0 110.83 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -109.99 -176.19 2.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.951 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -99.66 125.75 45.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 0.0 110.352 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.647 HG23 HG21 ' A' ' 85' ' ' THR . 50.9 mm -119.92 127.25 26.47 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.951 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.18 153.69 51.58 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.872 1.459 . . . . 0.0 110.609 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.671 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 6.2 mt -45.22 152.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.282 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 73.0 m-20 50.98 71.02 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.674 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.647 HG21 HG23 ' A' ' 81' ' ' ILE . 54.8 m -143.63 109.16 5.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.025 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.07 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.892 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.7 OUTLIER -89.64 144.0 26.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.893 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.627 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.1 p -128.41 179.11 5.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.942 . . . . 0.0 110.405 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -50.88 -28.45 9.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 110.286 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.2 t -54.38 -64.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.113 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.97 1.0 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.2 ttp -100.78 124.3 46.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.863 . . . . 0.0 109.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 9.9 mttt -122.99 88.83 3.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.345 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.27 102.01 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -121.38 164.33 17.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 110.12 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 1.0 OUTLIER -77.77 93.86 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.33 164.88 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.608 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 33.1 m -109.35 163.08 17.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -75.29 175.65 47.0 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.629 -2.238 . . . . 0.0 110.388 -0.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 72' ' ' LEU . 2.7 mmmm -84.05 84.36 7.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.1 -111.03 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 127' ' ' PRO . 17.2 mt -109.32 123.34 36.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 46.4 Cg_endo -72.24 159.74 48.89 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.899 1.473 . . . . 0.0 110.606 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.534 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.4 p -88.76 55.76 3.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 85.4 mt-10 -86.67 -38.02 17.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.412 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE1' HD11 ' A' ' 110' ' ' LEU . 8.0 pt-20 -115.93 10.37 15.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.2 mm -47.02 -52.51 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.007 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' ILE . 9.0 t -42.09 -28.75 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 110.118 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 107' ' ' ILE . 1.2 mttt -91.69 -24.11 19.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.091 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD11 ' OE1' ' A' ' 106' ' ' GLU . 18.5 mt -111.22 16.17 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.872 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.8 t -62.06 140.47 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.019 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.627 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 67.34 19.28 70.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.2 150.98 41.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -1.202 . . . . 0.0 110.002 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.79 123.41 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.7 p -80.18 153.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.454 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -100.62 -1.99 33.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.2 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.879 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -124.58 170.67 10.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.83 142.33 29.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.0 t -121.16 138.81 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.3 -0.875 . . . . 0.0 110.074 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.555 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 34.1 m-85 -97.6 -163.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.503 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.951 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.99 -149.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 110.446 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.71 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' LEU . 15.3 tp60 -118.77 149.63 41.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.971 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 90.1 m -78.78 131.87 36.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 126' ' ' MET . 3.9 tp -68.46 129.86 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.659 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.74 153.12 59.83 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.885 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.1 Cg_endo -73.28 -24.48 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.989 1.521 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.61 -24.97 62.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.4 mtt -86.93 -46.72 9.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.116 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.4 t -83.6 93.07 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 116' ' ' ASN . 12.7 ptpt -90.49 5.85 45.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -94.08 45.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.23 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.12 176.72 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.437 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.148 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.266 0.555 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -77.82 -172.49 2.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.684 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -75.92 144.52 41.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 110.26 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -111.27 163.79 13.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.1 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 22' ' ' MET . 68.8 t -78.5 96.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.917 . . . . 0.0 110.159 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.59 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.7 t -116.38 114.6 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.914 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -57.39 129.01 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -82.54 -39.78 21.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.921 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 12.2 pt20 -91.84 179.3 5.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.897 . . . . 0.0 110.007 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.78 130.4 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.914 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.5 mt -103.64 131.1 22.35 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.311 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.2 Cg_endo -73.6 -159.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.007 1.53 . . . . 0.0 110.209 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -93.97 161.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 13' ' ' ILE . 73.7 m-80 41.75 65.98 0.77 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.0 110.081 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 52.5 m -137.89 122.26 18.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.799 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.49 92.91 2.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.868 . . . . 0.0 109.546 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 11' ' ' ILE . 46.3 mt -41.52 148.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -120.81 173.95 6.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.801 . . . . 0.0 110.136 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -27.57 69.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.06 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.9 mp -67.61 -43.75 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.375 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.519 ' HE3' HD23 ' A' ' 17' ' ' LEU . 15.8 mtm -85.44 -5.0 59.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.9 . . . . 0.0 110.296 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -97.56 116.27 29.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -111.33 136.04 51.02 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.365 0.602 . . . . 0.0 109.612 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' N ' ' CD ' ' A' ' 23' ' ' LYS . . . -96.2 74.18 2.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -103.13 146.74 27.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.421 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG22 ' CA ' ' A' ' 3' ' ' ALA . 48.5 t -88.5 96.78 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 m -150.07 171.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 24.7 p -100.81 159.43 29.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -75.46 154.43 99.06 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.334 -0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 76.7 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.53 -140.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.76 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -81.35 137.2 48.79 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.201 -1.176 . . . . 0.0 110.178 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.64 -176.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.966 1.509 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -84.15 11.93 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.417 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.96 -45.68 82.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.964 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.628 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.4 mt-10 -94.82 32.63 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm -49.49 -55.79 20.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.28 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 47.1 Cg_endo -71.81 -14.1 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.751 1.395 . . . . 0.0 110.798 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.439 ' C ' ' HG3' ' A' ' 64' ' ' GLU . 5.0 m120 -98.8 -48.42 4.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.56 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.628 HD13 ' CB ' ' A' ' 36' ' ' GLU . 2.1 mp -71.54 -30.84 66.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -46.24 151.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 110.134 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.38 9.35 57.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.56 ' SD ' HD21 ' A' ' 55' ' ' LEU . 9.9 ptm -70.36 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.801 -1.411 . . . . 0.0 110.225 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.1 mt-30 -86.44 129.21 34.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.815 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -85.92 165.54 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 110.348 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 61' ' ' LYS . 1.5 t30 -95.09 -16.94 22.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.373 -0.829 . . . . 0.0 109.973 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 59' ' ' MET . 11.3 ptm180 -136.1 175.59 9.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.865 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 148.48 43.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.847 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -117.22 135.27 23.08 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.305 -0.872 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.7 Cg_endo -74.29 -179.69 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.829 1.436 . . . . 0.0 110.271 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.12 144.8 36.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.427 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 63.29 33.31 86.9 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.847 HG21 HG13 ' A' ' 49' ' ' VAL . 88.8 m -83.67 116.32 22.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -1.169 . . . . 0.0 110.27 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.59 ' CA ' HG13 ' A' ' 6' ' ' VAL . 15.1 t -65.2 163.16 15.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.66 88.77 0.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -95.72 136.6 22.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.225 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.15 -27.29 11.88 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.67 74.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.87 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.423 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 34.7 mtm -103.42 13.77 32.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' MET . 52.4 t -120.36 131.63 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.244 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HD3' ' CG ' ' A' ' 46' ' ' ASN . 11.1 tptt -70.53 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.691 ' OD1' HG11 ' A' ' 97' ' ' VAL . 12.9 m-80 -84.72 77.29 10.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.404 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 40.2 mm-40 -130.1 -148.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.874 -1.141 . . . . 0.0 110.274 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -86.4 36.61 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.384 -0.822 . . . . 0.0 110.363 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.12 17.09 53.65 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' OH ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -82.37 -155.99 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -1.094 . . . . 0.0 110.222 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 p -97.52 -127.6 0.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 13.9 m -82.75 144.9 49.3 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.917 -1.114 . . . . 0.0 110.675 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.89 -150.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.119 1.589 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.21 -65.94 1.56 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.48 52.0 2.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -1.12 . . . . 0.0 109.525 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -74.19 112.83 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.675 . . . . 0.0 110.563 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -87.05 152.59 22.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 102' ' ' ILE . 3.5 t -70.94 132.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.978 . . . . 0.0 110.559 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.36 133.33 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.53 95.77 4.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.239 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 53.0 t30 -58.93 -31.52 68.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.772 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -169.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 0.0 110.383 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 5.1 tt -101.8 128.03 48.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.0 110.379 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 87' ' ' LEU . 86.8 mt -120.78 127.92 26.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.403 -0.81 . . . . 0.0 109.981 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' HG21 ' A' ' 85' ' ' THR . 44.8 Cg_endo -72.75 158.22 50.74 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.845 1.445 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 11.0 mt -51.91 135.8 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.372 -0.83 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.1 t-20 63.16 72.8 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 110.501 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 31.9 m -143.59 114.23 7.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.88 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -55.06 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 110.363 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -77.46 141.96 39.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 0.0 109.685 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 92' ' ' MET . 18.4 p -119.55 -176.58 3.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 110.314 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.51 -31.14 65.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 111.125 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 91' ' ' MET . 2.6 p -57.05 -48.87 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.847 -1.158 . . . . 0.0 109.946 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.569 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.2 mtt -86.42 -10.1 54.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.121 -0.987 . . . . 0.0 109.685 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 75' ' ' VAL . 4.8 ttm -100.68 133.3 45.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 26.0 mttt -131.52 107.28 8.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.481 -0.762 . . . . 0.0 110.01 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -82.53 102.75 11.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.13 150.92 42.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 110.133 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.4 98.82 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.485 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG11 ' OD1' ' A' ' 62' ' ' ASN . 38.5 t -131.94 152.08 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.2 m -109.85 143.14 27.3 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -75.23 174.09 54.57 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.812 -2.162 . . . . 0.0 110.23 -0.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.11 102.09 13.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.23 -103.13 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.4 mt -114.4 123.73 31.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.273 -1.133 . . . . 0.0 110.018 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 147.89 48.69 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.917 1.483 . . . . 0.0 110.537 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -83.85 53.47 2.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 110.253 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 6.8 pt-20 -80.54 -31.82 36.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.337 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 2.2 mm-40 -115.84 39.98 2.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.3 tt -53.61 -44.56 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.488 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.556 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.28 -17.11 17.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.387 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.63 -27.93 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 113' ' ' MET . 14.4 mt -113.0 -1.17 14.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 110.917 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 3.0 t -53.83 130.75 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.909 -1.119 . . . . 0.0 110.009 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 65.93 34.37 88.35 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -92.93 157.95 16.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -1.163 . . . . 0.0 110.148 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -96.36 135.99 37.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.185 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 117' ' ' ARG . 2.0 m -87.82 166.22 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.87 . . . . 0.0 110.341 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.27 -11.52 20.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.644 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 115' ' ' VAL . 36.3 mmt-85 -124.74 176.78 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -84.21 147.75 27.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 110.604 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.0 t -122.24 133.82 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 14.6 m-85 -93.99 -163.61 1.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.388 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.34 -144.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.42 -0.8 . . . . 0.0 110.332 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.29 87.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.195 -0.94 . . . . 0.0 110.96 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' LEU . 29.9 tt0 -118.56 141.46 48.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 110.076 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 m -78.84 126.93 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -78.09 127.6 32.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.994 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.3 mtt -126.81 165.09 30.77 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 110.368 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.5 -22.3 21.44 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.065 1.561 . . . . 0.0 110.335 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -87.06 4.52 41.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.169 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 tpt -100.48 -52.61 3.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 132' ' ' ASN . 95.7 t -90.1 124.01 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -77.98 -5.15 50.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 110.143 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' H ' HG12 ' A' ' 130' ' ' VAL . 1.4 m-20 -101.99 29.66 4.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.123 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -66.55 166.59 12.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.212 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.88 165.25 17.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.95 141.39 40.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 29.4 t -103.51 158.16 16.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.151 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG22 HD11 ' A' ' 37' ' ' ILE . 56.0 t -75.75 96.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 27' ' ' VAL . 4.3 t -109.92 114.11 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.58 137.76 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 110.101 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' O ' HD23 ' A' ' 51' ' ' LEU . 55.5 t30 -82.98 -48.4 10.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.996 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.449 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 13.2 pt20 -92.28 -178.6 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 0.0 110.277 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -89.89 141.3 28.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 17' ' ' LEU . 18.7 mm -119.55 134.01 23.82 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.989 . . . . 0.0 110.513 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.3 Cg_endo -73.43 -159.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.97 1.51 . . . . 0.0 110.102 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 18.3 mm -86.82 152.4 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.132 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 44.19 74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.393 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 45.7 m -138.87 124.09 19.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -72.2 97.38 1.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD21 HG13 ' A' ' 11' ' ' ILE . 31.3 mt -53.19 150.92 5.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.324 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 59.1 p -120.19 174.76 6.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.066 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.46 82.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.03 -46.83 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 15.3 mtm -78.46 -3.0 41.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.531 ' CG ' HG13 ' A' ' 5' ' ' VAL . 12.8 ttm -114.03 111.41 21.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 125.56 53.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 110.275 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.78 75.36 4.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.96 162.75 12.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 8.8 t -88.19 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 110.39 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 6' ' ' VAL . 26.8 m -105.06 168.58 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -102.71 168.25 9.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.181 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.8 Cg_endo -74.23 154.53 99.69 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.582 -2.258 . . . . 0.0 110.439 0.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 85.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.2 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.38 -129.15 3.18 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.764 HD12 HD12 ' A' ' 55' ' ' LEU . 6.0 mt -84.5 135.63 40.77 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.215 -1.168 . . . . 0.0 110.12 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.6 Cg_endo -73.09 -171.65 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.954 1.502 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -103.78 38.95 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.191 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.6 -52.89 40.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.568 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.624 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -94.47 30.43 1.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.208 -0.933 . . . . 0.0 110.228 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -43.66 -59.81 3.14 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 110.103 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -69.92 -3.23 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.866 1.456 . . . . 0.0 110.69 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' OE2' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -103.84 -51.46 3.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 110.223 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -91.14 5.17 50.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.846 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -59.89 149.81 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.618 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 69.01 11.25 63.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.03 156.84 38.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.909 -1.348 . . . . 0.0 109.791 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -99.94 131.83 45.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.254 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 m -85.81 165.05 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.453 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -94.67 -13.34 25.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' ILE . 1.4 mtt180 -138.77 175.83 9.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -76.18 147.62 38.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.9 t -118.92 126.04 27.34 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.012 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.855 ' HD2' HG21 ' A' ' 53' ' ' THR . 43.7 Cg_endo -70.86 -169.36 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.892 1.469 . . . . 0.0 110.384 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.08 141.43 31.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.57 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 61.89 31.61 78.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.855 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.1 m -86.43 131.15 34.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -1.148 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 29' ' ' PRO . 8.9 t -75.24 159.77 31.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.764 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -75.77 107.1 7.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.249 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.24 135.74 19.56 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.093 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -16.11 25.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.379 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.86 -37.9 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.5 -8.35 57.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.982 . . . . 0.0 110.256 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -115.1 125.62 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.35 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 2.0 pttt -63.91 -135.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' ND2' ' OG1' ' A' ' 124' ' ' THR . 9.9 m-80 -71.07 85.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -54.16 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' CB ' ' A' ' 40' ' ' LEU . 2.4 mt-10 -138.26 -136.79 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 109.983 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.99 49.83 1.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.079 -1.013 . . . . 0.0 110.255 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.16 33.18 5.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.426 HG21 ' HB ' ' A' ' 97' ' ' VAL . 26.5 p -92.98 -147.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.145 -1.209 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 69' ' ' SER . 5.1 t -101.79 -140.66 0.34 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -75.7 161.41 76.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.137 -0.977 . . . . 0.0 110.358 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' C ' ' HG3' ' A' ' 96' ' ' GLU . 47.7 Cg_endo -72.65 -152.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.273 1.67 . . . . 0.0 110.288 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.63 -68.17 1.56 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.6 mt -86.77 51.04 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 109.722 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 2.2 mtpt -69.53 119.25 13.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.683 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -110.85 156.14 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -0.818 . . . . 0.0 109.723 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG22 ' HB3' ' A' ' 104' ' ' SER . 5.1 t -74.98 136.42 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.271 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 123' ' ' GLN . 97.3 t -134.47 140.91 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.216 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 81' ' ' ILE . . . -82.13 90.38 6.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.979 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -57.27 -28.41 62.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.917 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mm-40 -110.32 -170.7 1.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.086 -1.009 . . . . 0.0 110.54 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 80' ' ' LEU . 10.0 tt -99.84 137.46 38.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.272 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.652 HD11 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -120.98 103.69 42.48 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.5 Cg_endo -76.19 118.11 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.974 1.513 . . . . 0.0 111.486 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.899 HD13 ' N ' ' A' ' 118' ' ' ALA . 4.4 mm 3.43 119.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ILE . 0.7 OUTLIER 61.77 80.65 0.22 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -0.968 . . . . 0.0 110.92 178.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 81' ' ' ILE . 7.4 m -143.82 103.53 4.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -0.835 . . . . 0.0 109.564 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.65 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -89.93 142.29 27.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.83 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.534 ' OG1' HG12 ' A' ' 90' ' ' VAL . 1.2 p -119.8 -179.95 4.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 110.304 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.26 -29.85 4.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.492 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 91' ' ' MET . 13.5 p -59.35 -44.99 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.079 -1.013 . . . . 0.0 109.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.597 ' N ' HG13 ' A' ' 90' ' ' VAL . 1.4 mtt -85.4 -21.97 28.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 109.754 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.557 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.61 124.7 34.31 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.395 -0.816 . . . . 0.0 109.943 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttm -122.7 106.1 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.109 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.53 99.57 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.01 146.66 47.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.998 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.43 97.22 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.0 110.409 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' A' ' 67' ' ' THR . 8.3 p -145.36 158.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 110.316 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -110.05 153.63 43.11 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.522 -0.736 . . . . 0.0 110.205 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 98' ' ' SER . 51.6 Cg_endo -79.71 148.53 79.96 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.095 -0.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.03 116.18 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.344 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -90.45 -96.2 1.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.968 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -109.34 132.05 21.5 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.356 -1.085 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HG2' ' OE2' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.99 157.45 46.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.897 1.472 . . . . 0.0 110.473 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.674 ' HB3' HG22 ' A' ' 75' ' ' VAL . 2.2 p -83.67 47.01 1.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.479 ' OE2' ' HG2' ' A' ' 103' ' ' PRO . 15.8 pt-20 -87.76 -35.64 17.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.552 ' HG3' ' CD1' ' A' ' 110' ' ' LEU . 2.5 pt-20 -111.56 1.0 16.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.284 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.7 tp -55.77 -36.53 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.922 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 51.6 p -50.94 -38.72 52.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.846 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.01 -28.5 32.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.867 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' CD1' ' HG3' ' A' ' 106' ' ' GLU . 5.3 mt -96.7 13.5 28.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.19 -0.944 . . . . 0.0 110.458 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ILE . 4.9 t -59.84 132.69 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.948 . . . . 0.0 110.245 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 72.46 22.44 78.94 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 4.9 ptt? -81.52 153.43 26.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -1.201 . . . . 0.0 109.998 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -92.56 127.25 37.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -81.21 165.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.227 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 115' ' ' VAL . 2.2 m120 -100.09 -24.69 14.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.086 -1.009 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.586 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -116.0 157.71 24.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.923 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.899 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -78.79 132.25 36.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.637 ' HB ' HD12 ' A' ' 81' ' ' ILE . 85.9 t -109.61 149.16 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.2 m-85 -86.75 -166.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 111.094 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -57.46 -149.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.655 -0.653 . . . . 0.0 110.879 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -44.25 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 111.161 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.76 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.1 tt0 -118.37 155.01 31.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.729 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.504 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -78.71 135.97 37.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.476 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.65 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.5 tp -76.62 129.68 36.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.81 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.5 mmm -120.25 161.18 40.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.189 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.968 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.39 -33.92 8.3 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.955 1.503 . . . . 0.0 110.337 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.91 -8.04 54.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.447 ' HG3' ' HD2' ' A' ' 117' ' ' ARG . 28.1 ttp -81.24 -54.74 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG23 ' HE2' ' A' ' 129' ' ' MET . 54.9 t -76.33 123.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.259 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' HG3' ' CB ' ' A' ' 116' ' ' ASN . 1.8 mmpt? -79.65 -34.87 40.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.68 43.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -78.97 139.3 38.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.29 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.216 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.25 0.548 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.23 167.21 11.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.659 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -77.84 145.56 36.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 110.29 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 17.2 m -104.22 -178.76 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -81.54 100.53 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 54' ' ' THR . 3.1 t -119.65 109.63 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 110.08 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.93 122.68 10.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.0 t-20 -82.87 -36.03 25.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG3' ' A' ' 21' ' ' MET . 0.9 OUTLIER -91.82 176.18 6.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.151 -0.968 . . . . 0.0 110.352 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.74 132.56 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.879 HD13 ' CD2' ' A' ' 17' ' ' LEU . 17.3 mt -112.59 133.18 21.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.363 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.0 Cg_endo -73.79 -162.46 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.88 1.463 . . . . 0.0 110.262 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -88.21 163.35 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 14.5 p30 36.3 69.37 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.592 -0.692 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 45.4 m -138.7 129.31 26.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -77.1 112.0 13.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.879 ' CD2' HD13 ' A' ' 11' ' ' ILE . 4.5 mt -60.93 149.34 36.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.315 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -120.71 -170.74 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.426 -0.797 . . . . 0.0 110.279 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.25 -37.55 71.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 110.152 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.55 -34.95 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -86.35 -2.27 58.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.192 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.47 100.86 12.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.892 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.47 127.21 53.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -86.3 81.07 8.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -103.01 149.1 24.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.74 95.17 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.367 -0.833 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 6' ' ' VAL . 12.2 m -149.89 144.88 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.415 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 30.5 p -90.89 160.65 37.64 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.072 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.54 161.04 94.49 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.656 -2.227 . . . . 0.0 110.501 -0.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 31' ' ' GLY . 7.0 mtm -72.62 79.91 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.92 -127.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 55' ' ' LEU . 8.0 mt -88.9 122.12 69.24 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.258 -1.142 . . . . 0.0 110.109 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.61 -173.79 1.28 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.842 1.443 . . . . 0.0 110.37 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -84.37 14.13 4.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.388 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -66.55 -49.21 67.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.913 . . . . 0.0 110.523 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 52.3 mm-40 -91.97 24.94 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 34' ' ' ALA . 2.8 mm -39.95 -61.1 1.18 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 0.0 110.515 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -69.2 -2.77 10.36 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.76 1.4 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 4.2 m-20 -102.52 -55.04 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.982 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.12 1.36 53.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.098 . . . . 0.0 111.305 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.671 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.3 t -68.39 151.21 10.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.582 -1.324 . . . . 0.0 110.381 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 64.8 7.09 27.31 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.0 mmm -70.82 141.49 51.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.838 -1.39 . . . . 0.0 110.249 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 8.7 mt-30 -84.83 137.65 33.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.88 161.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.309 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.06 -12.76 32.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -146.91 176.51 9.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.21 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.96 148.98 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.0 129.41 25.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.2 Cg_endo -71.87 -177.36 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.934 1.492 . . . . 0.0 110.388 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.1 134.01 36.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.161 -0.962 . . . . 0.0 110.388 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 72.89 37.89 56.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.029 HG21 HG13 ' A' ' 49' ' ' VAL . 24.5 m -85.66 127.55 34.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -75.12 154.07 37.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.045 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.002 HD12 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.9 81.59 0.91 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.173 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -92.0 152.02 42.46 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 56' ' ' MET . 46.1 Cg_endo -72.56 -14.6 27.59 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.014 1.534 . . . . 0.0 110.605 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 6.1 t0 -78.16 -31.15 49.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.452 ' CE ' ' HB2' ' A' ' 56' ' ' MET . 10.6 mtm -91.03 -20.57 21.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG11 ' HB3' ' A' ' 63' ' ' TYR . 23.5 t -113.65 127.66 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.222 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -124.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.9 m120 -77.3 75.96 3.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.145 . . . . 0.0 110.592 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.69 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.87 -102.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.333 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 18.2 mm-40 -125.32 -162.9 1.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.938 -1.101 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 38.6 p-10 -86.27 56.29 3.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.282 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.6 -18.43 73.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -74.72 171.9 13.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.49 -79.12 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -74.45 115.88 47.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.323 -0.861 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 44.0 Cg_endo -71.83 -88.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.926 1.488 . . . . 0.0 110.421 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.81 -82.44 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.11 47.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -1.15 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -92.09 132.96 36.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 110.517 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 p -104.33 163.3 12.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.77 ' O ' HD23 ' A' ' 125' ' ' LEU . 49.7 t -84.19 126.11 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.745 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.002 HG22 ' HA ' ' A' ' 124' ' ' THR . 20.7 t -114.56 154.54 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 110.248 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -82.48 97.78 8.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.324 -0.86 . . . . 0.0 110.144 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.8 t-20 -56.98 -38.12 72.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.236 -0.915 . . . . 0.0 110.642 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -110.36 -177.8 3.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 109.778 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.968 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -79.87 135.78 36.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.968 ' N ' HD13 ' A' ' 80' ' ' LEU . 16.2 mm -122.82 114.14 29.9 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 110.227 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.1 Cg_endo -72.5 144.54 40.62 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.83 1.437 . . . . 0.0 110.232 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.678 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -40.38 161.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 110.341 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 11.6 p30 38.92 73.09 0.12 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.693 -0.629 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 87' ' ' LEU . 21.4 m -143.6 112.43 6.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.882 . . . . 0.0 110.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.3 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.726 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -79.19 139.5 37.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.029 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 90' ' ' VAL . 2.7 p -119.7 176.16 5.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.28 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -59.2 -28.89 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.453 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 88' ' ' THR . 26.9 m -59.09 -46.86 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.204 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG23 ' A' ' 90' ' ' VAL . 9.7 mtm -85.32 -10.14 56.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.726 ' SD ' HD12 ' A' ' 87' ' ' LEU . 2.2 mtt -105.69 127.66 53.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -119.2 126.22 51.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.398 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.12 102.8 13.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.27 -0.894 . . . . 0.0 110.486 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 16.6 pt-20 -119.37 153.22 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.44 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 3.3 tm-20 -85.95 89.61 7.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 109.979 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 98' ' ' SER . 7.8 p -150.55 170.32 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.498 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.9 p -109.34 159.68 30.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.338 -0.851 . . . . 0.0 110.145 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.66 175.21 48.4 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.688 -2.213 . . . . 0.0 110.44 -0.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 92.32 9.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.453 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.42 -118.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.937 HD12 ' HG2' ' A' ' 127' ' ' PRO . 10.9 mt -110.46 127.85 26.31 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.278 -1.13 . . . . 0.0 109.915 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' CD ' ' A' ' 105' ' ' GLU . 45.0 Cg_endo -72.3 168.28 24.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.848 1.446 . . . . 0.0 110.66 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.522 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 59.8 p -89.68 46.04 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.342 -0.849 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' CD ' ' HG2' ' A' ' 103' ' ' PRO . 84.4 mt-10 -72.45 -59.32 2.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.209 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.82 18.01 22.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.996 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.5 -28.64 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.2 m -56.68 -38.62 72.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.55 -21.99 23.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.283 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 113' ' ' MET . 51.1 mt -97.71 7.81 45.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -56.99 127.08 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.22 21.62 77.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 1.7 ppp? -73.96 154.87 39.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -1.103 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 8.5 mt-30 -93.1 124.17 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.382 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 117' ' ' ARG . 6.8 p -87.1 154.96 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -100.1 2.21 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.941 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.2 mtp180 -124.61 172.71 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.894 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.7 148.03 22.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 3.3 t -125.23 142.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.845 . . . . 0.0 109.819 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 4.2 m-85 -93.43 -165.17 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.828 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.24 -139.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.542 ' HB2' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER -56.59 72.57 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.126 -0.984 . . . . 0.0 111.268 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.656 ' C ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -118.55 146.5 44.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.926 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 1.002 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -59.96 145.48 45.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.881 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.014 HD12 ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -80.9 132.33 35.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.233 -0.917 . . . . 0.0 110.344 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 2.4 mmm -129.59 43.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 0.0 111.252 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 1.014 ' CD ' HD12 ' A' ' 125' ' ' LEU . 43.5 Cg_endo -73.49 75.64 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.466 1.245 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -91.69 -37.3 13.11 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.519 -0.738 . . . . 0.0 110.164 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.3 27.81 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.316 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.837 HG21 ' HB2' ' A' ' 127' ' ' PRO . 96.3 t -71.76 128.76 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 110.128 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -15.12 62.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.265 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.672 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -91.49 -6.17 53.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.846 . . . . 0.0 110.039 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -71.55 147.62 47.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 110.092 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 110' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.179 0.514 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.62 175.02 8.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.136 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.32 156.03 33.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.084 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 6.7 t -113.36 160.82 17.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 37' ' ' ILE . 40.0 t -84.41 101.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.244 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.6 t -117.52 126.94 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -65.17 133.05 50.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.928 . . . . 0.0 110.183 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 11.9 t30 -85.14 -43.85 13.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.531 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -92.56 176.57 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.2 tt -89.66 122.49 32.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.786 ' CD1' HD23 ' A' ' 17' ' ' LEU . 7.1 mt -110.67 141.81 24.83 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 47.1 Cg_endo -73.4 -163.46 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.076 1.566 . . . . 0.0 110.516 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.44 159.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 110.192 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 58.9 m-20 45.46 61.9 2.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.597 HG21 ' CG2' ' A' ' 11' ' ' ILE . 84.9 m -129.16 123.12 31.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.317 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -67.55 98.8 0.7 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.786 HD23 ' CD1' ' A' ' 11' ' ' ILE . 8.4 mt -46.28 151.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.455 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.6 p -119.98 163.18 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.127 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.47 -45.46 88.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -56.27 -49.35 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.282 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.531 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 1.9 mpp? -71.74 -16.71 62.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG2' HG13 ' A' ' 5' ' ' VAL . 2.6 mtt -86.75 119.78 27.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.531 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.25 112.77 24.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.084 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.78 68.04 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.967 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.02 156.51 17.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' ALA . 59.0 t -88.2 80.41 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.149 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.3 m -123.7 173.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.751 HG22 ' SD ' ' A' ' 30' ' ' MET . 2.3 p -108.03 156.49 38.19 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.208 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.7 Cg_endo -76.02 152.39 96.55 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.384 -0.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.751 ' SD ' HG22 ' A' ' 28' ' ' THR . 4.2 mpp? -70.63 69.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.73 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -80.76 133.86 54.67 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -1.17 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 44.3 Cg_endo -72.77 -174.92 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.975 1.513 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.706 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -101.39 35.66 2.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.925 . . . . 0.0 110.47 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.95 -56.62 9.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -0.897 . . . . 0.0 110.558 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.889 ' O ' HD23 ' A' ' 40' ' ' LEU . 2.3 mt-10 -95.22 30.38 2.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.441 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 5' ' ' VAL . 2.1 mm -40.83 -54.64 5.2 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 110.669 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -70.42 -1.09 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.667 1.351 . . . . 0.0 111.016 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.6 t30 -104.26 -49.75 3.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 36' ' ' GLU . 1.7 pt? -92.24 -10.88 36.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.097 -1.002 . . . . 0.0 110.953 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.74 154.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.942 -1.099 . . . . 0.0 109.708 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.67 5.58 69.18 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.866 ' SD ' HD12 ' A' ' 40' ' ' LEU . 8.4 ptm -70.1 132.92 46.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.237 . . . . 0.0 110.02 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 45.8 mt-30 -80.18 144.03 33.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.343 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.53 173.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 0.0 110.278 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 3.5 t-20 -97.34 -24.33 15.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -130.1 -177.76 4.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.274 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.96 157.86 35.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 53' ' ' THR . 3.6 t -119.65 115.7 33.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 178.48 6.0 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.844 1.444 . . . . 0.0 110.154 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 131.84 41.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.93 . . . . 0.0 110.149 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 72.08 38.96 59.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 49' ' ' VAL . 95.2 m -85.4 125.03 32.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -1.145 . . . . 0.0 110.286 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.528 ' CA ' HG13 ' A' ' 6' ' ' VAL . 5.5 t -74.23 165.96 24.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -85.73 90.25 7.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.233 -0.917 . . . . 0.0 110.312 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.463 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 24.7 ptp -103.21 148.49 35.74 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.203 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 46.3 Cg_endo -73.19 -10.3 24.17 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.952 1.501 . . . . 0.0 110.626 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.28 -47.29 71.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.463 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.0 mtm -103.4 21.76 15.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.83 HG11 ' HB3' ' A' ' 63' ' ' TYR . 5.3 t -120.16 117.86 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 110.31 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -69.07 -95.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 122' ' ' ASP . 7.7 p30 -91.36 78.35 5.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.983 . . . . 0.0 110.269 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.83 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.66 -99.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.112 -0.993 . . . . 0.0 110.435 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' OE1' HD13 ' A' ' 40' ' ' LEU . 1.5 pm0 -139.53 -149.51 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.91 -1.119 . . . . 0.0 110.358 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.47 54.76 0.77 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 110.261 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.53 -12.83 56.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -94.27 149.23 21.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -1.136 . . . . 0.0 110.464 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.7 -81.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 110.179 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.97 135.45 45.09 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 46.7 Cg_endo -73.15 -91.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.93 -81.24 0.55 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.5 mt -86.93 52.87 2.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 109.861 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.78 113.27 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 110.447 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -95.15 167.15 11.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.747 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HB ' HD23 ' A' ' 125' ' ' LEU . 13.6 t -84.72 130.16 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 97' ' ' VAL . 93.1 t -124.3 135.62 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HA ' ' CE ' ' A' ' 92' ' ' MET . . . -74.92 84.01 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.599 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t-20 -56.84 -27.8 60.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.391 -0.818 . . . . 0.0 110.635 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.35 -172.79 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.07 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 3.0 tt -103.5 131.45 50.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.987 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.053 HD11 ' CE ' ' A' ' 92' ' ' MET . 4.4 mt -120.75 126.78 26.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.993 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.9 Cg_endo -73.67 148.75 42.3 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.826 1.435 . . . . 0.0 110.714 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.609 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -39.66 150.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.52 -0.738 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 46.89 73.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 110.546 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' LEU . 19.1 m -144.08 111.55 5.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.42 84.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.0 109.989 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.8 OUTLIER -79.51 142.17 36.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 112' ' ' GLY . 22.2 p -123.38 179.3 4.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.88 -25.67 30.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.9 . . . . 0.0 110.412 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.3 t -51.6 -56.4 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.348 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.427 ' CE ' HG12 ' A' ' 81' ' ' ILE . 11.9 mtp -84.8 -21.58 29.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.053 ' CE ' HD11 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -94.26 143.75 26.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 2.0 mttp -131.3 119.56 21.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.931 . . . . 0.0 110.373 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -79.2 101.7 8.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -122.99 161.04 25.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -78.11 95.3 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.6 p -145.2 160.35 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 110.294 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -109.63 152.8 43.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 110.357 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -78.59 177.34 39.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.516 -2.285 . . . . 0.0 110.393 -0.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.7 OUTLIER -93.72 87.72 5.56 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.244 -0.91 . . . . 0.0 109.28 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.66 ' C ' HD12 ' A' ' 102' ' ' ILE . . . -73.47 -80.37 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.672 HG12 HD11 ' A' ' 125' ' ' LEU . 1.2 mp -107.13 107.66 60.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.248 -1.148 . . . . 0.0 109.869 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.72 164.95 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.922 1.485 . . . . 0.0 110.142 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.1 p -77.47 49.54 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.119 -0.988 . . . . 0.0 110.461 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -68.19 0.78 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.146 -0.972 . . . . 0.0 109.446 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.32 15.89 22.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.095 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.081 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -46.9 -31.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 107' ' ' ILE . 68.6 p -64.09 -22.92 67.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -26.18 15.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 133' ' ' TYR . 13.1 mt -92.19 -2.3 56.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 110.251 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.081 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -58.98 132.94 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 110.335 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.77 17.59 77.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -74.62 144.19 44.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -1.136 . . . . 0.0 110.161 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -86.71 129.2 34.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.785 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.9 p -87.64 158.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -100.58 -9.41 22.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.065 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.785 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.5 ptp180 -124.92 177.62 5.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.941 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.609 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.15 144.37 26.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.358 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 81' ' ' ILE . 50.7 t -120.65 138.44 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 109.984 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.437 ' O ' ' O ' ' A' ' 121' ' ' LEU . 4.0 m-85 -93.58 -165.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 110.931 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -58.99 -147.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.538 -0.726 . . . . 0.0 110.997 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.625 ' OD1' HD12 ' A' ' 121' ' ' LEU . 5.2 m-20 -44.42 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 111.417 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.6 tt0 -118.9 141.37 48.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 109.8 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.7 m -70.51 128.0 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.942 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD23 ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -81.89 127.56 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 0.0 109.655 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.759 ' N ' HD12 ' A' ' 125' ' ' LEU . 9.6 mtp -121.27 151.9 56.6 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.3 Cg_endo -73.77 -13.3 24.4 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.128 1.594 . . . . 0.0 110.72 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.52 -12.31 40.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.456 ' CG ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -100.63 -43.74 6.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 133' ' ' TYR . 4.8 t -90.27 107.24 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.356 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -90.59 42.64 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -111.0 -75.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.333 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.766 ' HB2' HD22 ' A' ' 110' ' ' LEU . 45.0 p90 -68.19 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.281 -0.887 . . . . 0.0 110.472 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.207 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.299 0.571 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -179.98 6.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 138.89 39.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.197 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 28.9 t -107.28 170.02 8.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 22' ' ' MET . 99.5 t -80.95 97.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.355 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -111.91 110.14 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.96 129.47 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 45.8 t30 -82.92 -41.75 18.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -91.89 -178.49 5.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.976 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -89.65 138.75 31.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.841 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' CB ' ' A' ' 7' ' ' ALA . 3.2 mp -108.31 129.6 23.84 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.923 . . . . 0.0 110.782 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 45.5 Cg_endo -76.37 -160.42 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.7 mp -87.66 155.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.133 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 0.6 OUTLIER 34.17 76.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.72 -0.613 . . . . 0.0 110.871 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 13.2 m -136.83 130.11 31.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.897 . . . . 0.0 110.27 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.33 99.55 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.116 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.9 mt -49.58 152.31 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.905 . . . . 0.0 110.461 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 4.7 p -120.06 -173.34 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.862 . . . . 0.0 110.236 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.06 -44.73 65.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.181 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.78 -26.31 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.2 mtp -87.03 -2.41 58.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.823 ' HG2' HG13 ' A' ' 5' ' ' VAL . 4.4 ttm -112.49 114.97 27.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.44 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -111.19 135.11 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 110.174 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -93.62 76.8 4.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 110.162 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -103.09 149.27 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG22 ' HA ' ' A' ' 3' ' ' ALA . 47.9 t -88.65 99.0 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.0 m -140.75 156.51 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.497 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.2 t -97.57 150.29 36.63 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.5 Cg_endo -75.89 165.01 86.61 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.747 -2.189 . . . . 0.0 110.496 -0.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.64 85.66 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.254 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.72 -145.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 40' ' ' LEU . 5.7 mt -79.85 140.38 54.39 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.75 175.31 10.93 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.962 1.506 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -92.44 20.32 6.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -66.56 -42.05 87.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.644 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.5 pm0 -95.14 29.66 2.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.377 -0.827 . . . . 0.0 110.18 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.0 mm -42.31 -51.77 10.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.7 Cg_endo -69.9 -6.09 17.85 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.497 1.261 . . . . 0.0 110.702 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.4 -54.87 2.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 109.764 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 63' ' ' TYR . 13.3 mt -71.03 -12.01 61.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.78 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -67.68 150.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.991 -1.068 . . . . 0.0 110.873 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 64.94 6.13 23.05 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.62 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 5.2 mmt -73.16 136.82 44.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.827 -1.396 . . . . 0.0 110.499 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' THR . 32.8 mt-30 -86.55 135.22 33.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.786 . . . . 0.0 110.288 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 45' ' ' VAL . 23.8 m -85.65 165.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.147 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' CG ' ' HD2' ' A' ' 61' ' ' LYS . 2.3 t-20 -83.48 -23.94 31.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 13' ' ' ILE . 4.2 ptt180 -148.7 169.78 19.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.35 141.76 57.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 53' ' ' THR . 72.0 t -119.09 147.2 42.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.719 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.3 Cg_endo -70.53 -179.18 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.932 1.49 . . . . 0.0 110.577 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -81.16 156.71 25.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.569 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.03 30.84 60.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.898 HG21 HG13 ' A' ' 49' ' ' VAL . 85.2 m -86.66 133.15 33.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -1.213 . . . . 0.0 110.27 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.4 t -75.05 160.67 30.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.714 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -72.96 105.39 4.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.201 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.8 mmm -103.06 137.3 19.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.02 -19.19 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.871 1.458 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -76.43 -33.58 58.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.3 mtm -91.43 -2.75 57.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 63' ' ' TYR . 74.3 t -119.43 126.62 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.226 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HD2' ' CG ' ' A' ' 46' ' ' ASN . 3.3 mppt? -70.61 -93.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 110.485 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' ' CE ' ' A' ' 43' ' ' MET . 6.7 t30 -90.39 80.67 6.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 110.415 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.934 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -64.94 -50.18 67.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.255 -0.903 . . . . 0.0 110.628 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' OE1' ' CB ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER 173.86 -177.83 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.869 -1.144 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.33 54.51 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.906 . . . . 0.0 110.396 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.59 -4.69 87.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.09 165.21 12.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -1.157 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -79.27 -133.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.27 147.31 97.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.12 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 47.2 Cg_endo -72.97 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.91 1.479 . . . . 0.0 110.532 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.65 -78.82 0.72 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 mt -87.76 51.83 2.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -1.127 . . . . 0.0 110.249 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -78.66 114.25 17.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 92.3 p -80.34 153.07 28.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.915 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 125' ' ' LEU . 5.6 t -65.19 123.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.973 . . . . 0.0 110.327 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 123' ' ' GLN . 51.9 t -114.79 131.28 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.985 . . . . 0.0 110.014 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.18 95.22 3.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 110.842 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG22 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -109.84 175.85 5.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.169 -0.957 . . . . 0.0 110.675 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 80' ' ' LEU . 2.0 tt -102.7 138.43 39.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.601 HG22 ' NE2' ' A' ' 79' ' ' GLN . 1.8 pp -121.09 131.46 24.47 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 83' ' ' ILE . 49.4 Cg_endo -78.15 70.84 6.96 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.934 1.492 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.051 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mm 56.63 152.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.448 -0.782 . . . . 0.0 110.705 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 3.6 m120 40.15 87.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 110.989 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 115' ' ' VAL . 53.2 m -144.39 102.68 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 110.185 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.8 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.932 . . . . 0.0 109.763 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.964 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.42 133.68 34.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.364 -0.835 . . . . 0.0 110.598 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.606 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.2 p -120.29 166.83 12.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.461 -0.774 . . . . 0.0 109.417 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.552 ' N ' ' HE2' ' A' ' 92' ' ' MET . 0.2 OUTLIER -45.85 -32.31 2.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.041 -1.037 . . . . 0.0 110.094 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 91' ' ' MET . 32.6 m -64.64 -39.19 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.085 -1.01 . . . . 0.0 109.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.523 ' N ' HG23 ' A' ' 90' ' ' VAL . 18.4 mtp -85.0 -26.29 27.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 110.42 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.964 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.63 145.6 30.8 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.17 -0.956 . . . . 0.0 110.183 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 16.8 mttt -123.39 113.71 19.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 110.297 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -77.07 100.44 5.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' CA ' ' HB2' ' A' ' 73' ' ' LYS . 9.8 mt-10 -122.2 163.75 19.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -79.92 83.69 5.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 110.426 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 76' ' ' VAL . 10.4 p -132.66 160.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.52 164.64 14.29 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.5 Cg_endo -75.12 173.68 56.65 Favored 'Cis proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.628 -2.238 . . . . 0.0 110.373 -0.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -76.54 83.74 3.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.187 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.75 -109.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' A' ' 127' ' ' PRO . 9.7 mt -109.33 116.09 55.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.265 -1.138 . . . . 0.0 110.121 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 46.4 Cg_endo -73.1 177.1 8.22 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.008 1.531 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.29 41.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 110.317 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 25.5 pt-20 -76.41 -42.33 44.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.5 mt-10 -116.03 1.62 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -47.25 -40.01 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 45.3 t -49.23 -32.3 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -95.73 -17.04 21.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.237 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.5 mt -105.83 12.25 31.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.352 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 107' ' ' ILE . 42.7 t -64.45 135.12 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 70.92 19.52 77.04 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.68 155.61 38.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.973 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -95.49 127.1 41.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 110.406 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.873 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.4 p -87.75 148.87 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 131' ' ' LYS . 21.1 t-20 -100.39 2.49 42.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.164 -0.96 . . . . 0.0 110.19 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.873 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -125.04 163.83 21.5 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.051 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -85.56 133.99 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.066 -1.022 . . . . 0.0 110.618 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 96.6 t -112.53 156.91 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 1.5 m-85 -105.86 -163.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.674 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.2 -152.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.158 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -44.65 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.52 -0.738 . . . . 0.0 111.066 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.4 tt0 -118.38 155.38 30.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.666 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -78.66 139.79 38.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 110.243 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 102' ' ' ILE . 6.7 tp -74.54 128.85 36.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.962 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.474 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -122.1 147.11 48.31 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 0.0 110.272 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.742 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.3 Cg_endo -73.55 -5.61 17.38 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.156 1.609 . . . . 0.0 110.468 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.76 -26.05 26.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.338 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.746 ' HG3' HG23 ' A' ' 130' ' ' VAL . 5.6 ptp -87.89 -24.52 23.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.188 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.746 HG23 ' HG3' ' A' ' 129' ' ' MET . 39.2 t -92.21 124.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 110.184 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' HG3' ' N ' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -90.56 -20.12 22.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 36.3 p30 -95.2 11.21 33.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' CE1' ' CG2' ' A' ' 102' ' ' ILE . 26.6 t80 -61.24 138.87 58.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.282 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 30' ' ' MET . 51.5 p-10 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.207 0.527 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -78.03 179.12 6.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 110.123 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -76.94 137.61 39.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 110.195 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -103.86 146.36 28.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG1' ' SD ' ' A' ' 22' ' ' MET . 89.3 t -72.7 103.12 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 110.219 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.723 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.3 t -113.35 120.6 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.223 -0.923 . . . . 0.0 109.929 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.75 129.87 43.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.679 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -82.73 -43.79 16.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.81 178.9 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.493 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 51' ' ' LEU . 9.2 tt -90.32 128.81 36.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 17' ' ' LEU . 12.3 mt -110.09 138.49 20.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 110.643 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.3 Cg_endo -74.62 -159.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.336 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -99.33 162.09 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 110.41 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.3 m120 42.14 64.88 0.99 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.12 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 44.7 m -140.94 135.12 30.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.746 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.673 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -73.51 128.94 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.214 -0.929 . . . . 0.0 109.752 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.621 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.3 mt -74.99 150.04 39.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.996 . . . . 0.0 110.727 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 60.4 p -120.75 167.8 12.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.36 -27.2 69.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -62.73 -51.58 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 3.5 ptp -84.75 13.58 5.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HE2' HG22 ' A' ' 41' ' ' VAL . 28.9 tpp -108.42 96.54 6.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -111.09 100.73 9.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.171 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -83.11 84.03 7.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.84 163.53 12.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 26' ' ' VAL . 94.6 t -87.63 74.62 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 110.255 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.94 161.05 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.955 . . . . 0.0 110.151 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -90.14 164.42 27.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.858 . . . . 0.0 110.228 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG2' HG21 ' A' ' 54' ' ' THR . 48.3 Cg_endo -74.64 160.8 95.86 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.639 -2.234 . . . . 0.0 110.486 -0.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 1' ' ' ASN . 30.5 mtm -72.57 68.23 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -144.76 0.09 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -80.51 132.14 59.42 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 47.4 Cg_endo -73.77 -179.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.957 1.504 . . . . 0.0 110.464 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.866 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.5 37.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.65 -50.72 62.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.862 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.2 mm-40 -95.03 30.57 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -40.58 -52.36 6.25 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.452 -0.78 . . . . 0.0 110.674 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.87 -12.34 28.46 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.626 1.33 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 36' ' ' GLU . 3.5 m-20 -104.11 -35.79 7.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD23 ' CB ' ' A' ' 36' ' ' GLU . 3.1 mm? -83.01 -34.65 26.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.301 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.498 HG22 ' HE2' ' A' ' 22' ' ' MET . 1.4 t -46.12 148.41 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.537 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.673 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 65.54 6.23 27.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.551 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.6 ptm -70.34 151.31 45.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.854 -1.38 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.7 128.24 39.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.967 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -85.99 164.22 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 110.349 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.49 ' OD1' ' HD3' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -98.05 -14.0 20.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.807 . . . . 0.0 109.682 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -140.73 162.01 36.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.147 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 150.55 48.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 110.375 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.3 127.71 26.32 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.779 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.8 Cg_endo -71.86 -175.27 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.842 1.443 . . . . 0.0 110.56 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -79.4 143.47 35.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 110.512 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.65 33.35 84.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG13 ' A' ' 49' ' ' VAL . 30.9 m -83.47 122.07 28.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 110.219 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.723 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.8 t -69.52 162.58 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.176 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -71.95 95.27 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.225 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -98.22 141.21 22.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.58 -23.11 20.2 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.045 1.55 . . . . 0.0 110.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -81.0 -25.04 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 28.7 mtt -101.32 11.65 38.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 63' ' ' TYR . 44.6 t -120.17 129.23 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.39 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 1.1 tttp -68.77 -111.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.538 ' HA ' HG21 ' A' ' 97' ' ' VAL . 6.0 m120 -90.96 86.07 6.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.164 . . . . 0.0 110.265 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.735 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -69.92 54.67 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.231 -0.918 . . . . 0.0 110.783 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ASN . 18.1 mm-40 42.69 -148.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.22 57.31 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.159 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.07 -9.03 59.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.27 170.76 9.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 0.0 110.263 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 69' ' ' SER . 48.9 m -92.17 -90.36 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.12 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' N ' HG22 ' A' ' 68' ' ' THR . 0.1 OUTLIER -73.56 135.33 78.56 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 45.7 Cg_endo -72.82 -91.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.984 1.518 . . . . 0.0 110.551 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.94 -81.16 0.44 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.93 51.79 2.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -1.103 . . . . 0.0 110.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -73.58 113.66 10.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.454 -0.778 . . . . 0.0 110.277 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -90.81 154.31 19.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.021 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.941 HG13 ' HG3' ' A' ' 92' ' ' MET . 16.2 t -64.28 132.7 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.565 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 74' ' ' SER . 58.6 t -135.13 122.95 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -70.54 91.43 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.952 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.3 t-20 -56.94 -31.46 64.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.704 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.6 tt0 -110.14 -174.68 2.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.987 . . . . 0.0 110.13 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.8 tt -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.629 HG23 HG21 ' A' ' 85' ' ' THR . 18.3 mm -121.14 139.97 30.31 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.27 159.56 43.56 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.094 1.576 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.579 HG22 ' OD1' ' A' ' 84' ' ' ASN . 2.4 mt -52.34 141.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.376 -0.827 . . . . 0.0 110.296 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' OD1' HG22 ' A' ' 83' ' ' ILE . 12.2 m120 59.58 77.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.492 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG23 ' A' ' 81' ' ' ILE . 63.4 m -143.49 106.13 4.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.835 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.13 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 110.13 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.22 138.6 31.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 111' ' ' VAL . 32.4 p -121.25 -174.28 2.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.135 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.47 -22.39 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.464 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 90' ' ' VAL . 21.5 t -55.72 -68.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.158 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -7.62 57.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 110.073 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.941 ' HG3' HG13 ' A' ' 75' ' ' VAL . 2.9 ttt -88.01 120.16 29.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 7.5 mttt -113.25 88.32 2.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.037 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.85 98.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.19 157.31 33.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.5 OUTLIER -72.7 88.78 1.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 110.432 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG23 ' CE1' ' A' ' 63' ' ' TYR . 8.6 p -132.43 155.68 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.29 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 66.0 m -110.03 148.59 38.6 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.489 -0.757 . . . . 0.0 110.273 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.1 Cg_endo -76.78 169.62 73.94 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.726 -2.198 . . . . 0.0 110.173 -0.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.54 100.31 12.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.37 -98.67 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 125' ' ' LEU . 9.9 mt -109.28 120.15 46.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -1.179 . . . . 0.0 109.991 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.3 Cg_endo -72.65 172.12 15.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.932 1.49 . . . . 0.0 110.501 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.7 p -81.04 48.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.208 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 11.8 mm-40 -76.3 -73.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -98.26 3.0 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.014 ' O ' HG23 ' A' ' 111' ' ' VAL . 8.3 tp -46.88 -42.42 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.29 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.585 ' N ' HG23 ' A' ' 107' ' ' ILE . 3.8 m -51.2 -25.32 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -95.76 -27.83 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.464 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 113' ' ' MET . 22.2 mt -99.74 6.94 45.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.014 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -59.02 136.05 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.94 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 85.6 10.13 77.22 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 15.7 ptm -74.58 153.69 38.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.238 . . . . 0.0 110.07 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -93.07 139.34 30.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 117' ' ' ARG . 1.6 m -87.82 162.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.385 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.484 ' OD1' ' HE3' ' A' ' 131' ' ' LYS . 1.1 t30 -101.14 -7.53 23.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.84 177.23 6.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -85.4 140.17 30.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.447 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 28.5 t -110.3 141.72 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.819 . . . . 0.0 110.022 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 80' ' ' LEU . 65.7 m-85 -109.35 -160.68 0.73 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 110.975 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.93 -149.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -44.09 87.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.0 110.993 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LEU . 20.1 tt0 -118.21 141.61 48.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 m -76.55 133.39 39.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 126' ' ' MET . 1.8 tp -68.07 128.5 36.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.0 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.721 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.2 mtt -126.9 134.68 26.37 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 0.0 110.32 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 102' ' ' ILE . 51.5 Cg_endo -78.05 -0.01 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.964 1.508 . . . . 0.0 110.44 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -41.83 68.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.539 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.422 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 2.2 tpp -98.22 -18.44 18.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.306 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 130' ' ' VAL . 37.9 t -75.2 89.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.083 -1.01 . . . . 0.0 110.229 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HE3' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -90.54 14.34 13.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.3 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.59 27.8 6.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.181 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 154.43 28.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 110.337 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.281 0.563 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 170.3 16.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.608 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.15 144.15 36.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.246 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.5 t -107.11 167.15 10.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.851 HG13 ' HG2' ' A' ' 22' ' ' MET . 77.2 t -84.57 86.62 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 6.5 t -99.76 139.26 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -70.59 138.17 50.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.226 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.687 ' O ' HD23 ' A' ' 51' ' ' LEU . 30.7 t-20 -82.79 -49.73 9.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.324 -0.86 . . . . 0.0 109.908 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.493 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 9.2 pt20 -93.01 -177.6 4.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.6 tt -89.66 124.44 34.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.776 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 11.9 mm -112.18 131.37 22.57 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 110.355 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.84 -164.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.803 1.422 . . . . 0.0 110.097 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 2.3 mp -82.48 170.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.549 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . 9.1 p30 36.54 68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.0 m -140.15 126.75 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.348 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -76.36 90.2 3.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 42' ' ' GLY . 5.5 mt -45.07 155.66 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.305 -0.872 . . . . 0.0 110.421 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -120.09 170.17 9.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.4 mt -63.68 -31.52 72.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.26 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.2 -46.63 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.089 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -72.76 -4.63 32.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.192 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.851 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.2 ttt -89.51 117.14 28.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 110.637 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HG3' ' CB ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.27 108.05 17.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -0.844 . . . . 0.0 110.025 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -77.63 66.22 3.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -103.17 151.34 22.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.251 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' CA ' ' A' ' 3' ' ' ALA . 5.5 t -88.66 98.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 6' ' ' VAL . 6.6 m -137.16 169.16 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -108.98 152.98 42.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.1 Cg_endo -76.38 155.29 98.21 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.664 -2.223 . . . . 0.0 110.558 -0.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 30' ' ' MET . 5.0 ptt? -72.07 123.09 22.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.33 -125.7 5.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 55' ' ' LEU . 9.9 mt -93.67 142.08 24.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.291 -1.123 . . . . 0.0 110.321 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.2 Cg_endo -73.14 169.46 22.19 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.068 1.562 . . . . 0.0 110.458 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -87.29 29.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.489 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -66.87 -47.54 71.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.095 -1.003 . . . . 0.0 110.074 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 4.8 mm-40 -95.09 31.42 1.9 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.92 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.3 mm -41.29 -52.41 7.55 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 110.801 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.01 -4.62 14.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.563 1.297 . . . . 0.0 110.832 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.8 t-20 -104.32 -53.2 2.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 109.891 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 7.3 mp -71.7 -12.44 61.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -64.31 150.21 10.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.894 0.854 . . . . 0.0 111.266 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.57 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 59.93 10.32 13.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 79.9 mmm -80.48 151.02 29.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.726 -1.455 . . . . 0.0 110.319 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.21 139.03 30.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.428 -0.795 . . . . 0.0 110.411 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.1 m -98.12 164.15 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.074 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 47' ' ' ARG . 12.4 m-20 -96.95 -14.74 21.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' C ' ' A' ' 46' ' ' ASN . 1.1 mmm180 -128.6 170.35 13.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.35 163.33 27.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.364 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.99 HG13 ' HB ' ' A' ' 53' ' ' THR . 22.3 t -120.12 101.39 47.28 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.86 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' LEU . 44.3 Cg_endo -71.49 54.05 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.941 1.495 . . . . 0.0 110.78 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER 56.16 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.416 -0.802 . . . . 0.0 111.208 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.47 6.05 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.99 ' HB ' HG13 ' A' ' 49' ' ' VAL . 53.8 m -86.69 114.73 23.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.191 -1.182 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 12.5 t -61.36 154.76 23.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -75.34 102.01 4.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.0 ttm -97.77 139.14 21.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.194 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.71 -22.08 21.01 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.382 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -73.82 -22.81 59.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 47' ' ' ARG . 17.4 mtt -104.11 1.87 31.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 63' ' ' TYR . 19.4 t -119.79 122.44 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -70.72 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.885 . . . . 0.0 110.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -90.94 73.49 6.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 110.583 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.822 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -53.54 -98.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.051 -1.03 . . . . 0.0 110.262 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 2.6 pt-20 -75.96 1.52 15.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.914 -1.116 . . . . 0.0 110.767 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -74.98 54.93 0.68 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 110.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.32 75.49 0.42 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.8 p -73.33 164.54 26.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.281 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.4 m -90.32 -45.65 8.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.274 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 20.0 m -64.31 135.2 96.24 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.908 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 49.4 Cg_endo -72.88 -97.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.885 1.466 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.69 -82.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' PRO . 10.0 mt -88.64 51.32 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.367 -1.079 . . . . 0.0 110.324 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -82.78 115.19 21.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.834 . . . . 0.0 110.093 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.17 158.78 16.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 104' ' ' SER . 4.7 t -74.06 114.59 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.07 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 97' ' ' VAL . 91.8 t -114.52 137.27 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -66.99 90.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.6 t-20 -58.15 -34.87 70.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.7 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -110.53 -170.5 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.449 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -101.77 130.0 48.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mp -120.9 122.4 28.41 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.7 Cg_endo -72.5 158.12 51.63 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.984 1.518 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -47.06 152.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.75 76.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HD23 ' A' ' 87' ' ' LEU . 25.2 m -143.45 110.14 5.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.59 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.299 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.559 HD12 ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -82.22 140.57 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.162 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.54 ' OG1' HG12 ' A' ' 90' ' ' VAL . 33.8 p -121.36 179.02 4.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.202 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.09 -25.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.747 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 9.2 p -61.59 -44.71 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 110.258 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 8.3 mtm -85.29 -21.52 28.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 0.0 110.358 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.559 ' CE ' HD12 ' A' ' 87' ' ' LEU . 8.7 mtm -100.33 128.08 46.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.388 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' CE ' ' OD1' ' A' ' 78' ' ' ASN . 6.4 mttm -122.02 123.13 40.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.857 . . . . 0.0 109.991 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.53 95.16 3.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.623 ' OE2' HG11 ' A' ' 76' ' ' VAL . 4.1 pt-20 -123.47 152.89 41.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.84 . . . . 0.0 109.876 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -69.2 97.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 110.129 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 76' ' ' VAL . 73.0 t -130.45 149.77 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.114 -0.991 . . . . 0.0 110.292 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.37 147.38 35.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.425 -0.797 . . . . 0.0 110.079 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -75.96 173.35 58.5 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.378 -0.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.5 94.46 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.3 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 125' ' ' LEU . 15.9 mt -109.38 128.18 25.88 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.87 153.61 53.19 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.93 1.49 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 75' ' ' VAL . 2.9 t -78.64 53.53 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.018 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 70.3 mt-10 -77.7 -52.94 8.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.64 20.1 15.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.869 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.01 -41.09 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.195 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 107' ' ' ILE . 19.8 t -45.59 -37.54 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -30.23 25.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.95 -0.33 57.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.855 . . . . 0.0 110.199 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.3 t -60.38 133.03 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 110.524 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 82.54 15.24 74.13 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.15 145.46 44.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -1.106 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 127.46 35.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.93 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.735 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.0 p -84.53 161.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.68 -12.47 19.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.735 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.11 174.26 7.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -81.35 148.46 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.643 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 17.7 t -122.79 138.26 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.903 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 121' ' ' LEU . 50.5 m-85 -97.34 -168.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.759 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.42 -142.53 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.521 -0.737 . . . . 0.0 110.815 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 16.6 p-10 -44.37 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 111.098 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' LEU . 5.4 tt0 -118.06 145.74 44.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.465 -0.772 . . . . 0.0 109.634 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' MET . 99.2 m -78.06 134.57 37.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.074 -1.016 . . . . 0.0 110.214 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.784 HD11 HD12 ' A' ' 102' ' ' ILE . 1.6 tp -71.35 124.91 25.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.13 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.724 ' N ' HD12 ' A' ' 125' ' ' LEU . 13.6 mtp -126.82 139.09 33.99 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.504 -0.747 . . . . 0.0 110.173 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.446 ' N ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo -73.21 -27.24 13.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.027 1.541 . . . . 0.0 110.471 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -70.82 -16.83 62.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -46.93 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.42 121.77 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 110.371 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -89.68 -14.63 34.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.903 . . . . 0.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -93.11 10.39 31.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 25.9 t80 -70.44 167.32 18.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.207 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.277 0.561 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -74.18 -177.62 3.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.77 145.66 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.179 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.95 159.31 15.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.55 102.91 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.9 t -113.41 116.15 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.21 132.54 38.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 59.1 t-20 -83.45 -44.99 14.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.372 -0.83 . . . . 0.0 109.9 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 7.9 pt20 -92.75 -179.59 5.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.338 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.3 tt -89.68 116.45 27.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.105 -0.997 . . . . 0.0 110.134 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.772 HG13 HD21 ' A' ' 17' ' ' LEU . 10.1 mm -99.24 124.93 43.25 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.19 -163.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.844 1.444 . . . . 0.0 110.347 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.0 mp -83.71 147.21 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 84.8 m-20 53.96 65.31 1.55 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.943 . . . . 0.0 110.201 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.551 ' HB ' HG22 ' A' ' 11' ' ' ILE . 56.7 m -136.0 127.12 28.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 110.003 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.42 97.77 5.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.214 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.772 HD21 HG13 ' A' ' 11' ' ' ILE . 5.1 mt -48.58 152.0 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.402 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 73.0 p -120.25 -176.83 3.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -37.41 84.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 109.986 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -62.45 -36.22 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 109.934 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 17.0 mtt -87.59 14.51 8.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.11 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.727 ' CE ' HD12 ' A' ' 37' ' ' ILE . 3.9 tmm? -111.38 107.29 16.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.284 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.25 114.09 27.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.9 73.93 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 146.53 28.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.304 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' C ' HG13 ' A' ' 27' ' ' VAL . 83.9 t -88.63 95.63 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.43 HG13 ' C ' ' A' ' 26' ' ' VAL . 27.8 m -147.71 155.63 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HE2' ' A' ' 30' ' ' MET . 0.6 OUTLIER -90.54 168.47 14.07 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 28' ' ' THR . 50.4 Cg_endo -75.43 169.13 75.37 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.617 -2.243 . . . . 0.0 110.479 -0.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 28' ' ' THR . 4.5 mtm -72.6 59.11 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 109.942 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -57.86 -112.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.052 HD12 HD12 ' A' ' 55' ' ' LEU . 11.1 mt -106.9 124.92 33.91 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.224 -1.163 . . . . 0.0 110.177 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.35 -177.7 3.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.927 1.488 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -95.11 23.47 5.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.24 -51.8 64.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.946 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -94.96 36.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.8 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.727 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.0 OUTLIER -41.89 -50.05 10.51 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 111.021 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.4 Cg_endo -68.75 -4.32 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.42 1.221 . . . . 0.0 110.729 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -103.96 -48.71 3.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.749 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.59 HD12 ' CG ' ' A' ' 36' ' ' GLU . 24.2 mt -74.54 -9.67 58.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 110.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -61.43 152.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.971 -1.08 . . . . 0.0 110.101 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 53.98 17.69 7.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.572 ' CE ' HG11 ' A' ' 60' ' ' VAL . 20.3 ptm -76.52 135.33 39.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.005 -1.291 . . . . 0.0 109.989 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -85.2 143.28 28.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.185 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -97.12 167.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.25 -15.54 17.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -131.74 178.74 6.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.4 146.44 42.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.213 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.1 t -119.94 118.96 31.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.34 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.5 Cg_endo -73.0 -173.55 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.932 1.491 . . . . 0.0 110.147 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.24 129.07 34.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 75.62 35.62 45.89 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 50' ' ' PRO . 7.7 m -86.08 120.35 27.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.199 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.632 HG23 ' CG ' ' A' ' 56' ' ' MET . 2.9 t -64.93 163.11 15.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.052 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -82.99 82.68 8.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.632 ' CG ' HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -85.91 141.91 36.06 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.339 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.45 -15.94 24.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.054 1.555 . . . . 0.0 110.59 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 56' ' ' MET . 2.1 p30 -72.75 -29.31 63.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.347 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.91 -41.01 12.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.477 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG11 ' CE ' ' A' ' 43' ' ' MET . 6.4 t -100.47 121.07 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 2.0 pttt -61.66 -136.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 109.889 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.623 ' HB3' HG11 ' A' ' 97' ' ' VAL . 2.0 p-10 -70.28 101.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.094 -1.004 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -75.53 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.157 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 34.2 mm-40 -113.62 -156.16 0.59 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.967 . . . . 0.0 110.297 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.88 54.52 3.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.115 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.17 11.44 57.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.48 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 43.4 p -82.98 150.05 26.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.119 . . . . 0.0 110.324 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 69' ' ' SER . 44.5 m -100.13 -87.29 0.37 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.164 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.446 ' N ' HG22 ' A' ' 68' ' ' THR . 0.7 OUTLIER -76.91 141.3 67.86 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.123 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' LEU . 47.4 Cg_endo -72.76 -92.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.949 1.499 . . . . 0.0 110.585 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 59.04 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PRO . 15.5 mt -88.1 52.51 2.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -1.084 . . . . 0.0 109.607 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.47 139.89 57.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.467 -0.771 . . . . 0.0 110.366 -179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -140.34 150.81 44.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.096 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.9 t -79.43 131.64 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 110.247 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 123' ' ' GLN . 26.8 t -129.86 143.06 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.276 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.69 81.82 8.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -57.44 -22.56 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.377 -0.827 . . . . 0.0 110.57 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 121' ' ' LEU . 28.0 mm100 -110.52 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.206 -0.934 . . . . 0.0 110.254 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -105.62 126.05 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.505 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 7.6 mt -120.73 121.4 29.03 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 159.13 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.843 1.444 . . . . 0.0 110.82 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.625 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -48.33 148.68 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 110.24 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 83' ' ' ILE . 23.0 m120 53.96 70.46 0.6 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 115' ' ' VAL . 93.3 m -143.67 101.28 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.88 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.416 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -90.89 149.07 22.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.93 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' HA2' ' A' ' 112' ' ' GLY . 3.3 p -127.06 176.53 7.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.337 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -49.43 -34.44 16.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.617 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.497 HG22 ' OG1' ' A' ' 88' ' ' THR . 27.7 m -64.81 -33.84 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 0.0 110.025 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.4 mtt -84.78 -28.3 26.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 110.161 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.6 mtt -102.63 138.94 38.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.25 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.74 120.04 37.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.91 97.86 2.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.436 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' SER . 24.5 mm-40 -123.11 126.0 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.862 . . . . 0.0 110.106 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -69.39 98.83 1.13 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.286 -0.884 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 62' ' ' ASN . 9.6 p -146.33 168.45 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 15.0 m -105.2 151.99 39.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.179 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -76.2 161.52 93.83 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.7 -2.208 . . . . 0.0 110.386 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 101.39 13.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -86.56 -99.71 0.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.557 HD11 ' CA ' ' A' ' 127' ' ' PRO . 10.6 mt -112.21 123.32 34.56 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.224 -1.163 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.52 175.86 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.791 1.416 . . . . 0.0 110.318 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.93 40.67 0.99 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.92 -48.75 7.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -94.76 -10.32 31.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.058 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.1 tp -47.32 -38.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.103 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 107' ' ' ILE . 28.5 p -45.29 -45.62 12.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.368 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -83.48 -26.42 30.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.256 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 21.0 mt -94.81 9.16 40.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.228 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.058 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.2 t -66.5 130.51 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 75.37 17.83 80.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 17.6 ptt? -79.93 145.62 32.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -1.177 . . . . 0.0 110.207 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -80.48 134.22 35.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.144 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.803 HG22 ' H ' ' A' ' 117' ' ' ARG . 13.7 p -87.39 153.8 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 131' ' ' LYS . 3.3 t-20 -100.66 -6.01 25.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 0.0 109.984 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.803 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.76 166.18 16.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.16 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.97 139.74 38.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.336 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.5 t -116.68 138.62 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.7 m-85 -97.09 -168.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.923 . . . . 0.0 110.866 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -57.74 -149.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -0.753 . . . . 0.0 111.043 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.51 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.486 -0.759 . . . . 0.0 111.212 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.9 tp-100 -118.58 154.98 31.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 0.0 109.683 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -78.67 145.76 34.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.387 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 126' ' ' MET . 4.3 tp -80.38 127.4 32.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 110.094 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.653 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.0 mtm -126.87 148.66 66.25 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.557 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -72.86 -16.48 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.949 1.499 . . . . 0.0 110.337 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -83.25 -3.31 57.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -47.88 6.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.204 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 t -91.49 124.3 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 110.311 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HD3' ' CG ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -82.01 -13.65 57.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -91.37 17.01 9.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 110.274 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.29 137.92 47.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' OE2' ' OXT' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.328 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.93 169.12 18.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.16 149.66 33.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -109.42 166.25 11.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG13 ' HG2' ' A' ' 22' ' ' MET . 32.5 t -79.89 100.18 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 7.8 t -117.94 113.01 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.231 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -51.68 130.32 28.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.081 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 51' ' ' LEU . 11.7 t-20 -85.56 -40.36 16.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.482 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 5.9 pt20 -91.75 177.38 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.239 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.8 tt -89.39 113.27 24.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.93 . . . . 0.0 110.231 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 12.1 mt -103.37 137.57 19.29 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.07 -162.73 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.044 1.549 . . . . 0.0 110.557 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.43 HG13 ' HA ' ' A' ' 48' ' ' ALA . 1.8 mp -87.13 163.47 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 6.8 m-80 42.23 66.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 11' ' ' ILE . 28.8 m -131.13 120.84 23.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.15 93.7 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.756 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.9 mt -42.08 148.84 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.479 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 25.3 p -120.82 170.89 9.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.458 -0.776 . . . . 0.0 110.069 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -37.79 87.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 110.364 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.86 -36.39 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' OE1' ' A' ' 9' ' ' GLN . 18.6 mtt -79.01 0.26 28.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.978 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.646 ' HG2' HG13 ' A' ' 5' ' ' VAL . 15.9 tmm? -105.26 119.74 39.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.04 120.17 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 110.316 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.29 75.19 10.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -102.63 149.67 24.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.69 81.27 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.0 110.18 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.6 165.73 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.5 t -109.05 151.74 42.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.3 Cg_endo -76.16 154.93 98.44 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.625 -2.24 . . . . 0.0 110.435 -0.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.7 mpp? -71.13 88.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.264 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.71 -142.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.7 mt -79.03 140.58 57.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.162 -1.199 . . . . 0.0 110.213 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.64 167.74 26.32 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.034 1.544 . . . . 0.0 110.474 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -89.47 27.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.67 -44.68 81.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 1.2 mm-40 -94.71 28.44 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.589 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.6 mm -41.75 -53.97 7.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 110.726 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.1 Cg_endo -68.22 -5.19 14.25 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.528 1.278 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 5.6 m-20 -104.5 -57.61 2.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.818 ' CD1' HD11 ' A' ' 55' ' ' LEU . 1.6 tt -75.87 -3.43 35.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.364 -0.835 . . . . 0.0 110.928 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -67.37 150.86 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.675 -1.266 . . . . 0.0 110.567 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.52 4.96 34.18 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.611 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 83.8 mmm -75.66 132.29 40.48 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.9 -1.353 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.1 mt-30 -80.8 136.1 36.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.503 -0.748 . . . . 0.0 110.265 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 45' ' ' VAL . 18.0 m -85.58 160.47 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.199 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -93.78 -7.15 44.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 177.62 7.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.24 145.61 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 53' ' ' THR . 15.2 t -118.9 106.82 43.08 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 49' ' ' VAL . 46.7 Cg_endo -72.83 -168.31 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.071 1.564 . . . . 0.0 110.436 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -77.87 138.63 39.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.3 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 68.79 31.52 73.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.642 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.4 m -77.45 116.96 18.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -1.214 . . . . 0.0 110.229 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 t -74.94 158.15 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.818 HD11 ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.51 102.85 3.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.415 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.17 138.22 19.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.49 -10.79 24.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.021 1.538 . . . . 0.0 110.458 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.71 -19.91 40.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mtt -104.06 -12.0 17.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 63' ' ' TYR . 9.5 t -111.14 125.22 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 2.8 mmmp? -70.8 -105.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.003 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.43 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 37.2 p-10 -91.02 79.59 5.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.835 -1.166 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.747 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.69 -101.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.405 -0.809 . . . . 0.0 110.502 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 2.4 mp0 -107.52 -170.84 1.76 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.832 -1.167 . . . . 0.0 110.368 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.09 46.8 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.788 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.43 19.73 51.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -89.16 160.41 17.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -1.15 . . . . 0.0 110.243 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.2 t -76.85 -140.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.104 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -67.04 168.88 9.55 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.2 Cg_endo -72.43 -92.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.973 1.512 . . . . 0.0 110.417 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -79.09 0.38 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 10.4 mt -83.9 53.86 2.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -1.096 . . . . 0.0 109.861 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 10.2 pttp -66.82 129.26 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.491 -0.755 . . . . 0.0 110.641 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -139.9 157.03 46.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HB ' HD23 ' A' ' 125' ' ' LEU . 12.8 t -82.92 132.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.69 134.04 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.234 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -76.04 80.12 2.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.248 -0.908 . . . . 0.0 109.897 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 22.8 t-20 -57.18 -21.38 32.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.78 -173.9 2.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.097 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.29 127.37 49.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.764 HG23 HG21 ' A' ' 85' ' ' THR . 32.6 mm -121.0 118.23 30.43 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.165 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -72.35 155.4 55.79 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.89 1.469 . . . . 0.0 110.625 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.618 HG13 ' HB2' ' A' ' 118' ' ' ALA . 3.1 mt -42.52 150.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 10.4 m120 50.62 75.15 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.414 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.764 HG21 HG23 ' A' ' 81' ' ' ILE . 19.0 m -143.57 102.37 3.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 110.223 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.03 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.07 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -82.65 139.52 33.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.211 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.805 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.1 178.91 5.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.326 -0.859 . . . . 0.0 110.148 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.01 -30.51 10.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.308 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -61.07 -50.2 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -17.07 46.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.07 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -93.24 126.51 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' C ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -110.82 108.52 18.38 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.207 -0.933 . . . . 0.0 109.348 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.48 99.43 6.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -114.79 132.16 56.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.901 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.599 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 4.0 mp0 -80.61 82.35 6.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 110.197 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' SER . 9.1 p -136.13 168.11 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -108.61 148.22 37.29 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 110.177 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -76.01 160.18 96.0 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.609 -2.246 . . . . 0.0 110.405 -0.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.51 119.98 33.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 110.182 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -78.07 -104.88 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.755 HD12 HD11 ' A' ' 125' ' ' LEU . 43.4 mt -108.93 131.82 21.56 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -1.172 . . . . 0.0 109.868 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -71.99 156.47 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.888 1.467 . . . . 0.0 110.513 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.03 41.61 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.144 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.441 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 3.4 mt-10 -67.29 -61.25 2.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -102.76 26.09 8.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.0 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -55.89 -43.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.167 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.2 p -47.72 -27.58 2.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.68 -28.56 15.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.252 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 113' ' ' MET . 17.3 mt -98.25 0.29 45.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.1 t -64.81 132.77 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 78.31 13.66 83.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 113' ' ' MET . 14.6 ptt? -76.47 145.54 39.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -1.117 . . . . 0.0 109.942 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.18 134.07 35.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 85' ' ' THR . 7.1 p -86.5 154.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.323 -0.861 . . . . 0.0 110.196 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.64 -10.94 20.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.0 ttm180 -124.07 165.14 18.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 109.697 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -75.19 152.0 38.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.953 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -130.16 137.58 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.855 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.455 ' O ' ' O ' ' A' ' 121' ' ' LEU . 16.3 m-85 -90.61 -169.64 2.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.908 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.53 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.522 -0.736 . . . . 0.0 110.604 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.8 m-20 -44.02 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 121' ' ' LEU . 49.8 tp60 -118.54 150.64 39.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.447 ' OG1' ' NZ ' ' A' ' 61' ' ' LYS . 6.4 m -78.62 129.4 34.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.105 -0.997 . . . . 0.0 110.514 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.755 HD11 HD12 ' A' ' 102' ' ' ILE . 2.7 tp -66.25 125.39 25.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 0.0 109.894 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.586 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.94 140.95 37.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.574 ' N ' HD11 ' A' ' 102' ' ' ILE . 47.5 Cg_endo -74.09 -0.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.026 1.54 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.43 -30.17 19.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.43 ' HG3' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -91.65 -24.03 19.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 129' ' ' MET . 46.3 t -84.19 96.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -73.19 -8.91 57.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -96.38 20.43 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.42 -174.78 2.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.168 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.28 0.562 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.66 -176.81 6.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.198 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.525 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.17 147.79 34.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.842 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 15.1 t -107.86 159.46 16.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 110.095 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 98.4 t -79.67 101.42 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.9 t -119.9 117.82 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.179 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -61.82 127.38 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.945 . . . . 0.0 110.069 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.594 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t30 -83.01 -40.09 20.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.329 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.07 175.62 6.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 50' ' ' PRO . 1.1 tt -90.22 128.39 36.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.964 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 17' ' ' LEU . 11.6 mt -107.36 138.46 19.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 0.0 110.175 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.53 -162.42 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.068 1.562 . . . . 0.0 110.541 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 1.7 mp -86.64 159.25 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.9 p30 36.54 76.03 0.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.651 -0.656 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 59.1 m -138.85 122.78 17.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.459 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.03 110.49 2.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.841 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 11' ' ' ILE . 20.7 mt -55.92 146.5 21.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.546 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 49.2 p -121.24 163.29 18.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -0.751 . . . . 0.0 110.014 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -26.5 68.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 110.074 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.7 -50.63 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.842 . . . . 0.0 110.343 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 23.4 ptp -81.24 2.77 26.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.804 ' HE2' HD12 ' A' ' 37' ' ' ILE . 3.1 tmm? -99.12 109.77 22.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.231 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.04 124.46 52.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.086 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.41 81.7 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.46 151.17 22.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG22 ' CA ' ' A' ' 3' ' ' ALA . 21.7 t -87.94 79.88 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.137 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.03 174.1 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 4.0 p -105.28 161.71 21.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.239 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.39 151.15 95.98 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.429 -0.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.0 mtt -69.73 79.59 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.931 . . . . 0.0 110.193 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.79 -127.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.009 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.9 mt -81.55 120.41 77.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.7 Cg_endo -73.24 62.06 4.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.93 1.49 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . 42.75 26.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.5 tt0 -60.51 -72.24 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.899 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.517 ' OE1' ' CA ' ' A' ' 66' ' ' GLY . 20.7 mt-10 -94.56 41.59 1.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.54 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.804 HD12 ' HE2' ' A' ' 22' ' ' MET . 0.7 OUTLIER -59.25 -55.55 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.565 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.44 -11.77 32.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.567 1.299 . . . . 0.0 110.839 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.85 -39.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.401 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -92.17 -11.83 34.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 111.031 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.3 t -54.56 156.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.678 -1.264 . . . . 0.0 110.201 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.7 4.69 41.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -70.56 156.68 39.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.805 -1.409 . . . . 0.0 109.596 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 121' ' ' LEU . 17.7 mt-30 -99.69 131.48 45.65 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.1 m -85.43 162.37 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.785 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.74 -19.0 29.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.271 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -138.37 173.72 11.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.74 150.32 39.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 53' ' ' THR . 11.2 t -112.97 130.14 23.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.107 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.8 Cg_endo -71.22 -171.97 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.815 1.429 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -83.4 136.48 34.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 68.68 33.06 75.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.756 HG21 HG13 ' A' ' 49' ' ' VAL . 6.8 m -81.51 121.51 26.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.521 ' CA ' HG13 ' A' ' 6' ' ' VAL . 14.7 t -70.6 156.99 38.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.009 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.01 86.59 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.438 ' CG ' HG23 ' A' ' 54' ' ' THR . 2.6 mmm -102.93 148.81 36.13 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.89 -17.79 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.927 1.488 . . . . 0.0 110.347 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -64.05 -38.64 91.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.1 mtt -91.0 -7.05 53.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 87.2 t -119.64 115.35 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -62.49 -140.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.976 . . . . 0.0 110.0 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 21.1 m120 -70.26 76.58 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.016 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -53.56 -102.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.172 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 28.0 mm-40 -129.2 176.8 7.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.795 -1.191 . . . . 0.0 110.653 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.74 ' OD1' HG23 ' A' ' 67' ' ' THR . 4.3 t0 -88.22 -65.05 1.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.373 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' OE1' ' A' ' 36' ' ' GLU . . . 104.42 15.22 21.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' OD1' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -91.52 172.15 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -1.088 . . . . 0.0 110.335 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.3 m -100.45 -68.53 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.876 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.456 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 18.3 m -84.74 123.87 73.62 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 110.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.535 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 47.0 Cg_endo -73.28 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.9 1.474 . . . . 0.0 110.461 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.66 -77.7 1.85 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.61 47.42 1.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.139 . . . . 0.0 108.815 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.635 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.53 129.43 39.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.387 0.613 . . . . 0.0 110.921 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 95' ' ' GLU . 81.3 p -98.62 164.43 12.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.669 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.61 HG12 ' SD ' ' A' ' 92' ' ' MET . 3.5 t -83.61 121.46 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.249 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.86 140.77 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.01 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.79 84.79 7.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 57.6 t30 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.381 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.86 -168.34 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.995 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -91.9 136.53 33.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 110.458 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.995 ' N ' HD13 ' A' ' 80' ' ' LEU . 15.1 mt -122.69 113.89 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.771 . . . . 0.0 109.951 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 85' ' ' THR . 44.9 Cg_endo -73.23 148.39 43.88 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.702 1.37 . . . . 0.0 110.763 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.757 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.0 mt -46.81 154.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.487 HD22 HG22 ' A' ' 83' ' ' ILE . 11.3 p30 38.62 73.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.642 -0.661 . . . . 0.0 110.964 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' LEU . 30.8 m -143.87 109.16 5.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.94 89.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.2 142.12 29.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.538 HG22 ' CG1' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -120.07 171.93 8.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.66 1.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.96 -46.02 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.7 mtt -84.69 -20.98 30.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.61 ' SD ' HG12 ' A' ' 75' ' ' VAL . 1.9 mmt -105.4 152.79 22.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.98 . . . . 0.0 110.493 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -130.16 114.78 16.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.31 98.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.915 . . . . 0.0 110.554 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 74' ' ' SER . 48.0 mm-40 -121.63 143.3 49.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.635 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 25.7 tt0 -84.87 96.42 9.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.118 -0.989 . . . . 0.0 110.5 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 13.2 p -139.46 164.91 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 57.1 p -108.59 151.24 41.55 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.7 Cg_endo -76.12 153.35 97.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.518 -0.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -80.43 105.17 11.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.268 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.04 -90.16 0.62 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 127' ' ' PRO . 11.8 mt -109.32 131.18 22.0 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.104 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.472 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 45.4 Cg_endo -72.43 167.34 27.25 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.928 1.488 . . . . 0.0 110.288 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.2 m -95.62 34.65 1.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 4.6 pt-20 -88.38 -35.94 16.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mp0 -98.03 -10.82 23.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 110.259 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -46.98 -40.6 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.268 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.476 ' N ' HD13 ' A' ' 107' ' ' ILE . 1.3 t -52.63 -33.06 44.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.335 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -94.53 -12.41 27.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.07 11.83 25.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' ILE . 13.2 t -53.83 125.82 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 110.324 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.527 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 74.51 31.01 59.34 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -77.99 151.98 33.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 110.11 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -94.39 121.93 36.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.308 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.789 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.2 p -79.74 158.84 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 110.072 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -100.49 -7.34 24.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.116 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.789 ' H ' HG22 ' A' ' 115' ' ' VAL . 4.3 ptm180 -125.31 177.33 6.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.006 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.757 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.22 146.84 23.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 7.3 t -124.55 139.54 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 17.0 m-85 -90.81 -163.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.406 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -59.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 4.0 p-10 -44.39 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 110.975 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.63 147.41 43.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.939 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 44.0 m -78.84 138.84 38.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.21 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.679 ' CD1' HG21 ' A' ' 130' ' ' VAL . 5.6 tp -79.86 128.56 33.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.836 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' LEU . 26.1 mtp -113.06 139.61 23.21 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.393 -0.817 . . . . 0.0 110.292 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.702 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.8 Cg_endo -74.29 -30.68 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.009 1.531 . . . . 0.0 110.628 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.96 -37.07 72.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.576 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -80.48 -49.42 11.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 110.271 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.679 HG21 ' CD1' ' A' ' 125' ' ' LEU . 58.9 t -75.39 109.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 32.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.097 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -108.32 -27.79 9.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -171.17 0.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' OE2' ' HB3' ' A' ' 106' ' ' GLU . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -77.79 175.26 10.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 137.36 54.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.196 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.2 t -109.0 160.97 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 110.157 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 34' ' ' ALA . 10.3 t -71.52 99.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 4' ' ' SER . 3.7 t -110.03 118.32 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -64.6 126.26 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.9 p30 -82.61 -39.17 22.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.509 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.3 pt20 -91.95 172.68 8.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.213 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.3 tt -90.25 135.91 33.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG13 ' CD2' ' A' ' 17' ' ' LEU . 22.6 mm -118.31 139.49 26.87 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.324 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.26 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.051 1.553 . . . . 0.0 110.246 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 10.5 mm -84.76 161.06 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 8.0 p30 37.51 73.27 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 110.726 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.5 m -136.86 126.9 26.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.29 95.58 2.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.073 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 11' ' ' ILE . 33.9 mt -51.66 151.32 3.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.342 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 HG23 ' HE3' ' A' ' 21' ' ' MET . 47.7 p -120.27 -179.18 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -66.67 -35.29 79.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.348 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 -38.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.203 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.509 ' SD ' ' NE2' ' A' ' 9' ' ' GLN . 5.2 mtm -87.89 16.7 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.027 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.502 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.34 109.63 19.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.478 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -111.08 109.79 20.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -0.933 . . . . 0.0 110.001 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.8 73.35 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.11 148.98 25.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -85.46 92.15 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 110.279 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.18 156.9 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.3 p -96.75 160.61 28.92 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.243 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.0 Cg_endo -75.93 159.41 97.05 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.69 -2.213 . . . . 0.0 110.431 -0.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.75 123.03 19.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.07 -131.85 4.36 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.0 mt -79.73 115.3 52.76 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 0.0 110.324 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 35' ' ' GLU . 46.5 Cg_endo -73.86 53.22 2.77 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.946 1.498 . . . . 0.0 110.707 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.895 ' HB2' HG22 ' A' ' 5' ' ' VAL . . . 40.66 27.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.324 -0.86 . . . . 0.0 110.554 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.2 tt0 -56.49 -57.5 12.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 33.6 mm-40 -94.91 38.72 1.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 109.513 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.827 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -38.93 -52.19 3.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 110.884 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -69.86 -15.78 36.84 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.556 1.293 . . . . 0.0 110.864 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 2.4 t-20 -104.22 -29.51 10.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.151 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -91.93 -11.01 37.43 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.298 -0.876 . . . . 0.0 110.181 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.18 151.41 10.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.873 -1.142 . . . . 0.0 110.453 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.2 4.74 30.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.595 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 98.6 mmm -72.01 139.83 48.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.744 -1.445 . . . . 0.0 109.973 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 13.4 mt-30 -85.84 139.23 31.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 110.389 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 45' ' ' VAL . 35.2 m -89.93 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -101.16 -21.93 14.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 110.126 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mtt180 -130.65 177.3 7.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.327 -0.858 . . . . 0.0 110.388 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -70.99 147.94 48.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 110.002 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.944 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -111.37 119.25 45.75 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.275 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.9 Cg_endo -71.41 168.92 22.13 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.782 1.412 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 134.23 52.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 69.87 41.75 71.83 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.944 HG21 HG13 ' A' ' 49' ' ' VAL . 16.2 m -86.49 125.52 33.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.1 t -75.22 159.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -71.87 89.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.421 ' HG3' ' HD2' ' A' ' 57' ' ' PRO . 5.8 tpp -91.59 132.09 34.27 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 110.247 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 48.9 Cg_endo -75.3 -14.67 20.44 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.981 1.517 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -16.68 50.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.479 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 69.0 mtp -103.87 -4.99 22.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.982 . . . . 0.0 110.438 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.794 HG11 ' HB3' ' A' ' 63' ' ' TYR . 61.4 t -119.98 130.47 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.496 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -68.31 -108.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.516 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.571 HD22 HG11 ' A' ' 97' ' ' VAL . 1.2 t-20 -84.06 68.0 9.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.84 -1.162 . . . . 0.0 110.922 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.794 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -53.94 -98.44 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.248 -0.908 . . . . 0.0 110.406 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -114.31 -167.1 1.17 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.07 . . . . 0.0 110.333 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -78.27 51.54 1.03 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.91 . . . . 0.0 110.357 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.41 -17.44 78.94 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.675 HG21 ' O ' ' A' ' 96' ' ' GLU . 0.8 OUTLIER -89.21 122.02 32.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -1.143 . . . . 0.0 110.203 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 32.2 m -96.29 -53.7 3.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.867 . . . . 0.0 110.175 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -82.7 111.42 29.11 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 110.183 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.3 Cg_endo -72.47 -90.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.915 1.481 . . . . 0.0 110.624 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.52 -81.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.4 mt -88.07 54.94 3.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -1.05 . . . . 0.0 109.956 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -77.37 119.5 21.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.92 160.37 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.825 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.541 ' CG1' ' HG2' ' A' ' 92' ' ' MET . 11.1 t -79.12 123.98 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.314 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 123' ' ' GLN . 54.4 t -122.79 140.29 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.343 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' CB ' HG11 ' A' ' 119' ' ' VAL . . . -80.84 97.24 7.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.006 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.829 ' O ' HD13 ' A' ' 121' ' ' LEU . 27.4 t-20 -57.8 -41.15 81.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -104.95 172.51 6.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.959 . . . . 0.0 110.481 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.6 tt -86.76 148.26 25.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 85' ' ' THR . 10.1 mt -119.74 130.42 24.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.134 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.802 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -77.27 46.87 2.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.91 1.479 . . . . 0.0 111.163 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 82' ' ' PRO . 3.2 mp 58.37 150.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 110.412 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 83' ' ' ILE . 8.0 p30 39.26 77.65 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.561 -0.712 . . . . 0.0 110.777 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.625 ' O ' HD23 ' A' ' 87' ' ' LEU . 1.8 m -143.66 110.4 5.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.122 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.04 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.89 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.5 OUTLIER -87.12 141.6 28.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.038 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.1 p -125.24 -170.64 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 110.218 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.2 -27.43 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 110.443 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -63.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 mtt -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.89 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -102.14 113.61 27.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 110.241 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -111.26 105.95 14.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.7 98.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 74' ' ' SER . 6.9 mt-10 -123.05 152.49 40.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.675 ' O ' HG21 ' A' ' 67' ' ' THR . 0.2 OUTLIER -77.36 85.35 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.193 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.571 HG11 HD22 ' A' ' 62' ' ' ASN . 8.5 p -133.35 162.3 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.476 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.64 157.54 37.24 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.84 174.05 55.03 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.532 -2.278 . . . . 0.0 110.279 -0.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 96.26 8.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -84.39 -103.92 0.6 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.953 HD12 HD11 ' A' ' 125' ' ' LEU . 20.6 mt -109.27 113.45 58.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.32 -1.106 . . . . 0.0 110.078 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.98 173.68 11.69 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.928 1.488 . . . . 0.0 110.425 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -88.77 43.2 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -75.16 -67.61 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 0.0 110.099 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -96.34 21.35 9.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.186 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.033 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.5 tp -55.26 -32.74 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 m -49.1 -37.93 23.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.83 -21.18 19.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.114 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.472 HD11 ' OE2' ' A' ' 134' ' ' GLU . 15.2 mt -93.36 0.85 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.033 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.0 t -65.0 132.33 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.79 18.36 80.09 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 110' ' ' LEU . 23.1 ptm -73.33 155.07 39.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.183 . . . . 0.0 110.018 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -97.75 123.75 41.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.451 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.978 HG23 HG12 ' A' ' 130' ' ' VAL . 6.2 p -86.67 155.13 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -100.41 -0.87 37.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.117 -0.989 . . . . 0.0 110.493 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.911 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.83 173.11 8.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -91.55 135.68 33.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 77' ' ' ALA . 53.0 t -109.93 132.55 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 110.077 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 121' ' ' LEU . 32.0 m-85 -81.1 -164.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -58.77 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 110.267 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' OD1' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -46.58 83.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.355 -0.841 . . . . 0.0 111.137 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 12.7 tt0 -118.75 156.21 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 110.001 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.93 132.81 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.07 HD12 ' N ' ' A' ' 126' ' ' MET . 0.4 OUTLIER -78.73 137.95 38.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.834 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 1.07 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.8 mmt -126.23 143.06 44.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.665 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.4 Cg_endo -75.6 -25.67 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.007 1.53 . . . . 0.0 110.727 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -20.52 63.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.234 -0.916 . . . . 0.0 110.256 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.65 -49.14 6.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.978 HG12 HG23 ' A' ' 115' ' ' VAL . 21.9 m -82.69 111.54 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -88.53 28.59 1.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.96 40.4 1.93 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -169.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.138 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' OE2' HD11 ' A' ' 110' ' ' LEU . 18.1 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.204 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.286 0.565 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -76.65 179.82 5.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.15 143.28 52.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.0 p -107.51 162.54 13.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' O ' HD23 ' A' ' 55' ' ' LEU . 38.8 t -84.15 95.99 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -111.72 111.41 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.897 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.685 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -51.63 124.58 12.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.8 -38.21 23.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.849 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.51 ' OE1' ' CG ' ' A' ' 21' ' ' MET . 6.1 pt20 -92.1 179.38 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.84 134.41 33.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.874 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.893 ' CG2' HD21 ' A' ' 17' ' ' LEU . 24.1 mt -110.85 128.47 25.27 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.257 -0.902 . . . . 0.0 110.642 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.9 Cg_endo -74.87 -161.67 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.852 1.448 . . . . 0.0 110.119 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -89.11 158.65 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 0.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 9.4 p30 36.77 73.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.76 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 32.5 m -140.5 123.67 16.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -77.06 92.49 3.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD21 ' CG2' ' A' ' 11' ' ' ILE . 93.8 mt -53.09 158.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.436 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.8 p -118.96 -179.27 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -63.84 -30.26 71.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -68.61 -46.11 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.322 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.51 ' CG ' ' OE1' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -71.55 -11.96 61.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.529 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.93 115.04 27.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 110.408 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.87 118.66 36.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.117 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 4' ' ' SER . . . -82.3 81.47 8.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -103.13 149.94 24.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.6 t -88.66 93.71 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.206 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.0 m -140.72 152.82 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.232 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 2.3 t -106.47 152.64 40.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 110.194 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -76.58 148.43 88.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.595 -2.252 . . . . 0.0 110.559 -0.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 30' ' ' MET . 0.7 OUTLIER -72.56 107.91 5.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.376 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.55 -128.81 2.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 55' ' ' LEU . 16.0 mm -63.14 121.22 67.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.169 -1.194 . . . . 0.0 109.955 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.5 170.5 19.21 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.813 1.428 . . . . 0.0 110.424 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -78.27 3.35 15.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.09 -45.3 85.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.373 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.62 19.33 2.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 110.496 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.7 mm -49.84 -60.46 5.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.29 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 42.3 Cg_endo -68.09 -5.89 15.84 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.13 -62.06 1.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.096 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 64' ' ' GLU . 13.7 mt -75.42 -0.12 18.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -58.02 147.7 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.784 -1.197 . . . . 0.0 109.48 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.5 19.27 62.21 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.503 ' HE1' HG13 ' A' ' 60' ' ' VAL . 21.1 ptm -80.74 139.25 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.892 -1.358 . . . . 0.0 110.021 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 3.6 mt-30 -86.8 139.83 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.294 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.3 m -89.08 169.42 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.907 . . . . 0.0 110.361 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.428 ' OD1' ' HD2' ' A' ' 61' ' ' LYS . 1.7 t-20 -94.67 -22.17 18.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.306 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -142.59 165.7 26.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.91 137.39 57.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG13 HG21 ' A' ' 53' ' ' THR . 16.2 t -112.89 139.13 22.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.9 Cg_endo -71.71 -175.39 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.77 143.41 31.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.6 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 64.12 32.89 85.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 HG13 ' A' ' 49' ' ' VAL . 20.3 m -86.56 127.82 34.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -1.205 . . . . 0.0 110.087 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.732 ' CA ' HG13 ' A' ' 6' ' ' VAL . 8.9 t -71.01 152.22 43.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.963 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 5' ' ' VAL . 1.5 mm? -72.04 81.3 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.3 mtp -87.18 151.05 50.87 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.6 -15.59 27.29 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.951 1.5 . . . . 0.0 110.57 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -76.99 -35.31 57.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.9 mtt -103.0 8.22 38.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG11 ' HD2' ' A' ' 63' ' ' TYR . 40.5 t -111.2 125.16 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -60.69 -144.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.114 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' ND2' HG11 ' A' ' 97' ' ' VAL . 8.0 m120 -78.74 71.87 5.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.91 -105.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 110.025 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.611 ' HG3' HD21 ' A' ' 40' ' ' LEU . 46.5 mt-10 -152.05 5.41 0.42 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.016 -1.052 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -86.82 -8.67 57.12 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 110.454 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -94.8 -23.79 19.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.809 HG22 ' O ' ' A' ' 67' ' ' THR . 15.5 m -74.76 60.33 0.93 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.208 -1.172 . . . . 0.0 110.193 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -107.87 -96.26 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 110.223 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -84.88 139.65 37.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.983 -1.073 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.77 -154.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.125 1.592 . . . . 0.0 110.04 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.82 -70.82 1.8 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 12.3 mt -87.41 52.62 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -1.143 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -79.32 113.25 17.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.46 -0.775 . . . . 0.0 110.663 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 35.4 p -99.61 154.08 18.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.837 . . . . 0.0 109.595 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.764 HG13 ' SD ' ' A' ' 92' ' ' MET . 19.9 t -68.44 130.34 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 124' ' ' THR . 75.0 t -130.53 133.43 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.317 -0.865 . . . . 0.0 109.941 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -83.0 95.15 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.4 p30 -58.55 -26.48 63.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.314 -0.866 . . . . 0.0 110.996 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -110.36 -170.43 1.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 110.591 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 9.0 tt -104.33 129.77 52.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 85' ' ' THR . 97.7 mt -121.2 130.17 24.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.92 151.56 56.68 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.877 1.462 . . . . 0.0 110.576 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 19.4 mt -45.23 153.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 11.6 t-20 48.71 76.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.199 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.845 HG21 HG23 ' A' ' 81' ' ' ILE . 17.5 m -143.8 114.04 7.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -60.54 78.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.246 -0.909 . . . . 0.0 110.386 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -73.67 142.38 46.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' CA ' ' A' ' 112' ' ' GLY . 65.3 p -119.8 -174.98 2.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.362 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.82 -27.32 41.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.13 -57.7 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.1 mtt -84.82 8.9 15.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.277 -0.89 . . . . 0.0 110.718 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.764 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.86 129.85 53.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.072 -1.018 . . . . 0.0 110.525 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 78' ' ' ASN . 12.5 mttp -124.33 86.89 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.351 -0.843 . . . . 0.0 109.711 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.47 98.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.794 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.53 158.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -69.46 100.15 1.35 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 110.365 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' ND2' ' A' ' 62' ' ' ASN . 78.1 t -130.12 144.21 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 110.314 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 25.4 t -110.29 138.01 20.77 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.391 -0.818 . . . . 0.0 110.286 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.33 162.24 92.34 Favored 'Cis proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.768 -2.18 . . . . 0.0 109.886 -0.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 2.5 pttp -82.06 122.63 28.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.083 -1.011 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.75 -101.36 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 127' ' ' PRO . 21.0 mt -108.86 126.52 29.22 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.238 -1.154 . . . . 0.0 109.798 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.88 151.49 50.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.486 ' OG ' ' CE ' ' A' ' 92' ' ' MET . 0.1 OUTLIER -83.68 46.48 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 110.41 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.8 pt-20 -85.12 -38.11 19.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.937 . . . . 0.0 110.095 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.7 mt-10 -115.85 9.98 15.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.038 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -55.86 -35.38 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.4 t -44.86 -42.92 8.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.67 -26.41 24.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD11 ' CG ' ' A' ' 134' ' ' GLU . 77.5 mt -92.35 0.52 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.038 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.6 t -61.45 136.22 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 78.45 14.97 81.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.525 ' CE ' HG11 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -75.73 148.73 38.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -1.136 . . . . 0.0 110.182 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -88.4 129.72 35.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.287 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.2 p -83.38 156.97 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 129' ' ' MET . 12.5 p-10 -100.25 -6.74 25.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.809 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -124.33 164.1 20.31 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -76.6 144.95 39.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 t -118.85 139.69 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.867 . . . . 0.0 109.945 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.509 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.0 m-85 -101.52 -161.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.565 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.11 -148.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 110.656 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 p30 -44.08 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.317 -0.864 . . . . 0.0 110.989 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.3 tt0 -118.15 144.92 45.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.988 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -78.9 126.22 30.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.548 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.714 HD23 ' HB ' ' A' ' 75' ' ' VAL . 3.2 tp -63.54 130.53 44.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.585 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.73 149.24 44.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.836 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.0 Cg_endo -73.18 -42.61 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.05 1.553 . . . . 0.0 110.357 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 129' ' ' MET . 42.4 p-10 -72.03 -14.44 61.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.484 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 31.4 ttm -85.87 -46.02 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 115' ' ' VAL . 34.4 t -91.19 108.34 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.171 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -72.8 -8.25 54.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 61.8 t-20 -91.55 5.78 48.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -66.44 -169.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.388 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.541 ' CG ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.221 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.222 0.534 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 177.06 7.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -61.32 145.22 52.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 49.1 m -110.01 160.28 16.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.625 HG13 ' CG ' ' A' ' 22' ' ' MET . 76.1 t -77.71 97.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.353 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 54' ' ' THR . 22.7 t -112.28 122.31 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -57.42 130.82 48.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 110.164 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.5 t30 -82.82 -43.46 16.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.872 . . . . 0.0 110.027 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.467 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.6 pt20 -92.23 178.44 5.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.146 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 51' ' ' LEU . 5.4 tt -86.75 131.75 34.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' CD2' ' A' ' 17' ' ' LEU . 47.6 mm -118.41 130.84 24.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 0.0 110.365 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.1 Cg_endo -74.71 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.912 1.48 . . . . 0.0 110.405 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 13' ' ' ILE . 1.9 mp -83.91 156.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 45.92 64.63 1.4 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 11' ' ' ILE . 57.2 m -134.85 112.92 11.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -65.88 108.13 2.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.95 . . . . 0.0 110.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' CD2' HG13 ' A' ' 11' ' ' ILE . 17.8 mt -62.81 153.49 32.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.556 ' H ' ' HE2' ' A' ' 21' ' ' MET . 47.3 p -119.78 176.9 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 110.273 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -42.47 99.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -60.17 -41.51 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.556 ' HE2' ' H ' ' A' ' 18' ' ' THR . 1.1 mpp? -82.13 4.63 22.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.337 -0.852 . . . . 0.0 110.312 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.625 ' CG ' HG13 ' A' ' 5' ' ' VAL . 2.9 ttm -102.38 113.78 27.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.465 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -111.19 111.36 22.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -79.65 77.23 6.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.143 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.36 150.93 22.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.47 85.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 6' ' ' VAL . 10.9 m -121.92 159.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 5.7 t -106.83 150.53 39.83 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -76.34 155.37 98.27 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.68 -2.217 . . . . 0.0 110.364 -0.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 82.44 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.22 -0.925 . . . . 0.0 110.282 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.35 -125.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.938 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -84.82 132.34 46.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.21 -1.171 . . . . 0.0 110.161 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.47 -172.4 1.04 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.023 1.539 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.15 25.65 11.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.214 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.95 -62.22 2.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.971 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 mm-40 -93.18 59.61 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 0.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.63 -30.45 2.11 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 0.0 111.851 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.913 ' HD3' HG22 ' A' ' 37' ' ' ILE . 48.8 Cg_endo -77.98 -9.92 16.72 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 122.612 0.796 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -104.61 -35.35 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 43' ' ' MET . 0.3 OUTLIER -88.61 -27.51 21.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.2 t -46.35 151.88 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.954 -1.091 . . . . 0.0 110.015 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 69.37 13.44 67.77 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.692 ' HE1' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -69.72 152.5 44.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.831 -1.394 . . . . 0.0 109.767 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.47 134.92 42.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.33 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 49' ' ' VAL . 26.6 m -89.39 161.84 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.44 -9.32 25.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.268 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -140.72 177.87 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 110.306 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.62 138.67 55.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG21 HG11 ' A' ' 45' ' ' VAL . 12.6 t -116.58 115.42 39.55 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 0.0 109.983 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 -169.43 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.956 1.503 . . . . 0.0 110.614 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.42 150.89 31.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.865 . . . . 0.0 110.29 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.66 36.78 65.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.509 ' CB ' HG13 ' A' ' 49' ' ' VAL . 93.0 m -86.6 111.44 20.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.0 t -60.99 157.88 14.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.244 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.938 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.9 97.45 4.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.349 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.29 131.45 29.83 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 110.107 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.505 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 48.1 Cg_endo -73.38 -13.72 25.32 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 0.0 110.504 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -32.08 42.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 110.224 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mtt -104.09 4.3 34.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.15 138.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.328 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.27 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.487 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -70.07 91.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.972 -1.08 . . . . 0.0 110.04 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -53.73 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.237 -0.914 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.14 -165.19 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 0.0 110.299 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 55.89 2.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.107 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.8 8.23 76.63 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.0 p -90.79 125.23 35.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 110.297 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.4 m -83.75 -80.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.44 123.09 85.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.1 Cg_endo -73.63 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.863 1.454 . . . . 0.0 110.444 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 61.53 -79.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 72' ' ' LEU . 5.8 mt -87.62 52.74 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -1.147 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 4.3 pttt -85.22 115.21 22.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.587 -0.696 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -96.89 150.22 20.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 107' ' ' ILE . 42.4 t -66.61 126.21 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.302 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 124' ' ' THR . 77.0 t -130.95 131.32 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.09 87.02 4.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.059 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 1.6 m-80 -57.07 -22.66 41.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.319 -0.863 . . . . 0.0 110.629 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.19 -172.02 1.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.981 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.989 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -92.79 137.18 32.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.989 ' N ' HD13 ' A' ' 80' ' ' LEU . 7.4 mm -122.71 114.86 29.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.473 -0.767 . . . . 0.0 109.959 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.0 Cg_endo -72.75 147.15 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.92 1.484 . . . . 0.0 110.563 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.642 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -41.15 159.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.428 -0.795 . . . . 0.0 110.29 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 83' ' ' ILE . 8.0 p30 39.3 78.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.4 m -143.47 112.68 6.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.139 -0.975 . . . . 0.0 110.037 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.36 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.981 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -74.4 141.48 45.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.883 . . . . 0.0 110.03 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 p -122.85 -175.36 3.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -50.18 -28.68 7.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.305 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.57 -52.49 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -9.47 59.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 110.217 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.981 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -99.34 117.56 34.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 110.214 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 2.7 mttp -112.0 98.06 7.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.158 -0.964 . . . . 0.0 110.135 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -77.33 96.69 4.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.356 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -123.17 150.04 43.83 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -69.34 94.61 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.979 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 HG21 ' A' ' 76' ' ' VAL . 8.0 p -146.32 164.85 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.5 m -109.11 154.81 41.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 110.099 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.16 171.81 66.26 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.43 -0.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -93.64 107.44 19.3 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.143 -0.973 . . . . 0.0 109.574 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.9 -97.02 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 127' ' ' PRO . 29.0 mt -114.52 127.87 26.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.24 -1.153 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' CG ' ' OE2' ' A' ' 105' ' ' GLU . 46.7 Cg_endo -72.77 170.22 20.12 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.826 1.435 . . . . 0.0 110.611 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -82.1 45.77 0.96 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' OE2' ' CG ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -67.43 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -95.06 27.22 3.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.022 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.1 tp -53.43 -33.42 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.7 p -58.17 -31.13 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.77 -22.02 21.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 113' ' ' MET . 5.0 mt -96.03 -9.91 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.022 HG23 ' O ' ' A' ' 107' ' ' ILE . 14.4 t -55.59 132.1 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -0.936 . . . . 0.0 110.444 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 80.33 19.57 68.83 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -79.87 146.84 31.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -1.143 . . . . 0.0 110.022 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -90.88 126.05 35.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 110.28 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.8 p -86.7 154.38 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 110.103 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.61 -2.0 33.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 110.219 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.858 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.91 170.99 10.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.897 . . . . 0.0 109.681 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.26 145.78 26.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.1 t -120.88 140.53 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.925 . . . . 0.0 109.902 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.606 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 22.7 m-85 -90.0 -167.59 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.956 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.49 -145.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 110.804 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 35.6 p30 -43.91 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 111.177 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 12.5 tt0 -118.58 145.34 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.733 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.0 m -78.73 130.01 35.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 110.353 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.834 HD12 ' N ' ' A' ' 126' ' ' MET . 1.1 tp -60.86 131.99 52.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.855 . . . . 0.0 109.731 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.834 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -119.36 154.99 54.28 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.259 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.835 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.6 Cg_endo -73.83 -28.55 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.012 1.533 . . . . 0.0 110.481 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.41 -2.23 55.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -29.22 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 110.283 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 131' ' ' LYS . 48.2 t -92.92 171.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -84.21 -65.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.232 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.42 75.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.74 ' CE1' HD13 ' A' ' 102' ' ' ILE . 56.3 t80 -68.16 161.87 26.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.223 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.354 0.597 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.61 167.99 11.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.389 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.05 141.98 38.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.23 153.05 24.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.36 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.16 99.28 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG21 ' CG2' ' A' ' 27' ' ' VAL . 2.8 t -114.69 109.78 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -52.59 125.57 16.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.922 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' O ' HD23 ' A' ' 51' ' ' LEU . 7.7 t-20 -82.54 -39.22 22.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 110.059 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.94 -179.7 5.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -89.98 132.1 35.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.055 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.961 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.8 mt -114.47 133.01 22.55 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.61 -160.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.977 1.514 . . . . 0.0 110.393 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -98.21 154.75 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.038 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 55.01 58.88 4.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 55.6 m -138.61 125.93 21.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -74.27 111.76 9.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.961 ' CD2' HD13 ' A' ' 11' ' ' ILE . 74.8 mt -50.28 149.99 2.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 110.639 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 21' ' ' MET . 25.0 p -120.49 161.22 21.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.414 -0.803 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.0 mm? -57.26 -26.95 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 110.212 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -65.98 -57.08 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.698 ' SD ' HD23 ' A' ' 17' ' ' LEU . 24.3 ptp -77.29 3.81 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 110.318 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -93.32 99.84 12.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 110.317 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.14 110.86 21.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.104 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.665 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -83.24 83.69 7.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.393 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -103.38 154.24 19.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.151 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 26' ' ' VAL . 92.0 t -83.23 72.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.255 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.765 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.3 m -124.24 169.95 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -106.44 165.89 12.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' HG21 ' A' ' 54' ' ' THR . 47.1 Cg_endo -74.41 168.85 75.74 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.583 -2.257 . . . . 0.0 110.44 -0.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 84.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.08 -149.64 3.4 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD12 ' A' ' 55' ' ' LEU . 7.2 mt -74.79 135.59 74.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.98 173.81 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.913 1.48 . . . . 0.0 110.485 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 14.08 11.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.862 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -61.48 -48.8 79.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.672 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.9 mm-40 -94.76 32.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.86 . . . . 0.0 109.739 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mm -41.21 -51.06 8.21 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.5 Cg_endo -70.21 -8.3 23.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.598 1.315 . . . . 0.0 110.832 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.21 -39.86 6.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 0.0 109.87 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.672 HD23 ' CB ' ' A' ' 36' ' ' GLU . 4.0 mm? -80.44 -37.92 31.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.8 t -46.62 156.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.0 . . . . 0.0 110.635 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.578 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.67 8.13 38.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.788 ' CG ' HD12 ' A' ' 17' ' ' LEU . 6.7 ptp -70.42 151.73 44.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.437 . . . . 0.0 109.896 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.18 130.96 46.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.058 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 13' ' ' ILE . 23.4 m -85.55 160.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HG2' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -98.44 -5.35 32.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' C ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -147.48 173.7 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.321 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.93 146.81 54.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.61 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -117.69 124.79 28.56 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.007 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.8 -176.56 2.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.857 1.451 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -80.26 132.09 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 74.72 36.37 48.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.61 HG21 HG13 ' A' ' 49' ' ' VAL . 11.0 m -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -1.19 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.623 HG21 ' HD2' ' A' ' 29' ' ' PRO . 3.7 t -74.62 163.17 28.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.747 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -77.68 90.93 4.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.302 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.458 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 9.0 mtm -85.72 120.99 73.32 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.307 -0.871 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.68 -34.24 5.73 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.854 1.449 . . . . 0.0 110.494 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' MET . 36.1 p30 -61.76 -23.81 66.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.354 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -98.26 4.17 48.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 63' ' ' TYR . 24.9 t -120.01 142.24 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 15.9 mmtt -70.04 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.99 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . 38.1 t-20 -90.83 71.67 6.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.986 -1.071 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.649 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.7 p90 -53.75 -38.69 64.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.138 -0.976 . . . . 0.0 110.297 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' CD ' HD21 ' A' ' 40' ' ' LEU . 1.9 pt-20 179.82 -173.99 0.24 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.159 -0.963 . . . . 0.0 110.359 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -86.49 48.49 1.64 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.383 -0.823 . . . . 0.0 110.054 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.83 23.77 28.59 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.529 HG21 ' OE1' ' A' ' 95' ' ' GLU . 4.8 p -79.21 142.27 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -1.163 . . . . 0.0 110.068 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.432 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 13.6 p -82.49 -99.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.184 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -85.0 141.77 38.06 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.022 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 41.2 Cg_endo -71.47 -78.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.992 1.522 . . . . 0.0 110.204 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.31 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD13 ' HZ2' ' A' ' 100' ' ' LYS . 8.9 mt -87.66 45.84 1.32 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.393 -1.063 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 2.3 pttt -68.16 122.14 17.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.657 -0.652 . . . . 0.0 110.082 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -131.27 162.37 30.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.605 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 102' ' ' ILE . 47.4 t -76.83 136.13 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.368 -0.832 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG21 HG11 ' A' ' 97' ' ' VAL . 18.1 t -127.1 129.16 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -71.91 92.95 1.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.014 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.577 ' O ' HD13 ' A' ' 121' ' ' LEU . 49.6 t30 -57.53 -36.25 71.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 0.0 110.894 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.3 mt-30 -110.3 -171.79 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.072 -1.017 . . . . 0.0 110.449 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.57 151.08 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.222 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 85' ' ' THR . 12.1 mt -120.79 112.2 33.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.328 -0.858 . . . . 0.0 110.321 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 83' ' ' ILE . 50.6 Cg_endo -80.65 59.72 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.846 1.445 . . . . 0.0 111.196 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.909 HD13 ' N ' ' A' ' 118' ' ' ALA . 6.0 mm 58.08 141.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 110.625 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 84.9 m-20 40.79 86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 110.843 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 87' ' ' LEU . 4.4 m -144.11 104.31 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.855 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.99 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.181 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -93.1 140.46 29.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.709 HG22 ' CA ' ' A' ' 112' ' ' GLY . 67.2 p -128.18 -167.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -0.821 . . . . 0.0 109.92 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.18 -32.5 4.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.07 -62.63 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 mtp -68.94 -21.07 64.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.192 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.501 ' SD ' HG11 ' A' ' 75' ' ' VAL . 3.6 mtm -105.59 115.28 29.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 12.0 mttm -111.55 107.17 16.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -85.13 101.18 12.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.075 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -122.55 -173.23 2.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.118 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 6.2 mt-10 -85.03 83.4 8.06 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.242 -0.911 . . . . 0.0 109.791 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.863 HG11 HG21 ' A' ' 76' ' ' VAL . 9.9 p -147.01 157.32 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.056 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.502 ' CB ' ' HA ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -109.91 170.01 5.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.709 -0.619 . . . . 0.0 110.017 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -75.05 171.97 65.4 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.485 -2.298 . . . . 0.0 110.257 -0.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.604 ' HZ2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -73.54 73.53 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.33 -100.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.8 mt -109.36 113.2 58.72 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 102' ' ' ILE . 44.5 Cg_endo -71.22 164.33 36.1 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.942 1.496 . . . . 0.0 110.492 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 5.2 p -82.08 46.01 0.98 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -87.69 -50.27 6.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 110.131 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 109' ' ' LYS . 54.1 mt-10 -110.8 8.58 22.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 110.243 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.967 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.3 mm -53.62 -48.42 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.881 . . . . 0.0 110.144 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.55 -21.4 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 2.0 mttp -95.45 -35.46 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.366 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.65 HD21 ' CG ' ' A' ' 134' ' ' GLU . 17.7 mt -93.7 8.63 40.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.7 t -65.24 140.73 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.709 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 74.86 10.67 83.69 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -73.47 156.78 37.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.792 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 123.9 44.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.668 HG23 HG12 ' A' ' 130' ' ' VAL . 5.1 p -87.66 163.73 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.461 -0.775 . . . . 0.0 110.272 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . 4.2 m120 -101.97 -21.42 14.51 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.442 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.5 ttp180 -116.82 160.04 21.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.909 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -86.54 162.21 18.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.998 -1.064 . . . . 0.0 110.86 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 120' ' ' TYR . 39.8 t -128.72 172.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.756 . . . . 0.0 109.575 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.588 ' N ' HG12 ' A' ' 119' ' ' VAL . 2.4 m-85 -102.23 -170.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 110.372 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.62 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -47.08 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.465 -0.772 . . . . 0.0 111.373 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.1 tp60 -119.07 162.6 18.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.755 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -74.93 119.2 18.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.964 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 126' ' ' MET . 0.3 OUTLIER -75.38 132.02 40.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 -179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.979 ' N ' HD12 ' A' ' 125' ' ' LEU . 35.0 mtp -126.84 157.62 71.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 110.043 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD3' HG13 ' A' ' 102' ' ' ILE . 51.3 Cg_endo -78.64 -22.66 8.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.888 1.468 . . . . 0.0 110.707 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -70.49 -23.86 62.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.131 -0.981 . . . . 0.0 110.367 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mtt -84.59 -40.37 17.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.187 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.668 HG12 HG23 ' A' ' 115' ' ' VAL . 27.1 m -90.87 99.07 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 110.387 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.46 4.47 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 0.0 110.329 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -94.43 36.05 1.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.25 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -75.37 124.9 27.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.281 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.65 ' CG ' HD21 ' A' ' 110' ' ' LEU . 2.6 pp20? . . . . . 0 C--N 1.299 -1.611 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.18 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.293 0.568 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -80.76 173.68 12.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -75.31 142.49 43.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.9 t -117.5 169.37 9.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 110.223 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.76 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.8 t -84.71 93.12 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 110.562 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.711 HG21 ' CG2' ' A' ' 27' ' ' VAL . 11.3 t -105.74 109.74 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.774 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.25 130.05 29.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.468 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.857 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.7 t-20 -83.1 -44.06 15.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.278 -0.888 . . . . 0.0 110.003 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.2 pt20 -93.03 176.16 6.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.5 tt -89.74 131.15 35.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.345 -0.847 . . . . 0.0 109.588 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 17.8 mm -109.55 138.39 20.58 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 0.0 110.78 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.449 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.6 Cg_endo -73.36 -162.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.085 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.3 mp -85.81 159.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.323 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 13' ' ' ILE . 9.8 p30 36.68 67.81 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.712 -0.618 . . . . 0.0 110.622 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 17.9 m -129.82 129.19 43.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.389 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.35 112.64 9.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.832 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 30.7 mt -62.84 149.05 45.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.2 p -120.8 166.6 13.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.0 110.008 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.603 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -65.71 -40.03 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.246 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -83.31 6.15 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.76 ' HG2' HG13 ' A' ' 5' ' ' VAL . 3.9 mtt -114.0 119.63 37.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -0.884 . . . . 0.0 110.427 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.15 117.34 32.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.9 68.05 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.12 150.5 23.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 3' ' ' ALA . 97.7 t -86.9 96.84 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.711 ' CG2' HG21 ' A' ' 6' ' ' VAL . 10.0 m -141.68 164.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 9.1 t -101.35 149.53 36.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.08 160.34 95.73 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.515 -0.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.18 76.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -56.0 -162.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 55' ' ' LEU . 5.3 mt -61.8 133.61 93.75 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.49 173.38 13.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.028 1.541 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -86.24 20.85 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.449 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -67.07 -46.35 74.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' ILE . 63.2 mm-40 -94.97 27.39 3.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 41' ' ' VAL . 4.1 mm -42.07 -57.45 4.26 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.493 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -69.39 -4.2 13.31 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.555 1.292 . . . . 0.0 110.934 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.8 OUTLIER -104.51 -46.85 4.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 0.0 110.721 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 3.4 tt -92.05 2.31 56.65 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -67.77 150.36 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.905 -1.122 . . . . 0.0 110.613 -179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 65.5 6.23 27.22 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 4.2 mmt -72.26 135.91 46.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.712 -1.464 . . . . 0.0 110.014 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' THR . 2.0 mt-30 -81.89 155.5 25.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.638 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.2 m -106.82 167.61 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.422 -0.799 . . . . 0.0 110.27 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -24.88 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 -179.5 5.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.09 152.37 36.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.262 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 53' ' ' THR . 6.5 t -120.22 133.14 23.93 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' HA ' HD12 ' A' ' 10' ' ' LEU . 45.7 Cg_endo -72.24 -173.11 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.936 1.493 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.82 149.24 28.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.23 35.25 77.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.005 HG21 HG13 ' A' ' 49' ' ' VAL . 60.4 m -86.54 130.93 34.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -1.2 . . . . 0.0 110.271 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.0 t -74.25 155.94 37.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.137 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.39 93.72 2.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.313 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.3 ttt -86.51 130.37 49.52 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.95 -19.75 20.28 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.985 1.518 . . . . 0.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -79.51 -17.73 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.948 . . . . 0.0 110.374 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.1 mtt -99.94 0.48 41.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.745 HG11 ' HB3' ' A' ' 63' ' ' TYR . 4.7 t -120.05 133.35 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -71.15 -85.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -91.9 62.31 4.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.179 -0.951 . . . . 0.0 111.018 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -53.84 -99.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.922 -1.112 . . . . 0.0 109.984 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' OE1' HG21 ' A' ' 32' ' ' ILE . 5.3 pt-20 -132.88 -164.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.876 -1.14 . . . . 0.0 110.492 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.92 54.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.398 -0.814 . . . . 0.0 110.243 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.59 -21.97 77.82 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.6 p -84.3 162.79 19.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -1.124 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 69' ' ' SER . 48.4 m -106.19 -90.2 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 68' ' ' THR . 2.2 t -79.91 130.04 68.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.928 . . . . 0.0 110.29 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.542 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.1 Cg_endo -73.54 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.485 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.29 -73.09 0.58 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.2 mt -86.78 53.1 2.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -1.109 . . . . 0.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 3.7 mttt -68.91 116.46 9.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.532 -0.73 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -96.47 159.98 14.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.785 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG13 ' SD ' ' A' ' 92' ' ' MET . 58.3 t -78.44 127.16 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 97' ' ' VAL . 94.9 t -124.0 132.61 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.321 -0.862 . . . . 0.0 110.354 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.36 94.28 3.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 t30 -57.47 -33.9 68.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.853 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -169.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.339 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.5 tt -102.03 129.56 48.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 110.152 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.675 HG23 HG21 ' A' ' 85' ' ' THR . 29.2 mm -120.79 122.77 28.29 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.868 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 83' ' ' ILE . 47.1 Cg_endo -72.82 153.8 53.5 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.775 1.408 . . . . 0.0 110.673 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.606 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -43.4 150.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.873 . . . . 0.0 110.316 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 83' ' ' ILE . 78.1 m-20 51.27 71.44 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.527 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.675 HG21 HG23 ' A' ' 81' ' ' ILE . 43.4 m -143.68 105.73 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.074 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.73 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -88.04 142.65 27.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.74 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.8 OUTLIER -122.64 -178.47 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 110.195 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.67 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -54.81 -27.6 43.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 110.328 -179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.71 HG23 ' H ' ' A' ' 91' ' ' MET . 2.7 m -53.82 -61.92 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.922 . . . . 0.0 110.558 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.71 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 mpp? -82.72 5.78 20.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.912 -1.117 . . . . 0.0 109.922 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.566 ' SD ' HG13 ' A' ' 75' ' ' VAL . 3.2 ttp -105.72 129.5 53.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.687 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 10.3 mttt -122.15 90.64 3.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -69.87 93.12 0.73 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -123.31 159.51 28.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -72.86 93.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.367 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 76' ' ' VAL . 10.0 p -139.74 163.83 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.32 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -109.35 155.49 41.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.188 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.6 Cg_endo -75.49 176.35 43.96 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.65 -2.229 . . . . 0.0 110.585 -0.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 80.74 5.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.07 -100.54 0.05 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 18.0 mt -109.19 119.47 48.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.167 -1.196 . . . . 0.0 110.356 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 45.9 Cg_endo -73.0 173.29 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.948 1.499 . . . . 0.0 110.606 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.0 m -82.67 51.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.397 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 28.6 mm-40 -80.74 -74.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.181 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.36 17.03 16.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.073 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.4 tp -58.1 -36.16 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.31 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 107' ' ' ILE . 8.1 t -56.8 -26.81 58.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.273 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -95.12 -22.49 17.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 110.227 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 113' ' ' MET . 15.5 mt -102.01 8.52 40.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.174 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.1 t -62.99 135.9 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 110.146 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.74 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 79.46 14.03 81.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -76.68 149.0 36.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.135 . . . . 0.0 110.207 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.64 131.51 34.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.193 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.865 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -86.98 156.79 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.27 -6.19 26.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 110.154 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.865 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -123.13 173.98 7.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.3 -0.875 . . . . 0.0 110.264 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.64 152.46 23.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 19.9 t -131.05 136.6 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 86.1 m-85 -94.59 -166.86 1.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 0.0 110.604 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -58.33 -147.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.993 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.58 84.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.553 -0.717 . . . . 0.0 111.517 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 121' ' ' LEU . 6.4 tt0 -118.85 153.52 34.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.773 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.445 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 50.1 m -78.84 145.9 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 126' ' ' MET . 2.3 tp -76.5 126.83 31.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.731 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -123.27 140.85 34.63 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.71 -18.03 22.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 22.2 p30 -70.43 -15.41 62.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.328 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 3.4 mtt -99.01 -47.34 5.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.251 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 t -73.77 103.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 0.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -80.37 -2.32 44.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.163 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -107.22 2.6 24.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.423 ' OH ' HG23 ' A' ' 102' ' ' ILE . 13.3 t80 -64.36 140.08 58.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.209 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.4 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.183 0.516 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.43 -178.93 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.607 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -76.98 141.46 40.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 110.275 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -107.05 -179.47 3.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG13 ' HG3' ' A' ' 22' ' ' MET . 80.1 t -84.73 101.77 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.423 -0.798 . . . . 0.0 110.399 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.3 t -118.45 115.69 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 0.0 110.051 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -59.26 126.0 25.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.072 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.716 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.93 -39.44 21.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.508 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 1.0 OUTLIER -92.16 174.36 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.106 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -88.56 141.18 28.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.77 179.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 5.4 mt -120.11 137.09 25.51 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.595 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.8 Cg_endo -74.77 -162.55 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.087 1.572 . . . . 0.0 110.151 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 48' ' ' ALA . 2.0 mp -89.1 161.72 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.0 p30 36.86 70.53 0.17 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.617 -0.677 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.461 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 42.1 m -135.41 129.33 33.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 110.243 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.59 113.02 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.932 . . . . 0.0 110.06 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.4 mt -59.87 147.77 37.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.066 -1.022 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' MET . 44.8 p -120.92 175.25 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.32 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 19' ' ' LEU . 4.0 mm? -65.3 -36.98 85.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.8 mp -70.97 -38.81 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.082 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.508 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 2.2 ttm -75.01 -3.72 34.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.085 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.551 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -112.77 114.57 27.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.2 142.9 42.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -94.09 76.65 4.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.06 149.34 24.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.217 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG22 ' CA ' ' A' ' 3' ' ' ALA . 13.2 t -88.54 100.16 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.584 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.9 m -151.98 148.97 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.479 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -96.34 168.39 10.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.9 Cg_endo -73.97 161.03 95.17 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.395 -0.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.438 ' CG ' ' O ' ' A' ' 30' ' ' MET . 3.5 ptm -69.06 92.68 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 110.383 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.19 -115.59 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD12 HD12 ' A' ' 55' ' ' LEU . 8.2 mt -99.62 124.86 42.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.247 -1.149 . . . . 0.0 110.141 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 47.2 Cg_endo -73.43 -172.24 1.0 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.864 1.455 . . . . 0.0 110.271 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -89.08 24.94 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 2.2 mm-40 -67.12 -72.57 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 111.111 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -87.98 22.04 2.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 111.209 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -46.42 -54.99 15.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 110.201 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 39.9 Cg_endo -67.07 -5.81 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.575 1.302 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.5 m-80 -97.55 -54.41 3.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.755 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' MET . 1.3 pt? -92.15 13.88 17.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -68.66 152.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.653 -1.279 . . . . 0.0 109.687 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.36 1.43 43.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.567 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 81.4 mmm -71.69 144.88 49.18 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.708 -1.466 . . . . 0.0 109.537 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 77.8 mt-30 -82.64 144.1 30.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.0 110.837 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 45' ' ' VAL . 19.4 m -93.51 162.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.53 -13.45 51.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.889 . . . . 0.0 110.474 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD2' ' SD ' ' A' ' 59' ' ' MET . 8.4 ptp85 -152.66 161.37 42.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 13' ' ' ILE . . . -64.66 141.95 58.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 53' ' ' THR . 95.8 t -109.81 139.59 21.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.164 -0.96 . . . . 0.0 110.399 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.3 Cg_endo -72.31 -171.87 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.036 1.545 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -84.86 148.09 26.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.02 31.32 64.88 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 49' ' ' VAL . 2.9 m -86.56 119.47 26.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -1.158 . . . . 0.0 110.134 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 8.9 t -58.73 161.37 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.82 96.94 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.209 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 tpt -93.64 120.26 66.37 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.206 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.36 -10.04 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.914 1.481 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.12 -22.71 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 110.384 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 47' ' ' ARG . 20.7 mtt -103.36 8.31 38.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.084 -1.01 . . . . 0.0 110.385 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 61' ' ' LYS . 84.0 t -120.16 135.98 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 0.5 OUTLIER -55.97 -165.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 110.145 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -71.92 77.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.084 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 110.306 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 40' ' ' LEU . 16.0 mm-40 -107.91 -141.36 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.991 -1.068 . . . . 0.0 110.29 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.23 54.39 2.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.26 -7.64 69.57 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -92.97 166.61 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.115 -1.226 . . . . 0.0 110.24 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.9 p -77.45 -138.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 t -64.47 144.55 98.59 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.1 -1.0 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.547 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 46.0 Cg_endo -73.19 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.045 1.55 . . . . 0.0 110.518 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.17 1.34 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 72' ' ' LEU . 11.6 mt -87.89 57.33 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 109.641 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 30.6 mtpt -72.07 120.13 17.24 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.523 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.8 p -107.65 161.0 15.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.763 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.73 ' HB ' HD23 ' A' ' 125' ' ' LEU . 7.1 t -74.06 133.89 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 97' ' ' VAL . 40.5 t -132.67 140.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.02 100.1 6.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.0 t-20 -57.48 -42.65 83.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 110.805 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.45 175.76 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.998 . . . . 0.0 110.395 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 80' ' ' LEU . 3.4 tt -102.2 127.55 49.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 110.189 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.582 ' HB ' HG21 ' A' ' 85' ' ' THR . 26.8 pt -122.11 146.27 46.16 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 110.119 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.2 Cg_endo -73.44 150.26 46.03 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.043 1.549 . . . . 0.0 110.293 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -38.46 150.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 83' ' ' ILE . 34.9 m120 58.11 75.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.332 -0.855 . . . . 0.0 110.727 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.632 ' O ' HD23 ' A' ' 87' ' ' LEU . 38.2 m -143.55 108.69 4.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.33 87.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.239 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -83.7 144.6 29.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.692 HG22 ' CA ' ' A' ' 112' ' ' GLY . 66.6 p -130.64 -175.17 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.27 -25.07 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.316 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 91' ' ' MET . 41.3 t -58.0 -63.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.447 ' HG3' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -82.33 -5.61 58.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.867 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.0 mtm -105.37 106.47 16.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.75 113.63 26.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.865 . . . . 0.0 110.256 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.52 98.35 2.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.9 pt-20 -123.79 159.49 29.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 110.08 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 6.9 tm-20 -69.2 102.49 1.7 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.347 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.039 HG21 HG21 ' A' ' 76' ' ' VAL . 3.0 t -129.46 128.04 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 24.3 p -109.99 136.69 20.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.435 -0.791 . . . . 0.0 110.126 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.3 Cg_endo -74.15 149.2 93.62 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.774 -2.178 . . . . 0.0 110.106 -0.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 23.3 pttm -73.38 127.54 32.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.256 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -82.79 -96.69 0.53 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.962 HD11 ' HA ' ' A' ' 127' ' ' PRO . 14.2 mt -109.19 124.68 33.36 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.127 -1.219 . . . . 0.0 109.814 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.44 158.7 50.78 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.858 1.452 . . . . 0.0 110.583 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.4 p -79.41 50.44 1.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 110.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.55 -58.75 2.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.094 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -105.21 17.03 24.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 110.011 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.867 HD11 ' SD ' ' A' ' 92' ' ' MET . 4.3 tp -48.79 -43.68 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.586 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.7 t -47.16 -40.49 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -77.84 -25.38 48.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 110.288 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.459 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 45.5 mt -101.7 3.76 39.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.522 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 107' ' ' ILE . 11.6 t -65.25 137.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.965 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.692 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 67.77 19.0 70.96 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 130' ' ' VAL . 4.7 ptt? -80.48 150.27 29.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -1.15 . . . . 0.0 110.051 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -88.21 124.49 33.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.216 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.933 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -83.76 152.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' OD1' ' HE2' ' A' ' 131' ' ' LYS . 3.3 t30 -100.28 2.88 43.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.933 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -124.56 170.97 10.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.43 139.48 30.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 24.8 t -119.07 137.98 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.324 -0.86 . . . . 0.0 109.956 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 22.2 m-85 -99.9 -164.5 1.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 110.93 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER -58.04 -149.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 0.0 110.77 -179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.6 p30 -44.6 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 111.317 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.7 tp60 -118.64 149.0 42.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.639 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.2 OUTLIER -76.99 127.94 33.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.114 -0.991 . . . . 0.0 110.258 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.73 HD23 ' HB ' ' A' ' 75' ' ' VAL . 2.8 tp -67.56 132.09 46.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.671 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -119.55 161.03 39.59 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.962 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.2 Cg_endo -73.42 -24.57 16.25 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.983 1.518 . . . . 0.0 110.415 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.03 7.12 9.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.229 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -99.0 -22.26 15.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 113' ' ' MET . 45.7 t -88.14 161.22 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.242 -0.911 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -73.24 -79.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.79 . . . . 0.0 110.365 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -102.63 77.52 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 102' ' ' ILE . 40.2 t80 -64.53 151.0 45.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.222 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.161 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.254 0.549 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 65.0 mmtt -75.94 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.33 148.12 43.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 159.19 15.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.832 HG13 ' HG2' ' A' ' 22' ' ' MET . 42.9 t -83.52 93.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 54' ' ' THR . 5.2 t -111.06 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.153 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.87 129.56 30.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.663 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.8 p-10 -82.78 -41.38 19.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.95 . . . . 0.0 110.167 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.492 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.7 pt20 -91.77 179.86 5.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -89.8 145.79 24.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.908 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.021 HD13 HD21 ' A' ' 17' ' ' LEU . 18.6 mt -120.01 125.19 27.46 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.421 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.6 Cg_endo -73.18 -160.91 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.882 1.464 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 48' ' ' ALA . 6.1 mm -89.33 146.65 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 51.94 67.27 0.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 110.535 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.8 m -142.44 132.84 25.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -0.946 . . . . 0.0 110.402 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.13 151.36 29.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.021 HD21 HD13 ' A' ' 11' ' ' ILE . 56.0 mt -102.25 151.8 21.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 0.0 110.358 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' MET . 20.4 p -120.31 -179.13 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.22 -43.96 92.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.29 -42.31 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.492 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 2.3 ttm -69.15 -6.62 29.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.237 -0.915 . . . . 0.0 110.229 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.87 ' HE3' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.85 123.82 50.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.371 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -111.09 119.66 39.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.28 64.75 3.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.14 150.47 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG22 ' CA ' ' A' ' 3' ' ' ALA . 17.5 t -83.26 80.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.16 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.39 175.65 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.935 . . . . 0.0 110.313 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 17.5 p -106.59 160.88 24.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.094 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 48.3 Cg_endo -75.52 -179.19 25.97 Favored 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.661 -2.224 . . . . 0.0 110.511 -0.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.5 mmm -72.58 -168.95 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.05 -162.15 33.43 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 55' ' ' LEU . 8.6 mt -70.33 129.96 89.85 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.26 -1.141 . . . . 0.0 110.114 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' C ' HG23 ' A' ' 5' ' ' VAL . 45.3 Cg_endo -72.03 179.88 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.968 1.509 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.81 17.66 8.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 110.434 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -66.74 -44.77 80.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.604 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.5 pt-20 -94.62 22.31 6.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.359 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.696 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.2 mm -41.33 -55.57 5.15 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.845 . . . . 0.0 111.132 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -68.45 -1.69 7.82 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.552 1.29 . . . . 0.0 111.35 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 92.6 m-20 -102.5 -59.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.028 -1.045 . . . . 0.0 110.467 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -84.64 2.28 42.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 111.28 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -56.03 147.09 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.738 -1.226 . . . . 0.0 109.914 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 68.46 16.65 69.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.67 ' HE2' HG11 ' A' ' 60' ' ' VAL . 1.6 ptp -69.92 151.77 45.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.017 -1.284 . . . . 0.0 109.879 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 15' ' ' THR . 5.6 mt-30 -100.36 147.39 25.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.35 -0.844 . . . . 0.0 110.434 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' VAL . 30.2 m -100.37 164.33 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -98.83 -11.3 21.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.361 -0.837 . . . . 0.0 110.099 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -143.39 179.24 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.334 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.41 139.46 42.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.201 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG13 HG21 ' A' ' 53' ' ' THR . 6.7 t -114.21 129.38 24.9 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.058 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.36 179.26 4.7 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.961 1.506 . . . . 0.0 110.597 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -77.95 132.74 38.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 110.482 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.08 32.13 50.11 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.739 HG21 HG13 ' A' ' 49' ' ' VAL . 19.0 m -86.69 117.4 25.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -1.199 . . . . 0.0 110.233 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.517 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.4 t -58.66 155.93 11.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -71.95 101.06 2.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.235 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 40.3 mtt -91.51 141.25 25.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.519 ' CB ' ' OH ' ' A' ' 63' ' ' TYR . 46.7 Cg_endo -73.19 -47.66 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -67.33 -9.91 45.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -0.919 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 30.1 mtp -89.84 -27.45 19.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.67 HG11 ' HE2' ' A' ' 43' ' ' MET . 11.4 t -112.05 159.07 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.437 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -70.41 -154.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.859 . . . . 0.0 110.133 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.737 ' HB3' HG11 ' A' ' 97' ' ' VAL . 3.9 m120 -71.23 82.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.22 -0.925 . . . . 0.0 110.354 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.532 ' HB3' ' CE ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -53.69 -100.36 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.237 -0.914 . . . . 0.0 109.825 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 39' ' ' ASN . 24.5 mm-40 -116.78 -152.37 0.5 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.855 -1.153 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -71.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.921 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.37 -46.43 3.21 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.49 167.52 11.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.337 -1.096 . . . . 0.0 110.356 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' SER . 1.8 t -67.23 -114.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 48.1 m -64.41 140.85 98.07 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.738 -1.226 . . . . 0.0 110.124 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 45.3 Cg_endo -73.59 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.037 1.546 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.29 -80.77 1.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.98 52.41 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 109.678 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.15 130.88 35.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.75 . . . . 0.0 110.713 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -102.91 154.27 19.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.813 . . . . 0.0 109.611 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.83 ' HB ' HD23 ' A' ' 125' ' ' LEU . 5.0 t -64.35 133.1 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.043 -1.036 . . . . 0.0 110.163 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 74' ' ' SER . 14.1 t -135.09 134.17 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.0 85.05 3.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 109.885 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 35.2 t30 -56.97 -29.02 62.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.698 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -110.05 -177.84 3.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.036 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.033 HD12 HD23 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -97.3 125.98 42.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 110.222 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 42.3 mt -116.88 123.75 29.96 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.83 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.25 153.32 56.45 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.891 1.469 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.8 mt -45.04 149.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.259 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 83' ' ' ILE . 31.2 m-20 52.96 72.88 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.52 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 81' ' ' ILE . 55.0 m -143.65 104.27 4.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.097 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.86 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -85.28 143.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.582 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.6 p -125.6 174.74 8.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.975 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' CG1' ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.69 -31.94 5.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.433 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 91' ' ' MET . 4.2 m -61.92 -42.09 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.126 -0.984 . . . . 0.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.578 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -84.68 -27.5 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.295 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.77 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.7 mtm -93.65 125.04 38.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 110.189 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -116.67 107.34 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 110.362 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.8 100.59 7.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 mm-40 -116.53 168.25 10.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.133 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -87.02 84.0 7.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 110.155 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.737 HG11 ' HB3' ' A' ' 62' ' ' ASN . 9.5 p -141.97 166.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.15 159.92 29.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.97 173.87 55.81 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.437 -0.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -85.78 96.51 9.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -113.4 0.12 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 133' ' ' TYR . 24.0 mt -109.31 131.25 21.95 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.15 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.42 151.91 48.57 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.885 1.466 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 6.5 t -78.87 54.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.903 . . . . 0.0 110.052 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.58 -46.86 9.18 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -104.07 4.43 34.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.428 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.925 ' O ' HG23 ' A' ' 111' ' ' VAL . 10.1 mm -54.17 -46.05 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.02 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t -44.29 -28.75 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.304 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.15 -30.25 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.305 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 113' ' ' MET . 16.7 mt -98.95 12.94 34.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 107' ' ' ILE . 37.4 t -59.33 131.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.43 20.81 74.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.2 ptm -73.85 148.67 42.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.108 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.46 124.2 34.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.923 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.44 151.88 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.201 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -100.43 0.9 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.159 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.923 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -121.98 165.07 16.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.6 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.31 146.82 30.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 18.6 t -123.21 136.43 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.95 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 121' ' ' LEU . 3.1 m-85 -94.12 -168.13 1.81 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.609 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.033 HD23 HD12 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -58.81 -147.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -44.23 85.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.351 -0.843 . . . . 0.0 111.276 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -118.58 146.38 44.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.75 . . . . 0.0 109.763 179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -72.26 140.51 48.67 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.068 -1.02 . . . . 0.0 110.539 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tp -80.97 127.15 32.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.829 ' N ' HD12 ' A' ' 125' ' ' LEU . 15.5 mtp -126.67 150.78 72.01 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.675 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -73.36 -19.52 22.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.033 1.544 . . . . 0.0 110.33 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -0.02 29.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -94.43 -21.32 19.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.208 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 131' ' ' LYS . 48.5 t -92.77 168.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' N ' HG12 ' A' ' 130' ' ' VAL . 17.6 mtpt -75.59 -82.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 110.134 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.89 82.58 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -68.34 159.15 31.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.325 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.257 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.265 0.555 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.71 -178.18 4.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.276 -0.89 . . . . 0.0 110.266 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.86 151.81 33.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -114.96 169.95 8.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.868 . . . . 0.0 110.137 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 22' ' ' MET . 98.2 t -84.56 95.77 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.929 . . . . 0.0 110.394 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -116.52 114.09 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.801 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.33 127.84 23.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.278 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 23' ' ' LYS . 11.2 p-10 -82.85 -42.22 18.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.322 -0.861 . . . . 0.0 109.867 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.2 pt20 -92.63 -178.53 4.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -89.46 141.03 28.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 109.682 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.77 HD13 ' CD2' ' A' ' 17' ' ' LEU . 11.4 mt -113.11 136.96 21.78 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.953 . . . . 0.0 110.727 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.2 Cg_endo -75.46 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.078 1.567 . . . . 0.0 110.255 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 14' ' ' ASN . 2.4 mp -100.32 160.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.241 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 13' ' ' ILE . 14.5 p30 36.43 64.99 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.659 -0.651 . . . . 0.0 110.858 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.477 ' H ' HG22 ' A' ' 45' ' ' VAL . 41.0 m -138.83 137.38 36.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -73.16 106.55 5.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.964 . . . . 0.0 110.128 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.77 ' CD2' HD13 ' A' ' 11' ' ' ILE . 1.9 mt -52.51 154.12 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.278 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.416 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 46.2 p -119.04 163.94 16.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 19' ' ' LEU . 1.1 mt -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.18 -44.72 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 38.2 mtp -67.42 -18.58 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.448 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -94.62 114.38 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 110.401 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' CD ' ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.44 136.41 50.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.178 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -87.03 74.6 9.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.212 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -98.02 145.88 26.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.0 110.225 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.07 81.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 6' ' ' VAL . 14.0 m -131.36 165.69 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -108.89 160.15 28.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.144 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.7 Cg_endo -75.22 159.29 97.98 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.666 -2.222 . . . . 0.0 110.444 -0.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -71.79 76.24 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.81 -141.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 55' ' ' LEU . 5.2 mt -73.98 131.95 80.66 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.146 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.42 -176.54 2.54 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.951 1.5 . . . . 0.0 110.439 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -95.81 26.25 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.82 -53.39 33.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 110.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 5.1 mm-40 -95.05 31.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.044 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.548 HG12 ' CA ' ' A' ' 34' ' ' ALA . 2.2 mm -42.03 -55.3 6.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.375 -0.828 . . . . 0.0 110.553 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.0 Cg_endo -70.37 -3.85 13.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.669 1.352 . . . . 0.0 110.582 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 1.1 t-20 -104.14 -42.34 5.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.1 tt -89.91 -7.2 54.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -68.33 150.97 10.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.83 -1.169 . . . . 0.0 110.561 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.37 3.86 27.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 6.8 mmm -70.35 145.94 50.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.832 -1.393 . . . . 0.0 109.987 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.527 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 5.0 mt-30 -79.94 145.82 32.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.469 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 15' ' ' THR . 27.6 m -103.56 166.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.66 -13.21 20.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.341 -0.849 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.24 154.6 32.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.64 58.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.708 HG13 HG21 ' A' ' 53' ' ' THR . 18.7 t -114.31 144.5 31.84 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 49' ' ' VAL . 43.6 Cg_endo -70.77 -170.47 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.896 1.472 . . . . 0.0 110.557 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -87.54 149.31 24.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.546 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 59.74 27.56 64.25 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 HG13 ' A' ' 49' ' ' VAL . 1.9 m -84.38 118.64 24.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 110.048 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.812 ' CA ' HG13 ' A' ' 6' ' ' VAL . 11.5 t -59.46 160.5 6.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 110.128 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.705 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.96 93.4 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 153.0 46.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.113 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.38 -46.76 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.999 1.526 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.1 -19.77 62.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.7 mtt -85.99 -24.9 26.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.593 HG21 ' CD1' ' A' ' 55' ' ' LEU . 26.9 t -108.48 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.158 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -60.84 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' O ' ' HE3' ' A' ' 43' ' ' MET . 0.4 OUTLIER -90.42 89.76 7.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.1 -56.39 18.57 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.467 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.2 OUTLIER 174.99 165.57 0.27 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 110.163 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -85.44 44.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 110.201 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.75 15.44 60.52 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 96' ' ' GLU . 18.0 p -74.04 156.02 37.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.183 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.8 m -107.46 -78.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -76.4 120.19 80.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.258 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HA ' ' HG2' ' A' ' 96' ' ' GLU . 46.1 Cg_endo -72.97 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.919 1.484 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.43 -77.29 0.26 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -87.59 52.59 2.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -1.179 . . . . 0.0 110.022 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 4.7 pttt -69.24 114.59 7.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -0.762 . . . . 0.0 110.219 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -98.02 161.1 13.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.954 HG13 ' SD ' ' A' ' 92' ' ' MET . 9.3 t -84.56 124.73 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 124' ' ' THR . 88.4 t -126.72 134.12 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.49 98.57 8.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.673 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 t-20 -62.39 -23.87 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -110.29 -177.87 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.131 -0.98 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.976 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.2 tm? -88.37 136.1 33.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.976 ' N ' HD13 ' A' ' 80' ' ' LEU . 35.3 mm -123.39 112.17 29.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.479 -0.763 . . . . 0.0 110.01 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 42.8 Cg_endo -71.27 147.66 53.82 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.904 1.476 . . . . 0.0 110.488 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' OD1' ' A' ' 84' ' ' ASN . 17.8 mt -43.48 151.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.718 ' OD1' HG22 ' A' ' 83' ' ' ILE . 14.1 m120 50.3 69.25 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.3 m -141.52 101.07 3.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 112' ' ' GLY . . . -53.81 89.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -82.26 147.37 28.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.157 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.9 p -119.79 -176.0 3.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.83 -28.47 61.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 90' ' ' VAL . 39.6 t -54.65 -53.67 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.9 mtt -84.87 2.81 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.319 -0.863 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.954 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -102.86 135.88 43.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.045 . . . . 0.0 110.208 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' A' ' 78' ' ' ASN . 1.8 mmtm -127.6 97.01 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.896 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.08 95.58 0.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.537 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE2' HG11 ' A' ' 76' ' ' VAL . 26.4 pt-20 -123.39 136.35 54.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.042 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -69.07 98.5 0.99 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.183 -0.948 . . . . 0.0 110.358 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 98' ' ' SER . 13.7 p -144.34 169.65 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 97' ' ' VAL . 2.0 p -107.9 151.12 41.09 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.193 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.6 Cg_endo -76.48 174.59 52.18 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.607 -2.247 . . . . 0.0 110.373 -0.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -89.18 90.38 8.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.41 -110.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.505 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 25.7 mt -110.17 131.96 21.72 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.154 -1.204 . . . . 0.0 110.068 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.64 158.3 47.44 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.009 1.531 . . . . 0.0 110.533 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.688 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -87.36 43.86 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 16.2 pt-20 -81.69 -33.81 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.209 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 6.3 pt-20 -115.76 -1.28 12.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 110.172 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.973 ' O ' HG23 ' A' ' 111' ' ' VAL . 3.2 tp -46.94 -34.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.9 t -50.18 -33.6 19.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.46 -27.18 16.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 113' ' ' MET . 12.3 mt -93.01 12.67 23.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 107' ' ' ILE . 27.5 t -64.83 130.15 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.492 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . 76.83 18.16 79.13 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -74.42 145.23 43.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -1.099 . . . . 0.0 110.081 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 4.6 mt-30 -87.55 127.32 35.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.914 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -87.65 154.11 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -100.84 -1.08 35.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.217 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.914 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.9 mmt85 -124.83 167.68 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.714 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -82.9 148.72 27.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 2.3 t -128.73 140.53 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -92.2 -167.52 1.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 0.0 111.084 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -59.07 -138.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.562 -0.711 . . . . 0.0 110.564 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 39.8 p30 -49.01 83.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.937 -1.102 . . . . 0.0 111.351 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -118.29 143.46 46.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.025 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 2.7 m -78.95 120.76 24.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.152 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -62.28 126.54 27.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 110.013 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.939 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.1 mtm -125.6 164.17 34.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.369 -0.832 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.6 Cg_endo -72.97 -24.45 17.43 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.04 1.547 . . . . 0.0 110.501 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 129' ' ' MET . 2.2 p30 -70.72 -25.15 62.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.158 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 119' ' ' VAL . 2.5 ttm -80.41 -36.91 33.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 133' ' ' TYR . 33.0 t -86.54 116.51 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -83.64 -18.78 36.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -107.13 28.45 8.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 130' ' ' VAL . 28.7 t80 -66.66 162.29 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.167 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.189 0.518 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.9 176.6 6.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 110.373 -179.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.74 137.28 51.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 110.268 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 41.4 m -111.76 151.11 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.834 HG13 ' HG3' ' A' ' 22' ' ' MET . 55.7 t -71.6 93.05 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' CA ' ' A' ' 54' ' ' THR . 4.5 t -111.66 114.66 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.39 126.6 23.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.7 t-20 -82.8 -40.41 20.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.472 ' OE1' ' HG3' ' A' ' 21' ' ' MET . 11.4 pt20 -92.09 178.01 6.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.117 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.2 tt -89.87 133.78 34.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.955 . . . . 0.0 109.9 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.514 HG13 HD21 ' A' ' 17' ' ' LEU . 10.5 mm -112.44 136.39 21.46 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.976 . . . . 0.0 110.422 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.8 Cg_endo -74.52 -160.92 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.02 1.537 . . . . 0.0 110.167 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.7 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -90.13 158.66 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 110.306 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.3 p30 36.56 75.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 33.1 m -141.49 118.61 11.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.361 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -64.72 92.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.826 HD12 ' HG3' ' A' ' 43' ' ' MET . 12.0 mt -40.33 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -119.42 -173.81 2.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.877 . . . . 0.0 110.246 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -64.89 -43.07 94.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.581 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.7 mp -64.28 -37.46 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.472 ' HG3' ' OE1' ' A' ' 9' ' ' GLN . 19.1 mtt -75.69 0.49 17.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.361 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.834 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.29 106.42 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.1 mtpp -111.1 118.0 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.13 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.5 75.28 2.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.05 147.14 27.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.53 97.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.231 -0.918 . . . . 0.0 110.252 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 6' ' ' VAL . 24.5 m -147.1 154.58 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 3.1 t -94.32 151.92 39.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.6 Cg_endo -75.81 154.21 98.43 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.748 -2.188 . . . . 0.0 110.545 -0.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 30' ' ' MET . 1.4 ptt? -71.56 80.53 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.78 -140.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD13 ' A' ' 55' ' ' LEU . 5.5 mt -75.48 135.06 72.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.78 166.17 30.69 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.022 1.538 . . . . 0.0 110.457 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -83.47 5.04 25.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -49.59 -69.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.705 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.6 mp0 -81.49 57.48 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.38 -0.825 . . . . 0.0 109.645 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.893 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -69.44 -30.09 2.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.475 -0.765 . . . . 0.0 112.088 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.893 ' HD3' HG22 ' A' ' 37' ' ' ILE . 47.7 Cg_endo -77.77 -10.84 16.94 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 N-CA-C 109.702 -0.922 . . . . 0.0 109.702 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 80.4 m-20 -104.19 -26.86 12.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.827 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.001 HD13 ' O ' ' A' ' 63' ' ' TYR . 2.8 mm? -82.14 -41.27 20.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.86 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG21 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -46.09 151.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 110.389 -179.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.789 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 70.68 5.77 57.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.834 ' HE2' HD21 ' A' ' 55' ' ' LEU . 13.6 ptm -70.24 119.67 14.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.371 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' OE1' ' HG ' ' A' ' 121' ' ' LEU . 2.9 mt-30 -80.78 126.17 30.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.84 160.06 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 110.421 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' OD1' ' CG ' ' A' ' 61' ' ' LYS . 9.3 m120 -97.9 -3.59 38.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -142.19 167.54 21.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 110.134 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.77 138.07 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.2 t -110.17 128.21 25.74 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.2 Cg_endo -73.18 -174.01 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.892 1.469 . . . . 0.0 110.442 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -81.64 139.61 34.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 110.371 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 65.71 34.17 88.09 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 50' ' ' PRO . 9.9 m -86.34 124.81 33.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 0.0 110.098 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.567 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.3 t -69.75 152.83 44.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.834 HD21 ' HE2' ' A' ' 43' ' ' MET . 0.3 OUTLIER -74.56 104.67 5.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 1.3 ptm -103.1 136.66 19.19 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.13 -12.4 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.95 1.5 . . . . 0.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -77.21 -36.54 54.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 110.312 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 0.6 OUTLIER -97.94 -10.44 24.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.728 HG11 ' HB3' ' A' ' 63' ' ' TYR . 50.5 t -106.78 119.31 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.296 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' CG ' ' OD1' ' A' ' 46' ' ' ASN . 29.8 mmtt -69.95 -91.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 31.1 p-10 -90.76 72.65 6.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.401 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.001 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -53.58 -33.03 53.38 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.19 -0.944 . . . . 0.0 110.22 -179.724 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' HB3' HD22 ' A' ' 40' ' ' LEU . 3.1 pt-20 -174.68 -167.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.01 -1.056 . . . . 0.0 110.316 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -80.79 56.43 2.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.246 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.14 -14.72 81.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.499 ' CG2' HG23 ' A' ' 97' ' ' VAL . 27.1 p -86.41 95.05 9.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -1.191 . . . . 0.0 110.347 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -82.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.925 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.74 158.21 73.42 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 109.954 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.61 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 46.0 Cg_endo -73.26 -91.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.854 1.449 . . . . 0.0 110.505 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.92 -75.12 0.12 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 5.9 mt -87.67 56.12 3.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -1.126 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.59 131.43 45.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 110.757 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 2.9 p -147.63 153.89 39.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.448 -0.782 . . . . 0.0 109.769 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG12 ' SD ' ' A' ' 92' ' ' MET . 5.0 t -79.7 134.85 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 123' ' ' GLN . 70.0 t -131.12 139.01 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.378 -0.826 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.56 90.83 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 12.7 t30 -57.34 -38.44 74.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.459 -0.776 . . . . 0.0 110.657 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -101.55 -176.09 3.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.744 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -101.87 132.58 47.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.308 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 4.5 mt -120.8 133.49 24.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.844 . . . . 0.0 110.162 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.4 Cg_endo -73.16 147.86 43.32 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.952 1.501 . . . . 0.0 110.587 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 10.9 mt -43.84 154.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.52 ' ND2' HG22 ' A' ' 83' ' ' ILE . 77.1 m-20 49.97 73.99 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 25.6 m -143.71 111.41 6.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.65 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -79.75 143.36 34.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 110.172 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.684 HG23 ' HA2' ' A' ' 112' ' ' GLY . 1.0 OUTLIER -128.71 178.08 6.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -32.06 4.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 110.406 -179.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 91' ' ' MET . 13.6 p -61.63 -43.22 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.273 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.592 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.6 mtm -84.59 -26.83 27.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 75' ' ' VAL . 2.3 mmt -96.6 135.86 37.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 110.192 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 133.17 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.29 99.84 9.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -118.92 127.62 53.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.61 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 3.0 mp0 -80.7 92.06 5.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 110.244 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 98' ' ' SER . 9.9 p -145.73 176.57 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.87 154.17 41.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -75.58 160.91 95.41 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.669 -2.221 . . . . 0.0 110.594 -0.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.63 101.16 9.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -83.11 -110.16 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.668 HD11 ' HA ' ' A' ' 127' ' ' PRO . 8.6 mt -109.44 128.34 25.6 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.263 -1.14 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 46.1 Cg_endo -72.84 166.96 28.52 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.004 1.528 . . . . 0.0 110.488 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.92 42.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 9.6 pt-20 -83.53 -26.86 29.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.189 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.3 mt-10 -114.64 10.68 16.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.9 tp -48.76 -46.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 107' ' ' ILE . 4.5 t -54.79 -22.18 13.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.332 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -25.97 16.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 110.323 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' MET . 4.3 mt -112.75 20.56 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.075 HG23 ' O ' ' A' ' 107' ' ' ILE . 10.7 t -68.49 124.81 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 0.0 110.094 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.79 21.23 79.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.02 152.06 40.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.046 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.16 119.21 31.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.846 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.6 p -78.47 154.92 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.551 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 26.5 t30 -102.1 -3.19 27.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.211 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.846 ' H ' HG22 ' A' ' 115' ' ' VAL . 5.1 ttm180 -123.98 167.99 13.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.69 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -81.85 146.83 29.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 7.0 t -117.66 138.71 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.004 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-85 -97.98 -167.88 1.58 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 110.651 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.37 -150.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 110.381 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -44.48 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.974 -179.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 121' ' ' LEU . 1.2 tp60 -118.36 147.69 43.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 109.853 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 89.7 m -78.85 132.27 36.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 126' ' ' MET . 2.6 tp -62.85 133.71 55.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.792 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.51 154.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.668 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.3 Cg_endo -72.6 -21.58 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.51 . . . . 0.0 110.565 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.65 -0.63 51.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.184 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.452 ' HG3' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -84.31 -44.49 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -0.893 . . . . 0.0 110.262 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 131' ' ' LYS . 51.0 t -78.88 162.88 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.988 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.7 mtmt -76.53 -73.71 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.255 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 11.4 p30 -105.28 68.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.886 . . . . 0.0 110.338 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE1' HD13 ' A' ' 102' ' ' ILE . 60.7 t80 -62.81 101.2 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.281 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.284 0.564 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 178.54 8.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.893 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -77.01 140.02 40.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.158 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.9 m -105.28 166.08 10.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.266 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.754 HG12 HD23 ' A' ' 55' ' ' LEU . 29.1 t -75.39 95.77 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 t -111.75 114.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -58.97 128.83 39.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.24 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' HD23 ' A' ' 51' ' ' LEU . 16.5 t-20 -82.95 -38.15 23.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.875 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' OE1' ' SD ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -91.87 176.26 6.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.3 tt -89.56 127.71 35.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 109.957 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 15' ' ' THR . 40.4 mt -117.8 134.46 23.24 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.406 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.17 -161.84 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.017 1.535 . . . . 0.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 46' ' ' ASN . 1.8 mp -83.36 169.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 10.7 p30 36.54 62.53 0.73 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.75 -0.594 . . . . 0.0 110.747 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 11' ' ' ILE . 84.0 m -128.86 114.02 15.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.431 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.556 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.81 104.79 0.89 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.707 HD23 HD13 ' A' ' 11' ' ' ILE . 20.3 mt -53.02 147.86 8.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -121.0 176.85 5.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -62.98 -39.62 95.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.4 mp -62.91 -44.48 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.926 . . . . 0.0 110.084 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 43.4 mtm -81.94 6.13 16.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.663 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -105.44 101.99 11.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.242 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 118.7 36.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -85.15 77.43 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -102.92 148.35 25.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.6 t -87.28 64.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.221 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.46 167.98 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.309 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -100.13 169.16 8.35 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.127 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 28' ' ' THR . 46.1 Cg_endo -73.47 154.86 99.77 Favored 'Cis proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.649 -2.229 . . . . 0.0 110.428 0.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 9.2 ptp -71.33 -170.97 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.21 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.02 -120.68 0.88 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.998 HD12 HD12 ' A' ' 55' ' ' LEU . 9.7 mt -95.17 137.78 22.1 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 110.106 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.59 177.39 8.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.964 1.507 . . . . 0.0 110.457 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . -93.71 9.04 38.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.203 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -67.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.069 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 mp0 -79.59 49.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.5 tp -69.45 -31.3 2.54 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 112.001 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.916 ' HD3' HG22 ' A' ' 37' ' ' ILE . 46.7 Cg_endo -76.5 -11.2 18.87 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 109.952 -0.826 . . . . 0.0 109.952 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -104.64 -40.43 6.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 109.938 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD22 ' CE ' ' A' ' 43' ' ' MET . 29.6 mt -84.38 -8.91 58.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 110.583 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -62.73 152.05 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.945 -1.097 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.556 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 61.14 11.96 28.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.721 ' CE ' HD22 ' A' ' 40' ' ' LEU . 11.5 ptm -70.53 128.83 37.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.996 -1.296 . . . . 0.0 109.971 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.27 149.54 26.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.58 171.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' C ' HG23 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -101.12 -19.79 15.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 -179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 178.1 5.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 13' ' ' ILE . . . -75.9 145.13 40.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 53' ' ' THR . 8.3 t -115.04 115.44 43.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.8 Cg_endo -72.79 -172.47 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.902 1.475 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -74.84 155.36 37.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.92 . . . . 0.0 110.226 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 51.28 31.64 27.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.728 HG21 HG13 ' A' ' 49' ' ' VAL . 16.4 m -79.94 111.26 16.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -1.147 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.5 t -63.32 161.11 14.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.892 . . . . 0.0 110.092 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.998 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.98 102.12 4.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.333 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.4 ttm -103.3 125.02 36.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.137 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.84 -19.78 20.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.912 1.48 . . . . 0.0 110.448 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -19.16 65.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.298 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mtm -103.5 -10.04 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 110.147 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 51.7 t -117.74 111.25 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -50.02 -99.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 110.119 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' ND2' ' OE2' ' A' ' 95' ' ' GLU . 9.3 t30 -83.45 103.11 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.906 -1.121 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -75.74 -76.09 0.16 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.174 -0.954 . . . . 0.0 109.402 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.703 ' HG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -133.63 174.42 10.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -0.786 . . . . 0.0 109.968 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.45 48.6 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.896 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.99 45.08 1.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 p -84.41 164.85 18.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.253 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 68' ' ' THR . 22.4 p -67.8 -138.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.1 m -64.19 151.94 89.31 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.131 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.8 Cg_endo -73.7 -92.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.945 1.498 . . . . 0.0 110.575 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.11 -82.43 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' PRO . 9.9 mt -88.21 52.36 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -1.098 . . . . 0.0 109.988 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -81.66 115.7 21.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.437 -0.789 . . . . 0.0 110.48 -179.732 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 11.3 p -96.97 151.85 19.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.97 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.5 t -72.97 120.46 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.236 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.1 t -116.14 146.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.925 . . . . 0.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.48 103.42 14.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.281 -0.887 . . . . 0.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 1.5 p-10 -57.96 -41.27 82.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.709 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -111.01 -171.15 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.138 -0.976 . . . . 0.0 109.856 179.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -96.58 153.19 17.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 110.629 -179.704 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 119' ' ' VAL . 6.2 mt -114.08 125.12 29.77 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.879 ' C ' HD12 ' A' ' 83' ' ' ILE . 48.8 Cg_endo -80.62 40.01 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.289 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.879 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 59.97 142.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.734 HD22 HG22 ' A' ' 83' ' ' ILE . 4.7 m-80 47.73 72.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.347 -0.846 . . . . 0.0 110.407 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.766 ' O ' HD23 ' A' ' 87' ' ' LEU . 7.3 m -143.52 100.26 3.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.263 -0.898 . . . . 0.0 110.029 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.12 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -91.94 149.94 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 44.6 p -125.65 -169.67 2.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.852 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.24 -26.63 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.254 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.93 -59.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.151 -0.968 . . . . 0.0 110.147 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 mtt -77.86 -12.12 59.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.712 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.2 mmt -102.5 129.98 49.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 27.8 mttm -123.5 109.95 14.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -85.27 98.27 10.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' OE2' ' ND2' ' A' ' 62' ' ' ASN . 8.6 pt-20 -123.29 155.76 36.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 110.226 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -75.0 94.15 2.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.192 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 62' ' ' ASN . 7.8 p -149.68 166.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.7 m -109.15 160.16 28.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -75.26 175.98 45.56 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.638 -2.234 . . . . 0.0 110.469 -0.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -88.27 95.57 10.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.384 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.29 -111.01 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.8 HD11 ' CA ' ' A' ' 127' ' ' PRO . 22.6 mt -109.31 126.12 29.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.149 -1.207 . . . . 0.0 109.914 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.71 160.18 48.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.524 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -84.96 51.7 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 110.243 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -49.67 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.42 7.08 33.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.003 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.5 tp -52.66 -39.78 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.53 ' N ' HG23 ' A' ' 107' ' ' ILE . 7.5 t -44.75 -36.16 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -28.64 18.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.209 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 113' ' ' MET . 26.6 mt -92.21 5.85 48.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.149 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 107' ' ' ILE . 35.1 t -64.28 135.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 76.11 14.09 82.6 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 26.4 ptt? -73.53 147.69 43.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.059 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 39.5 mt-30 -91.15 121.22 32.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.792 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -78.42 155.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.999 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 131' ' ' LYS . 5.0 t-20 -100.32 -6.72 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.928 . . . . 0.0 110.28 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.792 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.88 175.77 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.693 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -92.46 139.34 30.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 81' ' ' ILE . 48.4 t -120.01 118.73 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.4 m-85 -54.42 -174.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 110.108 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 79' ' ' GLN . 1.4 tp -67.42 -126.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.225 -0.922 . . . . 0.0 111.068 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.1 m-20 -51.42 75.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.44 -0.787 . . . . 0.0 111.606 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 121' ' ' LEU . 22.0 tt0 -118.92 152.39 36.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.33 -0.857 . . . . 0.0 109.456 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 99' ' ' PRO . 6.6 m -78.68 135.32 37.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.013 -1.054 . . . . 0.0 110.263 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 126' ' ' MET . 2.1 tp -63.59 133.32 53.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.112 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.754 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.6 mtt -124.0 137.39 28.83 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.8 ' CA ' HD11 ' A' ' 102' ' ' ILE . 47.1 Cg_endo -73.36 -7.37 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.011 1.532 . . . . 0.0 110.592 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -90.68 -20.28 22.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 31.7 ttm -85.79 -52.17 5.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.235 -0.915 . . . . 0.0 110.345 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 115' ' ' VAL . 42.1 t -73.34 110.64 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.279 -0.888 . . . . 0.0 110.25 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.526 ' HG2' ' CB ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -76.13 -5.2 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.283 179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -98.06 -6.93 30.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.302 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 28.4 t80 -59.6 156.1 14.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.174 -179.93 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.213 0.53 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -91.28 179.91 5.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.91 141.24 56.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 27.2 m -113.46 174.02 6.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.223 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 37' ' ' ILE . 55.3 t -84.77 97.22 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.0 t -116.1 109.44 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.192 -0.942 . . . . 0.0 109.864 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -54.74 122.56 10.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.757 ' O ' HD23 ' A' ' 51' ' ' LEU . 8.7 t-20 -82.57 -35.14 27.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.745 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -92.32 176.28 6.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 110.1 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.529 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -90.25 134.89 34.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.776 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.0 HG21 HD21 ' A' ' 17' ' ' LEU . 28.4 mm -117.97 137.84 24.84 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.076 -1.015 . . . . 0.0 110.724 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 48.5 Cg_endo -77.69 -160.9 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.982 1.517 . . . . 0.0 110.01 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.487 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 mt -91.63 162.67 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.132 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.93 68.14 0.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.62 -0.675 . . . . 0.0 110.543 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 m -137.84 131.42 31.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.53 125.94 29.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.912 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 11' ' ' ILE . 39.0 mt -93.89 148.26 22.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.504 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -120.99 -176.6 3.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.451 -0.781 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -61.88 -36.45 81.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.1 mp -62.59 -48.33 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 10.4 mtt -72.5 -9.58 58.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.86 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.729 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -107.37 122.88 47.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.158 179.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.12 124.21 51.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -80.96 73.06 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.852 . . . . 0.0 110.149 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.46 146.45 28.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.06 76.85 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.096 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.11 166.72 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.295 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 18.9 p -104.58 159.8 28.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 110.105 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -75.6 157.04 99.16 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.593 -2.253 . . . . 0.0 110.394 -0.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.3 mtp -72.27 96.19 1.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.25 -132.56 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.825 ' CD1' HD12 ' A' ' 55' ' ' LEU . 4.5 mt -87.12 127.71 58.31 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.204 -1.174 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.34 -171.81 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.868 1.457 . . . . 0.0 110.397 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HA ' ' CG1' ' A' ' 37' ' ' ILE . . . -88.01 27.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -67.13 -68.2 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 111.095 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 5.2 mm-40 -94.63 12.18 28.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 111.196 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.9 mm -46.12 -54.41 17.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.182 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 41.6 Cg_endo -68.75 -4.93 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.549 1.289 . . . . 0.0 110.369 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 14.3 t-20 -88.2 -67.45 0.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 64' ' ' GLU . 11.6 mt -92.86 18.32 9.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 110.384 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.1 t -45.47 144.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.013 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 75.59 15.95 80.94 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 7.8 ptp -69.95 154.64 41.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.267 . . . . 0.0 109.816 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' OE1' ' CB ' ' A' ' 121' ' ' LEU . 7.4 mt-30 -95.76 144.94 25.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 28.9 m -95.16 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.089 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' CG ' ' HZ3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -89.24 -21.01 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.269 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.63 175.19 9.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.01 142.35 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 53' ' ' THR . 3.7 t -113.33 134.56 21.89 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 110.037 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.815 ' HD2' HG21 ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.59 -169.16 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.004 1.528 . . . . 0.0 110.62 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -84.24 149.31 26.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.443 -179.782 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 54.94 31.65 55.54 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.815 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.7 m -86.18 118.2 25.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -1.143 . . . . 0.0 110.092 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.479 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -61.57 151.24 33.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 109.975 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.825 HD12 ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.16 105.53 4.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 0.0 110.123 -179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mtp -100.45 135.72 20.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.65 -21.58 21.78 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.015 1.534 . . . . 0.0 110.598 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.38 -20.42 60.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.261 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.0 mtp -104.07 -10.49 17.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.86 127.57 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HZ3' ' CG ' ' A' ' 46' ' ' ASN . 10.5 mtmm -59.22 -91.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.771 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.47 92.38 8.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 109.709 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.67 ' HB2' HD13 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.72 -5.78 49.48 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.329 -0.857 . . . . 0.0 111.019 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 1.047 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -179.33 163.27 1.24 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.913 -1.117 . . . . 0.0 110.398 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.89 45.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 110.074 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.93 -8.27 87.81 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.48 116.65 23.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -1.206 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.97 -76.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.239 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.25 134.12 56.01 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.349 -0.844 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 45.1 Cg_endo -72.86 -88.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 0.0 110.354 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.6 -78.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.6 mt -87.38 51.15 2.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 110.105 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.06 161.93 14.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -0.813 . . . . 0.0 110.301 179.648 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -137.27 159.9 40.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.766 HG12 ' SD ' ' A' ' 92' ' ' MET . 21.1 t -71.83 121.38 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.627 HG21 HG11 ' A' ' 97' ' ' VAL . 72.5 t -116.01 134.33 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 110.174 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -76.55 87.4 3.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 121' ' ' LEU . 15.1 p-10 -57.59 -30.43 65.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -109.11 -170.59 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 110.326 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.668 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -100.88 125.72 47.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.27 -179.86 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 80' ' ' LEU . 22.7 mm -120.64 123.46 28.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 153.59 57.78 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.835 1.439 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.673 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -46.12 159.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 83' ' ' ILE . 7.9 m120 43.61 72.98 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 22.1 m -143.57 109.05 5.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.107 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.75 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 110.157 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -79.1 138.48 37.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.425 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -120.11 175.85 5.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.222 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -56.69 -30.45 63.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.791 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 91' ' ' MET . 8.6 p -63.67 -41.55 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.277 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.547 ' N ' HG13 ' A' ' 90' ' ' VAL . 14.7 mtt -84.47 -22.95 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.429 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' HG12 ' A' ' 75' ' ' VAL . 6.4 mmt -96.96 146.99 24.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.0 110.346 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -130.45 107.92 9.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.923 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -83.17 100.61 10.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.252 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -123.55 164.74 18.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.963 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 1.9 tm-20 -73.34 96.99 2.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 76' ' ' VAL . 8.4 p -148.96 162.73 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.369 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 99' ' ' PRO . 51.6 p -109.36 160.78 26.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.741 . . . . 0.0 110.163 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 98' ' ' SER . 50.8 Cg_endo -79.53 174.35 50.22 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.395 -0.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.29 77.56 3.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.6 -111.99 0.03 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 127' ' ' PRO . 28.6 mt -109.23 115.92 55.88 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -1.171 . . . . 0.0 110.17 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 46.6 Cg_endo -73.13 162.1 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.957 1.504 . . . . 0.0 110.446 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.431 ' HB3' HG22 ' A' ' 75' ' ' VAL . 56.8 p -84.63 49.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 110.226 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 59.5 mt-10 -67.46 -73.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 110.246 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -95.05 27.58 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.895 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -52.45 -40.98 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.85 -31.92 0.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 -33.11 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.479 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 12.2 mt -92.63 5.86 49.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 107' ' ' ILE . 6.0 t -64.08 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.222 -0.924 . . . . 0.0 110.313 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 66.24 17.91 66.6 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 21.6 ptm -73.24 155.45 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.185 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.23 128.59 36.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 110.31 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.9 p -86.98 154.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.127 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -100.42 -1.95 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.104 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.853 ' H ' HG22 ' A' ' 115' ' ' VAL . 10.3 mmt180 -124.96 173.58 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.072 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.673 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.63 152.33 21.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.453 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 20.0 t -130.9 140.43 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 109.975 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 15.7 m-30 -101.56 -161.23 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.707 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -57.78 -150.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 110.709 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 24.1 t0 -44.62 85.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.212 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -118.67 143.96 46.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.787 179.602 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 22.2 m -74.91 136.27 41.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 0.0 110.255 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 126' ' ' MET . 3.1 tp -75.25 132.02 40.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.767 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -120.84 152.05 55.56 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.132 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.891 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.8 Cg_endo -72.44 -24.51 19.14 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.999 1.526 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.03 -28.3 63.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.173 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 9.2 mtt -82.29 -45.33 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -88.86 109.99 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.89 8.53 34.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.229 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -92.43 -25.37 18.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.287 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.15 174.08 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.315 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.181 -179.983 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.191 0.52 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.56 179.98 7.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 145.06 36.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.191 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -112.95 170.17 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.179 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.2 t -84.39 103.21 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 110.36 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.5 t -116.99 111.5 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.895 . . . . 0.0 110.039 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.41 129.08 30.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 110.075 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.676 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.4 t30 -82.51 -41.56 19.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.465 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 11.0 pt20 -91.86 -178.97 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.354 -0.841 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 10' ' ' LEU . 7.3 tt -89.85 115.15 26.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 40.4 mm -95.37 130.18 32.95 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.26 -0.9 . . . . 0.0 110.478 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 15' ' ' THR . 46.5 Cg_endo -73.9 -160.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.901 1.474 . . . . 0.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.603 HD13 ' HA ' ' A' ' 48' ' ' ALA . 18.5 mm -83.56 158.36 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 13' ' ' ILE . 8.3 p30 36.88 69.09 0.23 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 12' ' ' PRO . 9.9 m -129.91 114.66 16.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 110.311 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.8 89.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD12 ' CG ' ' A' ' 43' ' ' MET . 14.5 mt -41.65 149.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.418 -0.801 . . . . 0.0 110.641 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -120.68 172.41 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.469 -0.769 . . . . 0.0 109.975 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -34.84 76.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.096 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.1 -46.37 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 42.8 mtm -79.34 4.21 15.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.66 119.17 38.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.145 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -110.93 135.29 51.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.04 74.82 4.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.75 148.12 26.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG22 ' CA ' ' A' ' 3' ' ' ALA . 85.7 t -86.15 90.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.219 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -139.57 172.66 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -108.83 166.68 10.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD2' HG21 ' A' ' 54' ' ' THR . 51.1 Cg_endo -76.59 172.69 61.93 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.589 -2.255 . . . . 0.0 110.305 -0.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' GLY . 23.0 mtp -72.64 65.64 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -58.26 -114.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.739 HD12 HD12 ' A' ' 55' ' ' LEU . 12.4 mt -104.77 133.06 20.36 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 178.49 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.938 1.494 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -98.74 20.98 12.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.36 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.71 -46.23 76.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 37' ' ' ILE . 32.6 mm-40 -94.69 26.94 3.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.158 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.4 mm -41.28 -57.05 3.86 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.414 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.5 Cg_endo -69.71 -9.39 26.01 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.641 1.337 . . . . 0.0 110.677 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 36' ' ' GLU . 1.4 m-20 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.13 -20.84 20.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 -179.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.67 153.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.86 -1.15 . . . . 0.0 109.705 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 72.1 10.09 72.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 40' ' ' LEU . 28.4 ptm -69.52 131.67 45.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.3 . . . . 0.0 110.077 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 2.4 mt-30 -88.25 138.93 31.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.476 ' H ' HG22 ' A' ' 45' ' ' VAL . 25.5 m -91.54 162.46 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 10.0 m120 -101.16 -4.89 26.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 110.203 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' C ' ' CD1' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.18 178.93 6.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.251 -179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 13' ' ' ILE . . . -75.73 140.8 42.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.424 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 53' ' ' THR . 24.2 t -118.79 118.14 33.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.92 -169.86 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.899 1.473 . . . . 0.0 110.56 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.68 145.92 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.196 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 60.31 31.75 74.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.658 ' CB ' HG13 ' A' ' 49' ' ' VAL . 68.1 m -82.98 116.87 22.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -1.165 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 29' ' ' PRO . 10.8 t -61.83 164.99 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.739 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -87.35 98.01 11.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 0.0 110.297 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.5 OUTLIER -100.51 131.11 24.28 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.14 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 63' ' ' TYR . 47.0 Cg_endo -73.93 -9.65 22.42 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.017 1.535 . . . . 0.0 110.49 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -32.66 72.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.877 . . . . 0.0 110.542 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 3.4 mtt -98.21 -16.77 19.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.62 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 63' ' ' TYR . 77.2 t -100.11 137.01 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.111 -0.993 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 46' ' ' ASN . 7.4 mmmt -70.64 -101.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -90.91 68.55 6.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.162 179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.2 p90 -53.7 -38.59 64.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.257 -0.902 . . . . 0.0 110.573 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 2.6 pt-20 -178.17 -159.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.049 . . . . 0.0 110.365 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -75.49 54.67 0.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.533 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.53 30.4 7.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -86.91 119.14 26.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -1.172 . . . . 0.0 110.029 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.5 p -71.01 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.17 117.09 33.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.209 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.545 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 45.7 Cg_endo -72.08 -92.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.974 1.513 . . . . 0.0 110.484 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.24 -73.07 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' PRO . 8.9 mt -87.18 51.99 2.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 109.929 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -71.4 113.56 8.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 110.641 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.27 170.68 8.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.585 179.419 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.894 ' HB ' HD23 ' A' ' 125' ' ' LEU . 38.9 t -84.87 123.88 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 110.248 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 124' ' ' THR . 40.0 t -118.26 142.64 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.229 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -75.07 101.14 4.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 7.1 t-20 -57.01 -40.84 77.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.743 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -110.25 170.28 8.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.157 -0.964 . . . . 0.0 110.397 -179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -94.06 138.99 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.836 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 119' ' ' VAL . 26.0 pt -121.13 134.83 24.5 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 110.408 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.845 ' C ' HD12 ' A' ' 83' ' ' ILE . 47.4 Cg_endo -75.21 59.64 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.011 1.532 . . . . 0.0 110.904 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.845 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.84 156.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.353 -0.842 . . . . 0.0 110.588 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 83' ' ' ILE . 1.1 t-20 40.93 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.49 -0.756 . . . . 0.0 110.419 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.856 ' O ' HD23 ' A' ' 87' ' ' LEU . 2.4 m -143.52 93.5 2.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 110.136 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 114' ' ' GLN . . . -52.65 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.173 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -91.4 147.63 22.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.556 ' HA ' HG13 ' A' ' 111' ' ' VAL . 9.9 p -120.03 -170.38 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.315 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.58 -29.21 2.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.347 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.01 -48.56 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.078 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -15.22 46.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 110.185 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.789 ' SD ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.96 122.78 44.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -117.69 117.4 29.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.74 95.03 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 74' ' ' SER . 5.0 mm-40 -123.53 144.6 49.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.343 -0.848 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 3.3 tm-20 -71.93 98.24 2.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' OG1' ' A' ' 124' ' ' THR . 49.1 t -130.69 154.91 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.201 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.509 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -109.15 142.18 25.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 110.065 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 98' ' ' SER . 47.8 Cg_endo -74.76 -178.16 22.44 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.734 -2.194 . . . . 0.0 110.402 -0.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 3.4 ptpt -83.85 104.64 14.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.11 -116.54 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.037 HG13 HD11 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.51 129.84 23.5 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.91 -1.347 . . . . 0.0 109.143 179.072 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 43.7 Cg_endo -70.57 160.72 48.54 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.843 1.444 . . . . 0.0 110.474 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.53 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 1.6 p -78.9 47.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.869 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 2.2 mt-10 -88.17 -48.84 7.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.119 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.01 11.58 17.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.472 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.8 mm -47.14 -51.23 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.106 -0.997 . . . . 0.0 109.935 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.9 t -44.94 -26.28 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -92.63 -25.71 18.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' A' ' 113' ' ' MET . 86.4 mt -102.15 -1.38 31.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.247 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 107' ' ' ILE . 32.1 t -65.08 138.03 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.893 . . . . 0.0 110.36 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 80.68 6.82 89.13 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HG3' ' HA ' ' A' ' 110' ' ' LEU . 3.7 mmt -79.42 145.39 33.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.032 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HG3' ' HB2' ' A' ' 86' ' ' ALA . 29.1 mt-30 -88.61 132.44 34.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 117' ' ' ARG . 8.7 p -83.81 155.34 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.27 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -100.22 -1.01 37.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.91 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmm-85 -124.68 174.58 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.939 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -94.42 134.49 36.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 110.553 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 21.9 t -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD1' HD12 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -105.54 -160.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.976 -179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -57.71 -152.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.736 . . . . 0.0 110.628 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 7.7 m-20 -44.92 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.689 . . . . 0.0 111.42 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.729 ' O ' HG13 ' A' ' 76' ' ' VAL . 30.5 tt0 -118.85 151.3 38.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.873 . . . . 0.0 109.819 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.776 ' HA ' HG22 ' A' ' 76' ' ' VAL . 11.8 m -72.85 130.91 41.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -81.47 125.71 30.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 110.443 -179.598 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.511 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 mtm -125.48 164.94 29.36 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 0.0 110.35 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 102' ' ' ILE . 50.0 Cg_endo -77.32 -13.99 16.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.964 1.507 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' MET . 1.9 p30 -72.9 -33.14 65.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.444 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -81.09 -49.51 10.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.199 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.813 HG12 HG23 ' A' ' 115' ' ' VAL . 31.0 m -75.63 -171.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -97.95 112.57 24.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 130' ' ' VAL . 2.4 m-85 -70.56 -169.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.251 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.18 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.331 0.586 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.32 179.1 5.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 110.32 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.03 142.32 38.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 48.0 t -111.11 160.05 17.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 110.107 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 22' ' ' MET . 93.4 t -78.48 101.99 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' CG2' ' A' ' 27' ' ' VAL . 12.8 t -113.94 116.33 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -52.99 127.94 25.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.374 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.739 ' O ' HD23 ' A' ' 51' ' ' LEU . 54.8 t30 -82.67 -41.99 18.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.804 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.31 -179.89 5.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.5 tt -90.23 108.62 19.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.735 HD12 ' CE ' ' A' ' 21' ' ' MET . 48.1 mm -95.01 128.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.53 -161.71 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.787 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -91.55 170.74 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.378 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 17.1 p30 36.67 65.31 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.672 -0.642 . . . . 0.0 110.932 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 m -140.42 120.47 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 91.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.705 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.4 mt -43.28 147.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 47.8 p -121.34 170.65 9.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 110.039 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' HA ' ' CE ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -62.57 -21.25 65.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.129 179.847 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.5 -54.62 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 0.0 110.46 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.735 ' CE ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.31 16.36 5.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HG2' HG13 ' A' ' 5' ' ' VAL . 10.2 tmm? -106.25 99.98 9.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' CD ' ' HB2' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -111.36 131.48 55.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.462 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.64 80.43 3.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 158.27 15.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 110.324 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.38 90.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.725 ' CG2' HG21 ' A' ' 6' ' ' VAL . 22.4 m -146.72 147.91 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -89.89 169.33 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 110.073 179.966 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -73.88 163.94 88.71 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.578 -2.259 . . . . 0.0 110.487 -0.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 mmm -66.37 77.34 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.41 -124.45 0.05 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.991 HD12 HD12 ' A' ' 55' ' ' LEU . 20.4 mt -101.38 130.11 25.49 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.25 -1.147 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 177.01 8.36 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.841 1.443 . . . . 0.0 110.459 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CA ' HG12 ' A' ' 37' ' ' ILE . . . -91.68 25.86 2.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.473 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.29 -47.82 69.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.227 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' CB ' HD13 ' A' ' 40' ' ' LEU . 4.3 mm-40 -94.92 31.18 1.9 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 0.0 110.118 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.8 mm -45.35 -48.74 34.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.497 -0.752 . . . . 0.0 111.072 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.4 Cg_endo -69.31 -10.43 28.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.344 1.181 . . . . 0.0 110.837 -179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 43' ' ' MET . 1.3 m-20 -104.75 -44.69 4.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.055 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 64' ' ' GLU . 7.9 mp -76.78 -12.75 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.325 -0.86 . . . . 0.0 110.727 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.4 t -65.72 151.01 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.899 0.857 . . . . 0.0 111.19 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 62.51 8.53 20.21 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.628 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 16.6 mmt -77.09 140.01 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.736 -1.45 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 1.4 mp0 -81.42 141.93 33.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.425 -0.797 . . . . 0.0 110.364 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.9 m -100.41 161.0 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.827 . . . . 0.0 110.132 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' MET . 31.5 m-80 -101.44 -1.26 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.531 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -140.01 167.03 23.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.162 -0.961 . . . . 0.0 110.416 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 13' ' ' ILE . . . -75.61 142.44 42.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.288 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 53' ' ' THR . 14.3 t -117.95 115.68 36.59 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.4 Cg_endo -72.92 -168.9 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.882 1.464 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -76.98 146.34 37.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 58.52 35.75 81.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.736 ' CB ' HG13 ' A' ' 49' ' ' VAL . 38.0 m -86.7 126.48 34.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -1.137 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 7.1 t -69.33 154.58 41.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -78.6 105.98 10.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.16 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.453 ' CB ' ' HG3' ' A' ' 59' ' ' MET . 13.1 mtt -100.66 131.34 23.79 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' CA ' HD11 ' A' ' 32' ' ' ILE . 45.8 Cg_endo -73.67 -29.77 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.99 1.521 . . . . 0.0 110.356 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.76 -27.29 68.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -85.27 -18.21 34.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.123 179.941 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 63' ' ' TYR . 17.9 t -118.8 130.09 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.282 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.3 -146.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -0.883 . . . . 0.0 110.073 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.556 ' OD1' HG22 ' A' ' 97' ' ' VAL . 4.4 m120 -70.25 75.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.936 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 3.8 p90 -67.72 -10.82 55.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.413 -0.804 . . . . 0.0 111.303 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.666 ' HB3' HD12 ' A' ' 40' ' ' LEU . 17.7 pt-20 -140.22 5.37 2.08 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.794 -1.191 . . . . 0.0 111.024 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' CB ' ' HB3' ' A' ' 62' ' ' ASN . 2.4 t0 -77.6 58.12 1.72 Allowed 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.407 -0.808 . . . . 0.0 109.917 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.53 71.63 0.33 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.7 p -73.14 162.01 29.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.097 . . . . 0.0 110.508 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 4.0 m -68.93 -64.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 110.339 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -64.4 110.97 4.61 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.1 Cg_endo -73.82 -89.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.008 1.53 . . . . 0.0 110.603 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.9 -81.87 1.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 72' ' ' LEU . 10.2 mt -87.94 52.49 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -1.103 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -75.04 130.32 39.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 110.42 -179.809 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 75.2 p -114.73 152.26 32.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.878 HG13 ' SD ' ' A' ' 92' ' ' MET . 18.2 t -68.39 124.24 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 97' ' ' VAL . 35.2 t -123.81 136.5 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.297 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.62 90.7 5.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.619 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.1 t-20 -57.51 -25.89 60.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.386 -0.822 . . . . 0.0 110.845 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.2 177.67 4.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 tt -90.98 132.6 35.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.325 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 85' ' ' THR . 24.0 mm -120.57 117.28 31.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.017 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.8 Cg_endo -71.41 149.15 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.909 1.479 . . . . 0.0 110.589 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.662 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -41.0 134.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.487 -0.758 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.5 OUTLIER 65.4 76.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 110.333 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 81' ' ' ILE . 16.1 m -143.56 104.49 4.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.223 -0.923 . . . . 0.0 110.193 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.54 85.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.189 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -86.9 147.21 25.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.068 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.7 p -126.69 -172.44 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -53.32 -25.89 16.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.618 -179.648 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.47 -57.77 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 110.562 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 18.9 mtm -84.93 11.3 9.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.897 . . . . 0.0 110.733 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.878 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.75 129.53 53.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.29 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 78' ' ' ASN . 2.5 mttp -121.81 87.9 2.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.951 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.744 ' HB2' ' HE1' ' A' ' 92' ' ' MET . . . -70.38 96.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.602 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -123.59 167.51 13.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 3.7 tm-20 -76.09 90.9 3.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.07 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 76' ' ' VAL . 7.8 p -142.1 163.85 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.332 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -109.28 165.21 13.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.839 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 49.0 Cg_endo -75.67 173.64 56.98 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.332 -0.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 78.37 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -74.2 -117.65 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.548 HD13 ' CZ ' ' A' ' 133' ' ' TYR . 9.6 mt -109.32 128.82 24.74 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.307 -1.113 . . . . 0.0 110.198 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.99 166.78 29.12 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.83 1.437 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 t -85.55 40.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 17.2 pt-20 -87.8 -40.6 13.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.486 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 2.8 mt-10 -102.88 1.04 33.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.398 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.063 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -49.08 -42.7 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 110.273 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.571 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -51.81 -22.4 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -95.9 -29.32 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.375 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 3.7 mt -104.12 15.11 29.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 110.712 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.063 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -67.49 130.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.258 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.629 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 80.18 14.16 80.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.503 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 76.7 mmm -75.1 148.57 39.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -1.146 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -91.52 128.27 37.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.6 p -87.7 154.94 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 7.4 t-20 -101.13 -5.56 25.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.227 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 mmm180 -118.25 170.61 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.152 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.662 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.78 146.57 24.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 34.7 t -130.26 140.85 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 24.2 m-85 -92.34 -162.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.777 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -58.81 -143.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.546 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.1 m-20 -43.51 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.008 . . . . 0.0 110.727 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -117.81 150.84 38.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.571 -0.706 . . . . 0.0 109.806 179.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 48.3 m -78.68 144.87 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 110.482 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.773 HD12 ' N ' ' A' ' 126' ' ' MET . 2.2 tp -80.97 128.9 34.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.773 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.3 mtt -126.56 152.99 75.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 -18.31 23.93 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 110.294 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.75 7.9 11.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -100.29 -36.36 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.252 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 133' ' ' TYR . 25.4 t -79.61 152.74 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.477 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 42.1 mtpt -70.43 -75.12 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.66 66.79 0.8 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.548 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 88.6 t80 -73.21 120.51 18.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.336 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.253 179.88 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.275 0.56 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -75.94 160.8 29.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.587 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -78.02 163.79 25.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.885 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -108.17 158.68 17.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' A' ' 22' ' ' MET . 73.4 t -83.69 98.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.1 t -113.67 123.63 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.976 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -60.34 134.27 56.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.069 -1.019 . . . . 0.0 110.311 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.766 ' O ' HD23 ' A' ' 51' ' ' LEU . 44.0 t-20 -83.91 -45.45 13.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.916 . . . . 0.0 109.983 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 11.1 pt20 -92.5 -179.4 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 0.0 110.476 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 10' ' ' LEU . 3.7 tt -89.84 106.59 18.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG21 ' A' ' 15' ' ' THR . 34.0 mm -93.04 135.03 26.34 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.625 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.12 -160.6 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.888 1.467 . . . . 0.0 110.371 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.54 155.39 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.227 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 49.71 68.82 0.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.297 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 11' ' ' ILE . 44.0 m -139.33 113.47 8.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.209 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.61 92.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 11' ' ' ILE . 80.2 mt -44.61 149.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.634 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.8 p -120.45 -178.85 3.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.468 -0.77 . . . . 0.0 110.15 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.46 -45.9 74.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -57.69 -37.09 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 110.216 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 21.7 mtt -85.7 -22.78 27.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.547 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -88.01 124.16 33.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.514 -179.764 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.1 128.15 55.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 179.695 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' C ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.53 68.87 7.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.26 145.9 29.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.587 HG22 ' CA ' ' A' ' 3' ' ' ALA . 20.8 t -88.15 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.68 166.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.259 -0.901 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 68.9 p -96.49 160.36 29.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.018 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.1 Cg_endo -74.75 147.13 88.59 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.736 -2.193 . . . . 0.0 110.607 -0.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 31' ' ' GLY . 2.5 mtt -69.97 65.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.093 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.17 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.938 ' CG2' HD21 ' A' ' 40' ' ' LEU . 7.2 mt -93.96 132.08 30.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.38 -1.07 . . . . 0.0 110.223 -179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.29 179.68 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.943 1.496 . . . . 0.0 110.507 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -97.7 5.48 49.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -46.6 -40.26 12.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' CG ' ' OE1' ' A' ' 64' ' ' GLU . 2.9 mt-10 -95.04 39.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -40.16 -51.34 6.03 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.627 -0.67 . . . . 0.0 110.871 179.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -68.96 -12.08 33.46 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.38 1.2 . . . . 0.0 110.955 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 1.8 t-20 -104.45 -46.78 4.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.191 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.938 HD21 ' CG2' ' A' ' 32' ' ' ILE . 1.9 mp -71.81 -24.13 61.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -58.17 153.82 2.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.352 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.24 13.98 11.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 43' ' ' MET . 10.3 ptm -72.4 122.99 22.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.319 . . . . 0.0 110.071 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 148.78 31.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 49' ' ' VAL . 18.1 m -104.45 165.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.93 -7.55 23.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.85 -177.86 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.099 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.24 141.52 41.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.415 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' CB ' ' A' ' 53' ' ' THR . 20.6 t -116.11 113.6 41.51 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 45.7 Cg_endo -73.11 -171.9 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.929 1.489 . . . . 0.0 110.514 -179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -74.97 148.36 40.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.984 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 55.58 37.17 66.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.583 ' CB ' HG13 ' A' ' 49' ' ' VAL . 34.8 m -86.35 118.5 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -1.127 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.4 t -66.16 154.49 39.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -85.82 95.47 9.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.304 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.423 ' SD ' ' HG3' ' A' ' 59' ' ' MET . 23.5 ptp -102.15 145.9 31.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.076 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.1 Cg_endo -72.74 -10.12 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.976 1.514 . . . . 0.0 110.681 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -67.47 -38.2 84.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 110.385 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.423 ' HG3' ' SD ' ' A' ' 56' ' ' MET . 6.4 mtm -100.12 3.2 43.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.372 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.74 HG11 ' HB3' ' A' ' 63' ' ' TYR . 47.5 t -120.17 130.32 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 0.3 OUTLIER -70.63 -95.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.278 -0.889 . . . . 0.0 110.071 179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -90.96 70.93 6.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 110.307 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.74 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -53.42 -36.98 62.1 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.219 -0.925 . . . . 0.0 110.238 -179.709 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 7.0 pt-20 179.88 -172.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.26 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.44 41.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.379 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.76 8.13 67.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.71 162.84 22.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -1.152 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 68' ' ' THR . 4.0 t -106.31 -129.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.986 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 68' ' ' THR . 0.9 OUTLIER -64.05 120.67 66.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.007 -1.058 . . . . 0.0 110.165 -179.931 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 45.4 Cg_endo -72.46 -91.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.906 1.477 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.79 -82.4 0.84 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.03 53.42 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.09 . . . . 0.0 109.982 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.04 161.56 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.802 . . . . 0.0 110.124 179.785 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 15.3 m -123.58 151.63 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.001 HG13 ' HG3' ' A' ' 92' ' ' MET . 90.6 t -64.16 124.65 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.307 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 74' ' ' SER . 62.0 t -119.35 131.34 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 110.329 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.13 94.97 4.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.088 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.812 ' O ' HD13 ' A' ' 121' ' ' LEU . 36.3 p-10 -59.97 -23.12 63.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 111.309 -179.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -110.52 -179.81 3.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.92 -1.113 . . . . 0.0 110.992 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.998 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -101.6 133.57 46.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.79 HD11 HG23 ' A' ' 119' ' ' VAL . 1.9 pp -120.79 119.67 29.93 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.104 -0.997 . . . . 0.0 110.364 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.833 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.1 Cg_endo -73.6 63.57 4.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.935 1.492 . . . . 0.0 110.8 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.1 mp 57.46 150.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.427 -0.795 . . . . 0.0 110.589 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 24.5 m120 42.57 85.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 87' ' ' LEU . 80.0 m -143.82 109.09 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.51 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.95 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.17 135.98 33.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.86 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 112' ' ' GLY . 31.9 p -128.21 -177.45 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.92 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -47.49 -25.91 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 110.343 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 47.5 t -60.78 -64.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 mtt -78.67 -2.52 39.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.001 ' HG3' HG13 ' A' ' 75' ' ' VAL . 1.8 ttp -96.29 113.36 24.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -112.78 84.63 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.897 179.54 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.74 98.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 110.352 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -121.09 162.17 20.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.378 -0.826 . . . . 0.0 109.404 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.569 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -74.58 77.38 1.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.261 -179.887 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.51 163.64 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.259 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 32.6 m -109.26 161.08 25.23 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 124' ' ' THR . 48.9 Cg_endo -76.26 160.54 95.34 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.533 -2.278 . . . . 0.0 110.421 -0.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.75 83.52 4.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.29 -106.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.87 HD11 ' HA ' ' A' ' 127' ' ' PRO . 33.2 mt -109.38 129.61 23.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.143 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 47.4 Cg_endo -74.07 167.89 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.967 1.509 . . . . 0.0 110.433 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 75' ' ' VAL . 90.0 p -91.9 35.12 0.98 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 10.6 mt-10 -85.78 -46.15 10.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.6 pt-20 -94.63 -11.34 29.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.047 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -54.02 -32.26 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 179.69 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -42.61 -44.59 4.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.89 -30.06 23.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.63 HD21 ' HG3' ' A' ' 134' ' ' GLU . 1.5 mt -92.45 12.51 22.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 107' ' ' ILE . 30.5 t -63.53 146.62 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.018 -1.051 . . . . 0.0 110.278 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 64.01 14.35 55.67 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 110' ' ' LEU . 2.6 mmt -73.15 156.24 38.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -1.184 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -99.39 126.93 45.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.9 HG22 ' H ' ' A' ' 117' ' ' ARG . 5.8 p -87.43 155.13 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.386 -0.821 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 129' ' ' MET . 6.4 p30 -100.41 -3.21 31.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.218 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.9 ' H ' HG22 ' A' ' 115' ' ' VAL . 23.5 mmt180 -114.11 161.13 18.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -88.84 131.89 34.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.376 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.79 HG23 HD11 ' A' ' 81' ' ' ILE . 3.0 t -113.69 158.53 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.547 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.5 m-85 -102.39 -161.7 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.998 HD23 HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -58.87 -150.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.454 -0.779 . . . . 0.0 109.889 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.9 p-10 -44.72 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.199 -0.938 . . . . 0.0 111.071 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 121' ' ' LEU . 48.4 tp60 -118.69 153.58 34.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 109.934 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 99' ' ' PRO . 36.6 m -79.08 130.07 35.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.153 -0.967 . . . . 0.0 110.433 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.806 HD11 HD12 ' A' ' 102' ' ' ILE . 0.8 OUTLIER -68.87 137.4 53.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 109.747 179.668 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.701 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.0 mtt -117.63 146.76 39.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.152 -0.968 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.87 ' HA ' HD11 ' A' ' 102' ' ' ILE . 47.7 Cg_endo -73.41 -32.72 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.085 1.571 . . . . 0.0 110.716 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -70.41 -14.64 62.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 110.195 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.455 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 2.9 mtp -86.41 -52.19 5.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.285 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 96.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 110.288 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 8.03 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -103.47 41.86 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.49 177.25 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.63 ' HG3' HD21 ' A' ' 110' ' ' LEU . 40.8 mt-10 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -74.64 -178.97 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.205 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -69.57 141.73 53.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -109.76 170.81 7.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 110.185 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 22' ' ' MET . 38.5 t -84.38 92.28 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.3 t -105.1 110.33 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.947 179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -55.42 130.61 43.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.987 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' HD23 ' A' ' 51' ' ' LEU . 15.4 p-10 -82.5 -43.2 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 1.5 pt20 -92.46 178.96 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -89.7 133.2 34.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.611 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.648 HG13 HD21 ' A' ' 17' ' ' LEU . 18.1 mm -108.73 132.12 21.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.456 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.9 Cg_endo -73.29 -163.89 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.944 1.497 . . . . 0.0 110.198 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.09 149.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.965 . . . . 0.0 110.311 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 51.07 70.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 39.3 m -141.29 131.78 25.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -78.13 91.88 4.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.974 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.648 HD21 HG13 ' A' ' 11' ' ' ILE . 54.8 mt -42.0 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p -119.08 178.73 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.643 HD23 ' CE ' ' A' ' 22' ' ' MET . 0.8 OUTLIER -69.64 -40.69 76.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.631 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.3 mp -68.23 -29.85 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.27 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.54 -2.31 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 -179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.643 ' CE ' HD23 ' A' ' 19' ' ' LEU . 9.6 tmm? -111.08 124.31 51.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.235 -0.916 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -111.13 121.24 44.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.19 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.74 71.35 10.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' CG1' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -102.25 151.02 22.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 110.223 -179.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' CA ' ' A' ' 3' ' ' ALA . 63.8 t -88.36 86.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.333 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' CG1' ' OE1' ' A' ' 25' ' ' GLU . 28.7 m -135.44 171.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -108.23 163.73 16.33 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 110.226 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.1 Cg_endo -74.81 151.85 97.47 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.627 -2.239 . . . . 0.0 110.508 -0.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 93.32 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.96 -130.77 1.59 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 55' ' ' LEU . 6.5 mt -83.99 135.94 41.84 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 45.7 Cg_endo -71.96 178.48 5.84 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.978 1.515 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -98.86 27.07 5.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.548 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 50.7 mt-10 -66.74 -46.6 74.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 109.962 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.615 ' CB ' HD13 ' A' ' 40' ' ' LEU . 3.7 mm-40 -95.09 32.62 1.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm -41.43 -51.8 8.31 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.526 -0.734 . . . . 0.0 110.7 179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.65 -6.49 19.17 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.587 1.309 . . . . 0.0 110.776 -179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -104.11 -44.57 4.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.847 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.7 mp -75.43 -13.79 60.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.257 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.08 150.84 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.881 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.591 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 63.33 10.96 37.9 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 63' ' ' TYR . 11.6 ptm -70.5 124.68 24.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.944 -1.327 . . . . 0.0 110.131 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' THR . 8.7 mt-30 -80.11 129.99 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.101 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 45' ' ' VAL . 27.0 m -89.23 168.47 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.16 -23.23 17.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.029 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -132.09 170.66 14.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.0 136.23 39.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 53' ' ' THR . 4.5 t -104.9 140.57 21.21 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.225 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.796 ' HD2' HG21 ' A' ' 53' ' ' THR . 46.9 Cg_endo -74.51 -171.07 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 O-C-N 123.967 1.509 . . . . 0.0 110.306 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -86.67 144.48 27.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.19 -0.944 . . . . 0.0 110.178 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 61.66 30.32 74.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.796 HG21 ' HD2' ' A' ' 50' ' ' PRO . 2.3 m -85.2 130.54 34.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -1.229 . . . . 0.0 110.24 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.1 t -70.5 158.19 36.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 110.159 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -72.48 94.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.34 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.2 tpt -103.34 139.41 20.09 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 -14.03 24.47 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 110.374 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.45 -35.1 54.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.078 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 mtm -99.86 1.8 43.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.35 118.58 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 62' ' ' ASN . 5.3 ttpt -60.07 -91.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 122' ' ' ASP . 1.3 m120 -90.74 84.86 5.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.157 -0.964 . . . . 0.0 110.237 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.539 ' HA ' ' CE ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -54.1 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.675 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' OE1' ' HB2' ' A' ' 63' ' ' TYR . 8.4 pm0 -136.77 168.86 18.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.29 45.49 1.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 110.273 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.73 30.02 11.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -74.06 108.98 7.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -1.112 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 3.7 m -91.73 -64.74 1.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.239 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.77 111.92 30.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CG ' ' A' ' 73' ' ' LYS . 44.8 Cg_endo -73.19 -90.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.931 1.49 . . . . 0.0 110.383 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.32 -74.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.7 mt -87.94 53.79 2.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -1.1 . . . . 0.0 109.871 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 70' ' ' PRO . 15.7 mtpt -68.25 139.8 56.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.719 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 77.4 p -141.96 157.3 45.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 109.867 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 102' ' ' ILE . 4.6 t -77.72 130.47 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.982 . . . . 0.0 110.479 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 97' ' ' VAL . 21.3 t -134.99 140.07 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.198 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.44 93.11 8.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 109.982 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.56 ' O ' HD13 ' A' ' 121' ' ' LEU . 34.5 t30 -57.56 -40.29 78.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 110.652 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 121' ' ' LEU . 4.2 mt-30 -98.4 -174.31 2.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.991 . . . . 0.0 110.261 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' HD22 ' A' ' 121' ' ' LEU . 6.0 tt -97.84 130.21 44.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.686 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mp -120.76 127.8 26.08 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -72.75 148.18 46.13 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.911 1.48 . . . . 0.0 110.657 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.637 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mt -41.85 158.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 44.84 71.45 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.412 179.802 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.686 HG21 HG23 ' A' ' 81' ' ' ILE . 6.1 m -143.48 106.41 4.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.15 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.965 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -80.02 138.4 37.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.807 HG23 ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -125.65 175.27 7.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.827 . . . . 0.0 110.014 179.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.22 -28.16 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 110.463 -179.768 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.15 -65.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.5 mtt -81.51 -7.19 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.028 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 107' ' ' ILE . 4.5 ttt -93.66 141.15 28.81 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.406 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HG3' ' CB ' ' A' ' 78' ' ' ASN . 2.4 mttm -131.82 93.22 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 110.478 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.37 94.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.9 tt0 -123.47 161.92 23.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -69.36 100.55 1.37 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 110.169 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.874 HG21 HG21 ' A' ' 76' ' ' VAL . 15.3 t -129.95 137.46 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.299 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 3.5 p -109.7 140.57 22.32 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.0 Cg_endo -74.99 159.43 98.02 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.751 -2.187 . . . . 0.0 110.143 -0.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.99 105.05 6.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.164 -179.95 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 -93.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.753 ' O ' HG23 ' A' ' 75' ' ' VAL . 7.2 mt -109.65 124.07 34.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.173 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.47 158.3 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.891 1.469 . . . . 0.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.1 t -87.82 27.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.304 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 15.1 pt-20 -71.64 -40.31 69.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.947 . . . . 0.0 110.1 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.511 ' CD ' HD11 ' A' ' 110' ' ' LEU . 10.1 pt-20 -113.06 -5.45 13.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.5 OUTLIER -49.28 -38.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.308 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -42.39 -41.65 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.042 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -88.57 -24.62 22.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 0.0 110.137 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.942 HD21 ' CD ' ' A' ' 134' ' ' GLU . 44.9 mt -93.33 1.84 56.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 107' ' ' ILE . 38.0 t -62.73 138.24 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.353 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.807 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 77.3 11.26 85.69 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.469 ' SD ' ' HB3' ' A' ' 110' ' ' LEU . 27.5 ptm -73.97 144.62 45.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.12 -1.224 . . . . 0.0 109.998 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.68 131.39 35.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.366 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 117' ' ' ARG . 12.6 p -87.84 153.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -100.41 -1.97 34.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 115' ' ' VAL . 2.3 mtt180 -124.7 172.55 9.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.86 146.88 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 21.2 t -122.68 142.26 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.227 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 81.1 m-85 -100.83 -161.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -58.5 -151.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.327 -179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 3.5 m-20 -44.5 87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.324 -0.86 . . . . 0.0 111.029 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.0 tt0 -118.21 148.07 42.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.2 m -78.56 125.4 29.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 126' ' ' MET . 0.6 OUTLIER -81.15 128.71 34.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.995 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.1 mtm -121.55 157.24 57.11 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' HD11 ' A' ' 102' ' ' ILE . 46.9 Cg_endo -73.73 -24.81 15.31 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.946 1.498 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.74 -9.0 59.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 110.026 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.1 ttp -87.52 -33.81 18.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 131' ' ' LYS . 16.8 t -89.04 177.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.581 ' H ' HG12 ' A' ' 130' ' ' VAL . 2.7 pttt -71.27 -139.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 110.378 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -91.0 60.42 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 110.132 -179.942 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.4 OUTLIER -58.81 128.65 38.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.862 0.839 . . . . 0.0 110.832 -179.808 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.942 ' CD ' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.697 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.186 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.225 0.536 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -84.99 176.61 8.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.186 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.714 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.38 145.04 44.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.28 156.96 17.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 22' ' ' MET . 44.0 t -84.78 102.93 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.381 -0.824 . . . . 0.0 110.48 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -114.67 123.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -53.19 137.13 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.348 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.3 m-20 -82.73 -50.72 8.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' HG2' HD11 ' A' ' 11' ' ' ILE . 2.4 pt20 -93.76 -172.21 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 110.437 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.7 tt -89.7 114.56 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.23 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.672 HD12 ' HE3' ' A' ' 21' ' ' MET . 4.9 mm -98.7 127.57 35.21 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.528 -179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.94 -162.96 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.865 1.455 . . . . 0.0 110.173 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.781 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.4 pp -83.79 162.91 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.326 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.62 ' HB2' HD12 ' A' ' 13' ' ' ILE . 71.0 m-20 41.22 63.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.56 -0.713 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.4 m -136.92 110.53 8.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.271 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.93 101.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.775 HD12 ' HG3' ' A' ' 43' ' ' MET . 6.6 mt -53.56 148.8 8.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.596 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.0 p -120.72 169.14 10.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.509 -0.745 . . . . 0.0 110.027 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 22' ' ' MET . 1.0 OUTLIER -58.85 -24.6 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.216 179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.01 -57.44 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.24 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.672 ' HE3' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -84.33 12.27 7.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.362 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 5' ' ' VAL . 38.6 ttm -107.42 116.78 32.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.673 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HD2' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -111.32 122.51 48.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.667 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.714 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -89.45 60.48 5.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -103.37 156.24 17.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.703 HG22 ' HA ' ' A' ' 3' ' ' ALA . 24.9 t -88.42 94.06 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' CG2' HG21 ' A' ' 6' ' ' VAL . 8.7 m -138.81 168.39 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.4 p -108.99 165.04 13.37 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.142 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.9 Cg_endo -74.75 169.62 73.85 Favored 'Cis proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.659 -2.225 . . . . 0.0 110.413 -0.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 18.2 ptm -72.64 -173.21 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.379 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.55 -104.81 0.21 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HD12 ' A' ' 55' ' ' LEU . 27.8 mt -116.51 124.94 28.89 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.31 -1.112 . . . . 0.0 109.922 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.46 175.5 10.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.866 1.456 . . . . 0.0 110.366 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -86.84 32.36 0.67 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.44 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -66.94 -49.72 64.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.437 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.053 ' CB ' HD13 ' A' ' 40' ' ' LEU . 66.4 mm-40 -93.77 29.83 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.801 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.677 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.9 mm -38.17 -53.1 2.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.532 -0.73 . . . . 0.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.7 Cg_endo -71.83 -16.81 29.48 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.591 1.311 . . . . 0.0 111.314 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLU . 2.5 m-20 -103.91 -43.25 5.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.053 HD13 ' CB ' ' A' ' 36' ' ' GLU . 6.5 mp -76.82 -27.46 55.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.799 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -45.68 150.31 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.057 -1.027 . . . . 0.0 109.871 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.33 13.42 70.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD12 ' A' ' 17' ' ' LEU . 10.5 ptp -70.19 139.29 52.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.947 -1.325 . . . . 0.0 110.172 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.5 mt-30 -94.55 136.63 34.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.825 . . . . 0.0 109.742 179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 49' ' ' VAL . 27.1 m -85.87 162.87 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.434 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -12.59 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.978 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' C ' HG22 ' A' ' 13' ' ' ILE . 5.5 mtt180 -135.75 -174.78 3.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 110.181 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.34 145.48 41.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.249 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 45' ' ' VAL . 4.8 t -119.95 116.69 32.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.4 Cg_endo -72.11 178.58 5.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.866 1.456 . . . . 0.0 110.172 179.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -74.44 128.43 35.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 110.36 -179.821 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.56 32.65 37.07 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 49' ' ' VAL . 57.6 m -86.52 118.47 25.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.211 -1.17 . . . . 0.0 110.346 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 6.9 t -60.15 166.96 2.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.914 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -86.94 106.9 18.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 110.505 -179.783 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -99.05 129.21 30.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.765 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 46.8 Cg_endo -73.05 -12.62 25.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.817 1.43 . . . . 0.0 110.661 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -36.23 36.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mtm -104.02 6.11 35.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 55' ' ' LEU . 55.1 t -120.38 82.1 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -72.31 -2.08 17.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 0.0 111.303 -179.757 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.447 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 1.4 m120 -91.25 -36.93 13.62 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.823 -1.173 . . . . 0.0 112.146 -178.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -53.66 111.11 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.888 -1.132 . . . . 0.0 109.465 -179.3 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 21.8 mm-40 -48.14 178.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.668 0.746 . . . . 0.0 111.119 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -64.98 1.06 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.298 179.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.78 9.06 19.68 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.78 -179.58 7.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -1.089 . . . . 0.0 110.282 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 69' ' ' SER . 29.1 m -107.71 -85.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.468 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' THR . 0.4 OUTLIER -74.66 133.88 76.32 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.364 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.44 -89.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.999 1.526 . . . . 0.0 110.564 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.15 -81.55 1.62 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.86 52.27 2.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.922 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -89.06 129.71 35.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 110.348 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -104.43 156.39 17.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.956 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 104' ' ' SER . 3.8 t -67.74 111.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.542 HG22 ' HA ' ' A' ' 124' ' ' THR . 83.1 t -114.44 139.88 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -85.32 87.93 7.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.5 t-20 -57.33 -15.78 7.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.385 -0.822 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.34 -170.35 1.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.964 . . . . 0.0 110.177 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.3 tt -105.14 131.18 52.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 64.1 mt -121.19 121.08 28.81 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 85' ' ' THR . 48.1 Cg_endo -73.38 156.09 50.59 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.864 1.455 . . . . 0.0 110.748 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.58 HG13 ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -44.42 155.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 110.297 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 19.0 m-80 42.87 76.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' LEU . 18.2 m -142.7 100.91 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.32 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -75.93 140.06 41.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.851 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.638 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.6 p -119.23 168.61 10.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.159 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.757 HD23 HG13 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -47.29 -22.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 110.806 -179.354 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.638 HG22 ' OG1' ' A' ' 88' ' ' THR . 31.4 m -66.28 -44.98 90.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 0.0 110.046 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.601 ' N ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -85.27 10.9 11.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.35 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.637 ' SD ' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -105.78 137.28 43.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.134 -0.979 . . . . 0.0 110.506 -179.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' CG ' ' HB2' ' A' ' 78' ' ' ASN . 3.9 mttp -130.1 94.62 3.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.879 . . . . 0.0 109.929 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB1' ' HG3' ' A' ' 73' ' ' LYS . . . -70.3 99.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.836 . . . . 0.0 110.427 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -119.88 152.99 36.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -76.18 95.23 3.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 110.301 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -150.13 159.74 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 110.427 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -109.66 159.66 30.76 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.2 179.842 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.3 Cg_endo -76.97 167.6 79.49 Favored 'Cis proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.556 -2.268 . . . . 0.0 110.37 -0.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -84.95 98.96 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.32 -107.34 0.34 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 125' ' ' LEU . 7.1 mt -109.26 122.68 38.93 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 110.076 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.13 167.62 26.88 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.89 1.468 . . . . 0.0 110.401 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 75' ' ' VAL . 14.9 t -85.56 40.39 0.84 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.68 -40.84 13.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -99.51 -6.95 26.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.938 . . . . 0.0 110.332 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.948 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.9 mm -52.06 -37.18 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.295 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ILE . 1.1 p -43.02 -37.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.296 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -95.66 -26.68 15.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.365 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 134' ' ' GLU . 18.9 mt -94.45 11.67 29.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.8 t -58.48 128.89 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 79.55 22.87 63.68 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.4 143.21 46.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.157 . . . . 0.0 110.055 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -88.55 131.34 34.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.8 p -87.63 156.65 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -100.4 -7.05 24.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.174 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.834 ' H ' HG22 ' A' ' 115' ' ' VAL . 6.7 ttm-85 -124.68 165.66 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.42 -0.8 . . . . 0.0 109.642 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.58 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -76.99 152.26 35.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.359 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 10.9 t -128.55 137.4 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.021 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 121' ' ' LEU . 10.8 m-85 -91.21 -166.19 1.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.812 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -58.42 -145.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.508 -0.745 . . . . 0.0 110.903 -179.643 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 26.2 t70 -43.69 87.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.323 -0.861 . . . . 0.0 111.201 -179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 121' ' ' LEU . 2.2 tp-100 -118.24 148.9 41.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.752 . . . . 0.0 109.891 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' HG22 ' A' ' 76' ' ' VAL . 65.9 m -78.78 142.93 36.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.049 179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 102' ' ' ILE . 6.4 tp -78.5 123.97 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.461 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -127.05 157.37 72.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 0.0 110.185 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.42 -13.73 22.76 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.075 1.566 . . . . 0.0 110.489 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -20.43 60.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.287 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.447 ' HG3' ' HD2' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -81.36 -47.42 13.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 133' ' ' TYR . 17.8 t -87.93 134.29 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.922 . . . . 0.0 110.106 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -70.53 -79.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.94 63.07 3.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 130' ' ' VAL . 5.3 p90 -77.01 155.15 32.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.726 ' HB2' HD21 ' A' ' 110' ' ' LEU . 21.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.23 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.6 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -91.75 176.15 6.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.19 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -78.0 139.2 39.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 110.259 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -103.3 170.37 7.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.071 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.585 HG23 ' C ' ' A' ' 33' ' ' PRO . 70.9 t -84.68 90.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.151 -0.968 . . . . 0.0 110.58 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG21 ' CG2' ' A' ' 27' ' ' VAL . 3.0 t -113.22 130.83 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.581 179.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.857 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -70.39 131.38 44.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.648 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.8 p-10 -81.89 -37.93 26.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.73 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HG2' ' HG2' ' A' ' 21' ' ' MET . 6.6 pt20 -91.48 173.57 7.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.564 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -70.54 142.17 51.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.96 HG23 HD21 ' A' ' 17' ' ' LEU . 42.4 mm -106.35 125.31 33.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.592 -179.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.0 Cg_endo -73.63 -158.93 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.955 1.503 . . . . 0.0 110.156 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -110.75 156.88 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.259 -0.9 . . . . 0.0 110.021 179.685 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 13' ' ' ILE . 18.2 p30 37.01 53.6 1.16 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.672 -0.642 . . . . 0.0 110.554 -179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.494 ' CB ' ' HG2' ' A' ' 12' ' ' PRO . 88.1 m -126.02 139.29 53.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.436 -0.79 . . . . 0.0 110.269 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -81.25 90.12 6.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.031 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.96 HD21 HG23 ' A' ' 11' ' ' ILE . 62.1 mt -45.51 150.71 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.189 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -120.54 176.61 5.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.575 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.1 mm? -54.5 -42.22 70.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.877 . . . . 0.0 110.08 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.1 -39.74 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 9' ' ' GLN . 10.8 mtt -83.53 3.01 34.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.532 ' CG ' HG13 ' A' ' 5' ' ' VAL . 3.2 ttm -109.46 108.09 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.483 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 8' ' ' ASN . 3.9 mttm -111.31 125.01 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.649 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -84.17 74.39 10.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -103.03 152.43 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.34 99.92 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.756 ' CG2' HG21 ' A' ' 6' ' ' VAL . 9.3 m -142.49 170.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 1.7 t -109.06 152.78 42.66 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.2 Cg_endo -76.58 156.84 98.03 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.631 -2.237 . . . . 0.0 110.402 -0.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -71.35 74.59 0.73 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -61.03 -137.36 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.968 HD11 ' CE2' ' A' ' 63' ' ' TYR . 8.7 mt -83.57 136.26 42.64 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.101 -1.235 . . . . 0.0 110.077 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 5' ' ' VAL . 46.5 Cg_endo -73.5 -172.66 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.658 ' HB1' HG13 ' A' ' 37' ' ' ILE . . . -87.07 24.53 1.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.35 -53.68 33.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.303 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -88.58 32.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 HG13 ' HB1' ' A' ' 34' ' ' ALA . 2.0 mm -52.53 -56.15 25.49 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 43.8 Cg_endo -70.61 -11.21 29.37 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.787 1.414 . . . . 0.0 110.885 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -104.22 -36.11 7.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 0.0 110.615 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.959 HD12 ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -91.8 -15.09 28.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.929 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.793 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.1 t -56.37 151.79 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.55 7.6 61.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.605 ' HE2' ' O ' ' A' ' 62' ' ' ASN . 2.9 ptp -70.69 151.9 44.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.842 -1.387 . . . . 0.0 109.835 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' THR . 9.2 mt-30 -93.44 143.86 25.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' PRO . 31.9 m -96.49 170.91 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' ' CD ' ' A' ' 61' ' ' LYS . 2.2 t-20 -101.4 -20.78 15.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -149.19 157.27 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 110.432 -179.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.18 146.91 47.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.71 HG21 HG23 ' A' ' 53' ' ' THR . 58.2 t -120.08 139.18 27.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.88 . . . . 0.0 110.267 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 51' ' ' LEU . 45.6 Cg_endo -73.13 70.92 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.052 1.554 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER 54.14 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 179.645 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 52.78 53.84 31.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 56.2 m -86.66 106.37 17.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -1.185 . . . . 0.0 110.449 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 15.0 t -75.9 153.2 36.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -74.26 69.95 1.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.321 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.552 ' O ' HG23 ' A' ' 60' ' ' VAL . 34.0 ttm -87.82 140.82 31.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.72 -18.61 28.51 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.882 1.464 . . . . 0.0 110.652 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.76 -34.77 30.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtt -104.19 20.43 18.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.687 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 56' ' ' MET . 23.5 t -120.09 97.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.41 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' CD ' ' OD1' ' A' ' 46' ' ' ASN . 21.8 tttt -62.59 -59.17 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.559 179.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' O ' ' HE2' ' A' ' 43' ' ' MET . 11.3 t-20 -79.77 62.69 4.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.418 -0.801 . . . . 0.0 109.693 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.982 ' CE1' HG23 ' A' ' 67' ' ' THR . 26.6 t80 -71.09 104.43 3.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.46 -0.775 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.959 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -34.16 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.776 0.798 . . . . 0.0 111.875 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.59 53.82 1.13 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 110.285 179.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.16 19.32 15.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.982 HG23 ' CE1' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -73.95 168.15 20.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -1.089 . . . . 0.0 110.375 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -133.65 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.828 . . . . 0.0 109.915 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 139.36 97.7 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 110.116 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.47 -88.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.103 1.58 . . . . 0.0 110.502 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.94 -82.4 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.484 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 17.8 mt -87.91 51.46 2.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -1.118 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.595 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.0 132.25 47.52 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.566 -0.709 . . . . 0.0 110.567 -179.79 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -112.66 159.49 18.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.074 179.803 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG11 ' SD ' ' A' ' 92' ' ' MET . 13.2 t -82.71 127.18 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.267 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 123' ' ' GLN . 62.1 t -133.37 144.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.235 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.04 89.86 3.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.62 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.6 t30 -57.33 -34.54 68.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.631 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 -173.56 2.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.3 tt -96.78 130.48 44.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.513 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' ' CG1' ' A' ' 119' ' ' VAL . 11.4 mm -120.73 130.05 25.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.892 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.9 Cg_endo -74.14 157.34 46.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.894 1.471 . . . . 0.0 110.91 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.846 HG22 ' OD1' ' A' ' 84' ' ' ASN . 12.2 mt -53.12 137.99 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.508 -0.745 . . . . 0.0 110.228 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.846 ' OD1' HG22 ' A' ' 83' ' ' ILE . 11.8 m120 62.42 74.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.222 -0.924 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' LEU . 58.4 m -143.54 108.86 5.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.995 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.53 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -88.64 141.53 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 110.141 -179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.539 HG22 ' N ' ' A' ' 112' ' ' GLY . 72.1 p -127.47 -177.79 4.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -48.43 -28.95 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.085 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.35 -51.86 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.36 -21.65 35.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 110.187 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.95 135.44 43.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.9 . . . . 0.0 110.25 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.12 98.43 5.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 0.0 110.029 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 74' ' ' SER . 6.4 mm-40 -120.51 131.04 54.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.278 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.595 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . 3.6 tp10 -69.75 90.87 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 98' ' ' SER . 7.3 p -143.88 174.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -109.04 151.66 42.05 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 179.957 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.2 Cg_endo -76.61 159.25 96.48 Favored 'Cis proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.567 -2.264 . . . . 0.0 110.447 -0.259 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 94.81 8.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.89 . . . . 0.0 110.0 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -77.32 -111.78 0.16 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.604 HD11 ' CA ' ' A' ' 127' ' ' PRO . 7.9 mt -109.23 131.96 21.53 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.223 -1.163 . . . . 0.0 110.285 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 169.92 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.982 1.517 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 p -86.25 44.0 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 18.9 pt-20 -87.48 -34.44 18.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.918 . . . . 0.0 110.173 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 3.9 mt-10 -112.12 -0.36 15.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.024 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.1 tt -49.29 -34.46 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 110.03 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -45.61 -45.68 13.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.872 . . . . 0.0 110.181 179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -30.45 31.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 113' ' ' MET . 7.1 mt -92.47 14.55 16.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.2 t -65.56 136.48 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 110.361 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 88' ' ' THR . . . 61.03 22.89 60.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -74.82 144.77 43.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -1.166 . . . . 0.0 110.223 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -85.93 134.28 33.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -0.922 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 87' ' ' LEU . 1.6 m -87.82 161.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 131' ' ' LYS . 31.3 t-20 -100.48 -9.13 22.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.778 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 176.58 6.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.996 179.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -85.6 140.9 30.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 12.6 t -110.04 138.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.436 -0.79 . . . . 0.0 110.053 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 68.4 m-85 -99.88 -165.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -58.66 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.42 -0.8 . . . . 0.0 110.598 -179.812 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.1 t70 -43.78 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 110.943 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.721 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.2 tt0 -117.96 146.25 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.475 -0.765 . . . . 0.0 109.796 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -78.76 140.27 38.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 126' ' ' MET . 1.6 tp -70.58 132.98 46.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.954 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.781 ' N ' HD12 ' A' ' 125' ' ' LEU . 5.8 mtm -126.33 146.47 56.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.289 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.604 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.5 Cg_endo -74.05 -14.91 23.5 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.99 1.521 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.12 -3.35 58.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.24 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.4 tpp -97.2 -13.59 21.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 110.197 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.66 152.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 116' ' ' ASN . 10.8 mtpt -70.47 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.21 83.47 5.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.856 . . . . 0.0 110.227 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -65.25 168.37 7.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.226 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.24 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.5 t30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.306 0.574 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -90.22 175.7 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.138 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.668 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -73.32 136.9 44.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.46 154.56 18.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 110.174 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.726 HG13 ' HG3' ' A' ' 22' ' ' MET . 99.9 t -84.49 105.25 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 110.315 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 54' ' ' THR . 10.5 t -119.55 124.14 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.129 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -56.4 132.73 51.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.194 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.726 ' O ' HD23 ' A' ' 51' ' ' LEU . 17.8 t-20 -82.91 -44.61 15.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.546 ' NE2' ' HG2' ' A' ' 21' ' ' MET . 1.6 pt20 -92.2 -177.22 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB2' HD12 ' A' ' 51' ' ' LEU . 2.9 tt -89.62 128.84 36.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.805 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 32.5 mm -111.63 133.23 21.56 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.574 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 47.4 Cg_endo -75.33 -161.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.95 1.5 . . . . 0.0 110.306 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.63 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.0 mp -86.92 162.63 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 13' ' ' ILE . 8.1 p30 37.91 63.8 0.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.682 . . . . 0.0 110.673 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 53.1 m -135.89 126.83 27.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -75.62 124.67 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.937 . . . . 0.0 110.151 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 42' ' ' GLY . 61.8 mt -73.61 152.75 40.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.337 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 22' ' ' MET . 68.5 p -120.4 174.49 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 19' ' ' LEU . 1.5 mm? -61.93 -34.49 76.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.59 -36.54 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.546 ' HG2' ' NE2' ' A' ' 9' ' ' GLN . 46.0 mtm -87.39 9.54 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.882 . . . . 0.0 110.252 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.726 ' HG3' HG13 ' A' ' 5' ' ' VAL . 4.3 tpp -114.22 118.49 34.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.03 111.33 22.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.5 72.42 10.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.99 146.79 27.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.933 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 3' ' ' ALA . 96.8 t -88.65 73.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 m -140.31 -179.85 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -99.62 166.48 12.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.571 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.06 150.19 95.18 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.425 -0.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -70.42 163.01 27.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.38 -134.76 1.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 55' ' ' LEU . 5.7 mt -80.59 134.28 54.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.211 -1.17 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.51 172.72 14.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.449 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.92 15.18 4.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -70.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -81.89 53.9 2.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.221 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.921 HG22 ' HD3' ' A' ' 38' ' ' PRO . 3.8 tp -68.51 -30.77 2.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 111.809 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.921 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.8 Cg_endo -77.89 -14.58 15.39 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 N-CA-C 109.985 -0.813 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 32.5 m-80 -104.88 -41.06 5.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -76.11 -23.49 54.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.729 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG22 ' CE ' ' A' ' 22' ' ' MET . 1.1 t -56.36 150.46 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.03 -1.044 . . . . 0.0 110.209 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.542 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.48 13.65 61.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 60' ' ' VAL . 1.2 ptp -69.85 151.21 45.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.85 -1.382 . . . . 0.0 110.033 179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -100.16 139.35 35.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG21 ' A' ' 49' ' ' VAL . 19.3 m -88.56 163.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.21 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.29 -10.02 31.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.101 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.477 ' NH2' ' SD ' ' A' ' 59' ' ' MET . 5.1 ptm180 -146.79 -177.7 5.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.07 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.52 139.78 56.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.132 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.738 HG21 HG11 ' A' ' 45' ' ' VAL . 4.5 t -118.09 118.73 34.15 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.926 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.37 -170.64 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.924 1.486 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -79.82 148.69 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 110.29 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.58 90.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.624 ' CB ' HG13 ' A' ' 49' ' ' VAL . 98.2 m -84.05 109.64 17.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.1 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.571 HG21 ' HG2' ' A' ' 29' ' ' PRO . 12.5 t -63.66 161.17 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.196 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.0 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.57 100.21 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -0.861 . . . . 0.0 110.358 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.435 ' CG ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 tpt -92.31 134.7 27.85 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.142 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 46.4 Cg_endo -73.46 -29.45 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.016 1.535 . . . . 0.0 110.523 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' CG ' ' A' ' 56' ' ' MET . 6.9 p-10 -81.32 -34.91 31.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.477 ' SD ' ' NH2' ' A' ' 47' ' ' ARG . 5.5 mtt -85.24 -3.26 58.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' CE ' ' A' ' 43' ' ' MET . 98.3 t -119.37 125.56 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.0 110.369 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.65 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 109.789 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.513 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 1.7 t-20 -69.59 93.06 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.818 -1.176 . . . . 0.0 109.817 179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB2' ' OE2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -53.52 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 -179.286 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -106.62 178.42 4.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.1 . . . . 0.0 110.503 -179.588 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -86.8 59.67 5.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.535 -0.728 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.2 27.02 7.14 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 p -94.01 102.22 14.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -1.165 . . . . 0.0 110.223 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -81.32 -82.43 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 -179.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 m -83.75 111.02 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.187 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 47.8 Cg_endo -73.48 -90.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.982 1.517 . . . . 0.0 110.561 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.74 -82.42 0.61 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.12 39.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.375 -1.073 . . . . 0.0 110.183 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 3.0 pttt -74.33 155.32 38.3 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.631 -0.668 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -123.03 159.18 28.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.01 179.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.757 HG12 ' SD ' ' A' ' 92' ' ' MET . 6.6 t -71.16 127.5 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.168 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 97' ' ' VAL . 47.7 t -126.04 140.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.81 91.22 6.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.533 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.6 t-20 -57.47 -35.91 70.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -110.03 -169.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.137 -0.977 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 2.7 tt -99.47 125.8 45.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.585 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.5 mt -120.67 133.71 24.12 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 150.23 42.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.947 1.498 . . . . 0.0 110.936 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.737 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 13.0 mt -48.37 161.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ILE . 5.5 m-20 40.39 74.29 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 110.776 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.789 ' O ' HD23 ' A' ' 87' ' ' LEU . 52.8 m -143.85 113.2 6.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.031 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -54.44 85.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 85' ' ' THR . 0.5 OUTLIER -89.14 147.74 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 110.278 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 112' ' ' GLY . 2.9 p -125.14 177.75 5.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.51 -28.8 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 -179.942 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.66 -49.66 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.249 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.4 -25.62 28.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 75' ' ' VAL . 5.5 mmt -98.33 131.25 44.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 110.125 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -121.43 114.75 21.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.377 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 104' ' ' SER . . . -79.55 100.49 7.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.461 ' C ' ' HB2' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -117.88 165.03 14.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.986 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.704 ' OE2' HD21 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -83.03 84.77 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 76' ' ' VAL . 10.1 p -139.35 161.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.416 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 20.2 m -109.5 154.2 42.44 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 110.137 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 124' ' ' THR . 51.7 Cg_endo -77.47 168.29 76.94 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.351 -0.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -93.62 88.44 5.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.837 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -71.66 -96.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.699 HD12 HD11 ' A' ' 125' ' ' LEU . 7.6 mt -109.08 130.37 22.81 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.219 -1.165 . . . . 0.0 110.168 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 105' ' ' GLU . 44.7 Cg_endo -72.87 169.51 21.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.025 1.54 . . . . 0.0 110.698 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 50.8 p -89.04 9.41 25.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 15.9 pt-20 -73.38 -16.71 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.167 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 110' ' ' LEU . 18.0 mt-10 -105.04 -23.24 12.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.851 ' O ' HG23 ' A' ' 111' ' ' VAL . 26.2 mm -53.65 -36.26 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -47.41 17.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.088 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -85.75 -24.73 26.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.633 HD11 ' OE1' ' A' ' 134' ' ' GLU . 3.1 mt -101.51 22.68 12.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 110.07 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -59.67 127.37 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.905 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 88' ' ' THR . . . 72.81 24.01 76.83 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.5 ptm -73.42 158.69 34.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -1.086 . . . . 0.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.17 115.76 28.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.89 HG22 ' H ' ' A' ' 117' ' ' ARG . 4.2 p -81.08 154.79 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.916 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -102.76 3.64 37.08 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.132 -0.98 . . . . 0.0 110.7 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.89 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.75 158.66 32.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 110.182 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -78.73 140.1 38.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 55.8 t -114.23 120.97 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.533 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 4.7 m-85 -84.91 -162.37 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.325 -0.859 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.98 -149.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.328 -0.858 . . . . 0.0 110.236 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 50.9 p-10 -44.98 83.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.399 -0.813 . . . . 0.0 111.356 -179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 121' ' ' LEU . 4.1 tp-100 -119.31 150.89 39.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -78.98 139.79 38.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 110.177 179.798 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.912 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -79.79 125.71 30.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.912 ' N ' HD12 ' A' ' 125' ' ' LEU . 3.5 mtt -126.67 134.83 26.47 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.354 -0.841 . . . . 0.0 110.344 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.645 ' CB ' ' CD2' ' A' ' 133' ' ' TYR . 47.1 Cg_endo -83.08 60.31 6.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.031 1.542 . . . . 0.0 110.66 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.9 -72.32 0.6 Allowed 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.463 -0.773 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.535 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 21.6 ptm -101.68 2.63 38.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.454 -0.779 . . . . 0.0 111.1 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 130' ' ' VAL . 3.9 m -72.14 123.56 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.939 -1.101 . . . . 0.0 110.19 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 131' ' ' LYS . 1.9 mtmt -91.21 -10.05 43.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.294 -0.879 . . . . 0.0 110.739 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB3' ' CE ' ' A' ' 113' ' ' MET . 3.6 t-20 -90.67 1.9 56.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -0.972 . . . . 0.0 110.146 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.645 ' CD2' ' CB ' ' A' ' 127' ' ' PRO . 10.8 t80 -79.5 137.84 37.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.84 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.633 ' OE1' HD11 ' A' ' 110' ' ' LEU . 24.8 mt-10 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.173 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.482 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.41 0.624 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' N ' ' CG ' ' A' ' 1' ' ' ASN . 0.3 OUTLIER -73.53 -172.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.797 . . . . 0.0 110.207 179.994 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.05 147.86 52.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.271 -179.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -119.38 174.71 6.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 33' ' ' PRO . 79.9 t -82.49 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.422 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 6.8 t -119.92 114.73 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -50.86 128.13 20.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 110.242 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.55 ' O ' HD23 ' A' ' 51' ' ' LEU . 4.0 t-20 -88.57 -37.45 15.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' HD11 ' A' ' 11' ' ' ILE . 4.5 pt20 -92.08 172.8 8.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.089 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 11' ' ' ILE . 5.0 tt -89.82 128.96 36.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' HE3' ' A' ' 21' ' ' MET . 8.5 mm -111.45 142.85 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 11' ' ' ILE . 48.1 Cg_endo -74.13 -162.91 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.102 1.58 . . . . 0.0 110.23 179.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.3 mp -86.83 152.83 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' ND2' HG22 ' A' ' 13' ' ' ILE . 71.6 m-80 45.2 74.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 109.996 -179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 48.8 m -139.03 129.42 25.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 110.361 -179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -74.31 117.71 16.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HE1' ' A' ' 21' ' ' MET . 4.9 mt -72.04 148.96 45.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -120.78 -175.39 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 0.0 110.158 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.35 -35.24 77.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.9 . . . . 0.0 109.977 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.85 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.729 ' HE3' HD12 ' A' ' 11' ' ' ILE . 13.7 mtp -81.15 1.74 30.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.449 ' HG3' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -105.34 106.46 16.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.955 . . . . 0.0 110.289 -179.837 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -111.02 116.88 31.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 110.129 179.907 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.712 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -76.42 75.1 3.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -103.1 151.34 22.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 3' ' ' ALA . 93.4 t -88.09 101.19 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 6' ' ' VAL . 7.2 m -143.19 148.7 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.918 . . . . 0.0 110.19 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 7.6 t -102.41 148.48 35.51 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.8 Cg_endo -76.02 147.46 87.74 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.633 -2.236 . . . . 0.0 110.467 -0.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -72.64 96.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 110.308 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.65 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.948 HD12 HD12 ' A' ' 55' ' ' LEU . 7.6 mt -87.59 127.78 57.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 46.8 Cg_endo -72.84 -164.0 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -85.92 35.53 0.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.492 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.14 -79.47 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 110.966 -179.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -86.8 27.01 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.877 -179.282 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -42.53 -51.89 11.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.442 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.2 Cg_endo -70.89 -1.46 9.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.568 1.299 . . . . 0.0 110.767 -179.617 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -103.71 -60.51 1.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.349 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -86.22 4.15 39.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 0.0 111.485 -179.474 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.637 ' N ' HD13 ' A' ' 40' ' ' LEU . 1.2 t -55.75 150.77 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.668 -1.27 . . . . 0.0 109.844 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 66.72 12.69 59.87 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.55 179.103 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.566 ' CE ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -70.45 156.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.352 . . . . 0.0 109.908 179.719 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' NE2' HD23 ' A' ' 121' ' ' LEU . 61.9 mt-30 -98.34 133.06 43.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 110.275 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 m -86.91 160.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.53 -12.45 42.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 -140.45 167.86 21.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.74 140.88 56.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.0 t -103.07 124.67 37.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.159 -179.83 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.7 Cg_endo -72.92 -175.17 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.86 1.452 . . . . 0.0 110.328 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.49 125.74 30.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.356 -179.873 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 79.02 35.67 30.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.603 HG21 ' HD2' ' A' ' 50' ' ' PRO . 3.8 m -86.5 126.71 34.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 0.0 110.214 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 10.1 t -75.14 155.13 37.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.129 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD12 HD12 ' A' ' 32' ' ' ILE . 0.8 OUTLIER -72.93 96.59 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.89 . . . . 0.0 110.14 179.912 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.02 20.14 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.87 -14.4 26.63 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.976 1.514 . . . . 0.0 110.342 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -70.53 -31.35 68.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.04 8.8 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.142 -0.974 . . . . 0.0 110.269 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.1 128.03 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 110.307 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -152.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 63' ' ' TYR . 47.0 t30 -72.28 79.83 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.267 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.93 -102.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.323 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.6 mm-40 -106.47 -150.26 0.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 110.316 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -86.22 56.63 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.94 -25.34 75.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.15 139.06 31.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -1.119 . . . . 0.0 110.3 179.898 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 69' ' ' SER . 14.0 t -105.2 -40.67 5.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.159 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 68' ' ' THR . 3.4 m -83.69 111.07 29.33 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 45.5 Cg_endo -73.35 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.053 1.554 . . . . 0.0 110.704 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.48 -82.74 0.02 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 72' ' ' LEU . 6.5 mt -88.45 52.67 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -1.054 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 2.3 pttp -86.1 122.29 29.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -0.757 . . . . 0.0 110.646 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -111.22 167.46 10.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.527 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' HG2' ' A' ' 92' ' ' MET . 3.1 t -78.63 123.1 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 123' ' ' GLN . 69.9 t -125.09 141.72 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.8 89.16 5.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 60.8 t-20 -57.66 -28.16 63.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.394 -0.816 . . . . 0.0 110.921 -179.513 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -109.35 179.86 4.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.035 -1.041 . . . . 0.0 110.311 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.98 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 tm? -83.2 135.81 34.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.743 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.98 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.1 mm -122.87 110.75 31.34 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.537 -0.727 . . . . 0.0 109.92 179.363 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 46.3 Cg_endo -73.1 146.7 41.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.381 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.7 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 3.4 mt -41.59 147.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.371 -0.831 . . . . 0.0 110.245 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 53.55 73.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 82' ' ' PRO . 17.7 m -143.59 100.48 3.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 110.252 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.5 92.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 110.131 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -89.65 151.88 21.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 -179.911 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.65 HG22 ' CA ' ' A' ' 112' ' ' GLY . 50.8 p -130.44 -179.71 5.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.945 . . . . 0.0 110.258 -179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -47.48 -28.58 2.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.303 -179.888 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.29 -52.27 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 mtt -74.31 -21.59 59.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 75' ' ' VAL . 4.3 mtt -101.87 132.83 47.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -123.88 118.77 27.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.327 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.67 98.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -120.28 152.16 38.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -82.11 94.2 7.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -142.3 161.45 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.32 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 68.3 m -109.89 151.65 42.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.359 -0.838 . . . . 0.0 110.131 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -76.9 172.35 63.6 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.652 -2.228 . . . . 0.0 110.316 -0.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -93.71 93.92 8.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -70.72 -103.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 133' ' ' TYR . 5.5 mt -116.24 126.68 27.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.307 -1.114 . . . . 0.0 110.056 179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 44.5 Cg_endo -72.46 -171.79 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.78 1.41 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -95.81 49.01 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.506 -179.83 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 106' ' ' GLU . 4.3 pm0 -87.71 -26.4 22.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.419 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.549 ' N ' ' HG2' ' A' ' 105' ' ' GLU . 2.4 mt-10 -116.66 -12.42 10.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.339 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.041 ' O ' HG23 ' A' ' 111' ' ' VAL . 5.5 tp -46.83 -27.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 110.314 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -51.07 -52.61 41.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.201 -0.937 . . . . 0.0 110.32 179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -86.92 -15.47 38.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 110.315 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 113' ' ' MET . 13.0 mt -96.74 7.42 46.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.316 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 107' ' ' ILE . 20.9 t -62.04 127.32 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.39 19.55 79.38 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.4 145.0 41.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -1.136 . . . . 0.0 110.145 179.769 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -86.25 125.3 33.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.896 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.5 p -87.34 152.03 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.544 ' CB ' ' HG3' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -101.22 1.73 39.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.895 . . . . 0.0 110.254 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.896 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -123.34 165.31 17.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 110.158 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.7 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.15 147.8 25.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.9 t -129.8 142.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' HA ' ' CD2' ' A' ' 80' ' ' LEU . 83.2 m-85 -91.85 -166.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.594 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.3 OUTLIER -58.8 -145.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.502 -0.749 . . . . 0.0 110.447 -179.955 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 1.2 m-20 -44.4 85.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.259 -0.9 . . . . 0.0 111.277 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.585 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 tt0 -118.54 149.41 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.3 m -78.7 146.41 33.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.334 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -75.74 129.55 37.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 110.067 179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.663 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -126.77 147.32 60.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 0.0 110.326 179.853 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 49.2 Cg_endo -75.65 -14.42 19.78 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.898 1.473 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 126' ' ' MET . 3.0 p30 -80.14 -17.57 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.175 -0.953 . . . . 0.0 110.589 -179.677 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 126' ' ' MET . 5.8 ptp -94.72 -17.35 22.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 133' ' ' TYR . 85.1 t -92.69 141.86 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 110.2 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.544 ' HG3' ' CB ' ' A' ' 116' ' ' ASN . 1.6 mmmp? -80.7 -72.55 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.348 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.5 62.15 4.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.866 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 102' ' ' ILE . 7.3 t80 -79.55 147.89 31.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 23.1 mt-10 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.276 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 t30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.251 0.548 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -179.41 4.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.219 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 140.35 40.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.228 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -99.07 154.06 18.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG13 ' HG3' ' A' ' 22' ' ' MET . 37.8 t -81.98 95.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.271 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 4.3 t -112.34 117.19 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 110.149 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -60.19 128.71 38.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.163 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' GLN . 8.1 p-10 -82.66 -41.39 19.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 110.124 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' ASN . 7.7 pt20 -92.03 177.87 6.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.022 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.05 140.08 29.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.669 179.482 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 17' ' ' LEU . 2.0 mt -120.06 135.52 24.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.345 -179.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.96 -160.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.965 1.508 . . . . 0.0 110.348 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.582 HG22 ' ND2' ' A' ' 14' ' ' ASN . 10.4 mm -87.04 157.09 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.582 ' ND2' HG22 ' A' ' 13' ' ' ILE . 35.7 m-80 42.52 72.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.3 m -136.25 112.36 9.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.204 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.75 101.18 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.681 HD12 ' CG ' ' A' ' 43' ' ' MET . 83.6 mt -41.55 149.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.684 -179.552 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 21' ' ' MET . 6.6 p -120.61 175.18 6.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 0.0 109.819 179.581 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.26 -38.88 82.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.512 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -71.44 -31.51 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.618 -179.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.496 ' HB3' ' OG1' ' A' ' 18' ' ' THR . 6.0 ttp -88.11 -5.44 58.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.595 ' HG3' HG13 ' A' ' 5' ' ' VAL . 20.2 ttm -102.72 118.91 37.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.18 114.25 27.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.99 75.32 9.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.185 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.555 ' OE1' HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -102.45 152.3 21.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.337 -179.85 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -87.77 79.61 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG11 ' OE1' ' A' ' 25' ' ' GLU . 18.4 m -140.55 165.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.602 HG22 ' SD ' ' A' ' 30' ' ' MET . 0.9 OUTLIER -88.88 165.85 25.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.204 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.2 Cg_endo -74.25 165.48 85.17 Favored 'Cis proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.619 -2.242 . . . . 0.0 110.422 -0.083 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 28' ' ' THR . 0.1 OUTLIER -68.71 66.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.903 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -65.43 -160.89 0.67 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 55' ' ' LEU . 7.4 mt -69.4 138.62 89.06 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.172 -1.193 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.92 167.73 26.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.064 1.56 . . . . 0.0 110.478 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.83 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -94.05 36.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.77 61.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.196 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 39' ' ' ASN . 2.4 mm-40 -94.64 30.13 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.884 179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.83 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.2 mm -39.4 -54.19 3.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.555 -0.716 . . . . 0.0 110.789 -179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.9 Cg_endo -71.28 -13.43 30.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.661 1.348 . . . . 0.0 111.056 -179.641 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . 6.6 m120 -104.4 -34.05 8.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 43' ' ' MET . 0.3 OUTLIER -92.14 -25.71 18.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 -179.629 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.6 t -45.89 157.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.976 -1.077 . . . . 0.0 109.647 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 73.85 4.45 66.77 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.969 ' CE ' HG11 ' A' ' 60' ' ' VAL . 25.5 ptm -69.31 127.1 31.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.858 -1.378 . . . . 0.0 109.582 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -79.61 151.11 30.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.868 . . . . 0.0 110.659 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' HG22 ' A' ' 45' ' ' VAL . 29.1 m -106.16 168.51 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.208 179.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -14.62 18.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.46 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.473 ' HD3' ' SD ' ' A' ' 59' ' ' MET . 9.1 ptm180 -134.14 -179.08 5.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.955 . . . . 0.0 110.346 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' N ' ' CD1' ' A' ' 13' ' ' ILE . . . -75.84 152.12 37.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 110.159 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 53' ' ' THR . 3.5 t -119.2 120.61 30.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 44.3 Cg_endo -72.24 -177.64 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.55 137.48 39.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 110.251 -179.827 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 66.59 37.88 92.89 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 49' ' ' VAL . 91.4 m -86.54 121.09 28.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 110.231 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 29' ' ' PRO . 2.7 t -68.38 160.4 29.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -73.71 101.58 3.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 -179.745 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 60' ' ' VAL . 12.3 mmt -97.2 130.37 29.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 46.3 Cg_endo -73.18 -39.33 2.21 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.901 1.474 . . . . 0.0 110.825 -179.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -66.03 -13.04 59.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.603 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 12.9 mtt -104.37 -23.68 13.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 0.0 110.923 -179.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.969 HG11 ' CE ' ' A' ' 43' ' ' MET . 31.4 t -98.04 134.06 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.062 -1.024 . . . . 0.0 110.732 -179.638 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -70.96 -84.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.892 179.648 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' ND2' ' CB ' ' A' ' 122' ' ' ASP . 26.1 p-10 -91.27 104.11 16.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 3.7 m-85 -74.63 -63.82 1.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 40' ' ' LEU . 3.4 pt-20 -176.59 174.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.021 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.01 58.45 5.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.86 33.04 4.92 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 p -92.83 156.65 16.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -1.165 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 p -97.93 -97.98 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.7 m -82.99 128.66 64.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 0.0 110.178 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 45.6 Cg_endo -73.23 -89.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.825 1.434 . . . . 0.0 110.652 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.63 -81.1 1.0 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 72' ' ' LEU . 5.4 mt -87.62 53.24 2.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -1.143 . . . . 0.0 109.931 179.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -78.86 116.54 19.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.483 -0.761 . . . . 0.0 110.598 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -96.14 159.27 15.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.782 179.537 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.745 HG11 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -73.55 127.52 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 110.437 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.558 HG21 ' CD ' ' A' ' 95' ' ' GLU . 71.5 t -121.84 138.15 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.175 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -77.24 85.77 3.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.6 t-20 -57.67 -32.81 67.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.49 -175.97 2.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.159 -0.963 . . . . 0.0 110.266 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD12 HD23 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -95.35 128.24 42.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 110.036 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.846 HG23 HG21 ' A' ' 85' ' ' THR . 11.3 mm -121.53 113.9 31.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.137 -0.977 . . . . 0.0 110.153 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 83' ' ' ILE . 48.8 Cg_endo -74.89 160.52 40.37 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.918 1.483 . . . . 0.0 111.414 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.015 HD13 ' N ' ' A' ' 118' ' ' ALA . 9.4 mm -33.49 151.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.244 0.545 . . . . 0.0 110.843 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 39.65 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.393 -0.817 . . . . 0.0 111.099 178.831 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.846 HG21 HG23 ' A' ' 81' ' ' ILE . 15.9 m -144.25 109.32 5.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.91 90.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.822 179.802 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 92' ' ' MET . 0.7 OUTLIER -80.23 135.71 36.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.229 -179.675 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.649 HG23 ' CA ' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -129.15 170.68 13.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.413 -0.804 . . . . 0.0 109.963 179.871 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -48.44 -32.81 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.329 -179.854 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.0 t -63.95 -43.18 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.2 mtt -82.94 -23.01 33.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.437 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.745 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.4 mtt -105.63 135.05 47.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.234 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HE3' ' OD1' ' A' ' 78' ' ' ASN . 61.5 mttt -116.9 117.6 30.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -81.1 99.99 8.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' CD ' HG21 ' A' ' 76' ' ' VAL . 6.4 pt-20 -119.29 158.92 25.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 2.5 tm-20 -81.44 95.52 7.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.911 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.98 161.42 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 0.0 110.303 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -109.59 151.77 42.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 110.3 179.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.4 Cg_endo -77.56 179.45 31.08 Favored 'Cis proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.493 -2.295 . . . . 0.0 110.29 -0.351 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.05 93.62 8.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 110.085 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.76 -112.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 27.8 mt -109.48 119.57 47.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.199 -1.177 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.34 159.94 42.77 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.891 1.469 . . . . 0.0 110.338 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.4 t -83.37 55.74 3.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 106' ' ' GLU . 12.7 pt-20 -83.69 -42.75 16.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 0.0 110.467 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 5.5 mm-40 -112.96 22.01 14.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.994 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.017 ' O ' HG23 ' A' ' 111' ' ' VAL . 6.9 tp -58.77 -37.78 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.932 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 107' ' ' ILE . 1.4 t -45.05 -39.72 6.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.437 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -88.5 -26.98 21.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.912 . . . . 0.0 110.358 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 39.0 mt -98.57 12.08 36.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.017 HG23 ' O ' ' A' ' 107' ' ' ILE . 26.5 t -61.6 135.64 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.649 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 62.98 27.61 70.66 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.552 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 32.4 mmm -73.05 156.83 38.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.161 . . . . 0.0 109.859 179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -95.82 127.27 41.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.978 . . . . 0.0 110.495 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.82 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.7 p -87.26 157.51 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -100.58 -9.47 21.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.82 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.56 161.03 27.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.99 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.015 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -73.95 150.77 40.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 5.3 t -123.19 141.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.927 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 8.4 t80 -92.35 179.69 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.351 -179.306 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.009 HD23 HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -53.82 -146.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 111.46 -179.425 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 20.5 m-20 -44.61 84.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.14 -0.975 . . . . 0.0 111.609 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 121' ' ' LEU . 32.9 tt0 -119.19 148.76 42.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 179.243 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 86.4 m -78.63 132.88 37.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 110.132 179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 126' ' ' MET . 2.4 tp -72.96 126.56 30.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.751 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.74 161.93 50.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.403 -0.811 . . . . 0.0 110.244 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.67 -15.13 27.23 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.983 1.518 . . . . 0.0 110.524 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.0 m-20 -89.51 -8.26 53.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -55.26 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 131' ' ' LYS . 13.6 t -79.7 178.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.581 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -80.56 -142.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.463 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 28.2 t-20 -91.72 68.03 5.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.564 ' CD2' ' OXT' ' A' ' 134' ' ' GLU . 11.2 p90 -59.41 -171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' OXT' ' CD2' ' A' ' 133' ' ' TYR . 31.2 mt-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.29 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.232 0.539 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 175.08 9.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.183 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.647 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.96 142.95 38.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.97 165.36 11.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.156 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG23 ' HB2' ' A' ' 34' ' ' ALA . 44.4 t -79.59 98.78 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.31 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 27' ' ' VAL . 5.7 t -116.93 109.77 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.066 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -53.08 124.95 15.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.96 . . . . 0.0 110.096 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 9' ' ' GLN . 14.3 p30 -82.47 -37.0 25.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.996 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.456 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 10.4 pt20 -91.82 177.14 6.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.048 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 3.0 tt -89.68 131.12 35.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.01 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG21 HD21 ' A' ' 17' ' ' LEU . 34.0 mm -114.64 135.03 22.29 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 0.0 110.488 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.57 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.971 1.511 . . . . 0.0 110.553 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 48' ' ' ALA . 4.6 mm -82.11 158.3 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 8.4 p30 36.44 75.01 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.678 -0.639 . . . . 0.0 110.774 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.55 HG21 HG23 ' A' ' 11' ' ' ILE . 85.2 m -134.08 111.88 10.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.612 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.5 103.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.285 -0.884 . . . . 0.0 109.68 179.534 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD21 HG21 ' A' ' 11' ' ' ILE . 73.6 mt -65.46 148.89 50.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 110.761 -179.364 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 35.6 p -120.79 -176.84 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.773 . . . . 0.0 109.913 179.544 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.04 -30.07 70.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 110.115 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -69.24 -48.31 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -79.9 7.3 9.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.988 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.495 ' HE1' ' N ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -113.54 116.71 29.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.972 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -111.08 122.67 48.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.639 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -81.48 68.78 7.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.74 145.76 28.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 3' ' ' ALA . 21.7 t -88.58 78.55 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.903 . . . . 0.0 110.249 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 ' CG2' HG21 ' A' ' 6' ' ' VAL . 29.0 m -114.41 153.35 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 14.5 t -98.55 149.31 35.62 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.164 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.7 Cg_endo -76.15 154.84 98.38 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.687 -2.214 . . . . 0.0 110.45 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' GLY . 22.3 mtt -70.92 89.76 0.79 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 0.0 110.082 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.7 -142.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.768 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -76.97 139.88 66.19 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.153 . . . . 0.0 110.198 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.61 177.12 7.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.032 1.543 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.916 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -113.56 38.14 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -66.87 -50.53 62.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.402 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 1.4 mm-40 -94.64 28.77 2.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.202 -0.936 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.932 ' O ' HG23 ' A' ' 41' ' ' VAL . 2.7 mm -41.26 -53.66 6.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 110.789 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.2 Cg_endo -69.37 -2.56 10.1 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.615 1.324 . . . . 0.0 110.996 -179.331 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.6 t-20 -101.25 -57.77 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.004 179.54 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 40' ' ' LEU . 2.0 pt? -85.41 4.63 34.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.785 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.9 OUTLIER -46.08 155.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.881 -1.137 . . . . 0.0 109.314 179.674 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 71.72 10.65 72.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.518 ' SD ' ' CD1' ' A' ' 40' ' ' LEU . 14.6 ptm -68.76 125.65 27.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.245 . . . . 0.0 109.65 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -93.07 162.86 13.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 110.597 -179.728 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG22 ' A' ' 60' ' ' VAL . 21.5 m -109.37 168.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.278 -179.755 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 -12.78 20.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.101 179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 175.8 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.855 . . . . 0.0 110.295 -179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.782 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -76.17 138.71 40.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG13 ' CB ' ' A' ' 53' ' ' THR . 4.6 t -117.57 119.34 34.35 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.736 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' C ' ' HG1' ' A' ' 53' ' ' THR . 46.3 Cg_endo -72.34 -169.4 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.938 1.494 . . . . 0.0 110.787 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -77.46 150.39 34.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.352 -0.842 . . . . 0.0 110.155 179.988 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 55.59 30.51 56.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.731 ' CB ' HG13 ' A' ' 49' ' ' VAL . 87.3 m -83.11 112.43 19.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.136 -1.214 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 10.1 t -60.7 153.53 23.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.768 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -72.87 105.37 4.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.958 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.43 133.86 27.65 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.179 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.09 -15.41 23.17 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.958 1.504 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -81.71 -34.92 30.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.377 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.64 -14.07 28.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 45' ' ' VAL . 79.2 t -105.01 133.0 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -61.46 -146.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 179.921 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 7.5 m120 -69.98 79.04 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.087 . . . . 0.0 110.139 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 1.4 p90 -53.36 -39.27 64.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.103 -179.791 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 63' ' ' TYR . 4.6 pt-20 176.15 170.68 0.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.966 179.268 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.61 -85.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.879 . . . . 0.0 110.553 -179.698 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -21.77 36.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.22 153.96 20.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -1.091 . . . . 0.0 110.079 179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 13.6 t -107.19 -21.34 13.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.378 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.3 m -84.24 111.32 32.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.297 -179.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.1 Cg_endo -75.34 -89.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.941 1.495 . . . . 0.0 110.613 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -82.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.84 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.6 pt? -88.73 39.73 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.438 -1.036 . . . . 0.0 109.828 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -67.45 123.42 20.36 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.645 -0.659 . . . . 0.0 110.421 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.1 m -114.8 157.5 23.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -0.853 . . . . 0.0 109.939 179.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 125' ' ' LEU . 6.3 t -83.0 130.76 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.3 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 123' ' ' GLN . 42.1 t -127.81 139.65 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 110.289 -179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.77 91.98 6.0 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.814 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.9 p-10 -58.84 -31.45 68.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.82 . . . . 0.0 110.982 -179.553 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 174.13 6.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.97 -1.081 . . . . 0.0 110.725 -179.524 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 80' ' ' LEU . 1.1 tt -105.62 137.69 43.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 110.164 179.942 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.728 ' CD1' HG11 ' A' ' 115' ' ' VAL . 2.3 pt -121.02 134.47 24.38 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.164 -0.96 . . . . 0.0 110.107 179.853 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.871 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.6 Cg_endo -74.55 58.01 4.44 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.949 1.5 . . . . 0.0 110.851 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 82' ' ' PRO . 2.2 mp 57.45 156.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 110.532 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 83' ' ' ILE . 71.6 m-80 42.04 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.395 -0.816 . . . . 0.0 110.447 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 87' ' ' LEU . 39.7 m -143.76 105.53 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.49 89.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.081 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -86.53 138.75 31.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.386 -179.821 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.505 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.2 p -123.74 -177.17 3.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.843 179.643 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.26 -28.18 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 110.232 -179.845 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.6 -47.64 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.8 mtt -81.19 -13.61 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.56 ' HE2' HD22 ' A' ' 125' ' ' LEU . 3.2 mtt -105.07 125.7 51.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -110.96 111.15 22.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -78.41 97.47 5.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 12.9 pt-20 -123.3 131.13 53.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' HB2' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -69.36 94.11 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.946 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 98' ' ' SER . 11.6 p -142.1 165.63 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.103 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -106.05 148.8 37.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 179.977 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -76.0 167.78 79.2 Favored 'Cis proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.621 -2.241 . . . . 0.0 110.473 -0.142 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 99.8 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -72.21 -107.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.16 134.35 20.46 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.142 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.82 165.07 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.956 1.503 . . . . 0.0 110.573 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.505 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 17.6 p -87.89 44.74 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 24.3 pt-20 -86.5 -32.44 20.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 110.241 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 3.8 mt-10 -107.13 -7.64 16.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.893 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.7 mm -47.18 -54.4 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.97 -26.15 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 110.229 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -22.45 17.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 113' ' ' MET . 22.6 mt -112.73 19.06 17.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 107' ' ' ILE . 24.3 t -66.97 133.83 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -0.975 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 78.02 13.06 83.77 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 113' ' ' MET . 4.9 ptt? -73.38 142.48 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.017 179.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -81.49 119.34 23.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.218 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.4 p -77.93 146.94 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.189 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 6.35 44.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -124.74 163.04 22.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.969 179.887 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.593 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -89.01 129.79 35.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 81' ' ' ILE . 98.6 t -113.63 156.86 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.876 179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 121' ' ' LEU . 15.5 m-85 -108.37 -161.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.29 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.6 OUTLIER -58.02 -152.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 0.0 110.331 -179.904 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.47 87.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.972 -179.538 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 121' ' ' LEU . 30.2 tt0 -117.92 155.83 29.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.839 . . . . 0.0 109.657 179.684 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.9 m -78.54 142.06 37.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.01 . . . . 0.0 110.397 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -81.29 131.86 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 110.029 179.908 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.882 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -122.83 149.66 56.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.194 179.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.847 ' CA ' HD11 ' A' ' 102' ' ' ILE . 46.8 Cg_endo -73.12 -24.59 16.91 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.073 1.565 . . . . 0.0 110.675 -179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 30.4 p-10 -82.55 1.57 37.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.344 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.414 ' SD ' HG22 ' A' ' 119' ' ' VAL . 51.6 ttp -100.87 -21.77 15.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 131' ' ' LYS . 94.6 t -92.82 164.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 130' ' ' VAL . 1.9 pttm -70.02 -105.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 110.133 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -90.64 71.21 6.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -61.9 140.84 58.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.421 -0.799 . . . . 0.0 110.171 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.171 -179.992 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.228 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.62 170.03 14.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -73.46 140.69 46.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 47.0 t -95.12 165.12 12.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 55' ' ' LEU . 40.8 t -84.4 91.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 110.36 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.879 HG13 ' CA ' ' A' ' 54' ' ' THR . 3.1 t -109.12 130.42 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.095 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -70.6 135.89 48.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 3.9 p-10 -82.59 -45.35 14.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 4.9 pt20 -92.57 179.79 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.771 179.435 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.63 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -82.54 147.94 28.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.967 . . . . 0.0 109.75 179.529 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 7' ' ' ALA . 2.5 mp -120.43 129.41 25.34 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.083 -1.01 . . . . 0.0 110.93 -179.352 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 49.1 Cg_endo -76.24 -159.62 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.94 1.495 . . . . 0.0 110.157 179.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 48' ' ' ALA . 14.1 mm -89.71 148.75 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 179.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' GLN . 0.9 OUTLIER 45.69 74.56 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.459 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 16.8 m -135.34 115.8 13.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -64.84 94.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.96 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 17' ' ' LEU . 34.7 mt -44.52 149.95 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 110.349 -179.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 21' ' ' MET . 72.8 p -120.55 169.03 10.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 110.046 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 41' ' ' VAL . 2.5 mm? -56.2 -39.58 72.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 110.393 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.11 -48.64 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.331 -179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 35.6 mtt -68.68 -15.37 63.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.356 -0.84 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.432 ' CG ' HG13 ' A' ' 5' ' ' VAL . 4.0 tpp -94.5 116.09 28.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.4 -179.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -110.75 125.9 54.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.889 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.676 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -95.28 71.41 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 155.7 17.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.74 72.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.643 ' CG2' HG21 ' A' ' 6' ' ' VAL . 21.6 m -114.46 163.13 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 71.2 p -108.67 159.01 32.5 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 28' ' ' THR . 49.3 Cg_endo -75.33 149.12 92.72 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.602 -2.249 . . . . 0.0 110.495 -0.162 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.43 85.47 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.284 -179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.0 -110.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 55' ' ' LEU . 8.9 mt -99.86 142.28 24.32 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.312 -1.111 . . . . 0.0 110.043 179.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 45.6 Cg_endo -71.91 175.69 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.56 . . . . 0.0 110.59 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.806 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -99.65 33.79 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.369 -0.832 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -66.74 -45.06 79.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.983 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 pm0 -94.71 29.04 2.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 109.894 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.806 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 2.5 mm -41.52 -54.99 5.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.358 -0.839 . . . . 0.0 110.405 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.7 Cg_endo -69.94 -11.33 30.4 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.589 1.31 . . . . 0.0 110.335 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -100.59 -39.88 7.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.929 179.738 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 43' ' ' MET . 1.4 tt -87.31 -1.99 58.31 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.255 -0.903 . . . . 0.0 109.922 179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -67.94 151.65 10.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.84 -1.162 . . . . 0.0 110.42 -179.843 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.44 4.2 29.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.547 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.576 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 92.3 mmm -73.93 127.33 32.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.723 -1.457 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 2.9 mt-30 -80.08 142.17 35.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.829 . . . . 0.0 110.626 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 45' ' ' VAL . 28.5 m -87.31 171.32 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.061 179.772 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -101.02 -12.79 18.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.446 -179.892 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -141.18 174.47 10.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.443 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.657 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -75.79 139.72 41.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.953 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.856 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -120.34 134.07 24.07 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.0 Cg_endo -71.07 -175.04 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.845 1.445 . . . . 0.0 110.527 179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -79.67 151.84 30.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.721 -179.533 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 56.61 29.1 57.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.856 HG21 HG13 ' A' ' 49' ' ' VAL . 41.9 m -82.24 111.75 18.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.909 179.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.879 ' CA ' HG13 ' A' ' 6' ' ' VAL . 2.0 t -54.74 156.5 3.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -71.89 104.57 3.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 179.972 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.792 ' SD ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -102.53 149.05 36.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.82 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 56' ' ' MET . 47.9 Cg_endo -73.91 -25.7 14.0 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.042 1.548 . . . . 0.0 110.541 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.94 -39.84 41.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.317 -179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mtp -83.22 -15.18 51.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.231 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.759 HG21 ' CD1' ' A' ' 55' ' ' LEU . 24.1 t -101.37 127.39 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CD ' ' O ' ' A' ' 122' ' ' ASP . 1.2 ttmm -67.08 -139.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' ND2' HG11 ' A' ' 76' ' ' VAL . 63.2 t30 -70.19 78.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.73 -102.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.0 110.336 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 55.1 mm-40 -136.39 -141.59 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.942 -1.099 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.52 44.18 1.02 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.142 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.25 -16.11 75.1 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.1 141.87 31.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -1.163 . . . . 0.0 110.102 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.0 p -68.6 -96.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.75 145.4 44.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 72' ' ' LEU . 44.9 Cg_endo -73.3 -89.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.995 1.524 . . . . 0.0 110.337 179.816 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.4 -74.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.954 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' PRO . 4.9 mt -84.76 52.24 2.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -1.12 . . . . 0.0 109.979 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -77.22 116.06 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.821 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -98.8 162.53 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.864 179.601 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.776 ' HB ' HD23 ' A' ' 125' ' ' LEU . 8.4 t -75.93 131.35 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.983 . . . . 0.0 110.402 -179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG11 ' ND2' ' A' ' 62' ' ' ASN . 36.9 t -130.99 130.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.939 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -73.07 82.73 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.212 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.4 t-20 -57.12 -25.89 59.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HA ' HD13 ' A' ' 121' ' ' LEU . 2.1 mt-30 -110.52 -171.79 1.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.008 179.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 80' ' ' LEU . 7.0 tt -103.59 127.81 50.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.569 ' N ' HD23 ' A' ' 80' ' ' LEU . 4.6 mp -121.15 124.79 27.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.982 179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 85' ' ' THR . 45.3 Cg_endo -73.01 150.37 48.45 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.836 1.44 . . . . 0.0 110.622 -179.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.611 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.9 mt -40.23 151.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.385 -0.822 . . . . 0.0 110.509 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER 44.34 76.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -0.863 . . . . 0.0 110.393 179.708 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.551 HG21 HG23 ' A' ' 81' ' ' ILE . 16.3 m -143.68 109.68 5.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -51.1 90.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -88.68 139.65 30.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.295 -179.888 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.625 HG22 ' CA ' ' A' ' 112' ' ' GLY . 55.8 p -123.05 179.76 4.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.47 -22.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.946 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.3 t -51.74 -69.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -77.86 -17.13 57.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.308 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.466 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.13 125.39 34.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 110.413 -179.914 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -122.01 104.02 9.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.196 -0.94 . . . . 0.0 110.186 179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -71.14 98.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -180.0 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 14.5 mm-40 -122.57 162.36 21.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.372 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -83.51 92.23 7.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.197 179.958 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 62' ' ' ASN . 12.4 p -136.1 163.54 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.225 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.2 OUTLIER -108.9 152.47 42.39 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.299 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.8 Cg_endo -76.03 178.22 35.98 Favored 'Cis proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.493 -0.174 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.44 97.63 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.096 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -73.69 -124.8 0.1 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 125' ' ' LEU . 39.4 mt -109.0 126.05 30.22 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.212 -1.169 . . . . 0.0 109.97 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.48 149.18 49.57 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.872 1.459 . . . . 0.0 110.572 -179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.21 50.93 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.357 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 15.9 pt-20 -81.7 -40.34 22.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.147 -0.97 . . . . 0.0 110.006 179.86 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 1.6 mt-10 -110.77 7.74 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 110.045 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -49.14 -41.68 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 110.181 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.56 ' N ' HG23 ' A' ' 107' ' ' ILE . 23.0 t -41.79 -36.33 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -94.38 -21.57 18.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.103 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 18.4 mt -98.27 5.69 48.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.294 -0.879 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 107' ' ' ILE . 9.8 t -61.85 130.92 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.625 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.99 21.55 76.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.565 ' CE ' HG11 ' A' ' 130' ' ' VAL . 5.7 ptm -74.78 154.35 38.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -1.189 . . . . 0.0 109.992 179.754 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -93.21 125.68 37.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.771 HG22 ' H ' ' A' ' 117' ' ' ARG . 10.0 p -78.91 158.3 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.27 -11.05 20.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.771 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.99 177.63 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.102 179.901 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -87.01 147.85 25.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 24.4 t -126.36 141.05 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.456 ' O ' ' O ' ' A' ' 121' ' ' LEU . 19.4 m-85 -97.9 -161.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.691 -179.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -59.08 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.521 -0.737 . . . . 0.0 110.486 -179.827 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 12.3 p-10 -43.48 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 110.77 -179.381 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -117.87 146.03 44.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.92 179.776 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -79.0 125.82 29.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.816 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD23 ' HB ' ' A' ' 75' ' ' VAL . 4.7 tp -72.58 129.16 37.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.488 ' N ' HD12 ' A' ' 125' ' ' LEU . 14.8 mtm -124.92 152.12 69.61 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.907 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.5 Cg_endo -72.83 -26.78 15.37 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.055 1.555 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.31 -20.27 59.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.11 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.5 -46.98 7.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.167 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 125' ' ' LEU . 6.7 t -85.29 111.41 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.79 9.98 8.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -105.32 -11.64 16.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -60.97 136.37 58.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.205 179.89 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -88.8 178.07 6.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 110.184 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.563 ' CA ' HG22 ' A' ' 26' ' ' VAL . . . -69.27 142.46 54.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 0.0 110.252 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -106.29 170.03 8.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 22' ' ' MET . 90.6 t -84.34 95.41 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 27' ' ' VAL . 6.3 t -112.26 124.5 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -66.31 133.28 50.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.183 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.631 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -83.23 -43.18 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.932 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' OE1' ' HG2' ' A' ' 21' ' ' MET . 9.1 pt20 -91.96 176.35 6.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 10' ' ' LEU . 2.4 tt -88.78 115.48 26.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 17' ' ' LEU . 30.0 mm -95.79 134.04 24.61 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.892 . . . . 0.0 110.606 -179.559 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.64 -161.93 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.947 1.498 . . . . 0.0 110.318 179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.7 mp -91.64 166.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 179.767 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' ILE . 41.0 m-80 42.88 62.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.141 -179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.6 m -139.61 120.2 14.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.562 -179.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -72.34 95.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.271 -0.893 . . . . 0.0 109.689 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' GLY . 80.5 mt -41.44 150.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.845 . . . . 0.0 110.557 -179.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 22' ' ' MET . 60.8 p -120.37 179.0 4.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.38 -41.63 96.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.409 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.34 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.537 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 11' ' ' ILE . 14.5 mtt -81.39 5.14 18.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.398 -179.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.5 ' CG ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.04 113.18 24.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.954 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 1.9 mmtm -111.11 133.66 53.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -93.37 73.28 4.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 149.86 24.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.563 HG22 ' CA ' ' A' ' 3' ' ' ALA . 6.1 t -87.22 98.73 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 6' ' ' VAL . 35.3 m -135.64 161.77 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 58.0 p -107.36 152.11 41.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.6 Cg_endo -76.22 152.67 96.56 Favored 'Cis proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.676 -2.218 . . . . 0.0 110.365 -0.295 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 30' ' ' MET . 6.3 ptp -67.79 80.56 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.456 -179.893 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -62.51 -132.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.068 HD12 HD12 ' A' ' 55' ' ' LEU . 4.4 mt -77.63 128.1 80.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.126 -1.22 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.22 178.85 5.56 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.864 1.455 . . . . 0.0 110.533 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -83.42 12.7 5.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.93 -40.63 87.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.966 179.738 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' CB ' HD23 ' A' ' 40' ' ' LEU . 6.1 mt-10 -94.69 27.07 3.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.5 mm -46.4 -53.77 21.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.6 Cg_endo -69.25 -6.6 18.74 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.511 1.269 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 29.4 m120 -104.31 -50.77 3.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 179.727 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -72.72 -21.7 61.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.868 0.842 . . . . 0.0 110.191 -179.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 2.1 t -61.69 154.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.994 0.902 . . . . 0.0 111.381 -178.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 57.86 10.99 7.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.573 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 49.0 mmm -83.4 136.32 34.37 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.623 -1.516 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 6.9 mt-30 -82.14 140.86 33.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 110.437 -179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 13' ' ' ILE . 24.5 m -96.44 160.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 110.188 179.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -101.1 -3.23 29.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -136.36 173.37 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.388 -0.82 . . . . 0.0 110.158 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.86 140.53 45.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 3.9 t -116.41 114.23 40.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.05 -171.96 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.951 1.5 . . . . 0.0 110.549 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -78.18 148.35 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 57.55 36.89 80.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 49' ' ' VAL . 69.5 m -86.39 108.82 18.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -1.165 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 3.3 t -60.08 160.04 8.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.068 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.37 98.17 2.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 110.305 179.934 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.17 140.36 21.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.345 -0.847 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 -33.74 6.46 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.999 1.526 . . . . 0.0 110.528 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.09 -26.73 68.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.0 110.382 -179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mtp -96.99 -5.66 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 61' ' ' LYS . 33.6 t -120.29 127.67 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 110.345 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -58.93 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.905 179.807 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' HB2' HG11 ' A' ' 76' ' ' VAL . 14.6 m-80 -72.26 82.44 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.103 -0.998 . . . . 0.0 110.15 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.652 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.69 -102.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.412 -0.805 . . . . 0.0 110.331 179.989 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.534 ' CG ' ' HB3' ' A' ' 39' ' ' ASN . 4.7 mm-40 -125.61 -151.6 0.48 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.945 -1.097 . . . . 0.0 110.423 -179.781 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.26 58.79 5.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.0 110.335 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.99 -6.7 88.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.413 ' CG2' ' OE1' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -81.17 -160.6 0.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.373 -179.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 68' ' ' THR . 3.0 t -104.7 -129.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.001 179.988 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 3.5 t -64.18 151.41 90.5 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.933 -1.104 . . . . 0.0 109.916 179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.52 ' HA ' ' HG3' ' A' ' 96' ' ' GLU . 45.0 Cg_endo -72.15 -93.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.033 1.544 . . . . 0.0 110.573 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' LYS . . . 66.59 -82.41 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.812 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.5 pt? -88.36 39.84 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.312 -1.111 . . . . 0.0 110.293 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -69.94 154.17 42.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.619 -0.676 . . . . 0.0 110.673 179.992 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -129.97 156.24 44.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.351 -0.843 . . . . 0.0 109.835 179.764 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.87 HG11 ' SD ' ' A' ' 92' ' ' MET . 24.1 t -72.74 124.1 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.187 -179.879 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 62' ' ' ASN . 88.3 t -119.48 135.63 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -72.09 87.42 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.307 -0.871 . . . . 0.0 110.087 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.609 ' O ' HD13 ' A' ' 121' ' ' LEU . 5.0 t30 -57.66 -32.85 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.692 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.79 -176.58 3.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.157 -0.964 . . . . 0.0 110.25 179.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 8.1 tt -94.42 133.57 37.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.191 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.653 HG23 ' CG2' ' A' ' 85' ' ' THR . 23.5 mt -120.7 117.91 30.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.84 . . . . 0.0 110.099 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 83' ' ' ILE . 46.9 Cg_endo -73.81 153.03 47.87 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.834 1.439 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 118' ' ' ALA . 2.1 mm -31.44 147.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-O 121.435 0.636 . . . . 0.0 110.862 -179.534 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER 40.96 87.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.4 -0.813 . . . . 0.0 110.818 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.653 ' CG2' HG23 ' A' ' 81' ' ' ILE . 2.8 m -144.13 105.13 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 109.871 179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.14 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.662 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -81.48 135.58 35.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.862 179.77 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 90' ' ' VAL . 1.4 p -123.33 178.83 4.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 110.167 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.64 -31.92 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.838 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 91' ' ' MET . 33.8 m -62.9 -45.45 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.43 -179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.599 ' N ' HG23 ' A' ' 90' ' ' VAL . 28.6 mtm -85.18 -19.86 31.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.87 ' SD ' HG11 ' A' ' 75' ' ' VAL . 7.4 mtm -98.22 134.07 41.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.91 108.36 13.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -80.17 100.14 8.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.894 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -123.04 160.29 26.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.253 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 2.5 tm-20 -78.84 92.01 4.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 110.085 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 62' ' ' ASN . 8.9 p -145.34 162.23 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -109.5 158.24 35.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 109.898 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.7 Cg_endo -76.49 164.77 86.85 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.316 -0.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -85.97 96.52 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.141 179.942 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -81.67 -100.01 0.4 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 127' ' ' PRO . 13.4 mt -109.32 126.49 29.12 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.102 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 173.91 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.904 1.476 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -93.87 27.94 2.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' CG ' ' A' ' 106' ' ' GLU . 11.9 pt-20 -75.92 -33.81 59.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.146 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' CG ' ' HG3' ' A' ' 105' ' ' GLU . 4.4 mt-10 -108.57 3.17 22.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.883 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.064 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.2 tt -47.03 -43.31 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.563 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -46.8 -28.93 1.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -95.39 -28.14 15.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.0 mt -99.16 8.88 44.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.064 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.9 t -64.83 132.03 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 69.51 22.7 76.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 8.1 mmm -73.44 142.82 46.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.108 . . . . 0.0 110.125 179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.72 130.39 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 110.286 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.904 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.3 p -87.73 155.02 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.414 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -100.5 -4.08 29.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 110.076 179.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.904 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -125.6 -176.16 3.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.843 . . . . 0.0 110.033 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 83' ' ' ILE . . . -89.23 151.38 22.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 16.6 t -127.46 136.76 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 179.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' LEU . 61.9 m-85 -94.97 -170.14 2.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.877 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -58.74 -144.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.538 -0.727 . . . . 0.0 110.651 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 78' ' ' ASN . 55.0 m-20 -44.09 87.2 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.403 -0.811 . . . . 0.0 111.187 -179.323 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.0 tt0 -118.5 148.52 42.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.677 179.38 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.503 ' OG1' ' ND2' ' A' ' 62' ' ' ASN . 18.5 m -78.73 138.46 38.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.011 . . . . 0.0 110.381 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 126' ' ' MET . 4.0 tp -79.51 130.4 35.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 109.904 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HD12 ' A' ' 125' ' ' LEU . 7.4 mmm -126.43 155.73 73.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.4 Cg_endo -72.82 -20.15 22.9 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.003 1.528 . . . . 0.0 110.477 -179.832 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.77 -6.96 59.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.337 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.42 ' HG3' ' NE ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -83.64 -40.94 18.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.168 179.992 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 131' ' ' LYS . 85.1 t -81.83 172.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.099 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.6 ' N ' HG12 ' A' ' 130' ' ' VAL . 34.5 mtpt -74.73 -87.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -101.96 79.86 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.453 ' OH ' HG23 ' A' ' 102' ' ' ILE . 20.7 t80 -62.22 153.89 29.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.117 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.279 -179.959 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.264 0.554 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.39 179.25 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -66.11 142.37 57.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -114.25 168.06 10.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 110.284 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 22' ' ' MET . 28.2 t -79.61 90.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.128 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 27' ' ' VAL . 18.8 t -108.94 116.2 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -51.5 127.6 20.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' O ' HD23 ' A' ' 51' ' ' LEU . 6.1 p-10 -82.62 -40.55 20.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.567 ' HG2' HD11 ' A' ' 11' ' ' ILE . 6.7 pt20 -92.19 178.56 5.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 10' ' ' LEU . 5.4 tt -87.06 121.16 29.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.984 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.585 HG13 HD21 ' A' ' 17' ' ' LEU . 10.3 mm -109.02 133.56 20.68 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.385 -179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.42 -159.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.035 1.545 . . . . 0.0 110.519 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.632 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -88.72 157.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 45.27 67.34 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.2 m -135.19 117.63 15.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -70.56 92.84 0.86 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 11' ' ' ILE . 24.7 mt -46.89 151.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.329 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' MET . 22.7 p -120.28 177.59 4.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 110.144 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.68 -39.49 71.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.95 . . . . 0.0 110.032 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.14 -53.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mtt -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.063 179.915 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.744 ' HG2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.0 104.52 16.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.367 -179.915 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 8' ' ' ASN . 5.9 mttt -111.36 124.4 52.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.971 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -88.77 74.76 8.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.4 154.91 18.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.272 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' VAL . 7.2 t -88.56 100.56 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 6' ' ' VAL . 11.2 m -154.52 148.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 110.273 179.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -102.51 168.61 8.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.14 -179.936 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 28' ' ' THR . 47.3 Cg_endo -73.52 149.61 94.37 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.56 -2.267 . . . . 0.0 110.515 -0.189 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 136.67 55.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.372 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -123.58 -102.55 1.56 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -104.6 123.95 38.59 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.289 -1.124 . . . . 0.0 109.996 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.39 172.13 15.62 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 110.568 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.14 6.22 26.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.53 -56.85 5.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.164 -0.96 . . . . 0.0 110.057 179.9 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.504 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.4 mm-40 -94.7 61.98 2.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.707 179.694 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.923 HG22 ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -67.54 -30.66 3.06 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 111.878 -179.71 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.923 ' HD3' HG22 ' A' ' 37' ' ' ILE . 49.1 Cg_endo -80.03 -12.95 13.0 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -42.31 5.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HE1' ' A' ' 43' ' ' MET . 3.9 mm? -72.08 -37.19 69.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.1 t -46.25 149.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 110.264 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 67.59 15.9 66.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.717 ' HE1' HD12 ' A' ' 40' ' ' LEU . 14.3 ptp -70.28 147.27 49.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.891 -1.358 . . . . 0.0 110.115 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -100.49 128.57 46.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 19.8 m -86.59 159.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.215 -0.928 . . . . 0.0 110.34 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' MET . 76.2 m-20 -101.51 1.08 37.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.571 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD3' ' HG2' ' A' ' 59' ' ' MET . 0.2 OUTLIER -147.06 174.87 11.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.502 -179.803 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.1 146.57 54.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.202 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 15.7 t -120.28 114.77 33.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.433 -179.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 43.6 Cg_endo -71.48 177.91 6.22 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.853 1.449 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -72.73 127.96 34.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.443 -179.702 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.63 35.4 36.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.504 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 72.2 m -86.81 125.91 34.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -1.135 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.529 ' CA ' HG13 ' A' ' 6' ' ' VAL . 12.2 t -70.17 149.19 47.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.011 179.761 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -80.98 104.54 11.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.355 -179.765 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.485 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -103.18 165.75 13.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.145 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.59 -41.66 1.54 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.03 1.542 . . . . 0.0 110.545 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 56' ' ' MET . 29.8 p-10 -62.98 -13.92 41.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.311 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.482 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 3.9 mtt -92.36 -34.0 14.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 63' ' ' TYR . 17.5 t -114.85 138.99 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 -179.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HE2' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -69.21 -95.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 2.8 t-20 -90.96 67.21 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.03 . . . . 0.0 110.273 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.644 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.7 p90 -53.56 -39.59 64.87 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.176 -0.952 . . . . 0.0 110.292 -179.703 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 2.5 pt-20 -178.37 -149.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 179.468 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.31 43.91 0.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.257 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.8 27.3 19.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 95' ' ' GLU . 2.4 p -78.95 169.09 18.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.212 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.9 p -82.67 -150.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.271 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -67.8 153.96 94.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 110.336 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' LYS . 44.9 Cg_endo -71.68 -153.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.123 1.591 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.61 -74.39 1.55 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' C ' ' HG2' ' A' ' 96' ' ' GLU . 10.9 mt -88.04 50.46 1.99 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -1.091 . . . . 0.0 109.852 179.619 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' A' ' 70' ' ' PRO . 2.8 mtpm? -79.65 121.21 25.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.434 -0.791 . . . . 0.0 110.408 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 2.9 p -103.93 154.27 19.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 ' SD ' ' A' ' 92' ' ' MET . 7.7 t -77.11 125.42 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 124' ' ' THR . 38.2 t -121.81 141.76 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -80.73 89.21 5.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 110.105 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.5 t-20 -57.3 -34.55 68.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.66 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 78' ' ' ASN . 4.8 mt-30 -107.72 -169.71 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.109 -0.994 . . . . 0.0 110.137 -180.0 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.5 tt -102.15 125.85 48.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 -179.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 85' ' ' THR . 3.3 mt -117.09 127.17 26.89 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.825 . . . . 0.0 109.831 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 83' ' ' ILE . 44.9 Cg_endo -72.04 149.45 52.7 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.894 1.471 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.666 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -43.16 164.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.344 -0.848 . . . . 0.0 110.2 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.463 ' CG ' ' O ' ' A' ' 83' ' ' ILE . 9.7 p30 38.67 73.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.652 -0.655 . . . . 0.0 110.638 179.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.542 HG21 HG23 ' A' ' 81' ' ' ILE . 8.3 m -143.45 107.91 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.0 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.211 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.571 HD12 ' SD ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.46 145.76 26.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.187 179.947 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 ' CA ' ' A' ' 112' ' ' GLY . 53.0 p -128.42 176.9 7.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.166 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -54.53 -24.23 19.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.271 -179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.93 -58.93 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.5 mtt -73.03 -14.83 61.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.298 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.589 ' SD ' HG11 ' A' ' 75' ' ' VAL . 4.5 mtt -103.37 142.59 33.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -119.57 117.72 29.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -84.16 100.08 10.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -0.935 . . . . 0.0 110.247 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.469 ' HB2' HG21 ' A' ' 67' ' ' THR . 6.0 pt-20 -122.98 144.52 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.54 ' CG ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -71.93 83.99 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.09 167.18 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.064 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.4 p -106.69 158.59 32.41 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 98' ' ' SER . 49.5 Cg_endo -75.86 175.51 47.73 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.641 -2.233 . . . . 0.0 110.497 -0.234 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -82.97 104.68 13.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.67 -117.65 1.71 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.76 HD12 HD11 ' A' ' 125' ' ' LEU . 14.6 mt -109.07 123.18 37.65 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 110.036 179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.29 157.97 52.55 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.87 1.458 . . . . 0.0 110.553 -179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.59 51.25 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -81.08 -58.69 2.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -96.6 11.62 34.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.998 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -50.17 -37.15 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.138 179.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 107' ' ' ILE . 6.6 t -43.71 -37.85 2.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.978 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -90.42 -28.82 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.08 179.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 113' ' ' MET . 11.1 mt -92.44 3.44 55.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.998 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.1 t -60.14 129.35 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.655 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 72.68 26.24 72.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.683 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' MET . 6.8 ptm -77.2 145.9 37.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -1.116 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -83.92 122.71 29.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.008 . . . . 0.0 110.199 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.913 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.2 p -86.37 152.17 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 110.225 179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -100.89 2.1 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -124.82 171.91 9.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.181 -0.95 . . . . 0.0 110.098 -179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.666 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -91.03 143.82 26.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.526 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 69.6 t -118.18 136.65 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -97.39 -163.66 1.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.625 -179.62 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -58.23 -150.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.615 -179.767 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -44.62 84.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.4 -0.813 . . . . 0.0 111.355 -179.406 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.7 tt0 -118.76 148.98 42.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.706 179.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 ' HE2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.82 136.36 37.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.983 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.923 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -75.8 130.68 38.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 109.857 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.923 ' N ' HD12 ' A' ' 125' ' ' LEU . 23.7 mtm -123.54 153.77 66.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' CA ' HD11 ' A' ' 102' ' ' ILE . 44.9 Cg_endo -72.63 -30.23 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.019 1.536 . . . . 0.0 110.445 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 34.1 p-10 -71.98 -26.34 62.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.468 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -80.3 -54.65 5.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 0.0 110.01 179.838 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 115' ' ' VAL . 76.3 t -86.06 98.12 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.415 -0.803 . . . . 0.0 110.212 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 131' ' ' LYS . 1.4 ptmt -90.21 18.67 5.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.148 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB3' ' HE1' ' A' ' 113' ' ' MET . 38.5 t30 -111.55 -18.54 12.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -65.4 163.03 16.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.296 179.995 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.137 179.969 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.294 0.569 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 176.12 9.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -67.54 142.4 56.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.143 -179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 58.8 m -119.14 169.76 9.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 110.241 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 22' ' ' MET . 54.2 t -84.42 102.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.94 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.967 HG21 ' CG2' ' A' ' 27' ' ' VAL . 10.9 t -119.76 116.75 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -54.01 125.08 17.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.89 . . . . 0.0 110.168 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.835 ' O ' HD23 ' A' ' 51' ' ' LEU . 2.3 t30 -83.19 -39.05 21.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' CD ' ' CG ' ' A' ' 21' ' ' MET . 5.2 pt20 -92.4 174.17 7.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 10' ' ' LEU . 6.0 tt -90.25 117.2 28.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 110.042 179.599 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.738 ' CG2' HG21 ' A' ' 15' ' ' THR . 13.6 mt -108.21 139.64 20.92 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.248 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.05 -162.98 0.15 Allowed 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.055 1.556 . . . . 0.0 110.481 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.8 mp -84.03 170.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 12.9 p30 37.02 60.64 0.97 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.732 -0.605 . . . . 0.0 110.726 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.738 HG21 ' CG2' ' A' ' 11' ' ' ILE . 63.0 m -129.07 120.28 25.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.222 -0.924 . . . . 0.0 110.298 -179.919 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -69.32 107.11 3.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.613 HD23 HD13 ' A' ' 11' ' ' ILE . 46.9 mt -47.03 150.68 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.743 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 4.8 p -120.67 173.17 7.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -49.71 75.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 0.0 110.039 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.07 -41.28 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.49 ' CG ' ' CD ' ' A' ' 9' ' ' GLN . 0.0 OUTLIER -77.26 1.83 17.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.087 -179.972 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.503 ' HG2' HG13 ' A' ' 5' ' ' VAL . 7.5 tmm? -106.41 102.51 11.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.207 -179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -105.19 104.52 14.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.753 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -75.52 65.13 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.902 . . . . 0.0 110.294 -179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.08 157.45 16.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.0 103.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.967 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.1 m -145.57 153.98 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.273 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 28' ' ' THR . 2.6 t -97.42 152.64 38.33 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.069 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 28' ' ' THR . 50.0 Cg_endo -78.25 157.51 93.78 Favored 'Cis proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.598 -2.251 . . . . 0.0 110.568 -0.174 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 30' ' ' MET . 7.2 ptp -72.74 90.73 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.33 -132.32 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.005 HD12 HD12 ' A' ' 55' ' ' LEU . 7.5 mt -84.38 138.11 39.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.55 176.63 8.51 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.121 1.59 . . . . 0.0 110.567 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -90.49 28.66 1.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -52.68 50.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.955 ' HB2' HD13 ' A' ' 40' ' ' LEU . 1.9 mp0 -90.09 30.36 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 179.774 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.642 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 1.4 mm -39.65 -52.31 4.87 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.461 -0.775 . . . . 0.0 110.72 -179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 46.2 Cg_endo -73.67 -12.43 24.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.78 1.41 . . . . 0.0 110.84 -179.537 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.47 -44.16 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -0.942 . . . . 0.0 110.305 -179.988 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 36' ' ' GLU . 4.1 mp -75.08 -32.39 61.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.7 t -47.28 154.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.531 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 66.27 4.93 25.43 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 1.116 ' HE2' HG11 ' A' ' 60' ' ' VAL . 9.6 ptm -70.31 125.1 25.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.728 -1.454 . . . . 0.0 109.78 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.04 148.58 31.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.332 -179.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.709 HG12 HG22 ' A' ' 60' ' ' VAL . 18.5 m -108.12 163.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.386 -0.821 . . . . 0.0 110.182 179.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' C ' HG23 ' A' ' 13' ' ' ILE . 34.4 m120 -99.67 0.93 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HB2' ' SD ' ' A' ' 59' ' ' MET . 9.1 mtp180 -134.52 174.09 10.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.215 179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.93 155.53 40.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 110.301 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG13 HG21 ' A' ' 53' ' ' THR . 3.1 t -120.2 109.68 36.85 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' CD ' ' OG1' ' A' ' 53' ' ' THR . 44.1 Cg_endo -71.44 169.53 20.65 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.946 1.498 . . . . 0.0 110.215 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -66.73 134.19 51.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 110.314 -179.922 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 71.16 40.82 61.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 49' ' ' VAL . 17.7 m -86.32 126.61 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.159 179.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.7 t -74.95 160.52 30.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.342 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -72.29 96.6 1.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.147 179.957 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 59' ' ' MET . 0.2 OUTLIER -99.48 130.67 26.37 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.193 179.984 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 63' ' ' TYR . 47.1 Cg_endo -74.0 -9.5 22.22 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.99 1.521 . . . . 0.0 110.573 -179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -79.69 -22.61 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 110.623 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.471 ' HG3' ' HG3' ' A' ' 56' ' ' MET . 13.8 mtt -103.51 -2.56 26.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.668 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.116 HG11 ' HE2' ' A' ' 43' ' ' MET . 21.6 t -119.47 123.6 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.037 -1.04 . . . . 0.0 110.503 -179.924 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.573 179.556 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -91.41 108.75 20.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.974 179.399 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 57' ' ' PRO . 2.8 m-85 -62.92 -59.02 5.42 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.123 -0.986 . . . . 0.0 109.243 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -141.89 -177.32 5.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.989 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.1 58.88 5.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.79 48.07 1.0 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.483 HG21 ' OE2' ' A' ' 95' ' ' GLU . 18.4 p -94.14 168.35 10.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.288 -179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.34 -140.0 0.36 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -64.37 138.15 97.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.996 179.856 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' O ' HD12 ' A' ' 72' ' ' LEU . 46.1 Cg_endo -72.04 -93.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.947 1.498 . . . . 0.0 110.454 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.93 -81.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.024 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -85.77 29.85 0.68 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.3 -1.118 . . . . 0.0 111.821 -179.549 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 1.1 pttt -67.13 151.84 46.86 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.33 -0.856 . . . . 0.0 110.262 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -121.74 161.17 23.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 -179.994 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 92' ' ' MET . 47.1 t -72.38 130.88 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.8 t -123.84 134.11 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 110.166 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . . . -84.87 82.09 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.565 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -56.85 -25.04 55.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 -179.526 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.35 -171.56 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.956 179.724 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' HD22 ' A' ' 121' ' ' LEU . 7.1 tt -103.87 131.64 50.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.6 mm -120.64 127.43 26.28 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.3 Cg_endo -72.63 143.6 38.23 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.972 1.512 . . . . 0.0 110.567 179.97 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.689 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mt -39.86 155.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.527 -0.733 . . . . 0.0 110.486 -179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 26.4 m120 45.21 73.65 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.657 179.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LEU . 17.0 m -143.56 113.2 7.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.119 179.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.73 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.7 OUTLIER -85.07 139.22 31.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 110.157 179.991 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' HA2' ' A' ' 112' ' ' GLY . 19.6 p -127.24 170.12 12.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -49.05 -27.31 3.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 90' ' ' VAL . 20.9 t -54.23 -64.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.233 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 30.7 mtm -73.08 -24.1 60.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.54 ' HB3' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -88.89 128.59 35.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.767 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.49 100.95 8.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 110.131 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -72.92 98.73 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.483 ' OE2' HG21 ' A' ' 67' ' ' THR . 4.6 tt0 -121.18 162.66 19.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -77.75 96.16 4.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.319 -179.807 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p -148.21 162.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.397 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 4.5 m -109.61 159.63 30.86 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.1 Cg_endo -76.12 176.9 41.76 Favored 'Cis proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.3 -0.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 90.35 8.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -76.13 -107.13 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 127' ' ' PRO . 57.5 mt -109.41 123.12 37.5 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.032 179.892 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' CG ' ' OE1' ' A' ' 105' ' ' GLU . 46.8 Cg_endo -73.3 169.75 21.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.885 1.466 . . . . 0.0 110.627 -179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.515 ' O ' HG22 ' A' ' 107' ' ' ILE . 2.2 p -90.24 18.96 5.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 10.6 pt-20 -72.17 -36.53 69.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.356 -0.84 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 1.4 mm-40 -103.57 -7.17 21.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.907 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -48.03 -42.3 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 107' ' ' ILE . 48.6 m -47.1 -30.39 2.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.18 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -22.3 18.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 113' ' ' MET . 7.1 mt -109.39 17.07 21.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 107' ' ' ILE . 16.7 t -61.2 137.27 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 110.32 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 61.88 25.9 66.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.691 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.535 ' HG3' ' CA ' ' A' ' 110' ' ' LEU . 45.1 mmm -75.68 147.34 39.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -1.152 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -86.08 124.84 32.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.7 p -82.59 156.49 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.41 -4.54 28.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 110.161 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.3 mmt180 -125.2 174.51 8.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.054 179.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -90.3 148.61 22.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.126 -0.983 . . . . 0.0 110.363 179.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.948 HG13 ' CD ' ' A' ' 123' ' ' GLN . 55.8 t -123.14 139.88 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.444 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 57.4 m-85 -94.56 -160.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.912 . . . . 0.0 110.925 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -62.12 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.536 -0.727 . . . . 0.0 110.811 -179.584 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 25.2 p-10 -44.91 83.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.564 -0.71 . . . . 0.0 111.743 -179.2 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.948 ' CD ' HG13 ' A' ' 119' ' ' VAL . 9.0 pt20 -119.0 151.64 37.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 179.043 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 20.6 m -77.95 123.86 27.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.009 -1.057 . . . . 0.0 110.226 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 126' ' ' MET . 1.0 OUTLIER -73.03 127.6 33.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.062 179.954 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.886 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.5 mmm -126.21 157.31 70.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.185 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.14 -8.56 22.26 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.982 1.517 . . . . 0.0 110.293 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.38 -21.58 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 110.365 -179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 0.2 OUTLIER -84.71 -50.88 7.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.278 -179.926 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' VAL . 8.0 t -82.68 120.77 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 110.285 -179.831 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -89.76 -1.46 58.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 29.3 t-20 -92.42 0.8 57.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.156 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -71.82 167.19 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.244 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.221 -179.971 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 170.31 16.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -74.94 139.49 43.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -103.64 167.15 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.936 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG13 ' HG3' ' A' ' 22' ' ' MET . 42.5 t -81.72 103.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.659 HG13 ' CA ' ' A' ' 54' ' ' THR . 2.9 t -120.08 109.8 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -52.19 126.14 17.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.005 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -82.59 -39.39 22.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 110.063 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 21' ' ' MET . 3.2 pt20 -91.89 -179.56 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 110.018 179.832 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -89.93 134.72 34.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 109.804 179.634 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 17' ' ' LEU . 10.6 mt -113.07 140.6 24.39 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' O ' HG21 ' A' ' 45' ' ' VAL . 46.3 Cg_endo -73.28 -160.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.971 1.511 . . . . 0.0 110.444 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 47' ' ' ARG . 3.1 mt -103.01 158.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.259 -0.901 . . . . 0.0 110.291 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 44.31 59.83 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 41.5 m -139.91 127.87 22.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -65.78 127.64 32.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.779 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.692 ' CD2' HD13 ' A' ' 11' ' ' ILE . 83.5 mt -69.37 150.08 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.395 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 p -120.55 160.78 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -23.76 65.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 ' H ' ' A' ' 20' ' ' ILE . 2.7 mp -65.83 -54.87 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.541 ' HE1' HG23 ' A' ' 11' ' ' ILE . 4.9 ptm -83.64 12.39 5.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.476 ' HG3' HG13 ' A' ' 5' ' ' VAL . 28.0 ttm -104.81 107.54 18.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -111.09 123.88 51.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.31 -179.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -90.9 78.21 6.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.07 155.6 18.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.211 -179.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.476 HG22 ' CA ' ' A' ' 3' ' ' ALA . 47.9 t -87.77 99.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -148.25 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 69.5 p -97.37 158.25 33.49 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 28' ' ' THR . 48.4 Cg_endo -75.49 149.5 93.08 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.517 -0.251 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 30' ' ' MET . 0.0 OUTLIER -70.7 96.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.37 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.35 -121.69 0.12 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.086 HD12 HD12 ' A' ' 55' ' ' LEU . 6.1 mt -88.66 132.71 37.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 110.194 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.75 178.85 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.864 1.455 . . . . 0.0 110.48 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 37' ' ' ILE . . . -97.89 11.55 37.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.423 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -50.35 -52.88 33.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.578 ' CB ' HD23 ' A' ' 40' ' ' LEU . 1.6 mm-40 -95.15 38.49 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.357 -0.839 . . . . 0.0 109.597 179.532 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.573 ' CG1' ' HB1' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -40.63 -51.98 6.52 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.539 -0.725 . . . . 0.0 110.631 -179.863 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 43.6 Cg_endo -71.14 -6.47 19.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.656 1.345 . . . . 0.0 110.918 -179.313 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -104.43 -39.12 6.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 179.672 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' A' ' 64' ' ' GLU . 3.9 mm? -82.01 -37.96 25.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 110.242 -179.828 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 1.4 t -45.77 153.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.855 . . . . 0.0 110.384 -179.524 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.647 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 68.59 9.59 58.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.488 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.56 ' HE2' ' HA ' ' A' ' 63' ' ' TYR . 3.8 ptp -70.43 155.89 40.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.907 -1.349 . . . . 0.0 109.73 179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 121' ' ' LEU . 1.9 mp0 -95.33 137.25 34.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.401 -179.599 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 13' ' ' ILE . 17.6 m -92.78 160.56 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -95.35 -6.7 40.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.429 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' HG12 ' A' ' 13' ' ' ILE . 7.0 ptt180 -160.54 177.92 10.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.271 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.12 144.72 55.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' CG1' ' HB ' ' A' ' 53' ' ' THR . 4.3 t -112.66 131.02 22.88 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.584 ' HD2' HG21 ' A' ' 53' ' ' THR . 45.4 Cg_endo -73.76 -177.36 3.08 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.91 1.479 . . . . 0.0 110.414 -179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -80.62 127.96 33.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 -179.864 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 7' ' ' ALA . . . 77.93 33.87 40.04 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.863 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HD2' ' A' ' 50' ' ' PRO . 4.6 m -86.53 121.69 29.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -1.162 . . . . 0.0 110.164 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.659 ' CA ' HG13 ' A' ' 6' ' ' VAL . 9.1 t -66.0 162.87 18.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.252 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -76.7 102.5 6.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.463 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 1.1 mmt -93.97 130.89 33.11 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.818 179.752 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.65 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 45.8 Cg_endo -72.5 -34.14 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.948 1.499 . . . . 0.0 110.601 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.3 -15.59 62.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 110.296 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.469 ' SD ' ' NE ' ' A' ' 47' ' ' ARG . 1.2 mtt -98.54 -13.29 20.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 110.475 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.578 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 40.9 t -114.98 128.63 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 110.169 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -63.11 -96.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 122' ' ' ASP . 3.9 m120 -90.65 107.43 19.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.03 . . . . 0.0 109.969 179.641 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.65 ' CE1' ' HA ' ' A' ' 57' ' ' PRO . 0.8 OUTLIER -74.86 -50.54 16.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 0.0 109.409 179.94 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.702 ' HG2' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.15 178.75 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.945 179.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.66 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 110.125 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.62 58.77 0.59 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.937 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 p -79.03 145.58 33.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -1.149 . . . . 0.0 110.308 -179.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 69' ' ' SER . 3.6 t -74.66 -134.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 68' ' ' THR . 1.8 m -64.14 113.14 9.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.739 ' O ' HD23 ' A' ' 72' ' ' LEU . 46.9 Cg_endo -72.26 -95.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.959 1.505 . . . . 0.0 110.371 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 65.17 -76.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.72 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.803 HD23 ' H ' ' A' ' 72' ' ' LEU . 1.8 pt? -86.06 41.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -1.166 . . . . 0.0 110.772 -179.416 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -66.44 112.89 4.3 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 110.338 179.795 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 1.2 t -89.51 165.14 14.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.454 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' SD ' ' A' ' 92' ' ' MET . 4.6 t -76.1 136.96 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.13 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 123' ' ' GLN . 84.4 t -134.43 144.55 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 110.059 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -84.04 90.45 7.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.93 179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.621 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.3 p-10 -57.3 -33.19 67.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.665 -179.535 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.98 -173.97 2.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.963 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.079 HD12 HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -97.25 125.59 41.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.383 -179.826 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.945 HG23 HG21 ' A' ' 85' ' ' THR . 4.8 mt -118.9 130.85 24.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.048 179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.9 Cg_endo -73.42 149.95 45.58 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.906 1.477 . . . . 0.0 110.694 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 2.7 mt -41.42 155.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 110.221 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER 47.64 74.99 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.52 179.786 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.945 HG21 HG23 ' A' ' 81' ' ' ILE . 16.6 m -143.6 109.27 5.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -0.91 . . . . 0.0 110.109 179.729 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -50.89 99.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.286 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 92' ' ' MET . 0.6 OUTLIER -87.84 139.48 30.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.114 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.536 HG23 ' HA2' ' A' ' 112' ' ' GLY . 22.2 p -127.42 173.04 10.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -49.93 -32.29 14.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 179.901 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.1 -48.88 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.8 -17.67 37.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.218 179.986 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.909 ' SD ' HG12 ' A' ' 75' ' ' VAL . 3.2 mmt -104.51 128.55 52.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -113.01 110.79 21.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.33 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -73.82 99.58 3.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -123.23 161.05 25.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 110.143 179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 72' ' ' LEU . 5.8 tm-20 -74.15 98.85 3.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 110.118 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 76' ' ' VAL . 60.0 t -130.38 146.19 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 110.282 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -109.31 147.91 36.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.226 179.918 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -75.74 178.46 34.83 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.322 -0.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.647 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -73.97 96.35 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.17 -112.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.982 HD11 ' HA ' ' A' ' 127' ' ' PRO . 20.5 mt -109.18 119.82 47.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.143 -1.21 . . . . 0.0 109.906 179.873 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.21 164.97 34.0 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.013 1.533 . . . . 0.0 110.717 -179.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.41 59.53 2.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.319 -0.863 . . . . 0.0 110.143 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.63 -64.03 1.23 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.204 -0.935 . . . . 0.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -96.1 25.88 4.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.997 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.8 OUTLIER -53.95 -42.96 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 -179.981 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 107' ' ' ILE . 1.7 t -45.42 -28.66 0.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 110.041 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -26.35 15.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' O ' ' A' ' 134' ' ' GLU . 24.2 mt -103.58 6.24 37.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.375 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.997 HG23 ' O ' ' A' ' 107' ' ' ILE . 25.3 t -61.33 133.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' HG23 ' A' ' 88' ' ' THR . . . 73.77 21.5 79.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 20.4 ptm -73.29 152.15 41.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.177 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -89.88 132.29 35.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 110.356 -179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 117' ' ' ARG . 7.1 p -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 110.0 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.13 -5.03 28.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.119 179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.837 ' H ' HG22 ' A' ' 115' ' ' VAL . 3.7 ppt_? -124.84 174.72 7.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.56 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -86.81 142.95 27.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' CZ ' ' A' ' 117' ' ' ARG . 63.6 t -116.47 138.19 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 9.9 m-85 -95.98 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 110.45 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -59.1 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 13.3 m-20 -45.04 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.122 -179.613 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.661 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.8 tm0? -118.38 146.71 44.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.88 179.529 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' HG22 ' A' ' 76' ' ' VAL . 5.1 m -78.59 133.35 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.95 . . . . 0.0 110.134 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.989 HD12 ' N ' ' A' ' 126' ' ' MET . 0.7 OUTLIER -81.47 130.77 35.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.03 -179.965 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.989 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -121.03 154.29 57.97 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.982 ' HA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.32 -19.31 19.76 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.012 1.532 . . . . 0.0 110.479 179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 2.5 p30 -85.73 -17.94 34.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.285 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.445 ' HG3' ' HD3' ' A' ' 117' ' ' ARG . 2.0 tpt -90.28 -32.65 16.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 131' ' ' LYS . 71.5 t -86.22 172.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 110.039 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 130' ' ' VAL . 22.3 pttt -70.35 -139.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' N ' ' HG3' ' A' ' 131' ' ' LYS . 7.9 m120 -91.26 70.2 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.92 . . . . 0.0 110.174 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.27 159.0 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.453 -179.805 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.884 ' O ' HD11 ' A' ' 110' ' ' LEU . 46.8 mt-10 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.173 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 2' ' ' LYS . 8.5 p30 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' O ' ' OD1' ' A' ' 1' ' ' ASN . 11.4 mttt -83.47 177.52 8.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.09 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.69 140.35 51.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -105.44 157.43 17.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.954 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.711 HG13 ' HG3' ' A' ' 22' ' ' MET . 69.4 t -75.72 100.21 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 3.8 t -113.86 111.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 110.068 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 52' ' ' GLY . . . -55.45 128.63 35.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.053 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 21' ' ' MET . 22.2 p-10 -82.66 -41.82 18.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 110.005 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.504 ' NE2' ' SD ' ' A' ' 21' ' ' MET . 6.9 pt20 -92.15 178.26 5.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 110.113 179.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 2.3 tt -89.74 137.49 32.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.684 179.384 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 37.2 mm -117.23 132.9 23.27 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.414 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.85 -159.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.947 1.499 . . . . 0.0 109.8 179.278 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.79 ' O ' HD12 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -94.47 161.5 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.183 -0.948 . . . . 0.0 110.154 179.64 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER 43.54 66.82 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.72 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 m -137.01 129.77 30.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.422 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -78.85 93.13 4.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 90.6 mt -42.45 151.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 110.377 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 21' ' ' MET . 61.4 p -119.64 -175.15 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.917 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -38.12 72.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -65.3 -32.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 18' ' ' THR . 26.7 mtm -86.29 7.62 24.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.711 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -112.86 110.51 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.359 -179.837 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -110.83 114.73 28.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -82.29 74.13 9.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.04 155.48 18.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.489 ' C ' HG13 ' A' ' 27' ' ' VAL . 77.8 t -88.3 97.94 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 26' ' ' VAL . 24.5 m -149.0 163.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -99.19 164.2 17.2 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.238 -179.961 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 31' ' ' GLY . 48.3 Cg_endo -74.44 159.47 97.75 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.589 -2.254 . . . . 0.0 110.459 -0.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 ptm -65.19 69.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' PRO . . . -63.05 -143.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.638 HD12 HD12 ' A' ' 55' ' ' LEU . 8.1 mt -80.79 142.84 53.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.269 -1.136 . . . . 0.0 110.213 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 46.7 Cg_endo -72.67 168.65 23.92 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.993 1.523 . . . . 0.0 110.452 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -85.97 -4.99 59.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.3 -29.26 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HB2' HD13 ' A' ' 40' ' ' LEU . 3.5 mm-40 -95.0 35.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 mm -50.82 -54.96 31.14 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.619 -179.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.0 Cg_endo -67.98 -11.48 32.18 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.707 1.372 . . . . 0.0 110.829 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' O ' ' CE ' ' A' ' 43' ' ' MET . 11.9 m120 -104.35 -40.14 6.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -0.949 . . . . 0.0 109.801 179.383 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' GLU . 1.9 mp -74.18 -12.7 60.65 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.994 0.902 . . . . 0.0 110.329 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -67.42 152.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.11 -0.994 . . . . 0.0 111.003 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.838 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 59.2 12.41 16.64 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HA ' ' A' ' 40' ' ' LEU . 20.6 mmt -69.83 129.75 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.758 -1.436 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.636 ' OE1' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -81.43 133.29 35.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 110.101 179.826 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 45' ' ' VAL . 22.4 m -92.79 162.53 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.223 179.867 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.51 -7.4 26.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.202 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.82 161.63 42.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.857 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.89 138.66 58.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.245 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.89 HG13 HG21 ' A' ' 53' ' ' THR . 3.4 t -111.9 133.19 21.67 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 43.7 Cg_endo -72.01 -172.33 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.815 1.429 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.77 143.89 30.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.565 -179.637 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 63.16 34.5 90.13 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.752 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.89 HG21 HG13 ' A' ' 49' ' ' VAL . 64.0 m -86.75 137.45 32.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.364 -179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 9.0 t -75.09 169.94 17.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.131 179.843 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -91.32 106.46 18.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 0.0 110.235 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.64 129.76 25.27 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.083 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 32' ' ' ILE . 47.2 Cg_endo -73.76 -31.24 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.964 1.507 . . . . 0.0 110.592 -179.909 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.0 -34.86 78.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.385 -179.827 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.9 mtt -92.58 6.04 48.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.418 -179.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 HG11 ' HD2' ' A' ' 63' ' ' TYR . 64.9 t -120.04 127.28 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.447 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.35 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 0.0 109.755 179.669 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.89 ' OD1' HG21 ' A' ' 97' ' ' VAL . 52.7 t30 -70.82 69.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 109.825 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -53.92 -103.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.747 . . . . 0.0 110.627 -179.941 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 pt-20 -82.8 171.43 13.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.994 -1.066 . . . . 0.0 110.264 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -85.91 -87.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.377 -0.827 . . . . 0.0 110.041 179.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.19 3.25 69.16 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 p -94.09 120.3 34.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -1.165 . . . . 0.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.2 p -86.65 -65.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.056 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.95 142.23 72.52 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.596 ' HA ' ' CB ' ' A' ' 96' ' ' GLU . 48.2 Cg_endo -73.51 -92.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.079 1.568 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.91 -74.32 0.05 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 10.4 mt -82.61 51.99 1.99 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.16 . . . . 0.0 110.188 -179.659 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -67.15 126.59 29.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 110.449 -179.905 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 p -148.09 159.59 43.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.072 179.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.581 HG11 ' SD ' ' A' ' 92' ' ' MET . 38.3 t -84.8 140.04 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 110.312 -179.867 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.4 t -135.37 135.64 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.918 . . . . 0.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -81.32 85.08 6.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.029 179.842 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 6.8 p-10 -57.59 -24.9 58.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.82 -170.63 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 4.8 tt -102.72 129.42 49.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.459 -179.814 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.784 HG23 ' CG2' ' A' ' 85' ' ' THR . 2.1 mp -120.93 106.43 39.15 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 179.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 83' ' ' ILE . 44.2 Cg_endo -71.33 161.74 44.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.924 1.486 . . . . 0.0 111.262 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 ' N ' ' A' ' 118' ' ' ALA . 11.6 mm -33.72 147.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 121.137 0.494 . . . . 0.0 110.53 -179.81 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER 40.21 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -0.926 . . . . 0.0 110.868 179.147 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 81' ' ' ILE . 4.3 m -143.84 100.19 3.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.919 179.599 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.84 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -92.65 141.5 28.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.197 -179.9 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' CA ' ' A' ' 112' ' ' GLY . 63.9 p -126.83 -177.32 3.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 110.04 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -47.71 -31.17 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.191 -179.943 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -55.84 -65.0 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 21.7 mtt -68.66 -26.39 65.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.581 ' SD ' HG11 ' A' ' 75' ' ' VAL . 1.1 mmt -90.1 124.85 35.15 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.196 -0.94 . . . . 0.0 110.265 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.19 105.35 14.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.175 -0.953 . . . . 0.0 110.228 179.918 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.89 96.51 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.856 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.36 140.28 53.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.867 . . . . 0.0 109.855 179.747 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.596 ' CB ' ' HA ' ' A' ' 70' ' ' PRO . 5.1 mp0 -79.1 97.42 6.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 110.329 -179.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.89 HG21 ' OD1' ' A' ' 62' ' ' ASN . 10.7 p -149.54 165.53 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.029 -179.975 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.503 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 1.3 p -109.1 146.4 33.78 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 110.281 -179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 98' ' ' SER . 48.6 Cg_endo -75.99 153.54 97.7 Favored 'Cis proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.352 -0.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 19.4 pttp -93.24 127.25 38.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -0.972 . . . . 0.0 110.157 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -89.63 -102.7 1.09 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.878 HD11 ' CA ' ' A' ' 127' ' ' PRO . 20.3 mt -108.82 140.5 21.92 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.254 -1.145 . . . . 0.0 110.0 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 102' ' ' ILE . 45.9 Cg_endo -72.47 152.08 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.095 1.576 . . . . 0.0 110.589 -179.718 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.537 ' HA ' ' CG1' ' A' ' 107' ' ' ILE . 59.5 p -87.53 42.77 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -87.56 -33.08 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.213 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -112.84 3.69 16.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.35 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.072 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.0 mm -52.42 -41.24 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 t -47.36 -24.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -95.75 -36.61 11.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.474 ' HA ' ' CG ' ' A' ' 113' ' ' MET . 5.1 mt -92.5 13.56 19.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.342 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.072 HG23 ' O ' ' A' ' 107' ' ' ILE . 23.4 t -66.7 132.34 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.195 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.658 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 75.82 15.82 81.07 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.474 ' CG ' ' HA ' ' A' ' 110' ' ' LEU . 70.9 mmm -73.63 148.22 43.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.361 -1.082 . . . . 0.0 109.858 179.745 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -87.34 130.77 34.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.985 . . . . 0.0 110.396 -179.74 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.772 HG12 ' H ' ' A' ' 85' ' ' THR . 14.8 p -85.05 156.27 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.4 -0.813 . . . . 0.0 110.141 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.28 -13.96 18.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.07 -1.019 . . . . 0.0 110.407 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.688 ' H ' HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -124.6 159.21 31.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 110.0 -179.893 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.976 ' N ' HD13 ' A' ' 83' ' ' ILE . . . -74.14 151.23 40.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 81' ' ' ILE . 14.8 t -129.32 144.5 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 1.3 m-85 -93.25 -165.63 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.636 HD12 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -58.6 -144.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.516 -0.74 . . . . 0.0 110.906 -179.612 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 2.2 m-20 -43.85 87.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.29 -0.881 . . . . 0.0 111.288 -179.086 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 121' ' ' LEU . 7.0 tt0 -118.43 150.33 39.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.485 -0.759 . . . . 0.0 109.815 179.362 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.8 m -78.46 128.85 34.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 179.919 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 126' ' ' MET . 0.5 OUTLIER -77.89 121.94 24.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.044 179.963 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.835 ' N ' HD12 ' A' ' 125' ' ' LEU . 2.2 ptp -111.82 157.45 39.47 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.461 -0.774 . . . . 0.0 110.273 -179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.878 ' CA ' HD11 ' A' ' 102' ' ' ILE . 48.0 Cg_endo -74.5 -29.72 8.85 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.015 1.534 . . . . 0.0 110.76 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.21 3.55 10.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.558 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.455 ' CB ' ' HG3' ' A' ' 126' ' ' MET . 6.8 ttp -94.47 -45.03 7.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.327 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.3 t -81.43 123.69 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.279 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mmpp? -78.24 -20.04 52.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.074 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -93.01 14.51 17.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.12 108.74 4.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.197 179.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.6 t30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.241 0.543 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -74.42 173.9 9.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 24' ' ' ALA . . . -70.21 150.0 46.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.217 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -107.19 160.27 15.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.98 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG3' ' A' ' 22' ' ' MET . 27.0 t -80.86 95.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.392 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 11.6 t -113.35 113.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 11' ' ' ILE . . . -53.89 128.82 31.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -82.81 -40.58 20.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.447 ' CD ' ' HG2' ' A' ' 21' ' ' MET . 5.8 pt20 -92.14 175.49 6.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -83.89 144.82 28.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.863 179.636 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.742 HG12 HD21 ' A' ' 17' ' ' LEU . 2.3 mp -119.65 126.52 26.9 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.417 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 46.2 Cg_endo -74.01 -162.29 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.954 1.502 . . . . 0.0 110.328 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.94 146.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.341 -0.849 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 50.78 73.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.195 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 37.6 m -141.86 126.82 18.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.571 ' HB1' ' CA ' ' A' ' 42' ' ' GLY . . . -80.47 93.54 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CG ' ' A' ' 43' ' ' MET . 6.6 mt -42.75 157.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 p -117.58 -175.18 2.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.857 . . . . 0.0 110.188 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -49.96 64.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.855 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.2 mp -58.85 -34.45 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.284 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.447 ' HG2' ' CD ' ' A' ' 9' ' ' GLN . 6.5 mtt -76.8 -12.28 59.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.132 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG3' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -95.9 107.15 19.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 110.214 179.968 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 123.73 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.246 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -91.94 84.2 5.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.08 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -102.63 153.03 20.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' C ' HG13 ' A' ' 27' ' ' VAL . 6.3 t -87.09 88.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.883 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG13 ' C ' ' A' ' 26' ' ' VAL . 26.8 m -150.32 179.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.352 179.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -106.48 167.75 9.12 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 54' ' ' THR . 49.3 Cg_endo -76.81 166.92 81.43 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.591 -2.254 . . . . 0.0 110.41 -0.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.58 59.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.128 179.794 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' MET . . . -60.99 -136.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.984 HD12 HD12 ' A' ' 55' ' ' LEU . 9.2 mt -83.48 134.08 45.91 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.89 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.13 -178.99 4.26 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.97 1.51 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -89.16 21.51 3.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 110.361 -179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.79 -43.27 84.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.921 ' HB2' HD13 ' A' ' 40' ' ' LEU . 43.5 mm-40 -94.92 27.18 3.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 -179.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.8 mm -40.42 -51.33 6.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.2 Cg_endo -71.97 -27.84 16.97 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.568 1.299 . . . . 0.0 111.054 -179.481 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 64' ' ' GLU . 6.4 m120 -88.67 -30.12 19.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 0.0 110.026 179.894 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.921 HD13 ' HB2' ' A' ' 36' ' ' GLU . 5.1 mp -84.37 -38.65 20.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 110.403 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.38 150.95 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.571 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . 70.34 10.57 66.41 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 55' ' ' LEU . 23.5 ptp -70.35 143.3 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.927 -1.337 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -99.5 125.4 45.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.951 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 45' ' ' VAL . 31.5 m -85.75 163.53 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 12.9 m120 -95.7 -12.44 25.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ASN . 14.6 mtt180 -140.7 172.14 13.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 110.254 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.78 143.65 45.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.919 ' CG1' HG21 ' A' ' 53' ' ' THR . 5.7 t -119.64 139.08 27.41 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.303 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 53' ' ' THR . 46.6 Cg_endo -72.76 -177.71 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.985 1.518 . . . . 0.0 110.394 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -81.53 149.86 28.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.319 -179.944 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 7' ' ' ALA . . . 62.24 29.55 73.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.919 HG21 ' CG1' ' A' ' 49' ' ' VAL . 77.4 m -83.3 131.76 35.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -1.15 . . . . 0.0 110.342 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.501 HG21 ' HD2' ' A' ' 29' ' ' PRO . 6.7 t -69.01 155.82 39.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.898 . . . . 0.0 110.04 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -84.23 97.27 9.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.925 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -94.47 142.36 24.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.09 179.865 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . 46.6 Cg_endo -73.16 -26.48 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.019 1.536 . . . . 0.0 110.59 -179.802 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.32 -15.31 55.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' HB3' ' A' ' 56' ' ' MET . 16.2 mtt -104.1 -4.4 23.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.184 179.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.3 t -120.03 140.12 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.338 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HE2' ' OG1' ' A' ' 124' ' ' THR . 0.0 OUTLIER -63.02 -145.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.834 179.797 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 12.2 t-20 -70.12 76.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -53.38 -33.92 55.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.3 -0.875 . . . . 0.0 110.287 -179.705 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 40' ' ' LEU . 1.8 pt-20 -172.75 -161.94 0.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.988 -1.07 . . . . 0.0 110.705 179.432 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -86.35 58.99 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 -179.688 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.42 -15.08 74.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.761 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 96' ' ' GLU . 23.3 p -94.1 120.78 34.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.957 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 m -84.64 -68.53 0.71 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.6 m -76.57 126.8 85.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.176 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 72' ' ' LEU . 48.5 Cg_endo -73.46 -92.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.908 1.478 . . . . 0.0 110.369 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' N ' ' HD2' ' A' ' 73' ' ' LYS . . . 63.23 -73.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.777 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.771 HD13 ' HE2' ' A' ' 100' ' ' LYS . 6.8 mt -87.87 53.93 2.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.131 . . . . 0.0 110.109 -179.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -75.64 125.06 28.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.506 -0.746 . . . . 0.0 110.28 -179.943 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -110.71 157.38 19.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.249 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 92' ' ' MET . 19.0 t -76.9 128.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 97' ' ' VAL . 74.0 t -128.11 135.29 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -78.61 80.81 4.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 93' ' ' LYS . 6.6 p30 -57.27 -26.59 61.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -110.26 175.25 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' HD22 ' A' ' 121' ' ' LEU . 1.7 tt -89.58 127.73 35.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.635 HD11 ' SD ' ' A' ' 91' ' ' MET . 18.4 mm -120.67 121.29 29.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.766 179.625 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 83' ' ' ILE . 45.5 Cg_endo -71.84 153.26 58.72 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.836 1.44 . . . . 0.0 110.704 -179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 118' ' ' ALA . 2.9 mt -41.41 154.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.765 . . . . 0.0 110.389 179.914 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 8.9 m-80 42.49 80.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.395 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.574 HG21 HG23 ' A' ' 81' ' ' ILE . 15.3 m -143.58 112.51 6.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.096 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 113' ' ' MET . . . -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CE ' ' A' ' 92' ' ' MET . 0.6 OUTLIER -83.71 139.51 32.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 110.117 179.873 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' CA ' ' A' ' 112' ' ' GLY . 21.8 p -126.57 -179.36 4.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.9 . . . . 0.0 110.254 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -51.44 -29.26 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.608 -179.749 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 90' ' ' VAL . 8.8 t -62.25 -57.33 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HD11 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -72.52 -12.27 61.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -179.966 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 75' ' ' VAL . 5.3 mtt -105.48 126.63 52.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.521 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 13.2 mttt -111.46 97.37 6.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' SER . . . -70.96 97.04 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.898 . . . . 0.0 110.371 -179.786 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.29 163.48 20.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.248 -0.907 . . . . 0.0 110.238 179.893 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 67' ' ' THR . 5.5 tm-20 -81.63 92.63 6.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG11 HG21 ' A' ' 76' ' ' VAL . 10.9 p -137.69 160.92 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.395 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 11.2 p -109.53 153.86 42.64 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.419 -0.8 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 98' ' ' SER . 50.0 Cg_endo -77.25 161.64 92.42 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.564 -2.265 . . . . 0.0 110.337 -0.307 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.771 ' HE2' HD13 ' A' ' 72' ' ' LEU . 3.4 mptt -75.02 87.01 2.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.084 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 125' ' ' LEU . . . -69.42 -109.34 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.862 HD11 ' CA ' ' A' ' 127' ' ' PRO . 6.9 mt -109.34 112.52 59.23 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.136 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 43.4 Cg_endo -71.99 -178.87 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.464 . . . . 0.0 110.542 179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.9 p -84.16 56.35 3.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.636 -179.549 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HG3' ' HG2' ' A' ' 103' ' ' PRO . 78.4 mt-10 -72.58 -68.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.181 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -109.06 18.02 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.043 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.0 tp -48.19 -35.43 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.931 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.445 ' N ' HG23 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -50.25 -35.36 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.303 -179.97 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -89.04 -29.16 19.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD21 ' CD ' ' A' ' 134' ' ' GLU . 26.2 mt -93.66 11.08 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.289 179.976 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.043 HG23 ' O ' ' A' ' 107' ' ' ILE . 22.6 t -66.32 133.92 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' LEU . . . 70.0 18.27 74.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.866 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -73.64 161.97 29.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -1.125 . . . . 0.0 110.119 179.94 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -99.59 131.31 45.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 117' ' ' ARG . 14.6 p -87.13 156.86 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -100.47 -7.22 24.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.074 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.811 ' H ' HG22 ' A' ' 115' ' ' VAL . 8.8 ttt85 -124.41 171.29 10.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.406 -0.809 . . . . 0.0 109.629 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.54 ' CA ' HG13 ' A' ' 83' ' ' ILE . . . -84.19 150.09 25.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.427 179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 11.6 t -124.93 140.64 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.417 -0.802 . . . . 0.0 109.945 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' O ' ' A' ' 121' ' ' LEU . 83.0 m-85 -96.79 -168.03 1.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.636 -179.621 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.5 OUTLIER -57.85 -149.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 110.8 -179.745 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 15.0 t0 -44.09 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.406 -0.809 . . . . 0.0 111.268 -179.259 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 121' ' ' LEU . 35.7 tp60 -118.29 145.35 45.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.521 -0.737 . . . . 0.0 109.69 179.293 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.468 ' OG1' ' HE2' ' A' ' 61' ' ' LYS . 4.3 m -74.95 135.49 41.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 126' ' ' MET . 7.6 tp -71.99 129.64 39.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.105 -179.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.542 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -126.47 144.75 50.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.847 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.862 ' CA ' HD11 ' A' ' 102' ' ' ILE . 45.7 Cg_endo -73.1 -14.2 26.0 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.045 1.55 . . . . 0.0 110.525 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -85.74 -20.58 29.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.222 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.477 ' HG2' ' CD ' ' A' ' 117' ' ' ARG . 6.9 mtt -90.55 -49.47 6.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.189 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG22 HG23 ' A' ' 115' ' ' VAL . 41.6 t -86.23 116.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.32 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 3.87 30.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.147 179.95 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -95.01 -7.34 40.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.178 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -65.29 136.49 56.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.152 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' CD ' HD21 ' A' ' 110' ' ' LEU . 28.5 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 stop_ save_